|
G |
AARS1 |
alanyl-tRNA synthetase 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of AARS1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:70,252,298...70,289,506
Ensembl chr16:70,251,983...70,289,707
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions increases expression decreases expression |
EXP |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCB1 mRNA; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCB1 protein; [Paclitaxel results in increased expression of ABCB1] which results in decreased susceptibility to Fluorouracil; ABCB1 gene SNP affects the susceptibility to [Cisplatin co-treated with Fluorouracil]; ABCB1 protein affects the susceptibility to [Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil]; ABCB1 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide] Fluorouracil results in increased expression of ABCB1 protein Fluorouracil results in decreased expression of ABCB1 mRNA |
CTD |
PMID:12576456 PMID:15239124 PMID:17287894 PMID:21332314 PMID:21833476 PMID:32800223 More...
|
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCB6 |
ATP binding cassette subfamily B member 6 (LAN blood group) |
decreases expression decreases response to substance |
EXP |
Fluorouracil results in decreased expression of ABCB6 mRNA ABCB6 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:20737486 PMID:25202056 |
|
NCBI chr 2:219,209,772...219,218,958
Ensembl chr 2:219,209,772...219,218,994
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
multiple interactions |
EXP |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCC1 mRNA; ABCC1 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide] |
CTD |
PMID:12576456 PMID:32800223 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC11 |
ATP binding cassette subfamily C member 11 |
decreases response to substance |
EXP |
ABCC11 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18310281 |
|
NCBI chr16:48,164,819...48,247,539
Ensembl chr16:48,165,773...48,247,568
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
affects response to substance multiple interactions |
EXP |
ABCC2 protein affects the susceptibility to Fluorouracil [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCC2 mRNA |
CTD |
PMID:16217747 PMID:32800223 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCC5 |
ATP binding cassette subfamily C member 5 |
decreases response to substance multiple interactions |
EXP |
ABCC5 protein results in decreased susceptibility to Fluorouracil 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [ABCC5 protein results in decreased susceptibility to Fluorouracil]; ABCC5 protein results in increased export of and results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15897250 PMID:19077464 |
|
NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939
|
|
G |
ABCC6 |
ATP binding cassette subfamily C member 6 |
affects response to substance increases expression |
EXP |
ABCC6 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of ABCC6 protein |
CTD |
PMID:15352031 |
|
NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,522
|
|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 (JR blood group) |
multiple interactions |
EXP |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCG2 mRNA; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of ABCG2 protein; [ERBB2 results in increased expression of ABCG2] which results in decreased susceptibility to Fluorouracil; [Paclitaxel results in decreased expression of ABCG2] which results in decreased susceptibility to Fluorouracil; ABCG2 mutant form inhibits the reaction [ERBB2 results in decreased susceptibility to Fluorouracil]; ABCG2 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide] |
CTD |
PMID:12576456 PMID:21712253 PMID:21833476 PMID:32800223 |
|
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
|
|
G |
ABHD12B |
abhydrolase domain containing 12B |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ABHD12B mRNA |
CTD |
PMID:24737281 |
|
NCBI chr14:50,872,053...50,904,970
Ensembl chr14:50,872,053...50,904,970
|
|
G |
ABI1 |
abl interactor 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of ABI1 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr10:26,746,596...26,860,958
Ensembl chr10:26,746,593...26,861,087
|
|
G |
ABI2 |
abl interactor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ABI2 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 2:203,328,394...203,432,169
Ensembl chr 2:203,328,280...203,447,728
|
|
G |
ACAD9 |
acyl-CoA dehydrogenase family member 9 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ACAD9 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 3:128,879,620...128,913,114
Ensembl chr 3:128,879,596...128,924,003
|
|
G |
ACADL |
acyl-CoA dehydrogenase long chain |
increases expression |
EXP |
Fluorouracil results in increased expression of ACADL protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 2:210,187,923...210,225,447
Ensembl chr 2:210,187,126...210,225,447
|
|
G |
ACKR3 |
atypical chemokine receptor 3 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACKR3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:236,537,122...236,582,354
Ensembl chr 2:236,567,787...236,582,354
|
|
G |
ACOT13 |
acyl-CoA thioesterase 13 |
affects response to substance |
EXP |
ACOT13 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:24,667,077...24,705,046
Ensembl chr 6:24,667,035...24,705,065
|
|
G |
ACOT7 |
acyl-CoA thioesterase 7 |
affects response to substance |
EXP |
ACOT7 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:6,264,272...6,393,767
Ensembl chr 1:6,264,269...6,393,767
|
|
G |
ACSM3 |
acyl-CoA synthetase medium chain family member 3 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SAH mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:20,674,405...20,797,581
Ensembl chr16:20,610,243...20,797,581
|
|
G |
ACTB |
actin beta |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ACTB protein |
CTD |
PMID:21296659 |
|
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
|
|
G |
ACTC1 |
actin alpha cardiac muscle 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ACTC1 protein |
CTD |
PMID:21296659 |
|
NCBI chr15:34,790,230...34,795,549
Ensembl chr15:34,790,107...34,795,589
|
|
G |
ACTG2 |
actin gamma 2, smooth muscle |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ACTG2 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 2:73,893,008...73,919,865
Ensembl chr 2:73,892,314...73,919,865
|
|
G |
ACTL8 |
actin like 8 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACTL8 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:17,755,333...17,827,063
Ensembl chr 1:17,755,333...17,827,063
|
|
G |
ACY1 |
aminoacylase 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACY1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:51,983,535...51,989,197
Ensembl chr 3:51,983,340...51,989,197
|
|
G |
ADAM10 |
ADAM metallopeptidase domain 10 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAM10 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr15:58,588,809...58,749,707
Ensembl chr15:58,588,809...58,749,791
|
|
G |
ADAM3A |
ADAM metallopeptidase domain 3A (pseudogene) |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAM3A mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:39,451,045...39,522,989
Ensembl chr 8:39,451,045...39,522,852 Ensembl chr 8:39,451,045...39,522,852
|
|
G |
ADAMTS9 |
ADAM metallopeptidase with thrombospondin type 1 motif 9 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAMTS9 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:64,515,654...64,688,000
Ensembl chr 3:64,515,654...64,688,000
|
|
G |
ADCY9 |
adenylate cyclase 9 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ADCY9 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr16:3,953,387...4,116,442
Ensembl chr16:3,953,387...4,116,442
|
|
G |
ADD3 |
adducin 3 |
affects response to substance |
EXP |
ADD3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:109,996,373...110,135,565
Ensembl chr10:109,996,368...110,135,565
|
|
G |
ADGRG1 |
adhesion G protein-coupled receptor G1 |
affects response to substance |
EXP |
ADGRG1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr16:57,619,738...57,665,567
Ensembl chr16:57,610,652...57,665,580
|
|
G |
ADGRG6 |
adhesion G protein-coupled receptor G6 |
affects response to substance |
EXP |
ADGRG6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:142,302,007...142,446,261
Ensembl chr 6:142,301,854...142,446,266
|
|
G |
ADGRL2 |
adhesion G protein-coupled receptor L2 |
affects response to substance |
EXP |
ADGRL2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:81,306,132...81,993,932
Ensembl chr 1:81,306,147...81,993,932
|
|
G |
ADIRF |
adipogenesis regulatory factor |
increases expression |
EXP |
Fluorouracil results in increased expression of ADIRF mRNA |
CTD |
PMID:17039268 |
|
NCBI chr10:86,968,482...86,970,915
Ensembl chr10:86,968,432...87,007,922
|
|
G |
ADM |
adrenomedullin |
affects response to substance |
EXP |
ADM protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
|
|
G |
ADSS2 |
adenylosuccinate synthase 2 |
decreases expression increases expression |
EXP |
Fluorouracil results in decreased expression of ADSS2 mRNA Fluorouracil results in increased expression of ADSS2 protein |
CTD |
PMID:15585135 PMID:16709241 PMID:16803524 |
|
NCBI chr 1:244,408,494...244,452,060
Ensembl chr 1:244,408,494...244,451,909
|
|
G |
AFP |
alpha fetoprotein |
increases expression decreases expression |
ISO |
Fluorouracil results in increased expression of AFP protein Fluorouracil results in decreased expression of AFP; Fluorouracil results in decreased expression of AFP mRNA |
CTD |
PMID:20448262 PMID:21296659 PMID:26272751 |
|
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
|
|
G |
AGAP3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of AGAP3 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 7:151,085,867...151,144,434
Ensembl chr 7:151,085,831...151,144,436
|
|
G |
AGR2 |
anterior gradient 2, protein disulphide isomerase family member |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of AGR2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:16,791,811...16,804,999
Ensembl chr 7:16,791,811...16,833,433
|
|
G |
AHNAK |
AHNAK nucleoprotein |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of AHNAK protein AHNAK protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr11:62,433,544...62,546,806
Ensembl chr11:62,433,542...62,556,235
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
multiple interactions increases expression |
EXP ISO |
[Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased expression of AIFM1 protein Fluorouracil results in increased expression of AIFM1 protein [Fluorouracil co-treated with casticin] results in increased expression of AIFM1 protein |
CTD |
PMID:16168113 PMID:32270916 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
AKAP12 |
A-kinase anchoring protein 12 |
affects expression |
EXP |
Fluorouracil affects the expression of AKAP12 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 6:151,239,967...151,358,559
Ensembl chr 6:151,239,967...151,358,559
|
|
G |
AKR1B10 |
aldo-keto reductase family 1 member B10 |
affects expression |
EXP |
Fluorouracil affects the expression of AKR1B10 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
|
|
G |
AKR1C1 |
aldo-keto reductase family 1 member C1 |
affects response to substance affects expression |
EXP |
AKR1C1 protein affects the susceptibility to Fluorouracil Fluorouracil affects the expression of AKR1C1 mRNA |
CTD |
PMID:16217747 PMID:16584549 |
|
NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
|
|
G |
AKR1C2 |
aldo-keto reductase family 1 member C2 |
affects response to substance |
EXP |
AKR1C2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
|
|
G |
AKR1C3 |
aldo-keto reductase family 1 member C3 |
affects expression affects response to substance |
EXP |
Fluorouracil affects the expression of AKR1C3 mRNA AKR1C3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:16584549 |
|
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions affects expression decreases phosphorylation affects phosphorylation increases phosphorylation |
EXP ISO |
[Apigenin co-treated with Fluorouracil] results in decreased expression of AKT1 protein; AG 1879 inhibits the reaction [Fluorouracil results in increased phosphorylation of AKT1 protein]; Fluorouracil results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of AKT1 protein; Nicotine affects the reaction [Fluorouracil affects the phosphorylation of AKT1 protein] Fluorouracil affects the expression of AKT1 mRNA Fluorouracil results in decreased phosphorylation of AKT1 protein Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:16724238 PMID:17918158 PMID:18794807 PMID:19885610 PMID:24095863 PMID:30542770 PMID:34151400 More...
|
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
AKT2 |
AKT serine/threonine kinase 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of AKT2 protein |
CTD |
PMID:16803524 |
|
NCBI chr19:40,230,317...40,285,345
Ensembl chr19:40,230,317...40,285,536
|
|
G |
ALB |
albumin |
multiple interactions |
EXP |
[Leucovorin co-treated with Cisplatin co-treated with Fluorouracil] results in decreased expression of ALB protein |
CTD |
PMID:20180123 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALCAM |
activated leukocyte cell adhesion molecule |
affects response to substance decreases expression |
EXP |
ALCAM protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of ALCAM protein |
CTD |
PMID:15352031 |
|
NCBI chr 3:105,366,909...105,576,900
Ensembl chr 3:105,366,909...105,576,900
|
|
G |
ALDH1A1 |
aldehyde dehydrogenase 1 family member A1 |
affects response to substance |
EXP |
ALDH1A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
|
|
G |
ALDH1A3 |
aldehyde dehydrogenase 1 family member A3 |
affects response to substance decreases expression |
EXP |
ALDH1A3 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of ALDH1A3 protein |
CTD |
PMID:15352031 |
|
NCBI chr15:100,879,831...100,916,626
Ensembl chr15:100,861,924...100,916,626
|
|
G |
ALDH3A2 |
aldehyde dehydrogenase 3 family member A2 |
affects response to substance |
EXP |
ALDH3A2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760
|
|
G |
ALG3 |
ALG3 alpha-1,3- mannosyltransferase |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ALG3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:184,242,301...184,249,525
Ensembl chr 3:184,242,301...184,249,548
|
|
G |
ALKBH8 |
alkB homolog 8, tRNA methyltransferase |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ALKBH8 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr11:107,502,727...107,565,735
Ensembl chr11:107,502,727...107,565,742
|
|
G |
AMFR |
autocrine motility factor receptor |
multiple interactions |
EXP |
AMFR mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr16:56,361,452...56,425,545
Ensembl chr16:56,361,452...56,425,545
|
|
G |
AMPD2 |
adenosine monophosphate deaminase 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of AMPD2 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr 1:109,619,837...109,632,055
Ensembl chr 1:109,616,104...109,632,051
|
|
G |
AMT |
aminomethyltransferase |
increases expression |
EXP |
Fluorouracil results in increased expression of AMT protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 3:49,416,778...49,422,473
Ensembl chr 3:49,416,778...49,422,685
|
|
G |
ANG |
angiogenin |
affects response to substance |
EXP |
ANG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
|
|
G |
ANGPT1 |
angiopoietin 1 |
multiple interactions increases expression |
EXP |
ANGPT1 protein promotes the reaction [Fluorouracil results in increased expression of IFNA1 protein] Fluorouracil results in increased expression of ANGPT1 protein |
CTD |
PMID:17786339 |
|
NCBI chr 8:107,249,482...107,497,918
Ensembl chr 8:107,249,482...107,498,055
|
|
G |
ANGPT2 |
angiopoietin 2 |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of ANGPT2 protein ANGPT2 protein promotes the reaction [Fluorouracil results in decreased expression of IFNA1 protein] |
CTD |
PMID:17786339 |
|
NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409
|
|
G |
ANGPTL2 |
angiopoietin like 2 |
multiple interactions |
EXP |
ANGPTL2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 9:127,087,348...127,122,635
Ensembl chr 9:127,087,348...127,122,635
|
|
G |
ANGPTL3 |
angiopoietin like 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ANGPTL3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 1:62,597,520...62,606,313
Ensembl chr 1:62,597,520...62,606,313
|
|
G |
ANGPTL4 |
angiopoietin like 4 |
affects response to substance |
EXP |
ANGPTL4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370
|
|
G |
ANKRD1 |
ankyrin repeat domain 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of ANKRD1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr10:90,912,096...90,921,087
Ensembl chr10:90,912,096...90,921,087
|
|
G |
ANKRD11 |
ankyrin repeat domain containing 11 |
increases expression affects expression |
EXP |
Fluorouracil results in increased expression of ANKRD11 mRNA Fluorouracil affects the expression of ANKRD11 mRNA |
CTD |
PMID:16510598 PMID:16584549 |
|
NCBI chr16:89,267,630...89,490,561
Ensembl chr16:89,267,619...89,490,561
|
|
G |
ANKRD13C-DT |
ANKRD13C divergent transcript |
affects expression |
EXP |
Fluorouracil affects the expression of ANKRD13C-DT mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:70,354,811...70,368,023
Ensembl chr 1:70,354,780...70,385,339
|
|
G |
ANKRD36 |
ankyrin repeat domain 36 |
increases expression |
EXP |
Fluorouracil results in increased expression of ANKRD36 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 2:97,113,153...97,264,521
Ensembl chr 2:97,113,153...97,264,521
|
|
G |
ANKRD36B |
ankyrin repeat domain 36B |
affects expression |
EXP |
Fluorouracil affects the expression of ANKRD36B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:97,492,663...97,589,877
Ensembl chr 2:97,492,663...97,589,877
|
|
G |
ANLN |
anillin, actin binding protein |
multiple interactions decreases expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ANLN mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of ANLN mRNA] |
CTD |
PMID:15016801 PMID:17982676 |
|
NCBI chr 7:36,389,862...36,453,791
Ensembl chr 7:36,389,821...36,453,791
|
|
G |
ANP32E |
acidic nuclear phosphoprotein 32 family member E |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ANP32E mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:150,218,417...150,236,112
Ensembl chr 1:150,218,417...150,236,156
|
|
G |
ANXA1 |
annexin A1 |
affects response to substance decreases expression |
EXP |
ANXA1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of ANXA1 protein |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,629
|
|
G |
ANXA2 |
annexin A2 |
decreases response to substance multiple interactions increases expression |
EXP |
ANXA2 mRNA results in decreased susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in increased expression of ANXA2 mRNA] |
CTD |
PMID:15152939 |
|
NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
|
|
G |
ANXA3 |
annexin A3 |
increases expression |
EXP |
Fluorouracil results in increased expression of ANXA3 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 4:78,551,770...78,610,447
Ensembl chr 4:78,551,747...78,610,451
|
|
G |
ANXA4 |
annexin A4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ANXA4 mRNA |
CTD |
PMID:15109396 |
|
NCBI chr 2:69,643,808...69,827,112
Ensembl chr 2:69,644,425...69,827,112
|
|
G |
AP2S1 |
adaptor related protein complex 2 subunit sigma 1 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of AP2S1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr19:46,838,167...46,850,846
Ensembl chr19:46,838,136...46,850,846
|
|
G |
AP3S1 |
adaptor related protein complex 3 subunit sigma 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of AP3S1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:115,841,935...115,914,081
Ensembl chr 5:115,841,592...115,914,081
|
|
G |
AP4S1 |
adaptor related protein complex 4 subunit sigma 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of AP4S1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr14:31,025,106...31,096,450
Ensembl chr14:31,025,106...31,130,996
|
|
G |
APAF1 |
apoptotic peptidase activating factor 1 |
increases expression affects expression |
EXP |
Fluorouracil results in increased expression of APAF1 mRNA Fluorouracil affects the expression of APAF1 mRNA |
CTD |
PMID:16557594 PMID:34151400 |
|
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433
|
|
G |
APBA2 |
amyloid beta precursor protein binding family A member 2 |
affects response to substance |
EXP |
APBA2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr15:28,885,974...29,118,315
Ensembl chr15:28,884,483...29,118,315
|
|
G |
APBB2 |
amyloid beta precursor protein binding family B member 2 |
affects response to substance |
EXP |
APBB2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:40,810,027...41,214,542
Ensembl chr 4:40,810,027...41,216,714
|
|
G |
APEX1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases response to substance |
EXP |
APEX1 protein mutant form results in increased susceptibility to Fluorouracil |
CTD |
PMID:19470598 |
|
NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
|
|
G |
APOB |
apolipoprotein B |
decreases expression decreases secretion multiple interactions |
EXP |
Fluorouracil results in decreased expression of APOB mRNA Fluorouracil results in decreased secretion of APOB protein ursodoxicoltaurine inhibits the reaction [Fluorouracil results in decreased expression of APOB mRNA] |
CTD |
PMID:32535746 |
|
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
|
|
G |
APOBEC3C |
apolipoprotein B mRNA editing enzyme catalytic subunit 3C |
decreases expression increases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of APOBEC3C protein Fluorouracil results in increased expression of APOBEC3C mRNA APOBEC3C protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16510598 |
|
NCBI chr22:39,014,257...39,020,352
Ensembl chr22:39,014,257...39,020,352
|
|
G |
APOC1 |
apolipoprotein C1 |
affects response to substance |
EXP |
APOC1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:44,914,325...44,919,346
Ensembl chr19:44,914,247...44,919,349
|
|
G |
APOC3 |
apolipoprotein C3 |
decreases secretion decreases expression |
EXP |
Fluorouracil results in decreased secretion of APOC3 protein Fluorouracil results in decreased expression of APOC3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
|
|
G |
AQP12B |
aquaporin 12B |
decreases expression |
EXP |
Fluorouracil results in decreased expression of AQP12B mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 2:240,676,418...240,683,810
Ensembl chr 2:240,676,418...240,682,906
|
|
G |
AQP6 |
aquaporin 6 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of AQP6 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr12:49,972,947...49,977,139
Ensembl chr12:49,967,194...49,977,139
|
|
G |
AQP9 |
aquaporin 9 |
increases uptake |
ISO |
AQP9 protein results in increased uptake of Fluorouracil |
CTD |
PMID:9733774 |
|
NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
|
|
G |
AREG |
amphiregulin |
affects response to substance increases expression |
EXP |
AREG affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of AREG mRNA |
CTD |
PMID:15067352 PMID:16709241 |
|
NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
|
|
G |
ARF1 |
ARF GTPase 1 |
multiple interactions |
EXP |
ARF1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr 1:228,082,708...228,099,212
Ensembl chr 1:228,082,708...228,099,212
|
|
G |
ARF3 |
ARF GTPase 3 |
affects response to substance |
EXP |
ARF3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr12:48,935,723...48,957,487
Ensembl chr12:48,935,723...48,957,487
|
|
G |
ARFGAP1 |
ARF GTPase activating protein 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of ARFGAP1 protein |
CTD |
PMID:15331170 |
|
NCBI chr20:63,272,813...63,289,790
Ensembl chr20:63,272,785...63,289,790
|
|
G |
ARHGDIB |
Rho GDP dissociation inhibitor beta |
affects expression |
EXP |
Fluorouracil affects the expression of ARHGDIB mRNA |
CTD |
PMID:34151400 |
|
NCBI chr12:14,942,015...14,961,601
Ensembl chr12:14,942,031...14,961,728
|
|
G |
ARID5B |
AT-rich interaction domain 5B |
affects response to substance |
EXP |
ARID5B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944
|
|
G |
ARL4C |
ARF like GTPase 4C |
increases expression |
EXP |
Fluorouracil results in increased expression of ARL4C mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 2:234,493,041...234,497,081
Ensembl chr 2:234,493,041...234,497,081
|
|
G |
ARL6IP5 |
ARF like GTPase 6 interacting protein 5 |
multiple interactions |
EXP |
ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin]; ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Oxaliplatin] |
CTD |
PMID:22452940 |
|
NCBI chr 3:69,084,937...69,106,092
Ensembl chr 3:69,084,937...69,106,092
|
|
G |
ARMCX1 |
armadillo repeat containing X-linked 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ARMCX1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr X:101,550,547...101,554,700
Ensembl chr X:101,550,547...101,554,700
|
|
G |
ARPC3 |
actin related protein 2/3 complex subunit 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ARPC3 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr12:110,434,823...110,450,337
Ensembl chr12:110,434,823...110,450,422
|
|
G |
ASAH1 |
N-acylsphingosine amidohydrolase 1 |
affects response to substance multiple interactions |
EXP |
ASAH1 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of ASAH1 mRNA] |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998
|
|
G |
ASS1 |
argininosuccinate synthase 1 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of ASS1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
|
|
G |
ATF3 |
activating transcription factor 3 |
affects expression multiple interactions increases expression |
EXP |
Fluorouracil affects the expression of ATF3 mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of ATF3 mRNA] Fluorouracil results in increased expression of ATF3 mRNA; Fluorouracil results in increased expression of ATF3 protein |
CTD |
PMID:14665630 PMID:15016801 PMID:15205334 PMID:16557594 PMID:16709241 |
|
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
|
|
G |
ATF4 |
activating transcription factor 4 |
increases expression |
EXP |
Fluorouracil results in increased expression of ATF4 protein |
CTD |
PMID:29879413 |
|
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,686
|
|
G |
ATF6 |
activating transcription factor 6 |
affects expression |
EXP |
Fluorouracil affects the expression of ATF6 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
|
|
G |
ATG12 |
autophagy related 12 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ATG12 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 5:115,828,200...115,841,565
Ensembl chr 5:115,828,200...115,841,837
|
|
G |
ATM |
ATM serine/threonine kinase |
decreases response to substance |
EXP |
ATM protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:35608750 |
|
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
|
|
G |
ATOH8 |
atonal bHLH transcription factor 8 |
affects expression |
EXP |
Fluorouracil affects the expression of ATOH8 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:85,753,991...85,791,383
Ensembl chr 2:85,751,344...85,791,383
|
|
G |
ATP5F1D |
ATP synthase F1 subunit delta |
multiple interactions affects expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ATP5F1D mRNA] Fluorouracil affects the expression of ATP5F1D mRNA |
CTD |
PMID:15016801 PMID:34151400 |
|
NCBI chr19:1,241,751...1,244,825
Ensembl chr19:1,241,746...1,244,825
|
|
G |
ATP5PB |
ATP synthase peripheral stalk-membrane subunit b |
affects expression |
EXP |
Fluorouracil affects the expression of ATP5PB mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:111,449,464...111,462,773
Ensembl chr 1:111,448,864...111,462,773
|
|
G |
ATP5PF |
ATP synthase peripheral stalk subunit F6 |
increases expression |
EXP |
Fluorouracil results in increased expression of ATP5PF mRNA |
CTD |
PMID:34151400 |
|
NCBI chr21:25,724,500...25,735,653
Ensembl chr21:25,716,503...25,735,673
|
|
G |
ATP5PO |
ATP synthase peripheral stalk subunit OSCP |
multiple interactions |
EXP |
ATP5PO mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr21:33,903,453...33,915,804
Ensembl chr21:33,903,453...33,915,814
|
|
G |
ATP7B |
ATPase copper transporting beta |
increases response to substance |
EXP |
ATP7B mRNA results in increased susceptibility to Fluorouracil |
CTD |
PMID:18593893 |
|
NCBI chr13:51,932,669...52,012,132
Ensembl chr13:51,930,436...52,012,125
|
|
G |
ATP9A |
ATPase phospholipid transporting 9A (putative) |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of ATP9A protein ATP9A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr20:51,596,514...51,768,390
Ensembl chr20:51,596,514...51,768,390
|
|
G |
ATXN10 |
ataxin 10 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ATXN10 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr22:45,671,834...45,845,307
Ensembl chr22:45,671,798...45,845,307
|
|
G |
AURKA |
aurora kinase A |
decreases expression |
EXP ISO |
Fluorouracil results in decreased expression of AURKA mRNA |
CTD |
PMID:15205334 PMID:16557594 PMID:16709241 PMID:17039268 PMID:19272435 |
|
NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
|
|
G |
AVEN |
apoptosis and caspase activation inhibitor |
decreases expression increases expression |
EXP |
Fluorouracil results in decreased expression of AVEN mRNA Fluorouracil results in increased expression of AVEN mRNA |
CTD |
PMID:16510598 PMID:16709241 |
|
NCBI chr15:33,851,781...34,075,325
Ensembl chr15:33,858,782...34,075,155
|
|
G |
AXIN1 |
axin 1 |
multiple interactions |
ISO |
5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea decreases expression of Axin1 mRNA in colon] |
RGD |
PMID:28032729 |
RGD:150530464 |
NCBI chr16:287,440...352,723
Ensembl chr16:287,440...352,723
|
|
G |
BAD |
BCL2 associated agonist of cell death |
multiple interactions |
ISO |
Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of BAD mRNA] |
CTD |
PMID:31129132 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAG3 |
BAG cochaperone 3 |
affects response to substance |
EXP |
BAG3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,380...119,677,819
|
|
G |
BAK1 |
BCL2 antagonist/killer 1 |
increases expression multiple interactions increases response to substance |
EXP |
Fluorouracil results in increased expression of BAK1; Fluorouracil results in increased expression of BAK1 mRNA; Fluorouracil results in increased expression of BAK1 protein mithramycin A inhibits the reaction [Fluorouracil results in increased expression of BAK1 protein] BAK1 mRNA results in increased susceptibility to Fluorouracil |
CTD |
PMID:9792140 PMID:15489892 PMID:16557594 PMID:18593893 |
|
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
|
|
G |
BARX2 |
BARX homeobox 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of BARX2 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr11:129,375,233...129,452,279
Ensembl chr11:129,375,848...129,452,279
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions affects expression increases expression decreases expression increases response to substance |
EXP ISO |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of BAX mRNA; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of BAX protein; [Docosahexaenoic Acids co-treated with Fluorouracil] results in increased expression of BAX mRNA; [Fluorouracil co-treated with gamma-Tocopherol] results in increased expression of BAX mRNA; [Fluorouracil co-treated with Irinotecan co-treated with Vorinostat] results in increased expression of BAX protein; [SM-1 compound co-treated with Fluorouracil] results in increased expression of BAX protein; [wogonin co-treated with Fluorouracil] results in increased expression of BAX protein; Aspirin promotes the reaction [Fluorouracil results in increased expression of BAX protein]; Cadmium Chloride affects the reaction [Fluorouracil affects the expression of BAX mRNA]; Fluorouracil affects the reaction [Cadmium Chloride affects the expression of BAX mRNA]; Fluorouracil affects the reaction [rebamipide results in decreased expression of BAX protein]; Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of BAX protein]; Fluorouracil promotes the reaction [andrographolide affects the folding of BAX protein]; Fluorouracil promotes the reaction [Aspirin results in increased expression of BAX protein]; Fluorouracil promotes the reaction [Plant Extracts results in increased expression of BAX protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased expression of BAX mRNA]; rebamipide inhibits the reaction [Fluorouracil results in increased expression of BAX protein]; SM-1 compound promotes the reaction [Fluorouracil results in increased expression of BAX mRNA] Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX mRNA] Fluorouracil results in increased expression of BAX; Fluorouracil results in increased expression of BAX mRNA; Fluorouracil results in increased expression of BAX protein [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in increased expression of BAX protein; casticin inhibits the reaction [Fluorouracil results in increased expression of BAX protein]; IL1RN protein affects the reaction [Fluorouracil results in increased expression of BAX protein] Fluorouracil results in decreased expression of BAX mRNA; Fluorouracil results in decreased expression of BAX protein BAX protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:9388485 PMID:9792140 PMID:11062132 PMID:11750847 PMID:12442003 PMID:15641988 PMID:15754201 PMID:15986848 PMID:16168113 PMID:16686938 PMID:16888818 PMID:17045692 PMID:17056233 PMID:17589894 PMID:18567086 PMID:18834353 PMID:19015929 PMID:19097688 PMID:19116755 PMID:20570612 PMID:20844880 PMID:22525470 PMID:23941782 PMID:25824412 PMID:28599477 PMID:29054700 PMID:30542770 PMID:31129132 PMID:31587439 PMID:32270916 PMID:32800223 PMID:38078205 PMID:38423379 More...
|
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BBC3 |
BCL2 binding component 3 |
increases response to substance increases expression multiple interactions |
EXP |
BBC3 protein results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of BBC3 mRNA; Fluorouracil results in increased expression of BBC3 protein [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of BBC3 mRNA; mithramycin A inhibits the reaction [Fluorouracil results in increased expression of BBC3 protein]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BBC3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BBC3 protein] |
CTD |
PMID:14665630 PMID:15016801 PMID:15489892 PMID:16481741 PMID:16557594 PMID:22525470 PMID:32800223 More...
|
|
NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766
|
|
G |
BBS4 |
Bardet-Biedl syndrome 4 |
multiple interactions |
EXP |
BBS4 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr15:72,686,207...72,738,473
Ensembl chr15:72,686,186...72,742,006
|
|
G |
BBX |
BBX high mobility group box domain containing |
affects response to substance |
EXP |
BBX protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:107,522,962...107,811,339
Ensembl chr 3:107,522,936...107,811,339
|
|
G |
BCAR3 |
BCAR3 adaptor protein, NSP family member |
affects response to substance decreases expression |
EXP |
BCAR3 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of BCAR3 protein |
CTD |
PMID:15352031 |
|
NCBI chr 1:93,561,741...93,848,151
Ensembl chr 1:93,561,741...93,847,150
|
|
G |
BCAS4 |
breast carcinoma amplified sequence 4 |
affects response to substance |
EXP |
BCAS4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:50,794,894...50,882,676
Ensembl chr20:50,794,894...50,877,177
|
|
G |
BCAT1 |
branched chain amino acid transaminase 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of BCAT1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:24,810,024...24,949,340
Ensembl chr12:24,810,024...24,949,101
|
|
G |
BCKDHA |
branched chain keto acid dehydrogenase E1 subunit alpha |
affects expression |
EXP |
Fluorouracil affects the expression of BCKDHA mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:41,397,818...41,425,002
Ensembl chr19:41,397,808...41,425,002
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions affects expression affects response to substance decreases expression increases expression increases phosphorylation decreases response to substance |
EXP ISO |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of BCL2 mRNA; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of BCL2 protein; [Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA; [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of BCL2 mRNA; [Fluorouracil co-treated with Irinotecan co-treated with Vorinostat] results in decreased expression of BCL2 protein; [Fluorouracil co-treated with Irinotecan] results in decreased expression of BCL2 mRNA; [Fluorouracil co-treated with Irinotecan] results in decreased expression of BCL2 protein; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 protein; [SM-1 compound co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA; [SM-1 compound co-treated with Fluorouracil] results in decreased expression of BCL2 protein; [wogonin co-treated with Fluorouracil] results in decreased expression of BCL2 protein; BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA]; Cadmium Chloride affects the reaction [Fluorouracil affects the expression of BCL2 protein]; Fluorouracil affects the reaction [Cadmium Chloride affects the expression of BCL2 mRNA]; Fluorouracil affects the reaction [rebamipide results in increased expression of BCL2 protein]; Fluorouracil promotes the reaction [gambogic acid results in decreased expression of BCL2 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein]; rebamipide inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein]; SM-1 compound promotes the reaction [Fluorouracil results in decreased expression of BCL2 mRNA] Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein] BCL2 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of BCL2 mRNA; Fluorouracil results in increased expression of BCL2 protein [Fluorouracil co-treated with casticin] results in decreased expression of BCL2 protein; [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein; IL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein] Fluorouracil results in increased phosphorylation of BCL2 protein Fluorouracil results in decreased expression of BCL-2 protein; Fluorouracil results in decreased expression of BCL2; Fluorouracil results in decreased expression of BCL2 mRNA; Fluorouracil results in decreased expression of BCL2 protein BCL2 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:7654318 PMID:9388485 PMID:14503796 PMID:15177426 PMID:15754201 PMID:15996812 PMID:16332177 PMID:16391804 PMID:16407826 PMID:16412276 PMID:16557594 PMID:16596200 PMID:16603448 PMID:16888818 PMID:16929163 PMID:17287894 PMID:17439414 PMID:17589894 PMID:18161298 PMID:18205257 PMID:18567086 PMID:18949393 PMID:19015929 PMID:19084572 PMID:20570612 PMID:20844880 PMID:23941782 PMID:28599477 PMID:29054700 PMID:30542770 PMID:31129132 PMID:31587439 PMID:32270916 PMID:32800223 PMID:37625625 PMID:38078205 More...
|
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions affects response to substance increases expression decreases expression affects expression decreases response to substance |
EXP ISO |
3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein]; [Fluorouracil co-treated with IFNA1 protein] results in decreased expression of BCL2L1 mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 protein; BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 mRNA]; BCL2L1 protein inhibits the reaction [BID protein results in increased susceptibility to Fluorouracil]; Fluorouracil affects the reaction [rebamipide results in increased expression of BCL2L1 protein]; Gemcitabine inhibits the reaction [Fluorouracil affects the expression of BCL2L1 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil affects the expression of BCL2L1 protein]; IFNA1 promotes the reaction [Fluorouracil results in decreased expression of BCL2L1 mRNA]; rebamipide inhibits the reaction [Fluorouracil results in decreased expression of BCL2L1 protein] Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] BCL2L1 protein affects the susceptibility to Fluorouracil 3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein]; casticin promotes the reaction [Fluorouracil results in decreased expression of BCL2L1 protein]; Fluorouracil promotes the reaction [casticin results in decreased expression of BCL2L1 protein]; IL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2L1 protein] Fluorouracil results in increased expression of BCL2L1 mRNA; Fluorouracil results in increased expression of BCL2L1 protein Fluorouracil results in decreased expression of BCL2L1; Fluorouracil results in decreased expression of BCL2L1 mRNA; Fluorouracil results in decreased expression of BCL2L1 protein Fluorouracil affects the expression of BCL2L1 mRNA; Fluorouracil affects the expression of BCL2L1 protein BCL2L1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:12442003 PMID:15289866 PMID:15767554 PMID:16407826 PMID:16557594 PMID:16596200 PMID:16875599 PMID:16929163 PMID:17033717 PMID:17045692 PMID:17399942 PMID:17439414 PMID:19116755 PMID:20844880 PMID:21474236 PMID:29054700 PMID:29879413 PMID:31129132 PMID:32270916 PMID:34151400 More...
|
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BCL2L11 |
BCL2 like 11 |
multiple interactions increases expression |
EXP |
Fluorouracil affects the reaction [rebamipide results in decreased expression of BCL2L11 protein]; rebamipide inhibits the reaction [Fluorouracil results in increased expression of BCL2L11 protein] |
CTD |
PMID:29054700 |
|
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
|
|
G |
BCL2L12 |
BCL2 like 12 |
multiple interactions |
EXP |
[Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of BCL2L12 mRNA |
CTD |
PMID:19015929 |
|
NCBI chr19:49,665,142...49,673,916
Ensembl chr19:49,665,142...49,673,916
|
|
G |
BDH1 |
3-hydroxybutyrate dehydrogenase 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of BDH1 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of BDKRB2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
|
|
G |
BDNF |
brain derived neurotrophic factor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of BDNF protein |
CTD |
PMID:18702703 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
G |
BEAN1 |
brain expressed associated with NEDD4 1 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of BEAN1 protein BEAN1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr16:66,427,295...66,495,288
Ensembl chr16:66,427,295...66,493,529
|
|
G |
BECN1 |
beclin 1 |
multiple interactions increases expression |
EXP ISO |
BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] Fluorouracil results in increased expression of BECN1 protein Apigenin promotes the reaction [Fluorouracil results in increased expression of BECN1 protein]; Fluorouracil promotes the reaction [Apigenin results in increased expression of BECN1 protein] |
CTD |
PMID:16896004 PMID:28025107 |
|
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
increases expression |
ISO |
Fluorouracil results in increased expression of BGLAP mRNA |
CTD |
PMID:16888818 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
BHLHE41 |
basic helix-loop-helix family member e41 |
affects response to substance |
EXP |
BHLHE41 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr12:26,120,030...26,125,037
Ensembl chr12:26,120,030...26,125,037
|
|
G |
BID |
BH3 interacting domain death agonist |
multiple interactions increases expression decreases response to substance decreases expression increases response to substance |
EXP ISO |
[Fluorouracil co-treated with irinotecan co-treated with vorinostat] results in increased cleavage of BID protein; BCL2L1 protein inhibits the reaction [BID protein results in increased susceptibility to Fluorouracil]; Fluorouracil results in increased cleavage of and results in increased activity of BID protein; IFNA1 promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of BID protein] Fluorouracil results in increased expression of BID protein casticin inhibits the reaction [Fluorouracil results in increased expression of BID protein] BID protein mutant form results in decreased susceptibility to Fluorouracil Fluorouracil results in decreased expression of BID protein |
CTD |
PMID:15095271 PMID:15289866 PMID:15754201 PMID:21474236 PMID:32270916 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
BIRC2 |
baculoviral IAP repeat containing 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of BIRC2 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
|
|
G |
BIRC3 |
baculoviral IAP repeat containing 3 |
increases expression affects expression |
EXP |
Fluorouracil results in increased expression of BIRC3 mRNA Fluorouracil affects the expression of BIRC3 mRNA |
CTD |
PMID:16557594 PMID:34151400 |
|
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
|
|
G |
BIRC5 |
baculoviral IAP repeat containing 5 |
decreases response to substance increases expression decreases expression multiple interactions affects response to substance |
EXP |
BIRC5 protein results in decreased susceptibility to Fluorouracil; BIRC5 results in decreased susceptibility to Fluorouracil Fluorouracil results in increased expression of BIRC5 mRNA; Fluorouracil results in increased expression of BIRC5 protein Fluorouracil results in decreased expression of BIRC5 mRNA; Fluorouracil results in decreased expression of BIRC5 protein [Fluorouracil co-treated with RNF34 protein] results in increased expression of BIRC5 protein; [SM-1 compound co-treated with Fluorouracil] results in decreased expression of BIRC5 mRNA; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 protein]; SM-1 compound inhibits the reaction [Fluorouracil results in increased expression of BIRC5 mRNA]; SM-1 compound promotes the reaction [Fluorouracil results in decreased expression of BIRC5 protein] BIRC5 affects the susceptibility to Fluorouracil; BIRC5 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:15109396 PMID:15685548 PMID:16217747 PMID:16546719 PMID:16596200 PMID:16709241 PMID:16929163 PMID:17399942 PMID:18714155 PMID:19618606 PMID:28599477 PMID:29054700 More...
|
|
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
|
|
G |
BIRC6 |
baculoviral IAP repeat containing 6 |
affects response to substance decreases response to substance |
EXP |
BIRC6 protein affects the susceptibility to Fluorouracil BIRC6 results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18239605 PMID:21542283 |
|
NCBI chr 2:32,357,023...32,618,878
Ensembl chr 2:32,357,023...32,619,571
|
|
G |
BIRC7 |
baculoviral IAP repeat containing 7 |
decreases response to substance |
EXP |
BIRC7 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:17437058 |
|
NCBI chr20:63,235,905...63,240,495
Ensembl chr20:63,235,883...63,240,495
|
|
G |
BLM |
BLM RecQ like helicase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of BLM mRNA |
CTD |
PMID:19272435 |
|
NCBI chr15:90,717,346...90,816,166
Ensembl chr15:90,717,346...90,816,166
|
|
G |
BLVRB |
biliverdin reductase B |
affects response to substance |
EXP |
BLVRB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764
|
|
G |
BNIP1 |
BCL2 interacting protein 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of BNIP1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 5:173,144,531...173,164,387
Ensembl chr 5:173,144,442...173,164,387
|
|
G |
BNIP3 |
BCL2 interacting protein 3 |
multiple interactions affects response to substance |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of BNIP3 mRNA] BNIP3 affects the susceptibility to Fluorouracil |
CTD |
PMID:15016801 PMID:15067352 |
|
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
|
|
G |
BNIP3L |
BCL2 interacting protein 3 like |
affects response to substance decreases expression increases expression |
EXP |
BNIP3L affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of BNIP3L mRNA Fluorouracil results in increased expression of BNIP3L mRNA |
CTD |
PMID:15067352 PMID:15109396 PMID:16557594 PMID:16709241 PMID:17039268 |
|
NCBI chr 8:26,383,054...26,413,127
Ensembl chr 8:26,383,054...26,505,636
|
|
G |
BOLL |
boule homolog, RNA binding protein |
multiple interactions |
EXP |
BOLL mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 2:197,726,890...197,786,206
Ensembl chr 2:197,726,879...197,786,762
|
|
G |
BOP1 |
BOP1 ribosomal biogenesis factor |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of BOP1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:144,262,045...144,291,438
Ensembl chr 8:144,262,045...144,291,438
|
|
G |
BORA |
BORA aurora kinase A activator |
decreases expression |
EXP |
Fluorouracil results in decreased expression of BORA mRNA |
CTD |
PMID:17374387 |
|
NCBI chr13:72,727,923...72,756,196
Ensembl chr13:72,727,749...72,756,198
|
|
G |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
decreases expression |
EXP |
Fluorouracil results in decreased expression of BRAF mRNA |
CTD |
PMID:38423379 |
|
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
|
|
G |
BRCA1 |
BRCA1 DNA repair associated |
increases expression decreases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of BRCA1 mRNA Fluorouracil results in decreased expression of BRCA1 mRNA TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of BRCA1 mRNA] |
CTD |
PMID:15607317 PMID:16101138 PMID:16557594 PMID:17982676 |
|
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
|
|
G |
BRIX1 |
biogenesis of ribosomes BRX1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of BRIX1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 5:34,915,711...34,925,996
Ensembl chr 5:34,915,677...34,925,996
|
|
G |
BTG2 |
BTG anti-proliferation factor 2 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of BTG2 mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of BTG2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of BTG2 mRNA] |
CTD |
PMID:15016801 PMID:17982676 |
|
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
|
|
G |
BTG3 |
BTG anti-proliferation factor 3 |
multiple interactions |
EXP |
BTG3 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr21:17,593,653...17,612,901
Ensembl chr21:17,593,653...17,612,945
|
|
G |
BTN3A3 |
butyrophilin subfamily 3 member A3 |
increases expression |
EXP |
Fluorouracil results in increased expression of BTN3A3 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 6:26,440,504...26,453,415
Ensembl chr 6:26,440,472...26,453,415
|
|
G |
BUB1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
EXP ISO |
Fluorouracil results in decreased expression of BUB1 mRNA |
CTD |
PMID:16709241 PMID:19272435 |
|
NCBI chr 2:110,637,528...110,678,063
Ensembl chr 2:110,637,528...110,678,063
|
|
G |
BUB1B |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
EXP ISO |
Fluorouracil results in decreased expression of BUB1B mRNA |
CTD |
PMID:16557594 PMID:16709241 PMID:19272435 |
|
NCBI chr15:40,161,069...40,221,123
Ensembl chr15:40,161,023...40,221,123
|
|
G |
BUB3 |
BUB3 mitotic checkpoint protein |
affects response to substance decreases expression |
EXP |
BUB3 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of BUB3 protein |
CTD |
PMID:15548681 PMID:15585135 PMID:16803524 |
|
NCBI chr10:123,154,402...123,170,467
Ensembl chr10:123,154,402...123,170,467
|
|
G |
C11orf24 |
chromosome 11 open reading frame 24 |
affects response to substance |
EXP |
C11ORF24 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr11:68,261,338...68,271,973
Ensembl chr11:68,261,338...68,272,001
|
|
G |
C14orf132 |
chromosome 14 open reading frame 132 |
increases expression |
EXP |
Fluorouracil results in increased expression of C14ORF132 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr14:96,039,362...96,093,971
Ensembl chr14:96,039,362...96,093,971
|
|
G |
C1orf35 |
chromosome 1 open reading frame 35 |
affects expression |
EXP |
Fluorouracil affects the expression of C1ORF35 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:228,100,731...228,103,325
Ensembl chr 1:228,100,726...228,105,411
|
|
G |
C4BPB |
complement component 4 binding protein beta |
affects expression |
EXP |
Fluorouracil affects the expression of C4BPB mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:207,088,860...207,099,993
Ensembl chr 1:207,088,860...207,099,993
|
|
G |
CA12 |
carbonic anhydrase 12 |
multiple interactions |
EXP |
CA12 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr15:63,321,378...63,381,846
Ensembl chr15:63,321,378...63,381,846
|
|
G |
CA14 |
carbonic anhydrase 14 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CA14 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:150,257,774...150,265,078
Ensembl chr 1:150,257,251...150,265,078
|
|
G |
CABYR |
calcium binding tyrosine phosphorylation regulated |
affects response to substance |
EXP |
CABYR protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr18:24,139,062...24,161,600
Ensembl chr18:24,138,987...24,161,600
|
|
G |
CAD |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CAD mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:27,217,369...27,243,943
Ensembl chr 2:27,217,369...27,243,943
|
|
G |
CALB2 |
calbindin 2 |
increases response to substance increases expression |
EXP |
CALB2 protein results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of CALB2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr16:71,358,723...71,390,433
Ensembl chr16:71,358,713...71,390,436
|
|
G |
CANX |
calnexin |
multiple interactions |
EXP |
CANX results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CANX mRNA] |
CTD |
PMID:15016801 PMID:18678097 |
|
NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641
|
|
G |
CAP2 |
cyclase associated actin cytoskeleton regulatory protein 2 |
affects response to substance |
EXP |
CAP2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:17,393,595...17,557,780
Ensembl chr 6:17,393,595...17,557,780
|
|
G |
CASD1 |
CAS1 domain containing 1 |
affects expression |
ISO |
Fluorouracil affects the expression of CASD1 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 7:94,509,809...94,634,172
Ensembl chr 7:94,509,219...94,557,019
|
|
G |
CASP1 |
caspase 1 |
increases cleavage |
EXP |
Fluorouracil results in increased cleavage of CASP1 protein |
CTD |
PMID:15162350 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP10 |
caspase 10 |
increases expression |
EXP |
Fluorouracil results in increased expression of CASP10 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 2:201,183,141...201,229,406
Ensembl chr 2:201,182,872...201,229,428
|
|
G |
CASP2 |
caspase 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CASP2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696
|
|
G |
CASP3 |
caspase 3 |
increases expression increases cleavage affects expression multiple interactions increases activity decreases cleavage decreases expression |
EXP ISO |
Fluorouracil results in increased expression of CASP3; Fluorouracil results in increased expression of CASP3 mRNA; Fluorouracil results in increased expression of CASP3 protein; Fluorouracil results in increased expression of CASP3 protein modified form Fluorouracil results in increased cleavage of CASP3 protein Fluorouracil affects the expression of CASP3 mRNA [diacerein co-treated with Fluorouracil] inhibits the reaction [Trichloroacetic Acid results in decreased cleavage of CASP3 protein]; Bosentan inhibits the reaction [Fluorouracil results in increased cleavage of CASP3 protein]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]; Silybin inhibits the reaction [Fluorouracil results in increased expression of CASP3 protein] Fluorouracil results in increased activity of CASP3 protein Fluorouracil results in decreased cleavage of CASP3 protein 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP3 protein]; [10-hydroxycamptothecin co-treated with Fluorouracil co-treated with Leucovorin] results in increased activity of CASP3 protein; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of CASP3 mRNA; [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of CASP3 protein; [Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP3 protein; [Fluorouracil co-treated with aloe emodin] affects the expression of CASP3; [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP3 protein; [Fluorouracil co-treated with Cisplatin] results in increased expression of CASP3 protein; [Fluorouracil co-treated with IFNB1 protein] results in increased activity of CASP3 protein; [Fluorouracil co-treated with olaparib] results in increased cleavage of CASP3 protein; [Fluorouracil co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased activity of CASP3 protein; [SM-1 compound co-treated with Fluorouracil] results in increased cleavage of CASP3 protein; [wogonin co-treated with Fluorouracil] results in increased activity of CASP3 protein; Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased cleavage of CASP3 protein]; CA 074 methyl ester inhibits the reaction [Fluorouracil results in increased cleavage of CASP3 protein]; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]]; Celecoxib inhibits the reaction [Fluorouracil results in increased expression of CASP3 protein]; chan-yu-bao-yuan-tang promotes the reaction [Fluorouracil results in increased cleavage of and results in increased expression of CASP3 protein]; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP3 protein]; Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP3 protein modified form]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]; Fluorouracil promotes the reaction [chan-yu-bao-yuan-tang results in increased cleavage of and results in increased expression of CASP3 protein]; Fluorouracil promotes the reaction [gambogic acid results in decreased expression of CASP3 mRNA]; Fluorouracil promotes the reaction [Sirolimus results in increased expression of CASP3 mRNA]; Fluorouracil promotes the reaction [temsirolimus results in increased expression of CASP3 mRNA]; Fluorouracil promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein]; Fluorouracil results in increased activity of and results in increased cleavage of CASP3 protein; Fluorouracil results in increased cleavage of and results in increased activity of CASP3 protein; Fluorouracil results in increased cleavage of and results in increased expression of CASP3 protein; HK2 protein affects the reaction [Fluorouracil results in increased activity of CASP3 protein]; IFI6 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP3 protein]; PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [Fluorouracil results in decreased cleavage of CASP3 protein]; RNF34 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; Sirolimus promotes the reaction [Fluorouracil results in increased expression of CASP3 mRNA]; temsirolimus promotes the reaction [Fluorouracil results in increased expression of CASP3 mRNA]; TNFRSF10B mutant form inhibits the reaction [Fluorouracil results in increased cleavage of CASP3 protein] Fluorouracil results in decreased expression of CASP3 mRNA 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP3 protein]; Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP3 protein]; casticin inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; Fluorouracil promotes the reaction [Apigenin results in increased activity of CASP3 protein]; Fluorouracil results in increased cleavage of and results in increased activity of CASP3 protein; IL1RN protein affects the reaction [Fluorouracil results in increased expression of CASP3 protein modified form] |
CTD |
PMID:10891390 PMID:11300326 PMID:12414664 PMID:12934351 PMID:12941601 PMID:14503796 PMID:15120327 PMID:15282376 PMID:15585135 PMID:15685448 PMID:16080519 PMID:16168113 PMID:16407826 PMID:16803524 PMID:17016659 PMID:17056233 PMID:17219956 PMID:17399942 PMID:17461495 PMID:17498489 PMID:17589894 PMID:18161298 PMID:18205257 PMID:18608205 PMID:18772588 PMID:18830594 PMID:19084572 PMID:19097688 PMID:19116755 PMID:19764996 PMID:19815060 PMID:19816940 PMID:19885610 PMID:19928967 PMID:20570612 PMID:20844880 PMID:20876774 PMID:21036698 PMID:21461573 PMID:25940438 PMID:26310874 PMID:26544897 PMID:28025107 PMID:28599477 PMID:29678497 PMID:31129132 PMID:31288002 PMID:32270916 PMID:32634519 PMID:32800223 PMID:34151400 PMID:34794354 PMID:34800596 PMID:36203040 PMID:37335224 PMID:37625625 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP4 |
caspase 4 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of CASP4 protein CASP4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
|
|
G |
CASP6 |
caspase 6 |
multiple interactions affects expression |
EXP |
Fluorouracil results in increased cleavage of and results in increased activity of CASP6 protein; resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein]; TP53 affects the reaction [resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein]] Fluorouracil affects the expression of CASP6 mRNA |
CTD |
PMID:18497562 PMID:34151400 |
|
NCBI chr 4:109,664,388...109,709,767
Ensembl chr 4:109,688,622...109,703,583
|
|
G |
CASP7 |
caspase 7 |
multiple interactions increases expression increases cleavage |
EXP |
[Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP7 protein Fluorouracil results in increased expression of CASP7 mRNA Fluorouracil results in increased cleavage of CASP7 protein |
CTD |
PMID:16168113 PMID:26544897 PMID:34151400 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
multiple interactions increases activity increases cleavage decreases expression increases expression |
EXP ISO |
[Cadmium Chloride co-treated with Fluorouracil] affects the expression of CASP8 protein; [Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP8 protein; [Fluorouracil co-treated with aloe emodin] affects the expression of CASP8; [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP8 protein; [Fluorouracil co-treated with Cisplatin] results in increased expression of CASP8 protein; [Fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein]; Cadmium Chloride affects the reaction [Fluorouracil results in decreased expression of CASP8 mRNA]; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]]; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]]; CASP8 results in increased susceptibility to [andrographolide co-treated with Fluorouracil]; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP8 protein]; Fluorouracil affects the reaction [Cadmium Chloride results in decreased expression of CASP8 mRNA]; Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP8 protein modified form]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP8 protein]; Fluorouracil promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]; IFNA1 promotes the reaction [Fluorouracil results in increased expression of CASP8 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP8 protein]; isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Fluorouracil results in increased activity of CASP8 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 protein] Fluorouracil results in increased cleavage of CASP8 protein Fluorouracil results in increased expression of CASP8 mRNA; Fluorouracil results in increased expression of CASP8 protein |
CTD |
PMID:10779637 PMID:10891390 PMID:12414664 PMID:14607657 PMID:15585135 PMID:16168113 PMID:16803524 PMID:17016659 PMID:17056233 PMID:17637740 PMID:18830594 PMID:19097688 PMID:19816940 PMID:19928967 PMID:20876774 PMID:21474236 PMID:23941782 PMID:26544897 PMID:32270916 PMID:34151400 More...
|
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases activity decreases expression increases expression increases cleavage |
EXP ISO |
[Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of CASP9 mRNA; [Fluorouracil co-treated with aloe emodin] affects the expression of CASP9; [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP9 protein; [Fluorouracil co-treated with Cisplatin] results in increased expression of CASP9 protein; Cadmium Chloride promotes the reaction [Fluorouracil results in decreased expression of CASP9 mRNA]; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]]; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP9 protein]; Fluorouracil inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 mRNA]; Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP9 protein]; Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP9 protein modified form]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]; Fluorouracil promotes the reaction [Arsenic Trioxide results in decreased expression of CASP9 protein]; Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP9 protein]; N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]; PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein]; RNF34 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein]; TP53 protein inhibits the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]] Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 mRNA]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein] Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP9 protein]; casticin promotes the reaction [Fluorouracil results in increased activity of CASP9 protein]; Fluorouracil promotes the reaction [Apigenin results in increased activity of CASP9 protein] Fluorouracil results in increased expression of CASP9 protein Fluorouracil results in increased cleavage of CASP9 protein |
CTD |
PMID:10779637 PMID:12414664 PMID:15546879 PMID:15996812 PMID:16168113 PMID:16407826 PMID:16803524 PMID:17016659 PMID:17056233 PMID:17498489 PMID:18830594 PMID:19015929 PMID:19097688 PMID:19816940 PMID:19928967 PMID:22963400 PMID:23941782 PMID:28025107 PMID:31129132 PMID:32270916 More...
|
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions decreases expression decreases activity |
ISO EXP |
Fluorouracil inhibits the reaction [casticin results in increased expression of CAT protein]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Fluorouracil promotes the reaction [Luteolin results in decreased activity of CAT protein]; Fluorouracil promotes the reaction [Valsartan results in decreased activity of CAT protein]; Luteolin promotes the reaction [Fluorouracil results in decreased activity of CAT protein]; Valsartan promotes the reaction [Fluorouracil results in decreased activity of CAT protein] [Fluorouracil co-treated with Leucovorin co-treated with 1,2-Dimethylhydrazine] results in increased expression of CAT protein; Silybin inhibits the reaction [Fluorouracil results in decreased expression of CAT protein] [Fluorouracil co-treated with Arsenic Trioxide] results in decreased activity of CAT protein |
CTD |
PMID:27836789 PMID:29117755 PMID:31288002 PMID:32270916 PMID:32524861 PMID:32752303 PMID:33634982 PMID:35235860 PMID:37335224 More...
|
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CAV1 |
caveolin 1 |
affects response to substance increases expression decreases expression |
EXP |
CAV1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CAV1 mRNA Fluorouracil results in decreased expression of CAV1 protein |
CTD |
PMID:15352031 PMID:24737281 |
|
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
|
|
G |
CAV2 |
caveolin 2 |
decreases expression increases expression |
EXP |
Fluorouracil results in decreased expression of CAV2 mRNA Fluorouracil results in increased expression of CAV2 mRNA |
CTD |
PMID:16510598 PMID:24737281 |
|
NCBI chr 7:116,499,738...116,508,541
Ensembl chr 7:116,287,380...116,508,541
|
|
G |
CBR3 |
carbonyl reductase 3 |
affects expression |
ISO |
Fluorouracil affects the expression of CBR3 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr21:36,135,079...36,146,562
Ensembl chr21:36,135,079...36,146,562
|
|
G |
CBS |
cystathionine beta-synthase |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CBS mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr21:43,053,191...43,076,873
Ensembl chr21:43,053,191...43,076,943
|
|
G |
CBX1 |
chromobox 1 |
affects response to substance |
EXP |
CBX1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:48,070,059...48,101,478
Ensembl chr17:48,070,052...48,101,478
|
|
G |
CCAT2 |
colon cancer associated transcript 2 |
decreases response to substance |
EXP |
CCAT2 results in decreased susceptibility to Fluorouracil |
CTD |
PMID:35968984 |
|
NCBI chr 8:127,400,399...127,402,150
Ensembl chr 8:127,400,399...127,402,150
|
|
G |
CCDC186 |
coiled-coil domain containing 186 |
increases expression |
EXP |
Fluorouracil results in increased expression of CCDC186 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr10:114,120,862...114,174,220
Ensembl chr10:114,120,862...114,174,232
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of CCL2 mRNA Fluorouracil promotes the reaction [Valsartan results in decreased expression of CCL2 mRNA]; Valsartan promotes the reaction [Fluorouracil results in decreased expression of CCL2 mRNA] |
CTD |
PMID:35235860 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCN1 |
cellular communication network factor 1 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of CCN1 mRNA; Fluorouracil results in increased expression of CCN1 protein CCN1 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:17699798 PMID:24737281 |
|
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
|
|
G |
CCN2 |
cellular communication network factor 2 |
affects expression |
EXP |
Fluorouracil affects the expression of CCN2 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CCN3 |
cellular communication network factor 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of CCN3 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 8:119,416,446...119,424,434
Ensembl chr 8:119,416,446...119,424,434
|
|
G |
CCNA1 |
cyclin A1 |
multiple interactions affects expression |
EXP |
[Cadmium Chloride co-treated with Fluorouracil] affects the expression of CCNA1 protein; Cadmium Chloride affects the reaction [Fluorouracil affects the expression of CCNA1 mRNA]; Fluorouracil affects the reaction [Cadmium Chloride affects the expression of CCNA1 mRNA] Fluorouracil affects the expression of CCNA1 mRNA; Fluorouracil affects the expression of CCNA1 protein |
CTD |
PMID:23941782 |
|
NCBI chr13:36,431,517...36,442,870
Ensembl chr13:36,431,520...36,442,870
|
|
G |
CCNA2 |
cyclin A2 |
multiple interactions affects response to substance affects expression decreases expression |
EXP |
N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNA2 protein]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNA2 protein]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNA2 protein]] CCNA2 protein affects the susceptibility to Fluorouracil Fluorouracil affects the expression of CCNA2 mRNA Fluorouracil results in decreased expression of CCNA2 mRNA; Fluorouracil results in decreased expression of CCNA2 protein |
CTD |
PMID:15205334 PMID:15546879 PMID:15548681 PMID:16557594 PMID:18383818 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCNB1 |
cyclin B1 |
multiple interactions decreases expression |
EXP |
N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNB1 protein]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCNB1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNB1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNB1 protein]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNB1 protein]] Fluorouracil results in decreased expression of CCNB1 mRNA; Fluorouracil results in decreased expression of CCNB1 protein |
CTD |
PMID:15016801 PMID:15205334 PMID:15546879 PMID:16557594 PMID:17982676 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCNB2 |
cyclin B2 |
multiple interactions decreases expression |
EXP ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCNB2 mRNA] Fluorouracil results in decreased expression of CCNB2 mRNA; Fluorouracil results in decreased expression of CCNB2 protein |
CTD |
PMID:15016801 PMID:16557594 PMID:16709241 PMID:17982488 PMID:19272435 |
|
NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
|
|
G |
CCNC |
cyclin C |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CCNC mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 6:99,542,387...99,568,814
Ensembl chr 6:99,542,387...99,568,825
|
|
G |
CCND1 |
cyclin D1 |
affects response to substance decreases expression multiple interactions affects expression |
EXP ISO |
CCND1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CCND1 protein Fluorouracil promotes the reaction [Luteolin results in decreased expression of CCND1 protein]; Luteolin promotes the reaction [Fluorouracil results in decreased expression of CCND1 protein] Fluorouracil affects the expression of CCND1 mRNA; Fluorouracil affects the expression of CCND1 protein Fluorouracil results in decreased expression of CCND1 mRNA; Fluorouracil results in decreased expression of CCND1 protein [allose co-treated with Fluorouracil] results in decreased expression of CCND1 protein; [Cadmium Chloride co-treated with Fluorouracil] affects the expression of CCND1 protein; [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of CCND1 mRNA; Cadmium Chloride affects the reaction [Fluorouracil affects the expression of CCND1 mRNA]; Fluorouracil affects the reaction [Cadmium Chloride affects the expression of CCND1 mRNA]; Fluorouracil promotes the reaction [allose results in decreased expression of CCND1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCND1 protein] |
CTD |
PMID:15352031 PMID:17982676 PMID:18930000 PMID:23941782 PMID:31288002 PMID:31587439 More...
|
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCND2 |
cyclin D2 |
increases expression decreases expression multiple interactions affects response to substance |
EXP ISO |
Fluorouracil results in increased expression of CCND2 protein Fluorouracil results in decreased expression of CCND2 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCND2 mRNA] CCND2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15016801 PMID:15352031 PMID:19272435 |
|
NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353
|
|
G |
CCND3 |
cyclin D3 |
affects response to substance increases expression |
EXP |
CCND3 affects the susceptibility to Fluorouracil; CCND3 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CCND3 mRNA |
CTD |
PMID:15067352 PMID:15548681 PMID:16709241 PMID:18383818 |
|
NCBI chr 6:41,934,933...42,050,035
Ensembl chr 6:41,934,934...42,050,357
|
|
G |
CCNE1 |
cyclin E1 |
decreases expression multiple interactions increases expression |
EXP |
Fluorouracil results in decreased expression of CCNE1 mRNA [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of CCNE1 mRNA; [Leucovorin co-treated with Fluorouracil] results in increased expression of CCNE1 mRNA Fluorouracil results in increased expression of CCNE1 mRNA; Fluorouracil results in increased expression of CCNE1 protein |
CTD |
PMID:9930367 PMID:15342418 PMID:16101138 PMID:18930000 PMID:31587439 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
|
|
G |
CCNE2 |
cyclin E2 |
affects response to substance |
EXP |
CCNE2 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 |
|
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
|
|
G |
CCNF |
cyclin F |
affects response to substance |
EXP |
CCNF affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 |
|
NCBI chr16:2,429,447...2,458,854
Ensembl chr16:2,429,394...2,458,854
|
|
G |
CCNG1 |
cyclin G1 |
affects response to substance increases expression multiple interactions decreases expression |
EXP ISO |
CCNG1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CCNG1 mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of CCNG1 mRNA] Fluorouracil results in decreased expression of CCNG1 mRNA |
CTD |
PMID:15152939 PMID:16217747 PMID:16557594 PMID:16709241 PMID:17982676 PMID:19272435 PMID:22525470 More...
|
|
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,448,199
|
|
G |
CCNG2 |
cyclin G2 |
affects response to substance decreases expression increases expression |
EXP ISO |
CCNG2 affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CCNG2 mRNA Fluorouracil results in increased expression of CCNG2 mRNA |
CTD |
PMID:15067352 PMID:16510598 PMID:16557594 PMID:17039268 PMID:18754885 PMID:19272435 More...
|
|
NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388
|
|
G |
CCNJL |
cyclin J like |
affects expression |
EXP |
Fluorouracil affects the expression of CCNJL mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 5:160,249,083...160,339,570
Ensembl chr 5:160,249,083...160,345,396
|
|
G |
CD109 |
CD109 molecule |
affects response to substance |
EXP |
CD109 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:37661780 |
|
NCBI chr 6:73,679,192...73,828,313
Ensembl chr 6:73,695,785...73,828,316
|
|
G |
CD24 |
CD24 molecule |
increases expression |
EXP |
Fluorouracil results in increased expression of CD24 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
|
|
G |
CD274 |
CD274 molecule |
increases expression |
EXP |
Fluorouracil results in increased expression of CD274 protein |
CTD |
PMID:17920123 |
|
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
|
|
G |
CD34 |
CD34 molecule |
increases expression |
ISO |
Fluorouracil results in increased expression of CD34 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:207,880,972...207,911,125
Ensembl chr 1:207,880,972...207,911,402
|
|
G |
CD38 |
CD38 molecule |
affects expression |
EXP |
Fluorouracil affects the expression of CD38 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 4:15,778,328...15,853,232
Ensembl chr 4:15,778,275...15,853,232
|
|
G |
CD40 |
CD40 molecule |
decreases response to substance multiple interactions |
EXP |
CD40 results in decreased susceptibility to Fluorouracil Fluorouracil inhibits the reaction [[CD40LG protein co-treated with CD40 protein] inhibits the reaction [EIF4E protein binds to EIF4EBP1 protein]] |
CTD |
PMID:15611226 PMID:20188757 |
|
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CD40LG |
CD40 ligand |
multiple interactions |
EXP |
Fluorouracil inhibits the reaction [[CD40LG protein co-treated with CD40 protein] inhibits the reaction [EIF4E protein binds to EIF4EBP1 protein]] |
CTD |
PMID:15611226 |
|
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
|
|
G |
CD44 |
CD44 molecule (IN blood group) |
multiple interactions |
ISO |
[gimeracil co-treated with Fluorouracil] results in decreased expression of CD44 |
CTD |
PMID:12364819 |
|
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
|
|
G |
CD52 |
CD52 molecule |
affects expression multiple interactions |
EXP |
Fluorouracil affects the expression of CD52 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of CD52 mRNA] |
CTD |
PMID:15016801 PMID:16584549 |
|
NCBI chr 1:26,317,958...26,320,523
Ensembl chr 1:26,317,958...26,320,523
|
|
G |
CD63 |
CD63 molecule |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CD63 |
CTD |
PMID:15485462 |
|
NCBI chr12:55,723,535...55,730,041
Ensembl chr12:55,725,323...55,729,707
|
|
G |
CD8A |
CD8 subunit alpha |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CD8A mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:86,784,605...86,808,396
Ensembl chr 2:86,784,610...86,808,396
|
|
G |
CD8B |
CD8 subunit beta |
affects response to substance decreases expression |
EXP |
CD8B protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CD8B protein |
CTD |
PMID:15352031 |
|
NCBI chr 2:86,815,369...86,861,886
Ensembl chr 2:86,815,339...86,861,924
|
|
G |
CD9 |
CD9 molecule |
decreases expression |
ISO |
Fluorouracil results in decreased expression of CD9 protein |
CTD |
PMID:21296659 |
|
NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271
|
|
G |
CDA |
cytidine deaminase |
multiple interactions |
ISO |
[CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil]; [CYP2B1 co-treated with CDA] results in increased susceptibility to Fluorouracil |
CTD |
PMID:10811482 |
|
NCBI chr 1:20,589,097...20,618,903
Ensembl chr 1:20,589,086...20,618,903
|
|
G |
CDC20 |
cell division cycle 20 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CDC20 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203
|
|
G |
CDC25A |
cell division cycle 25A |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CDC25A mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 3:48,157,146...48,188,417
Ensembl chr 3:48,157,146...48,188,417
|
|
G |
CDC25B |
cell division cycle 25B |
decreases expression |
EXP ISO |
Fluorouracil results in decreased expression of CDC25B mRNA |
CTD |
PMID:16709241 PMID:19272435 |
|
NCBI chr20:3,786,951...3,806,115
Ensembl chr20:3,786,772...3,806,121
|
|
G |
CDC25C |
cell division cycle 25C |
affects response to substance decreases expression |
EXP ISO |
CDC25C protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CDC25C mRNA |
CTD |
PMID:15548681 PMID:19272435 |
|
NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355
|
|
G |
CDC34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
affects response to substance |
EXP |
CDC34 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:531,760...542,087
Ensembl chr19:531,760...542,092
|
|
G |
CDC40 |
cell division cycle 40 |
increases expression |
EXP |
Fluorouracil results in increased expression of CDC40 protein |
CTD |
PMID:16803524 |
|
NCBI chr 6:110,180,427...110,232,232
Ensembl chr 6:110,180,141...110,254,275
|
|
G |
CDC42EP1 |
CDC42 effector protein 1 |
affects response to substance |
EXP |
CDC42EP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr22:37,560,480...37,569,405
Ensembl chr22:37,560,480...37,569,405
|
|
G |
CDC45 |
cell division cycle 45 |
multiple interactions decreases expression affects expression |
EXP ISO |
[Leucovorin co-treated with Fluorouracil] results in increased expression of CDC45 mRNA Fluorouracil results in decreased expression of CDC45 mRNA Fluorouracil affects the expression of CDC45 mRNA |
CTD |
PMID:15342418 PMID:16557594 PMID:19272435 |
|
NCBI chr22:19,479,466...19,520,612
Ensembl chr22:19,479,457...19,520,612
|
|
G |
CDC6 |
cell division cycle 6 |
affects expression decreases expression multiple interactions increases expression |
EXP ISO |
Fluorouracil affects the expression of CDC6 mRNA Fluorouracil results in decreased expression of CDC6 mRNA [Leucovorin co-treated with Fluorouracil] results in increased expression of CDC6 mRNA Fluorouracil results in increased expression of CDC6 mRNA |
CTD |
PMID:15342418 PMID:16557594 PMID:16709241 PMID:17039268 PMID:19272435 |
|
NCBI chr17:40,287,879...40,304,657
Ensembl chr17:40,287,879...40,304,657
|
|
G |
CDC73 |
cell division cycle 73 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CDC73 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:193,122,031...193,254,815
Ensembl chr 1:193,121,983...193,254,815
|
|
G |
CDCA5 |
cell division cycle associated 5 |
increases expression |
EXP |
Fluorouracil results in increased expression of CDCA5 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr11:65,061,093...65,084,040
Ensembl chr11:65,066,300...65,084,164
|
|
G |
CDCA7 |
cell division cycle associated 7 |
affects expression |
ISO |
Fluorouracil affects the expression of CDCA7 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 2:173,354,872...173,368,997
Ensembl chr 2:173,354,820...173,368,997
|
|
G |
CDCA8 |
cell division cycle associated 8 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CDCA8 mRNA |
CTD |
PMID:17374387 |
|
NCBI chr 1:37,692,516...37,709,719
Ensembl chr 1:37,692,481...37,709,719
|
|
G |
CDH1 |
cadherin 1 |
affects response to substance decreases expression multiple interactions |
EXP |
CDH1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CDH1 protein resveratrol inhibits the reaction [Fluorouracil results in decreased expression of CDH1 protein] |
CTD |
PMID:15352031 PMID:26310874 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CDH5 |
cadherin 5 |
increases expression multiple interactions |
ISO EXP |
Fluorouracil results in increased expression of CDH5 protein Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 protein] |
CTD |
PMID:21296659 PMID:31404653 |
|
NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784
|
|
G |
CDH6 |
cadherin 6 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CDH6 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 5:31,193,686...31,329,146
Ensembl chr 5:31,193,686...31,329,146
|
|
G |
CDIPT |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
affects expression |
EXP |
Fluorouracil affects the expression of CDIPT mRNA |
CTD |
PMID:16584549 |
|
NCBI chr16:29,858,357...29,863,226
Ensembl chr16:29,858,357...29,863,414
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
decreases expression multiple interactions increases expression affects expression |
EXP ISO |
Fluorouracil results in decreased expression of CDK1 mRNA [Leucovorin co-treated with Fluorouracil] results in increased expression of CDK1 mRNA Fluorouracil results in increased expression of CDK1 mRNA Fluorouracil affects the expression of CDK1 mRNA |
CTD |
PMID:15152939 PMID:15205334 PMID:15342418 PMID:16557594 PMID:17039268 PMID:26272751 More...
|
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CDK2 |
cyclin dependent kinase 2 |
affects response to substance multiple interactions increases expression |
EXP |
CDK2 protein affects the susceptibility to Fluorouracil; CDK2 protein modified form affects the susceptibility to Fluorouracil [Leucovorin co-treated with Fluorouracil] results in increased expression of CDK2 mRNA Fluorouracil results in increased expression of CDK2 mRNA |
CTD |
PMID:15342418 PMID:15548681 PMID:16557594 PMID:18383818 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
G |
CDK5R1 |
cyclin dependent kinase 5 regulatory subunit 1 |
affects expression |
EXP |
Fluorouracil affects the expression of CDK5R1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr17:32,486,993...32,491,253
Ensembl chr17:32,486,993...32,491,253
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
affects response to substance multiple interactions increases expression decreases degradation decreases expression decreases response to substance increases response to substance |
EXP ISO |
CDKN1A affects the susceptibility to Fluorouracil; CDKN1A protein affects the susceptibility to Fluorouracil Fluorouracil promotes the reaction [Luteolin results in increased expression of CDKN1A protein]; Luteolin promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein] Fluorouracil results in increased expression of CDKN1A mRNA; Fluorouracil results in increased expression of CDKN1A protein Fluorouracil results in increased expression of CDKN1A; Fluorouracil results in increased expression of CDKN1A mRNA; Fluorouracil results in increased expression of CDKN1A protein Fluorouracil results in decreased degradation of CDKN1A protein Fluorouracil results in decreased expression of CDKN1A mRNA; Fluorouracil results in decreased expression of CDKN1A protein [Fluorouracil co-treated with Genistein] results in increased expression of CDKN1A mRNA; [Fluorouracil co-treated with irinotecan co-treated with vorinostat] results in increased expression of CDKN1A protein; [Fluorouracil co-treated with Plant Extracts] results in increased expression of CDKN1A protein; [Leucovorin co-treated with Fluorouracil] results in increased expression of CDKN1A mRNA; CDKN1A protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; CDKN1A protein affects the reaction [Fluorouracil results in decreased expression of UBE2C protein]; Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of CDKN1A protein]; Fluorouracil promotes the reaction [[TP53 protein binds to SP1 protein] which binds to CDKN1A promoter]; Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein]; Fluorouracil promotes the reaction [Sirolimus results in increased expression of CDKN1A mRNA]; Fluorouracil promotes the reaction [temsirolimus results in increased expression of CDKN1A mRNA]; mithramycin A inhibits the reaction [Fluorouracil results in increased expression of CDKN1A protein]; Pravastatin inhibits the reaction [Fluorouracil results in decreased degradation of CDKN1A protein]; Simvastatin inhibits the reaction [Fluorouracil results in decreased degradation of CDKN1A protein]; Sirolimus promotes the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; temsirolimus promotes the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein]]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein] CDKN1A protein results in decreased susceptibility to Fluorouracil CDKN1A protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:14646558 PMID:14665630 PMID:15016801 PMID:15067352 PMID:15205334 PMID:15331170 PMID:15342418 PMID:15375580 PMID:15489892 PMID:15546879 PMID:15625077 PMID:15754201 PMID:15896711 PMID:16168113 PMID:16434701 PMID:16557594 PMID:16584549 PMID:16686938 PMID:16709241 PMID:16949053 PMID:17039268 PMID:17207318 PMID:17355264 PMID:17699798 PMID:17982676 PMID:18834353 PMID:19098008 PMID:19764996 PMID:24211769 PMID:27129209 PMID:27163855 PMID:31288002 PMID:38423379 More...
|
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
affects response to substance decreases expression |
EXP |
CDKN1B protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CDKN1B mRNA |
CTD |
PMID:17217824 PMID:18930000 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDKN1C |
cyclin dependent kinase inhibitor 1C |
affects response to substance increases expression |
EXP ISO |
CDKN1C affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CDKN1C mRNA |
CTD |
PMID:15067352 PMID:19272435 |
|
NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775
|
|
G |
CDKN2A |
cyclin dependent kinase inhibitor 2A |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CDKN2A protein |
CTD |
PMID:17982676 |
|
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
|
|
G |
CDKN2AIP |
CDKN2A interacting protein |
affects response to substance |
EXP |
CDKN2AIP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:183,444,636...183,449,064
Ensembl chr 4:183,444,635...183,449,064
|
|
G |
CDKN2C |
cyclin dependent kinase inhibitor 2C |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CDKN2C mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:50,960,745...50,974,634
Ensembl chr 1:50,960,745...50,974,634
|
|
G |
CDKN3 |
cyclin dependent kinase inhibitor 3 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CDKN3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218
|
|
G |
CDX2 |
caudal type homeobox 2 |
decreases expression |
ISO EXP |
Fluorouracil results in decreased expression of CDX2 protein Fluorouracil results in decreased expression of CDX2 mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr13:27,960,918...27,969,315
Ensembl chr13:27,960,918...27,969,315
|
|
G |
CEBPB |
CCAAT enhancer binding protein beta |
increases expression |
EXP |
Fluorouracil results in increased expression of CEBPB mRNA |
CTD |
PMID:16557594 PMID:16584549 PMID:34151400 |
|
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,734...50,192,690
|
|
G |
CENPQ |
centromere protein Q |
affects response to substance increases expression |
EXP |
CENPQ protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CENPQ mRNA |
CTD |
PMID:15331170 |
|
NCBI chr 6:49,463,370...49,493,107
Ensembl chr 6:49,463,370...49,493,107
|
|
G |
CENPU |
centromere protein U |
affects response to substance |
EXP |
CENPU protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 4:184,694,085...184,734,096
Ensembl chr 4:184,694,085...184,734,130
|
|
G |
CENPX |
centromere protein X |
affects response to substance |
EXP |
CENPX protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:82,018,703...82,022,878
Ensembl chr17:82,018,702...82,024,107
|
|
G |
CEP55 |
centrosomal protein 55 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CEP55 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr10:93,496,612...93,529,092
Ensembl chr10:93,496,612...93,529,092
|
|
G |
CER1 |
cerberus 1, DAN family BMP antagonist |
increases expression decreases expression |
ISO EXP |
Fluorouracil results in increased expression of CER1 mRNA Fluorouracil results in decreased expression of CER1 mRNA |
CTD |
PMID:24737281 PMID:26272751 |
|
NCBI chr 9:14,717,326...14,722,733
Ensembl chr 9:14,719,724...14,722,733
|
|
G |
CES2 |
carboxylesterase 2 |
multiple interactions increases expression |
EXP |
Fluorouracil promotes the reaction [TP53 protein binds to CES2 intron]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CES2 mRNA] |
CTD |
PMID:15205334 PMID:16963839 PMID:17287894 |
|
NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096
|
|
G |
CFLAR |
CASP8 and FADD like apoptosis regulator |
multiple interactions affects response to substance decreases expression increases expression |
EXP |
[Fluorouracil co-treated with IFNA1 protein] results in decreased expression of CFLAR protein; [Fluorouracil results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein; CFLAR protein alternative form inhibits the reaction [Fluorouracil results in increased activity of TNFSF10 protein]; CFLAR protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of CFLAR mRNA] CFLAR protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CFLAR mRNA; Fluorouracil results in decreased expression of CFLAR protein Fluorouracil results in increased expression of CFLAR mRNA |
CTD |
PMID:15152939 PMID:15548681 PMID:16217747 PMID:16373718 PMID:17045692 PMID:20876774 More...
|
|
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
|
|
G |
CHEK1 |
checkpoint kinase 1 |
affects response to substance decreases expression increases expression multiple interactions |
EXP ISO |
CHEK1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CHEK1 mRNA Fluorouracil results in increased expression of CHEK1 protein [CHEK1 protein co-treated with TP53 protein] affects the susceptibility to Fluorouracil; Fluorouracil results in increased phosphorylation of and results in increased activity of CHEK1 protein; TP53 protein affects the reaction [CHEK1 protein affects the susceptibility to Fluorouracil]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CHEK1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of CHEK1 protein] |
CTD |
PMID:15016801 PMID:18698031 PMID:19272435 PMID:21613406 PMID:22194930 |
|
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
|
|
G |
CHEK2 |
checkpoint kinase 2 |
multiple interactions |
EXP |
Fluorouracil results in increased phosphorylation of and results in increased activity of CHEK2 protein |
CTD |
PMID:21613406 |
|
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
|
|
G |
CHI3L1 |
chitinase 3 like 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of CHI3L1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 1:203,178,931...203,186,704
Ensembl chr 1:203,178,931...203,186,704
|
|
G |
CHRNA4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CHRNA4 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401
|
|
G |
CHST7 |
carbohydrate sulfotransferase 7 |
affects response to substance |
EXP |
CHST7 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:46,573,765...46,598,496
Ensembl chr X:46,573,765...46,598,496
|
|
G |
CIAO1 |
cytosolic iron-sulfur assembly component 1 |
affects response to substance |
EXP |
CIAO1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 2:96,266,225...96,274,173
Ensembl chr 2:96,266,159...96,274,173
|
|
G |
CIDEB |
cell death inducing DFFA like effector b |
increases expression |
EXP |
Fluorouracil results in increased expression of CIDEB protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr14:24,305,187...24,311,435
Ensembl chr14:24,305,187...24,311,430
|
|
G |
CITED2 |
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 |
affects response to substance |
EXP |
CITED2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648
|
|
G |
CKB |
creatine kinase B |
affects response to substance |
EXP |
CKB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
|
|
G |
CKS2 |
CDC28 protein kinase regulatory subunit 2 |
decreases expression |
EXP ISO |
Fluorouracil results in decreased expression of CKS2 mRNA |
CTD |
PMID:17374387 PMID:19272435 |
|
NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
|
|
G |
CLCN3 |
chloride voltage-gated channel 3 |
affects response to substance |
EXP |
CLCN3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:169,620,578...169,723,673
Ensembl chr 4:169,612,633...169,723,673
|
|
G |
CLDN2 |
claudin 2 |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of CLDN2 protein resveratrol inhibits the reaction [Fluorouracil results in decreased expression of CLDN2 protein] |
CTD |
PMID:26310874 |
|
NCBI chr X:106,900,164...106,930,861
Ensembl chr X:106,900,164...106,930,861
|
|
G |
CLDN4 |
claudin 4 |
affects response to substance decreases expression |
EXP |
CLDN4 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CLDN4 protein |
CTD |
PMID:15352031 |
|
NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690
|
|
G |
CLEC11A |
C-type lectin domain containing 11A |
affects response to substance decreases expression |
EXP |
CLEC11A protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CLEC11A protein |
CTD |
PMID:15352031 |
|
NCBI chr19:50,723,364...50,725,708
Ensembl chr19:50,723,364...50,725,708
|
|
G |
CLIC1 |
chloride intracellular channel 1 |
affects response to substance |
EXP |
CLIC1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:31,730,581...31,737,318
Ensembl chr 6:31,730,581...31,739,763
|
|
G |
CLTC |
clathrin heavy chain |
multiple interactions |
EXP |
CLTC protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CLTC mRNA] |
CTD |
PMID:15016801 PMID:18927307 |
|
NCBI chr17:59,619,895...59,696,956
Ensembl chr17:59,619,680...59,696,956
|
|
G |
COCH |
cochlin |
affects response to substance |
EXP |
COCH protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:30,874,559...30,895,615
Ensembl chr14:30,874,514...30,895,065
|
|
G |
COL12A1 |
collagen type XII alpha 1 chain |
decreases expression |
EXP |
Fluorouracil results in decreased expression of COL12A1 mRNA |
CTD |
PMID:15205334 PMID:16510598 |
|
NCBI chr 6:75,084,326...75,206,053
Ensembl chr 6:75,084,326...75,206,267
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of COL1A1 mRNA; Fluorouracil results in decreased expression of COL1A1 protein Fluorouracil promotes the reaction [Valsartan results in decreased expression of COL1A1 mRNA]; Valsartan promotes the reaction [Fluorouracil results in decreased expression of COL1A1 mRNA] |
CTD |
PMID:21296659 PMID:35235860 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL1A2 |
collagen type I alpha 2 chain |
affects expression |
ISO |
Fluorouracil affects the expression of COL1A2 mRNA |
CTD |
PMID:24704097 |
|
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
COL2A1 |
collagen type II alpha 1 chain |
decreases expression |
ISO EXP |
Fluorouracil results in decreased expression of COL2A1 protein Fluorouracil results in decreased expression of COL2A1 mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr12:47,972,967...48,006,212
Ensembl chr12:47,972,967...48,004,554
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
affects response to substance |
EXP |
COL3A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
COL4A2 |
collagen type IV alpha 2 chain |
affects response to substance decreases expression |
EXP |
COL4A2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of COL4A2 protein |
CTD |
PMID:15352031 |
|
NCBI chr13:110,307,284...110,513,209
Ensembl chr13:110,305,812...110,513,209
|
|
G |
COL5A2 |
collagen type V alpha 2 chain |
affects response to substance |
EXP |
COL5A2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:189,031,898...189,441,111
Ensembl chr 2:189,031,898...189,225,312
|
|
G |
COL6A3 |
collagen type VI alpha 3 chain |
affects response to substance multiple interactions |
EXP |
COL6A3 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of COL6A3 mRNA] |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr 2:237,324,018...237,414,164
Ensembl chr 2:237,324,003...237,414,328
|
|
G |
COX14 |
cytochrome c oxidase assembly factor COX14 |
affects expression |
EXP |
Fluorouracil affects the expression of COX14 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr12:50,112,236...50,120,453
Ensembl chr12:50,112,082...50,120,457
|
|
G |
COX5B |
cytochrome c oxidase subunit 5B |
affects expression |
EXP |
Fluorouracil affects the expression of COX5B mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 2:97,646,062...97,648,383
Ensembl chr 2:97,646,062...97,648,383
|
|
G |
COX6C |
cytochrome c oxidase subunit 6C |
affects expression |
EXP |
Fluorouracil affects the expression of COX6C mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 8:99,877,865...99,893,707
Ensembl chr 8:99,873,200...99,893,707
|
|
G |
COX7C |
cytochrome c oxidase subunit 7C |
affects expression |
EXP |
Fluorouracil affects the expression of COX7C mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 5:86,617,941...86,620,962
Ensembl chr 5:86,617,928...86,620,962
|
|
G |
CP |
ceruloplasmin |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
|
|
G |
CPA4 |
carboxypeptidase A4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CPA4 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 7:130,293,161...130,324,180
Ensembl chr 7:130,293,134...130,324,180
|
|
G |
CPD |
carboxypeptidase D |
affects response to substance multiple interactions |
EXP |
CPD protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of CPD mRNA] |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr17:30,378,927...30,469,989
Ensembl chr17:30,378,927...30,469,989
|
|
G |
CPE |
carboxypeptidase E |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of CPE protein CPE protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 4:165,379,008...165,498,547
Ensembl chr 4:165,361,194...165,498,547
|
|
G |
CPT1A |
carnitine palmitoyltransferase 1A |
affects response to substance |
EXP |
CPT1A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
|
|
G |
CPXM1 |
carboxypeptidase X, M14 family member 1 |
affects expression |
EXP |
Fluorouracil affects the expression of CPXM1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr20:2,794,074...2,800,627
Ensembl chr20:2,794,074...2,800,627
|
|
G |
CRABP1 |
cellular retinoic acid binding protein 1 |
affects response to substance increases expression |
EXP |
CRABP1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CRABP1 protein |
CTD |
PMID:15352031 |
|
NCBI chr15:78,340,353...78,348,225
Ensembl chr15:78,340,353...78,348,225
|
|
G |
CRABP2 |
cellular retinoic acid binding protein 2 |
affects expression |
ISO |
Fluorouracil affects the expression of CRABP2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:156,699,606...156,705,784
Ensembl chr 1:156,699,606...156,705,816
|
|
G |
CRHBP |
corticotropin releasing hormone binding protein |
affects expression |
EXP |
Fluorouracil affects the expression of CRHBP mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 5:76,953,045...76,981,159
Ensembl chr 5:76,953,045...76,981,158
|
|
G |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 |
affects response to substance increases expression decreases expression |
EXP |
CRIM1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CRIM1 protein Fluorouracil results in decreased expression of CRIM1 mRNA |
CTD |
PMID:15352031 PMID:16510598 |
|
NCBI chr 2:36,355,778...36,551,135
Ensembl chr 2:36,355,778...36,551,135
|
|
G |
CRIPTO |
cripto, EGF-CFC family member |
decreases expression |
ISO EXP |
Fluorouracil results in decreased expression of CRIPTO protein Fluorouracil results in decreased expression of CRIPTO mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr 3:46,574,535...46,582,457
Ensembl chr 3:46,574,534...46,582,457
|
|
G |
CRK |
CRK proto-oncogene, adaptor protein |
affects response to substance |
EXP |
CRK protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:1,420,693...1,456,232
Ensembl chr17:1,420,689...1,463,162
|
|
G |
CRYGS |
crystallin gamma S |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CRYGS mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:186,538,443...186,544,380
Ensembl chr 3:186,538,441...186,546,702
|
|
G |
CRYL1 |
crystallin lambda 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CRYL1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:20,403,669...20,525,857
Ensembl chr13:20,403,666...20,525,873
|
|
G |
CRYZ |
crystallin zeta |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of CRYZ mRNA TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CRYZ mRNA] |
CTD |
PMID:17982676 |
|
NCBI chr 1:74,705,486...74,733,050
Ensembl chr 1:74,705,482...74,733,408
|
|
G |
CSE1L |
chromosome segregation 1 like |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CSE1L mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr20:49,046,312...49,096,949
Ensembl chr20:49,046,246...49,096,960
|
|
G |
CSF1 |
colony stimulating factor 1 |
affects response to substance |
EXP |
CSF1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
|
|
G |
CSF2 |
colony stimulating factor 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of CSF2 mRNA |
CTD |
PMID:18344199 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CSNK1E |
casein kinase 1 epsilon |
affects expression |
EXP |
Fluorouracil affects the expression of CSNK1E mRNA |
CTD |
PMID:16584549 |
|
NCBI chr22:38,290,691...38,318,084
Ensembl chr22:38,290,691...38,318,084
|
|
G |
CSRP1 |
cysteine and glycine rich protein 1 |
affects response to substance |
EXP |
CSRP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:201,483,530...201,507,123
Ensembl chr 1:201,483,530...201,509,456
|
|
G |
CST7 |
cystatin F |
affects response to substance decreases expression |
EXP |
CST7 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of CST7 protein |
CTD |
PMID:15352031 |
|
NCBI chr20:24,949,269...24,959,928
Ensembl chr20:24,949,269...24,959,928
|
|
G |
CST8 |
cystatin 8 |
affects expression |
EXP |
Fluorouracil affects the expression of CST8 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr20:23,491,117...23,507,124
Ensembl chr20:23,491,101...23,496,010
|
|
G |
CSTF3 |
cleavage stimulation factor subunit 3 |
affects response to substance increases expression |
EXP |
CSTF3 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CSTF3 mRNA |
CTD |
PMID:15331170 |
|
NCBI chr11:33,084,584...33,161,480
Ensembl chr11:33,077,188...33,162,371
|
|
G |
CTBP2 |
C-terminal binding protein 2 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of CTBP2 mRNA; CTBP2 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:16391804 PMID:18927307 |
|
NCBI chr10:124,984,317...125,162,463
Ensembl chr10:124,984,317...125,161,170
|
|
G |
CTNND2 |
catenin delta 2 |
multiple interactions |
EXP |
CTNND2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 5:10,971,836...11,904,446
Ensembl chr 5:10,971,836...11,904,446
|
|
G |
CTPS1 |
CTP synthase 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CTPS1 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr 1:40,979,696...41,012,565
Ensembl chr 1:40,979,300...41,012,565
|
|
G |
CTSB |
cathepsin B |
multiple interactions increases cleavage |
EXP |
CA 074 methyl ester inhibits the reaction [Fluorouracil results in increased cleavage of CTSB protein] |
CTD |
PMID:19816940 |
|
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
|
|
G |
CTSH |
cathepsin H |
affects response to substance increases expression |
EXP |
CTSH protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of CTSH protein |
CTD |
PMID:15352031 |
|
NCBI chr15:78,921,058...78,945,046
Ensembl chr15:78,921,058...78,949,574
|
|
G |
CTTN |
cortactin |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CTTN protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr11:70,398,529...70,436,575
Ensembl chr11:70,398,404...70,436,584
|
|
G |
CUL4A |
cullin 4A |
affects response to substance |
ISO |
CUL4A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16467204 |
|
NCBI chr13:113,208,193...113,267,108
Ensembl chr13:113,208,193...113,267,108
|
|
G |
CUL4B |
cullin 4B |
increases expression |
EXP |
Fluorouracil results in increased expression of CUL4B protein |
CTD |
PMID:16803524 |
|
NCBI chr X:120,523,858...120,575,532
Ensembl chr X:120,505,920...120,604,074
|
|
G |
CUL5 |
cullin 5 |
increases expression |
EXP |
Fluorouracil results in increased expression of CUL5 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr11:108,008,898...108,107,761
Ensembl chr11:108,008,898...108,107,761
|
|
G |
CUTC |
cutC copper transporter |
affects response to substance multiple interactions |
EXP |
CUTC protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of CUTC mRNA] |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr10:99,732,234...99,756,134
Ensembl chr10:99,702,558...99,756,134
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
multiple interactions increases expression |
ISO |
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Fluorouracil results in increased expression of CXCL1 mRNA]; 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Fluorouracil results in increased expression of CXCL1 mRNA]; 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Fluorouracil results in increased expression of CXCL1 protein]; Bortezomib inhibits the reaction [Fluorouracil results in increased expression of CXCL1 mRNA]; Curcumin inhibits the reaction [Fluorouracil results in increased expression of CXCL1 mRNA]; Curcumin inhibits the reaction [Fluorouracil results in increased expression of CXCL1 protein] Fluorouracil results in increased expression of CXCL1 mRNA; Fluorouracil results in increased expression of CXCL1 protein |
CTD |
PMID:27194111 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL12 |
C-X-C motif chemokine ligand 12 |
increases expression affects expression |
ISO |
Fluorouracil results in increased expression of CXCL12 mRNA Fluorouracil affects the expression of CXCL12 mRNA |
CTD |
PMID:16337237 PMID:18344199 |
|
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO |
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Fluorouracil results in increased expression of CXCL2 mRNA]; 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Fluorouracil results in increased expression of CXCL2 mRNA]; Bortezomib inhibits the reaction [Fluorouracil results in increased expression of CXCL2 mRNA]; Curcumin inhibits the reaction [Fluorouracil results in increased expression of CXCL2 mRNA] |
CTD |
PMID:27194111 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
affects expression multiple interactions increases secretion increases expression |
EXP |
Fluorouracil affects the expression of CXCL8 mRNA 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Fluorouracil results in increased expression of CXCL8 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Fluorouracil results in increased secretion of CXCL8 protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Fluorouracil results in increased expression of CXCL8 mRNA]; SB 203580 inhibits the reaction [Fluorouracil results in increased expression of CXCL8 mRNA]; SB 203580 inhibits the reaction [Fluorouracil results in increased secretion of CXCL8 protein] |
CTD |
PMID:16584549 PMID:35147423 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCR1 |
C-X-C motif chemokine receptor 1 |
multiple interactions |
EXP |
CXCR1 gene SNP affects the susceptibility to [oxaliplatin co-treated with Fluorouracil] |
CTD |
PMID:16098254 |
|
NCBI chr 2:218,162,841...218,166,962
Ensembl chr 2:218,162,841...218,166,962
|
|
G |
CXCR4 |
C-X-C motif chemokine receptor 4 |
affects expression |
EXP |
Fluorouracil affects the expression of CXCR4 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
|
|
G |
CYC1 |
cytochrome c1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CYC1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:144,095,076...144,097,525
Ensembl chr 8:144,095,039...144,097,525
|
|
G |
CYCS |
cytochrome c, somatic |
multiple interactions |
EXP |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of CYCS mRNA |
CTD |
PMID:32800223 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
affects response to substance multiple interactions increases expression |
EXP |
CYFIP2 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA] |
CTD |
PMID:15016801 PMID:16217747 PMID:17039268 PMID:17982676 |
|
NCBI chr 5:157,266,123...157,395,594
Ensembl chr 5:157,266,079...157,395,595
|
|
G |
CYLD |
CYLD lysine 63 deubiquitinase |
increases response to substance |
EXP |
CYLD protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:21109933 |
|
NCBI chr16:50,742,086...50,801,935
Ensembl chr16:50,742,050...50,801,935
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases metabolic processing |
ISO |
CYP1A1 protein results in increased metabolism of Fluorouracil |
CTD |
PMID:17230597 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
increases chemical synthesis |
EXP |
CYP2A6 protein results in increased chemical synthesis of Fluorouracil |
CTD |
PMID:11376561 PMID:18212800 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
CYP2F1 |
cytochrome P450 family 2 subfamily F member 1 |
affects expression |
EXP |
Fluorouracil affects the expression of CYP2F1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:41,114,432...41,128,381
Ensembl chr19:41,114,432...41,128,381
|
|
G |
CYP2S1 |
cytochrome P450 family 2 subfamily S member 1 |
affects expression |
ISO |
Fluorouracil affects the expression of CYP2S1 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr19:41,193,219...41,207,539
Ensembl chr19:41,193,210...41,207,539
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
affects expression |
EXP |
Fluorouracil affects the expression of CYP3A4 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
CYP51A1 |
cytochrome P450 family 51 subfamily A member 1 |
affects response to substance |
EXP |
CYP51A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
|
|
G |
CYP51A1P2 |
cytochrome P450 family 51 subfamily A member 1 pseudogene 2 |
affects response to substance |
EXP |
CYP51A1P2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr13:28,720,868...28,724,155
Ensembl chr13:28,722,386...28,724,021
|
|
G |
CYTH3 |
cytohesin 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of CYTH3 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 7:6,161,779...6,272,624
Ensembl chr 7:6,161,779...6,272,644
|
|
G |
DAPK1 |
death associated protein kinase 1 |
affects expression increases expression |
ISO EXP |
Fluorouracil affects the expression of DAPK1 mRNA Fluorouracil results in increased expression of DAPK1 protein |
CTD |
PMID:20421339 PMID:30177839 |
|
NCBI chr 9:87,497,228...87,708,634
Ensembl chr 9:87,497,228...87,708,634
|
|
G |
DARS1 |
aspartyl-tRNA synthetase 1 |
affects expression |
EXP |
Fluorouracil affects the expression of DARS1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:135,905,881...135,985,684
Ensembl chr 2:135,905,881...135,986,100
|
|
G |
DBF4 |
DBF4-CDC7 kinase regulatory subunit |
decreases expression |
EXP |
Fluorouracil results in decreased expression of DBF4 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 7:87,876,493...87,909,553
Ensembl chr 7:87,876,216...87,909,553
|
|
G |
DBNDD2 |
dysbindin domain containing 2 |
affects response to substance |
EXP |
DBNDD2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:45,405,993...45,410,610
Ensembl chr20:45,406,057...45,410,610
|
|
G |
DCC |
DCC netrin 1 receptor |
multiple interactions |
EXP |
DCC protein results in increased susceptibility to [Fluorouracil co-treated with Levamisole] |
CTD |
PMID:15148649 |
|
NCBI chr18:52,340,197...53,535,899
Ensembl chr18:52,340,197...53,535,899
|
|
G |
DCK |
deoxycytidine kinase |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCK mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:70,993,649...71,030,914
Ensembl chr 4:70,992,538...71,030,914
|
|
G |
DCLK1 |
doublecortin like kinase 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCLK1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:35,768,652...36,131,939
Ensembl chr13:35,768,652...36,131,382
|
|
G |
DCT |
dopachrome tautomerase |
affects expression |
EXP |
Fluorouracil affects the expression of DCT mRNA |
CTD |
PMID:15205334 |
|
NCBI chr13:94,436,811...94,549,406
Ensembl chr13:94,436,811...94,479,682
|
|
G |
DCX |
doublecortin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of DCX protein |
CTD |
PMID:18702703 |
|
NCBI chr X:111,293,779...111,412,192
Ensembl chr X:111,293,779...111,412,429
|
|
G |
DCXR |
dicarbonyl and L-xylulose reductase |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCXR mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr17:82,035,858...82,037,697
Ensembl chr17:82,035,136...82,037,709
|
|
G |
DDAH2 |
DDAH family member 2, ADMA-independent |
affects response to substance |
EXP |
DDAH2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:31,727,040...31,730,263
Ensembl chr 6:31,727,038...31,730,617
|
|
G |
DDB2 |
damage specific DNA binding protein 2 |
affects response to substance increases expression multiple interactions |
EXP |
DDB2 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of DDB2 mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of DDB2 mRNA] |
CTD |
PMID:15331170 PMID:16584549 PMID:17982676 PMID:22525470 |
|
NCBI chr11:47,214,454...47,239,217
Ensembl chr11:47,214,465...47,239,217
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of DDIT3 mRNA; Fluorouracil results in increased expression of DDIT3 protein |
CTD |
PMID:17355264 PMID:29879413 PMID:32535746 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DDIT4 |
DNA damage inducible transcript 4 |
increases expression |
EXP |
Fluorouracil results in increased expression of DDIT4 mRNA |
CTD |
PMID:16510598 PMID:16557594 PMID:17039268 |
|
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
|
|
G |
DDX39B |
DExD-box helicase 39B |
increases expression |
EXP |
Fluorouracil results in increased expression of DDX39B mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:31,530,226...31,542,003
Ensembl chr 6:31,530,219...31,542,448
|
|
G |
DDX4 |
DEAD-box helicase 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of DDX4 protein |
CTD |
PMID:21296659 |
|
NCBI chr 5:55,738,061...55,817,157
Ensembl chr 5:55,738,017...55,817,157
|
|
G |
DENND2C |
DENN domain containing 2C |
affects expression |
ISO |
Fluorouracil affects the expression of DENND2C mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 1:114,582,850...114,670,049
Ensembl chr 1:114,582,848...114,670,422
|
|
G |
DEPDC7 |
DEP domain containing 7 |
affects expression |
ISO |
Fluorouracil affects the expression of DEPDC7 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr11:33,015,878...33,033,582
Ensembl chr11:33,015,876...33,033,582
|
|
G |
DES |
desmin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of DES protein |
CTD |
PMID:21296659 |
|
NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,735
|
|
G |
DFFA |
DNA fragmentation factor subunit alpha |
decreases expression |
EXP |
Fluorouracil results in decreased expression of DFFA mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:10,456,522...10,472,529
Ensembl chr 1:10,456,522...10,472,529
|
|
G |
DHFR |
dihydrofolate reductase |
affects expression increases expression |
EXP |
Fluorouracil affects the expression of DHFR mRNA Fluorouracil results in increased expression of DHFR mRNA |
CTD |
PMID:15109396 PMID:16557594 PMID:21814787 |
|
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
|
|
G |
DHX15 |
DEAH-box helicase 15 |
increases expression |
EXP |
Fluorouracil results in increased expression of DHX15 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 4:24,527,475...24,584,554
Ensembl chr 4:24,517,441...24,584,554
|
|
G |
DIABLO |
diablo IAP-binding mitochondrial protein |
increases response to substance increases expression |
EXP |
DIABLO protein results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of DIABLO mRNA |
CTD |
PMID:16557594 PMID:18031615 |
|
NCBI chr12:122,207,662...122,227,456
Ensembl chr12:122,207,668...122,226,062
|
|
G |
DICER1 |
dicer 1, ribonuclease III |
decreases expression |
EXP |
Fluorouracil results in decreased expression of DICER1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr14:95,086,228...95,158,010
Ensembl chr14:95,086,228...95,158,010
|
|
G |
DIMT1 |
DIM1 rRNA methyltransferase and ribosome maturation factor |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DIMT1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:62,387,254...62,403,905
Ensembl chr 5:62,347,284...62,403,943
|
|
G |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of DKK1 protein DKK1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042
|
|
G |
DKK4 |
dickkopf WNT signaling pathway inhibitor 4 |
increases expression |
EXP |
Fluorouracil results in increased expression of DKK4 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 8:42,374,063...42,391,322
Ensembl chr 8:42,374,063...42,377,229
|
|
G |
DLC1 |
DLC1 Rho GTPase activating protein |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DLC1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:13,083,361...13,604,620
Ensembl chr 8:13,083,361...13,604,610
|
|
G |
DLG1 |
discs large MAGUK scaffold protein 1 |
multiple interactions |
EXP |
DLG1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr 3:197,042,560...197,299,321
Ensembl chr 3:197,042,560...197,299,330
|
|
G |
DLK1 |
delta like non-canonical Notch ligand 1 |
multiple interactions increases expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DLK1 mRNA] Fluorouracil results in increased expression of DLK1 mRNA |
CTD |
PMID:15016801 PMID:24737281 |
|
NCBI chr14:100,726,892...100,738,224
Ensembl chr14:100,725,705...100,738,224
|
|
G |
DNAH2 |
dynein axonemal heavy chain 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of DNAH2 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr17:7,717,744...7,833,742
Ensembl chr17:7,717,744...7,833,742
|
|
G |
DNER |
delta/notch like EGF repeat containing |
increases expression |
EXP |
Fluorouracil results in increased expression of DNER mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 2:229,357,629...229,714,555
Ensembl chr 2:229,357,629...229,714,555
|
|
G |
DNMT3B |
DNA methyltransferase 3 beta |
decreases expression |
ISO |
Fluorouracil results in decreased expression of DNMT3B protein |
CTD |
PMID:21296659 |
|
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
|
|
G |
DPAGT1 |
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 |
affects response to substance |
EXP |
DPAGT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr11:119,093,874...119,101,853
Ensembl chr11:119,096,025...119,108,331
|
|
G |
DPY19L1 |
dpy-19 like C-mannosyltransferase 1 |
affects response to substance |
EXP |
DPY19L1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:34,928,881...35,038,041
Ensembl chr 7:34,927,292...35,038,271
|
|
G |
DPYD |
dihydropyrimidine dehydrogenase |
multiple interactions decreases activity decreases expression increases metabolic processing decreases response to substance increases activity increases expression affects activity increases degradation decreases metabolic processing affects degradation increases response to substance affects response to substance affects metabolic processing |
EXP ISO |
[Cisplatin co-treated with Fluorouracil] results in decreased expression of DPYD mRNA; [docetaxel co-treated with Fluorouracil] results in decreased expression of DPYD mRNA; [Leucovorin co-treated with Fluorouracil] results in decreased activity of DPYD protein; Camptothecin inhibits the reaction [Fluorouracil results in increased expression of DPYD mRNA]; Cisplatin inhibits the reaction [Fluorouracil results in increased expression of DPYD mRNA]; docetaxel inhibits the reaction [Fluorouracil results in increased activity of DPYD protein]; DPYD protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin]; DPYD results in increased susceptibility to [Fluorouracil co-treated with gimeracil]; Fluorouracil inhibits the reaction [docetaxel results in increased expression of DPYD protein]; gimeracil affects the reaction [DPYD protein results in increased susceptibility to Fluorouracil]; gimeracil inhibits the reaction [DPYD protein results in decreased susceptibility to Fluorouracil]; gimeracil inhibits the reaction [DPYD protein results in increased degradation of Fluorouracil]; gimeracil inhibits the reaction [DPYD protein results in increased metabolism of Fluorouracil] Fluorouracil results in decreased activity of DPYD protein Fluorouracil results in decreased expression of DPYD mRNA DPYD mRNA results in decreased susceptibility to Fluorouracil; DPYD protein results in decreased susceptibility to Fluorouracil Fluorouracil results in increased expression of DPYD mRNA; Fluorouracil results in increased expression of DPYD protein Fluorouracil metabolite affects the activity of DPYD protein DPYD gene polymorphism results in decreased metabolism of Fluorouracil; DPYD protein mutant form results in decreased metabolism of Fluorouracil DPYD protein affects the degradation of Fluorouracil DPYD gene mutant form results in increased susceptibility to Fluorouracil; DPYD gene polymorphism results in increased susceptibility to Fluorouracil; DPYD mRNA results in increased susceptibility to Fluorouracil DPYD gene polymorphism affects the susceptibility to Fluorouracil; DPYD gene SNP affects the susceptibility to Fluorouracil; DPYD intron polymorphism affects the susceptibility to Fluorouracil; DPYD mRNA affects the susceptibility to Fluorouracil; DPYD promoter modified form affects the susceptibility to Fluorouracil; DPYD protein affects the susceptibility to Fluorouracil; DPYD protein mutant form affects the susceptibility to Fluorouracil DPYD affects the metabolism of Fluorouracil; DPYD protein affects the metabolism of Fluorouracil |
CTD |
PMID:3335642 PMID:7503095 PMID:8680084 PMID:9470816 PMID:9816193 PMID:9893640 PMID:10099659 PMID:11148247 PMID:12044515 PMID:12562666 PMID:12635664 PMID:14689231 PMID:15017333 PMID:15109396 PMID:15239142 PMID:15246190 PMID:15591715 PMID:15655543 PMID:15737843 PMID:15858133 PMID:15865071 PMID:15890242 PMID:15930747 PMID:15949589 PMID:15993511 PMID:16033824 PMID:16115930 PMID:16282729 PMID:16361556 PMID:16525674 PMID:16557585 PMID:16568373 PMID:16646564 PMID:16761622 PMID:17046731 PMID:17064846 PMID:17121937 PMID:17330233 PMID:17377791 PMID:18075467 PMID:18197934 PMID:18225548 PMID:18299612 PMID:18383874 PMID:18443386 PMID:18600527 PMID:18619742 PMID:18846242 PMID:18986760 PMID:19020767 PMID:19093184 PMID:19104657 PMID:19105824 PMID:19219653 More...
|
|
NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
|
|
G |
DPYSL3 |
dihydropyrimidinase like 3 |
affects expression |
EXP |
Fluorouracil affects the expression of DPYSL3 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 5:147,390,808...147,510,068
Ensembl chr 5:147,390,808...147,510,068
|
|
G |
DRAM1 |
DNA damage regulated autophagy modulator 1 |
multiple interactions increases expression |
EXP ISO |
TP53 protein promotes the reaction [Fluorouracil results in increased expression of DRAM1 mRNA] Fluorouracil promotes the reaction [Luteolin results in increased expression of DRAM1 protein]; Luteolin promotes the reaction [Fluorouracil results in increased expression of DRAM1 protein] |
CTD |
PMID:17982676 PMID:31288002 |
|
NCBI chr12:101,877,580...101,923,612
Ensembl chr12:101,877,580...102,012,130
|
|
G |
DRD5 |
dopamine receptor D5 |
multiple interactions |
EXP |
DRD5 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 4:9,781,634...9,784,009
Ensembl chr 4:9,781,634...9,784,009
|
|
G |
DST |
dystonin |
affects response to substance |
EXP |
DST protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:56,457,996...56,954,830
Ensembl chr 6:56,457,987...56,954,830
|
|
G |
DTWD1 |
DTW domain containing 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of DTWD1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr15:49,621,048...49,656,232
Ensembl chr15:49,621,037...49,656,232
|
|
G |
DTYMK |
deoxythymidylate kinase |
affects response to substance multiple interactions increases expression |
EXP |
DTYMK affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of DTYMK mRNA] Fluorouracil results in increased expression of DTYMK mRNA |
CTD |
PMID:15016801 PMID:15067352 PMID:15109396 |
|
NCBI chr 2:241,675,747...241,686,815
Ensembl chr 2:241,675,747...241,686,944
|
|
G |
DUSP14 |
dual specificity phosphatase 14 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of DUSP14 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr17:37,488,566...37,513,498
Ensembl chr17:37,489,891...37,513,501
|
|
G |
DUSP5 |
dual specificity phosphatase 5 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of DUSP5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:110,497,907...110,511,533
Ensembl chr10:110,497,907...110,511,533
|
|
G |
DUSP6 |
dual specificity phosphatase 6 |
increases expression |
EXP |
Fluorouracil results in increased expression of DUSP6 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
|
|
G |
DUT |
deoxyuridine triphosphatase |
decreases response to substance decreases expression |
EXP |
DUT protein results in decreased susceptibility to Fluorouracil Fluorouracil results in decreased expression of DUT mRNA |
CTD |
PMID:16557594 PMID:19015155 |
|
NCBI chr15:48,331,095...48,343,373
Ensembl chr15:48,331,011...48,343,373
|
|
G |
E2F1 |
E2F transcription factor 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of E2F1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
|
|
G |
E2F2 |
E2F transcription factor 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of E2F2; Fluorouracil results in decreased expression of E2F2 mRNA |
CTD |
PMID:11300326 PMID:34151400 |
|
NCBI chr 1:23,505,212...23,531,233
Ensembl chr 1:23,506,438...23,531,233
|
|
G |
E2F3 |
E2F transcription factor 3 |
multiple interactions |
EXP |
E2F3 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 6:20,401,879...20,493,714
Ensembl chr 6:20,401,879...20,493,714
|
|
G |
E2F4 |
E2F transcription factor 4 |
multiple interactions decreases expression |
EXP |
CDKN1A protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]; TP53 protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]] Fluorouracil results in decreased expression of E2F4 mRNA |
CTD |
PMID:27129209 PMID:34151400 |
|
NCBI chr16:67,192,155...67,198,918
Ensembl chr16:67,192,155...67,198,918
|
|
G |
E2F8 |
E2F transcription factor 8 |
affects expression |
EXP |
Fluorouracil affects the expression of E2F8 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,620
|
|
G |
EBP |
EBP cholestenol delta-isomerase |
affects response to substance |
EXP |
EBP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 PMID:16217747 |
|
NCBI chr X:48,521,808...48,528,716
Ensembl chr X:48,521,799...48,528,716
|
|
G |
ECHDC3 |
enoyl-CoA hydratase domain containing 3 |
affects response to substance |
EXP |
ECHDC3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:11,742,382...11,764,070
Ensembl chr10:11,742,366...11,764,070
|
|
G |
ECHS1 |
enoyl-CoA hydratase, short chain 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of ECHS1 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr10:133,362,485...133,373,354
Ensembl chr10:133,362,485...133,373,354
|
|
G |
ECT2 |
epithelial cell transforming 2 |
multiple interactions decreases expression |
EXP |
TP53 protein promotes the reaction [Fluorouracil results in decreased expression of ECT2 mRNA] |
CTD |
PMID:17982676 |
|
NCBI chr 3:172,750,726...172,829,265
Ensembl chr 3:172,750,682...172,821,474
|
|
G |
EDIL3 |
EGF like repeats and discoidin domains 3 |
affects response to substance |
EXP |
EDIL3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 5:83,940,554...84,384,880
Ensembl chr 5:83,940,554...84,384,880
|
|
G |
EDN1 |
endothelin 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of EDN1 mRNA; Fluorouracil results in increased expression of EDN1 protein |
CTD |
PMID:1606078 PMID:19098008 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EDNRA |
endothelin receptor type A |
affects response to substance |
EXP |
EDNRA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:17032313 |
|
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
|
|
G |
EDNRB |
endothelin receptor type B |
decreases expression |
EXP |
Fluorouracil results in decreased expression of EDNRB mRNA |
CTD |
PMID:24737281 |
|
NCBI chr13:77,895,487...77,975,527
Ensembl chr13:77,895,481...77,975,529
|
|
G |
EEF1A1 |
eukaryotic translation elongation factor 1 alpha 1 |
increases expression affects expression multiple interactions |
EXP ISO |
Fluorouracil results in increased expression of EEF1A1 mRNA Fluorouracil affects the expression of EEF1A1 protein TP53 protein inhibits the reaction [Fluorouracil results in increased expression of EEF1A1 mRNA] |
CTD |
PMID:17982676 PMID:21296659 |
|
NCBI chr 6:73,515,750...73,521,032
Ensembl chr 6:73,489,308...73,525,587
|
|
G |
EEIG1 |
estrogen-induced osteoclastogenesis regulator 1 |
affects expression |
EXP |
Fluorouracil affects the expression of EEIG1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 9:127,940,582...127,980,989
Ensembl chr 9:127,940,582...127,980,989
|
|
G |
EFEMP1 |
EGF containing fibulin extracellular matrix protein 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of EFEMP1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 2:55,865,967...55,923,782
Ensembl chr 2:55,865,967...55,924,139
|
|
G |
EFHD1 |
EF-hand domain family member D1 |
affects response to substance |
EXP |
EFHD1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:232,606,057...232,682,776
Ensembl chr 2:232,606,057...232,682,776
|
|
G |
EFHD2 |
EF-hand domain family member D2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of EFHD2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:15,409,888...15,430,339
Ensembl chr 1:15,409,888...15,430,339
|
|
G |
EFNB2 |
ephrin B2 |
affects response to substance decreases expression |
EXP |
EFNB2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of EFNB2 protein |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr13:106,489,745...106,535,662
Ensembl chr13:106,489,745...106,535,662
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
[Fluorouracil co-treated with EGF protein] results in increased expression of MT2A mRNA; EGF protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; EGF protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]] |
CTD |
PMID:28507149 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
decreases response to substance decreases expression increases phosphorylation affects response to substance multiple interactions |
EXP |
EGFR gene polymorphism results in decreased susceptibility to Fluorouracil Fluorouracil results in decreased expression of EGFR protein Fluorouracil results in increased phosphorylation of EGFR protein EGFR protein affects the susceptibility to Fluorouracil [Cisplatin co-treated with Fluorouracil] results in decreased expression of EGFR mRNA; EGFR gene polymorphism affects the susceptibility to [oxaliplatin co-treated with Fluorouracil]; EGFR protein affects the susceptibility to [Cyclophosphamide co-treated with Doxorubicin co-treated with Fluorouracil]; EGFR results in increased susceptibility to [Cisplatin co-treated with docetaxel co-treated with Fluorouracil]; Fluorouracil promotes the reaction [Curcumin results in decreased expression of EGFR protein]; Fluorouracil promotes the reaction [Curcumin results in decreased phosphorylation of and results in decreased activity of EGFR protein]; Fluorouracil results in decreased phosphorylation of and results in decreased activity of EGFR protein; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EGFR protein] |
CTD |
PMID:15737843 PMID:15981280 PMID:16098254 PMID:16836928 PMID:17169374 PMID:17918158 PMID:17982676 PMID:18794807 PMID:19217205 PMID:21947696 More...
|
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGR1 |
early growth response 1 |
multiple interactions affects expression affects localization increases expression decreases expression |
EXP |
EGR1 protein affects the reaction [Fluorouracil results in increased expression of THBS1 mRNA]; EGR1 protein affects the reaction [Fluorouracil results in increased expression of THBS1 protein]; Fluorouracil promotes the reaction [EGR1 protein binds to THBS1 promoter]; SB 203580 inhibits the reaction [Fluorouracil results in increased expression of EGR1 mRNA]; SB 203580 inhibits the reaction [Fluorouracil results in increased expression of EGR1 protein] Fluorouracil affects the expression of EGR1 mRNA Fluorouracil affects the localization of EGR1 protein Fluorouracil results in decreased expression of EGR1 mRNA |
CTD |
PMID:15205334 PMID:16557594 PMID:17039268 PMID:18757417 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EHD2 |
EH domain containing 2 |
affects response to substance |
EXP |
EHD2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:47,713,422...47,743,134
Ensembl chr19:47,713,422...47,743,134
|
|
G |
EHF |
ETS homologous factor |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of EHF mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr11:34,621,093...34,663,288
Ensembl chr11:34,621,093...34,663,288
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases phosphorylation increases expression |
EXP |
Fluorouracil results in increased phosphorylation of EIF2AK3 protein Fluorouracil results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:29879413 PMID:32535746 |
|
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
|
|
G |
EIF2B2 |
eukaryotic translation initiation factor 2B subunit beta |
decreases expression |
EXP |
Fluorouracil results in decreased expression of EIF2B2 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr14:75,002,921...75,012,366
Ensembl chr14:75,002,921...75,012,366
|
|
G |
EIF2S1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation |
EXP |
Fluorouracil results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:29879413 |
|
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
|
|
G |
EIF3H |
eukaryotic translation initiation factor 3 subunit H |
increases expression |
EXP |
Fluorouracil results in increased expression of EIF3H protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 8:116,642,130...116,766,374
Ensembl chr 8:116,642,130...116,766,925
|
|
G |
EIF4E |
eukaryotic translation initiation factor 4E |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of EIF4E mRNA Fluorouracil inhibits the reaction [[CD40LG protein co-treated with CD40 protein] inhibits the reaction [EIF4E protein binds to EIF4EBP1 protein]]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EIF4E mRNA] |
CTD |
PMID:15016801 PMID:15611226 PMID:16584549 |
|
NCBI chr 4:98,879,276...98,929,133
Ensembl chr 4:98,879,276...98,929,133
|
|
G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
EXP |
Fluorouracil inhibits the reaction [[CD40LG protein co-treated with CD40 protein] inhibits the reaction [EIF4E protein binds to EIF4EBP1 protein]] |
CTD |
PMID:15611226 |
|
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
|
|
G |
EIF4H |
eukaryotic translation initiation factor 4H |
increases expression |
EXP |
Fluorouracil results in increased expression of EIF4H protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 7:74,174,356...74,197,096
Ensembl chr 7:74,174,231...74,197,122
|
|
G |
EIF5 |
eukaryotic translation initiation factor 5 |
increases expression |
EXP |
Fluorouracil results in increased expression of EIF5 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025
|
|
G |
EIPR1 |
EARP complex and GARP complex interacting protein 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of EIPR1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:3,188,970...3,377,818
Ensembl chr 2:3,188,925...3,377,830
|
|
G |
ELMO2 |
engulfment and cell motility 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of ELMO2 protein |
CTD |
PMID:16803524 |
|
NCBI chr20:46,366,050...46,406,615
Ensembl chr20:46,366,050...46,432,985
|
|
G |
ELN |
elastin |
affects expression |
EXP |
Fluorouracil affects the expression of ELN mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 7:74,028,173...74,069,907
Ensembl chr 7:74,027,789...74,069,907
|
|
G |
ELOA |
elongin A |
affects expression |
EXP |
Fluorouracil affects the expression of ELOA mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 1:23,743,471...23,762,059
Ensembl chr 1:23,743,448...23,762,059
|
|
G |
ELOVL5 |
ELOVL fatty acid elongase 5 |
affects response to substance |
EXP |
ELOVL5 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:53,267,404...53,348,950
Ensembl chr 6:53,267,398...53,349,179
|
|
G |
EMC1 |
ER membrane protein complex subunit 1 |
affects expression |
EXP |
Fluorouracil affects the expression of EMC1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:19,215,660...19,251,524
Ensembl chr 1:19,215,660...19,251,552
|
|
G |
EML2 |
EMAP like 2 |
multiple interactions |
EXP |
EML2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr19:45,609,400...45,645,629
Ensembl chr19:45,606,994...45,645,602
|
|
G |
EMP3 |
epithelial membrane protein 3 (MAM blood group) |
increases expression |
ISO |
Fluorouracil results in increased expression of EMP3 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr19:48,325,552...48,330,553
Ensembl chr19:48,321,310...48,330,559
|
|
G |
ENAH |
ENAH actin regulator |
affects response to substance |
EXP |
ENAH protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:225,486,829...225,653,878
Ensembl chr 1:225,486,765...225,653,142
|
|
G |
ENDOG |
endonuclease G |
multiple interactions increases expression |
ISO |
casticin inhibits the reaction [Fluorouracil results in increased expression of ENDOG protein] |
CTD |
PMID:32270916 |
|
NCBI chr 9:128,818,500...128,822,676
Ensembl chr 9:128,818,500...128,822,676
|
|
G |
ENOSF1 |
enolase superfamily member 1 |
affects response to substance decreases response to substance |
EXP |
ENOSF1 protein affects the susceptibility to Fluorouracil ENOSF1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15548681 PMID:18357371 |
|
NCBI chr18:662,986...712,630
Ensembl chr18:670,318...712,662
|
|
G |
ENTPD1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ENTPD1 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr10:95,694,186...95,877,266
Ensembl chr10:95,711,779...95,877,266
|
|
G |
ENTREP3 |
endosomal transmembrane epsin interactor 3 |
affects response to substance |
EXP |
ENTREP3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:155,247,205...155,255,483
Ensembl chr 1:155,247,205...155,255,483
|
|
G |
EOMES |
eomesodermin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of EOMES protein |
CTD |
PMID:21296659 |
|
NCBI chr 3:27,715,953...27,722,713
Ensembl chr 3:27,715,949...27,722,711
|
|
G |
EP300 |
E1A binding protein p300 |
multiple interactions |
EXP |
Fluorouracil promotes the reaction [EP300 protein binds to UBE2C promoter] |
CTD |
PMID:27129209 |
|
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,510...41,180,077
|
|
G |
EP400 |
E1A binding protein p400 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of EP400 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:131,949,942...132,080,460
Ensembl chr12:131,949,942...132,080,460
|
|
G |
EPAS1 |
endothelial PAS domain protein 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of EPAS1 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
|
|
G |
EPB41L3 |
erythrocyte membrane protein band 4.1 like 3 |
affects expression |
ISO |
Fluorouracil affects the expression of EPB41L3 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr18:5,392,386...5,630,663
Ensembl chr18:5,392,381...5,630,700
|
|
G |
EPHA2 |
EPH receptor A2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of EPHA2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:16,124,337...16,156,069
Ensembl chr 1:16,124,337...16,156,069
|
|
G |
EPHX1 |
epoxide hydrolase 1 |
affects response to substance increases expression |
EXP |
EPHX1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of EPHX1 mRNA |
CTD |
PMID:15205334 PMID:16217747 |
|
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
|
|
G |
EPO |
erythropoietin |
increases response to substance increases expression |
EXP ISO |
EPO protein results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of EPO protein |
CTD |
PMID:2206997 PMID:16103069 PMID:20020992 |
|
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
|
|
G |
EPOR |
erythropoietin receptor |
affects response to substance |
ISO |
EPOR gene mutant form affects the susceptibility to Fluorouracil |
CTD |
PMID:16511603 |
|
NCBI chr19:11,377,207...11,384,314
Ensembl chr19:11,377,207...11,384,342
|
|
G |
EPPK1 |
epiplakin 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of EPPK1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 8:143,857,324...143,879,194
Ensembl chr 8:143,857,324...143,878,467
|
|
G |
EPRS1 |
glutamyl-prolyl-tRNA synthetase 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of EPRS1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 1:219,968,600...220,046,505
Ensembl chr 1:219,968,600...220,046,530
|
|
G |
EPYC |
epiphycan |
affects expression |
EXP |
Fluorouracil affects the expression of EPYC mRNA |
CTD |
PMID:15205334 |
|
NCBI chr12:90,963,682...91,004,972
Ensembl chr12:90,963,682...91,005,026
|
|
G |
ERAS |
ES cell expressed Ras |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ERAS protein |
CTD |
PMID:21296659 |
|
NCBI chr X:48,826,513...48,829,869
Ensembl chr X:48,826,513...48,830,138
|
|
G |
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions decreases expression affects response to substance affects expression decreases response to substance |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ERBB2 results in decreased susceptibility to Fluorouracil]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [ERBB2 results in decreased susceptibility to Fluorouracil]; [Apigenin co-treated with Fluorouracil] results in decreased expression of ERBB2 protein; [Cisplatin co-treated with Fluorouracil] results in decreased expression of ERBB2 mRNA; [ERBB2 results in increased expression of ABCG2] which results in decreased susceptibility to Fluorouracil; ABCG2 mutant form inhibits the reaction [ERBB2 results in decreased susceptibility to Fluorouracil]; Curcumin promotes the reaction [Fluorouracil results in decreased phosphorylation of and results in decreased expression of and results in decreased activity of ERBB2 protein]; ERBB2 protein affects the susceptibility to [Cyclophosphamide co-treated with pirarubicin co-treated with Fluorouracil]; ERBB2 protein affects the susceptibility to [Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide]; ERBB2 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide]; Fluorouracil results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of ERBB2 protein Fluorouracil results in decreased expression of ERBB2 protein ERBB2 mRNA alternative form affects the susceptibility to Fluorouracil Fluorouracil affects the expression of ERBB2 mRNA ERBB2 mRNA results in decreased susceptibility to Fluorouracil; ERBB2 results in decreased susceptibility to Fluorouracil |
CTD |
PMID:9816327 PMID:15205334 PMID:15737843 PMID:15940066 PMID:16446318 PMID:16682728 PMID:17918158 PMID:18337622 PMID:19885610 PMID:21712253 PMID:36639866 PMID:39334374 More...
|
|
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
|
|
G |
ERBB3 |
erb-b2 receptor tyrosine kinase 3 |
multiple interactions |
EXP |
Fluorouracil promotes the reaction [Curcumin results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of ERBB3 protein]; Fluorouracil results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of ERBB3 protein |
CTD |
PMID:17918158 |
|
NCBI chr12:56,080,108...56,103,505
Ensembl chr12:56,076,799...56,103,505
|
|
G |
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
multiple interactions |
EXP |
ERBB4 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841
|
|
G |
ERCC1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
multiple interactions decreases expression |
EXP |
[Cisplatin co-treated with Fluorouracil] results in decreased expression of ERCC1 mRNA; ERCC1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with oxaliplatin]; ERCC1 gene SNP affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin]; ERCC1 gene SNP results in increased susceptibility to [Cisplatin co-treated with Fluorouracil]; ERCC1 mRNA affects the susceptibility to [Cisplatin co-treated with Fluorouracil] Fluorouracil results in decreased expression of ERCC1 mRNA |
CTD |
PMID:15173087 PMID:15213713 PMID:15737843 PMID:17016597 PMID:17401013 PMID:18448328 PMID:21286668 More...
|
|
NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
|
|
G |
ERCC2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
multiple interactions |
EXP |
ERCC2 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with Oxaliplatin]; ERCC2 gene SNP affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Oxaliplatin] |
CTD |
PMID:15213713 PMID:17401013 |
|
NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
|
|
G |
EREG |
epiregulin |
decreases expression |
EXP |
Fluorouracil results in decreased expression of EREG mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of ERN1 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
|
|
G |
ERP29 |
endoplasmic reticulum protein 29 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ERP29 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr12:112,013,426...112,023,449
Ensembl chr12:112,013,348...112,023,449
|
|
G |
ESPL1 |
extra spindle pole bodies like 1, separase |
affects response to substance |
EXP |
ESPL1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr12:53,268,299...53,293,638
Ensembl chr12:53,268,299...53,293,638
|
|
G |
ETF1 |
eukaryotic translation termination factor 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ETF1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:138,506,095...138,543,236
Ensembl chr 5:138,506,095...138,543,236
|
|
G |
ETFB |
electron transfer flavoprotein subunit beta |
affects response to substance |
EXP |
ETFB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr19:51,345,155...51,366,388
Ensembl chr19:51,345,169...51,366,388
|
|
G |
ETS1 |
ETS proto-oncogene 1, transcription factor |
multiple interactions increases expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ETS1 mRNA] Fluorouracil results in increased expression of ETS1 protein |
CTD |
PMID:15016801 PMID:30177839 |
|
NCBI chr11:128,458,765...128,587,558
Ensembl chr11:128,458,761...128,587,558
|
|
G |
ETV2 |
ETS variant transcription factor 2 |
multiple interactions |
EXP |
Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 protein]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN protein] |
CTD |
PMID:31404653 |
|
NCBI chr19:35,641,745...35,644,871
Ensembl chr19:35,641,745...35,644,871
|
|
G |
EXO1 |
exonuclease 1 |
affects response to substance |
EXP |
HEXO1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16477629 |
|
NCBI chr 1:241,847,986...241,889,939
Ensembl chr 1:241,847,967...241,895,148
|
|
G |
EXOSC10 |
exosome component 10 |
affects response to substance increases metabolic processing |
EXP |
EXOSC10 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased metabolism of EXOSC10 protein |
CTD |
PMID:18567802 |
|
NCBI chr 1:11,066,618...11,099,869
Ensembl chr 1:11,066,618...11,099,869
|
|
G |
F12 |
coagulation factor XII |
affects response to substance decreases expression |
EXP |
F12 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of F12 protein |
CTD |
PMID:15352031 |
|
NCBI chr 5:177,402,141...177,409,564
Ensembl chr 5:177,402,133...177,416,583
|
|
G |
F2 |
coagulation factor II, thrombin |
decreases expression |
EXP |
Fluorouracil results in decreased expression of F2 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of F3 mRNA F3 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:16510598 |
|
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
|
|
G |
F8 |
coagulation factor VIII |
multiple interactions |
EXP |
F8 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr X:154,835,792...155,022,723
Ensembl chr X:154,835,788...155,026,940
|
|
G |
FABP7 |
fatty acid binding protein 7 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FABP7 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 6:122,749,201...122,784,074
Ensembl chr 6:122,779,716...122,784,074
|
|
G |
FADD |
Fas associated via death domain |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FADD mRNA |
CTD |
PMID:34151400 |
|
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
|
|
G |
FADS1 |
fatty acid desaturase 1 |
affects response to substance |
EXP |
FADS1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr11:61,799,627...61,817,003
Ensembl chr11:61,799,627...61,829,318
|
|
G |
FAH |
fumarylacetoacetate hydrolase |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of FAH mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr15:80,152,789...80,186,949
Ensembl chr15:80,152,490...80,186,946
|
|
G |
FAM107B |
family with sequence similarity 107 member B |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of FAM107B mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:14,518,557...14,774,897
Ensembl chr10:14,518,557...14,774,897
|
|
G |
FAM114A1 |
family with sequence similarity 114 member A1 |
affects expression |
EXP |
Fluorouracil affects the expression of FAM114A1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 4:38,867,806...38,945,739
Ensembl chr 4:38,867,677...38,945,739
|
|
G |
FAM171A1 |
family with sequence similarity 171 member A1 |
affects response to substance |
EXP |
FAM171A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:15,211,643...15,374,554
Ensembl chr10:15,211,643...15,371,289
|
|
G |
FAM20C |
FAM20C golgi associated secretory pathway kinase |
affects expression |
EXP |
Fluorouracil affects the expression of FAM20C mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:192,571...260,772
Ensembl chr 7:192,571...260,772
|
|
G |
FAM234B |
family with sequence similarity 234 member B |
multiple interactions |
EXP |
FAM234B mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr12:13,044,381...13,083,449
Ensembl chr12:13,044,381...13,142,521
|
|
G |
FAM76B |
family with sequence similarity 76 member B |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FAM76B mRNA |
CTD |
PMID:16510598 |
|
NCBI chr11:95,768,953...95,789,782
Ensembl chr11:95,768,953...95,790,409
|
|
G |
FANCC |
FA complementation group C |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FANCC mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 9:95,099,054...95,317,709
Ensembl chr 9:95,099,054...95,426,796
|
|
G |
FANCG |
FA complementation group G |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of FANCG mRNA FANCG affects the susceptibility to Fluorouracil; FANCG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:15109396 PMID:15548681 |
|
NCBI chr 9:35,073,839...35,079,942
Ensembl chr 9:35,073,835...35,080,004
|
|
G |
FANCI |
FA complementation group I |
affects response to substance |
EXP |
FANCI protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr15:89,243,979...89,317,259
Ensembl chr15:89,243,945...89,317,261
|
|
G |
FARS2 |
phenylalanyl-tRNA synthetase 2, mitochondrial |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FARS2 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 6:5,249,934...5,771,583
Ensembl chr 6:5,261,044...5,829,192
|
|
G |
FAS |
Fas cell surface death receptor |
multiple interactions increases expression |
EXP |
[Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of FAS mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of FAS protein; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP3 protein]; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP8 protein]; FAS protein affects the reaction [Fluorouracil results in increased activity of CASP9 protein]; N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased expression of FAS protein]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FAS mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FAS protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FAS protein]; TP53 protein promotes the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased expression of FAS protein]] Fluorouracil results in increased expression of FAS; Fluorouracil results in increased expression of FAS mRNA; Fluorouracil results in increased expression of FAS protein |
CTD |
PMID:11300326 PMID:14665630 PMID:15016801 PMID:15034078 PMID:15152939 PMID:15161716 PMID:15546879 PMID:15585135 PMID:16557594 PMID:16596200 PMID:16709241 PMID:16957513 PMID:17039268 PMID:17045692 PMID:17056233 PMID:17982676 PMID:18074150 PMID:19015929 PMID:22525470 PMID:33770205 PMID:34151400 More...
|
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
increases response to substance increases expression |
ISO |
FASL results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of FASL |
CTD |
PMID:11196169 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FASTK |
Fas activated serine/threonine kinase |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FASTK mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:151,076,624...151,080,809
Ensembl chr 7:151,076,624...151,080,866
|
|
G |
FBLN1 |
fibulin 1 |
affects expression increases expression |
EXP |
Fluorouracil affects the expression of FBLN1 mRNA Fluorouracil results in increased expression of FBLN1 mRNA |
CTD |
PMID:15205334 PMID:17039268 |
|
NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135
|
|
G |
FBXO5 |
F-box protein 5 |
decreases expression |
EXP ISO |
Fluorouracil results in decreased expression of FBXO5 mRNA |
CTD |
PMID:16557594 PMID:19272435 |
|
NCBI chr 6:152,970,535...152,983,579
Ensembl chr 6:152,970,519...152,983,579
|
|
G |
FDXR |
ferredoxin reductase |
multiple interactions increases expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of FDXR mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FDXR mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FDXR protein] Fluorouracil results in increased expression of FDXR mRNA; Fluorouracil results in increased expression of FDXR mRNA alternative form; Fluorouracil results in increased expression of FDXR protein |
CTD |
PMID:14665630 PMID:15016801 PMID:15205334 PMID:16557594 PMID:17982676 PMID:22966307 More...
|
|
NCBI chr17:74,862,497...74,872,994
Ensembl chr17:74,862,497...74,873,031
|
|
G |
FEN1 |
flap structure-specific endonuclease 1 |
affects response to substance increases expression |
EXP |
FEN1 affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of FEN1 mRNA |
CTD |
PMID:15067352 PMID:15109396 |
|
NCBI chr11:61,792,911...61,797,238
Ensembl chr11:61,792,911...61,797,238
|
|
G |
FERMT2 |
FERM domain containing kindlin 2 |
affects response to substance |
EXP |
FERMT2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:52,857,273...52,951,050
Ensembl chr14:52,857,268...52,952,435
|
|
G |
FGD6 |
FYVE, RhoGEF and PH domain containing 6 |
affects response to substance |
EXP |
FGD6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr12:95,076,749...95,217,467
Ensembl chr12:95,076,749...95,217,482
|
|
G |
FGF2 |
fibroblast growth factor 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FGF2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
|
|
G |
FGF4 |
fibroblast growth factor 4 |
affects expression |
ISO |
Fluorouracil affects the expression of FGF4 protein |
CTD |
PMID:21296659 |
|
NCBI chr11:69,771,022...69,775,341
Ensembl chr11:69,771,022...69,775,341
|
|
G |
FGF5 |
fibroblast growth factor 5 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FGF5 protein |
CTD |
PMID:21296659 |
|
NCBI chr 4:80,266,588...80,291,017
Ensembl chr 4:80,266,639...80,336,680
|
|
G |
FGF7 |
fibroblast growth factor 7 |
decreases response to substance multiple interactions |
EXP |
FGF7 protein results in decreased susceptibility to Fluorouracil; FGF7 results in decreased susceptibility to Fluorouracil FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Fluorouracil]; FGFR2 protein alternative form inhibits the reaction [FGF7 protein results in decreased susceptibility to Fluorouracil] |
CTD |
PMID:18575591 |
|
NCBI chr15:49,423,242...49,488,775
Ensembl chr15:49,423,237...49,488,775
|
|
G |
FGFR2 |
fibroblast growth factor receptor 2 |
multiple interactions |
EXP |
FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Fluorouracil]; FGFR2 protein alternative form inhibits the reaction [FGF7 protein results in decreased susceptibility to Fluorouracil] |
CTD |
PMID:18575591 |
|
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
|
|
G |
FGG |
fibrinogen gamma chain |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of FGG mRNA FGG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:17039268 |
|
NCBI chr 4:154,604,136...154,612,656
Ensembl chr 4:154,604,134...154,612,967
|
|
G |
FHL2 |
four and a half LIM domains 2 |
affects response to substance |
EXP |
FHL2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:105,357,712...105,438,529
Ensembl chr 2:105,357,712...105,438,513
|
|
G |
FHL3 |
four and a half LIM domains 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of FHL3 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 1:37,996,770...38,005,514
Ensembl chr 1:37,996,764...38,005,606
|
|
G |
FIBCD1 |
fibrinogen C domain containing 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FIBCD1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 9:130,902,440...130,940,709
Ensembl chr 9:130,902,438...130,939,286
|
|
G |
FILIP1L |
filamin A interacting protein 1 like |
affects response to substance increases expression |
EXP |
FILIP1L protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of FILIP1L protein |
CTD |
PMID:15352031 |
|
NCBI chr 3:99,828,811...100,114,501
Ensembl chr 3:99,828,811...100,114,513
|
|
G |
FKBP11 |
FKBP prolyl isomerase 11 |
affects response to substance |
EXP |
FKBP11 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr12:48,921,963...48,939,034
Ensembl chr12:48,921,518...48,926,474
|
|
G |
FKBP1B |
FKBP prolyl isomerase 1B |
affects response to substance |
EXP |
FKBP1B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:24,033,206...24,063,681
Ensembl chr 2:24,049,701...24,063,681
|
|
G |
FKBP5 |
FKBP prolyl isomerase 5 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of FKBP5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
|
|
G |
FKBPL |
FKBP prolyl isomerase like |
increases expression |
EXP |
Fluorouracil results in increased expression of FKBPL mRNA |
CTD |
PMID:14503796 |
|
NCBI chr 6:32,128,707...32,130,288
Ensembl chr 6:32,128,707...32,130,288
|
|
G |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
affects response to substance |
EXP |
FLRT2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:85,530,144...85,654,428
Ensembl chr14:85,530,144...85,654,428
|
|
G |
FLT1 |
fms related receptor tyrosine kinase 1 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of FLT1 protein IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of FLT1 protein] |
CTD |
PMID:18157009 |
|
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
|
|
G |
FMOD |
fibromodulin |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of FMOD mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:203,340,628...203,351,122
Ensembl chr 1:203,340,628...203,351,758
|
|
G |
FN1 |
fibronectin 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FN1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FNBP1 |
formin binding protein 1 |
affects response to substance |
EXP |
FNBP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:129,887,187...130,053,879
Ensembl chr 9:129,887,187...130,043,189
|
|
G |
FNDC3B |
fibronectin type III domain containing 3B |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of FNDC3B mRNA FNDC3B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:16510598 |
|
NCBI chr 3:172,039,578...172,401,669
Ensembl chr 3:172,039,578...172,401,669
|
|
G |
FOLR1 |
folate receptor alpha |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FOLR1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr11:72,189,709...72,196,323
Ensembl chr11:72,189,558...72,196,323
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression affects expression |
EXP |
Fluorouracil results in increased expression of FOS mRNA Fluorouracil affects the expression of FOS mRNA |
CTD |
PMID:15205334 PMID:17039268 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
FOSL1 |
FOS like 1, AP-1 transcription factor subunit |
affects expression |
EXP |
Fluorouracil affects the expression of FOSL1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
|
|
G |
FOXA2 |
forkhead box A2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FOXA2 protein |
CTD |
PMID:21296659 |
|
NCBI chr20:22,580,998...22,585,490
Ensembl chr20:22,580,998...22,585,455
|
|
G |
FOXC1 |
forkhead box C1 |
affects expression |
EXP |
Fluorouracil affects the expression of FOXC1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 6:1,609,915...1,613,897
Ensembl chr 6:1,609,915...1,613,897
|
|
G |
FOXD3 |
forkhead box D3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of FOXD3 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:63,322,567...63,325,128
Ensembl chr 1:63,322,567...63,325,128
|
|
G |
FOXG1 |
forkhead box G1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FOXG1 mRNA |
CTD |
PMID:30518710 |
|
NCBI chr14:28,766,787...28,770,277
Ensembl chr14:28,764,329...28,770,277
|
|
G |
FOXL2 |
forkhead box L2 |
increases expression |
EXP |
Fluorouracil results in increased expression of FOXL2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 3:138,944,224...138,947,137
Ensembl chr 3:138,944,224...138,947,137
|
|
G |
FOXM1 |
forkhead box M1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of FOXM1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr12:2,857,680...2,877,174
Ensembl chr12:2,857,680...2,877,174
|
|
G |
FOXN3 |
forkhead box N3 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of FOXN3 protein FOXN3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr14:89,156,177...89,619,165
Ensembl chr14:89,124,871...89,619,149
|
|
G |
FOXO3 |
forkhead box O3 |
affects response to substance |
EXP |
FOXO3 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 |
|
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
|
|
G |
FPGS |
folylpolyglutamate synthase |
increases response to substance |
EXP |
FPGS protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:15542523 |
|
NCBI chr 9:127,802,858...127,814,506
Ensembl chr 9:127,794,597...127,814,494
|
|
G |
FTLP3 |
ferritin light chain pseudogene 3 |
affects response to substance |
EXP |
FTLP3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:4,023,718...4,024,588
Ensembl chr20:4,023,917...4,024,444
|
|
G |
FUT1 |
fucosyltransferase 1 (H blood group) |
affects response to substance |
EXP |
FUT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15649251 |
|
NCBI chr19:48,748,011...48,755,358
Ensembl chr19:48,748,011...48,755,390
|
|
G |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of FXYD3 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr19:35,115,823...35,124,324
Ensembl chr19:35,115,823...35,124,324
|
|
G |
FYN |
FYN proto-oncogene, Src family tyrosine kinase |
affects response to substance |
EXP |
FYN protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452
|
|
G |
FZD2 |
frizzled class receptor 2 |
affects response to substance |
EXP |
FZD2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:44,557,484...44,561,262
Ensembl chr17:44,557,484...44,561,262
|
|
G |
G0S2 |
G0/G1 switch 2 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of G0S2 protein G0S2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390
|
|
G |
GABRB3 |
gamma-aminobutyric acid type A receptor subunit beta3 |
increases expression |
ISO |
Fluorouracil results in increased expression of GABRB3 protein |
CTD |
PMID:21296659 |
|
NCBI chr15:26,543,552...26,773,763
Ensembl chr15:26,543,552...26,939,539
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
increases expression decreases expression affects response to substance increases response to substance multiple interactions |
EXP ISO |
Fluorouracil results in increased expression of GADD45A mRNA; Fluorouracil results in increased expression of GADD45A protein Fluorouracil results in decreased expression of GADD45A mRNA GADD45A protein affects the susceptibility to Fluorouracil GADD45A protein results in increased susceptibility to Fluorouracil GADD45A affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in increased expression of GADD45A mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of GADD45A mRNA] |
CTD |
PMID:15016801 PMID:15067352 PMID:15205334 PMID:16709241 PMID:16732331 PMID:17982676 PMID:19003803 PMID:19098008 PMID:19272435 PMID:22525470 PMID:30177839 More...
|
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GADD45B |
growth arrest and DNA damage inducible beta |
decreases response to substance affects response to substance multiple interactions |
EXP ISO |
GADD45B protein results in decreased susceptibility to Fluorouracil GADD45B protein affects the susceptibility to Fluorouracil IFNG protein inhibits the reaction [GADD45B protein results in decreased susceptibility to Fluorouracil] |
CTD |
PMID:16732331 PMID:17711513 |
|
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,805
|
|
G |
GADD45G |
growth arrest and DNA damage inducible gamma |
increases expression |
ISO |
Fluorouracil results in increased expression of GADD45G mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555
|
|
G |
GAL |
galanin and GMAP prepropeptide |
decreases expression |
ISO |
Fluorouracil results in decreased expression of GAL protein |
CTD |
PMID:21296659 |
|
NCBI chr11:68,684,544...68,691,175
Ensembl chr11:68,683,779...68,691,175
|
|
G |
GALNT3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
affects response to substance |
EXP |
GALNT3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:165,747,588...165,794,692
Ensembl chr 2:165,747,588...165,846,201
|
|
G |
GAMT |
guanidinoacetate N-methyltransferase |
increases expression affects response to substance multiple interactions |
EXP |
Fluorouracil results in increased expression of GAMT protein GAMT protein affects the susceptibility to Fluorouracil GAMT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GAMT mRNA] |
CTD |
PMID:15016801 PMID:15352031 PMID:16896004 |
|
NCBI chr19:1,397,026...1,401,542
Ensembl chr19:1,397,026...1,401,570
|
|
G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
affects splicing decreases expression |
EXP ISO |
Fluorouracil affects the splicing of GAPDH mRNA Fluorouracil results in decreased expression of GAPDH protein |
CTD |
PMID:17169984 PMID:21296659 |
|
NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
|
|
G |
GART |
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase |
increases expression |
EXP |
Fluorouracil results in increased expression of GART mRNA |
CTD |
PMID:19219653 |
|
NCBI chr21:33,503,931...33,542,893
Ensembl chr21:33,503,931...33,543,491
|
|
G |
GAST |
gastrin |
decreases response to substance |
ISO |
GAST protein modified form results in decreased susceptibility to Fluorouracil |
CTD |
PMID:16618411 |
|
NCBI chr17:41,712,331...41,715,969
Ensembl chr17:41,712,331...41,715,969
|
|
G |
GATA2 |
GATA binding protein 2 |
multiple interactions |
EXP |
Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 protein]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN protein] |
CTD |
PMID:31404653 |
|
NCBI chr 3:128,479,422...128,493,201
Ensembl chr 3:128,479,427...128,493,201
|
|
G |
GATA4 |
GATA binding protein 4 |
affects expression |
ISO |
Fluorouracil affects the expression of GATA4 protein |
CTD |
PMID:21296659 |
|
NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,959...11,760,002
|
|
G |
GATA6 |
GATA binding protein 6 |
affects expression |
ISO |
Fluorouracil affects the expression of GATA6 protein |
CTD |
PMID:21296659 |
|
NCBI chr18:22,169,589...22,202,528
Ensembl chr18:22,169,589...22,202,528
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
affects response to substance |
EXP |
GCLM protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GCSH |
glycine cleavage system protein H |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of GCSH mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:81,081,945...81,096,395
Ensembl chr16:81,081,945...81,096,395
|
|
G |
GDF1 |
growth differentiation factor 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of GDF1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:18,868,545...18,896,158
Ensembl chr19:18,868,545...18,896,158
|
|
G |
GDF15 |
growth differentiation factor 15 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of GDF15 mRNA; Fluorouracil results in increased expression of GDF15 protein TP53 protein affects the reaction [Fluorouracil results in increased expression of GDF15 mRNA] |
CTD |
PMID:14665630 PMID:15016801 PMID:15205334 PMID:24737281 |
|
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
|
|
G |
GDF3 |
growth differentiation factor 3 |
affects expression |
ISO |
Fluorouracil affects the expression of GDF3 protein |
CTD |
PMID:21296659 |
|
NCBI chr12:7,689,784...7,695,775
Ensembl chr12:7,689,784...7,695,775
|
|
G |
GEM |
GTP binding protein overexpressed in skeletal muscle |
affects expression |
EXP |
Fluorouracil affects the expression of GEM mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 8:94,249,253...94,262,319
Ensembl chr 8:94,249,253...94,262,350
|
|
G |
GFAP |
glial fibrillary acidic protein |
increases expression |
ISO |
Fluorouracil results in increased expression of GFAP protein |
CTD |
PMID:21296659 |
|
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
|
|
G |
GFRA1 |
GDNF family receptor alpha 1 |
multiple interactions |
EXP |
GFRA1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803
|
|
G |
GINS1 |
GINS complex subunit 1 |
increases response to substance |
ISO |
GINS1 gene mutant form results in increased susceptibility to Fluorouracil |
CTD |
PMID:18984863 |
|
NCBI chr20:25,407,673...25,448,563
Ensembl chr20:25,391,008...25,452,700
|
|
G |
GINS2 |
GINS complex subunit 2 |
affects expression |
EXP |
Fluorouracil affects the expression of GINS2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr16:85,676,198...85,688,954
Ensembl chr16:85,676,198...85,690,073
|
|
G |
GJA1 |
gap junction protein alpha 1 |
affects response to substance |
ISO EXP |
GJA1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:16531325 |
|
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
|
|
G |
GJC1 |
gap junction protein gamma 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of GJC1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr17:44,794,104...44,831,364
Ensembl chr17:44,798,448...44,830,816
|
|
G |
GLA |
galactosidase alpha |
affects response to substance |
EXP |
GLA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:101,397,803...101,407,925
Ensembl chr X:101,393,273...101,408,012
|
|
G |
GLI1 |
GLI family zinc finger 1 |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of GLI1 mRNA GLI1 protein inhibits the reaction [Fluorouracil affects the localization of PTCH1 protein] |
CTD |
PMID:18776995 |
|
NCBI chr12:57,459,785...57,472,268
Ensembl chr12:57,459,785...57,472,268
|
|
G |
GLIPR1 |
GLI pathogenesis related 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of GLIPR1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr12:75,480,755...75,503,863
Ensembl chr12:75,480,753...75,503,863
|
|
G |
GNB2 |
G protein subunit beta 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of GNB2 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 7:100,673,740...100,679,169
Ensembl chr 7:100,673,567...100,679,174
|
|
G |
GNE |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of GNE protein GNE protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 9:36,214,441...36,276,978
Ensembl chr 9:36,214,441...36,277,042
|
|
G |
GOLGA8A |
golgin A8 family member A |
multiple interactions |
EXP |
GOLGA8A mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr15:34,379,068...34,437,808
Ensembl chr15:34,378,935...34,437,808
|
|
G |
GOLPH3 |
golgi phosphoprotein 3 |
increases response to substance |
EXP |
GOLPH3 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:38828452 |
|
NCBI chr 5:32,124,716...32,174,319
Ensembl chr 5:32,124,716...32,174,319
|
|
G |
GP1BB |
glycoprotein Ib platelet subunit beta |
affects expression |
EXP |
Fluorouracil affects the expression of GP1BB mRNA |
CTD |
PMID:16584549 |
|
NCBI chr22:19,723,539...19,724,771
Ensembl chr22:19,723,539...19,724,771
|
|
G |
GPR132 |
G protein-coupled receptor 132 |
increases expression |
EXP |
Fluorouracil results in increased expression of GPR132 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr14:105,049,395...105,065,430
Ensembl chr14:105,049,395...105,065,445
|
|
G |
GPR137C |
G protein-coupled receptor 137C |
affects expression |
EXP |
Fluorouracil affects the expression of GPR137C mRNA |
CTD |
PMID:16584549 |
|
NCBI chr14:52,552,836...52,637,713
Ensembl chr14:52,552,836...52,637,713
|
|
G |
GPR35 |
G protein-coupled receptor 35 |
affects response to substance increases expression |
EXP |
GPR35 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of GPR35 mRNA |
CTD |
PMID:15331170 |
|
NCBI chr 2:240,605,430...240,633,159
Ensembl chr 2:240,605,430...240,633,159
|
|
G |
GPR87 |
G protein-coupled receptor 87 |
increases expression |
EXP |
Fluorouracil results in increased expression of GPR87 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 3:151,294,086...151,316,820
Ensembl chr 3:151,294,086...151,316,820
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions increases activity |
ISO |
Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased activity of GPT protein] Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of GPT protein] Fluorouracil results in increased activity of GPT protein |
CTD |
PMID:27836789 PMID:29678497 PMID:31129132 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GPX1 |
glutathione peroxidase 1 |
increases expression decreases activity multiple interactions |
EXP ISO |
Fluorouracil results in increased expression of GPX1 mRNA Fluorouracil results in decreased activity of GPX1 protein TP53 protein promotes the reaction [Fluorouracil results in increased expression of GPX1 mRNA] |
CTD |
PMID:17982676 PMID:29117755 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GPX2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of GPX2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
|
|
G |
GPX4 |
glutathione peroxidase 4 |
multiple interactions decreases expression |
ISO |
ferrostatin-1 inhibits the reaction [Fluorouracil results in decreased expression of GPX4 protein] |
CTD |
PMID:35101590 |
|
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
|
|
G |
GRAMD4 |
GRAM domain containing 4 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of GRAMD4 mRNA TP73 protein promotes the reaction [Fluorouracil results in increased expression of GRAMD4 mRNA] |
CTD |
PMID:21127500 |
|
NCBI chr22:46,575,744...46,682,756
Ensembl chr22:46,576,012...46,679,790
|
|
G |
GRB7 |
growth factor receptor bound protein 7 |
increases expression |
ISO |
Fluorouracil results in increased expression of GRB7 protein |
CTD |
PMID:21296659 |
|
NCBI chr17:39,737,938...39,747,285
Ensembl chr17:39,737,927...39,747,291
|
|
G |
GRHL3 |
grainyhead like transcription factor 3 |
affects expression |
EXP |
Fluorouracil affects the expression of GRHL3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:24,319,357...24,364,482
Ensembl chr 1:24,199,558...24,364,482
|
|
G |
GRINA |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
affects expression |
EXP |
Fluorouracil affects the expression of GRINA mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 8:143,990,056...143,993,415
Ensembl chr 8:143,990,056...143,993,415
|
|
G |
GSPT1 |
G1 to S phase transition 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of GSPT1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:11,868,128...11,916,654
Ensembl chr16:11,868,128...11,916,082
|
|
G |
GSR |
glutathione-disulfide reductase |
decreases activity |
EXP |
Fluorouracil results in decreased activity of GSR protein |
CTD |
PMID:32752303 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GSTA4 |
glutathione S-transferase alpha 4 |
affects response to substance |
EXP |
GSTA4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:52,977,953...52,995,284
Ensembl chr 6:52,977,948...52,995,304
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
multiple interactions |
EXP |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of GSTM1 mRNA |
CTD |
PMID:32800223 |
|
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of GSTP1 mRNA [Cisplatin co-treated with Fluorouracil] results in decreased expression of GSTP1 mRNA; GSTP1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with oxaliplatin]; GSTP1 gene polymorphism results in decreased susceptibility to [Fluorouracil co-treated with Cisplatin] |
CTD |
PMID:15205334 PMID:15213713 PMID:15737843 PMID:16622263 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
GSTT1 |
glutathione S-transferase theta 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of GSTT1 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
|
|
G |
GTPBP4 |
GTP binding protein 4 |
affects response to substance |
EXP |
GTPBP4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:988,434...1,019,932
Ensembl chr10:988,434...1,019,932
|
|
G |
GUCY1B1 |
guanylate cyclase 1 soluble subunit beta 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of GUCY1B1 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr 4:155,759,021...155,807,811
Ensembl chr 4:155,758,992...155,807,811
|
|
G |
GYG2 |
glycogenin 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of GYG2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr X:2,828,930...2,882,818
Ensembl chr X:2,828,822...2,882,818
|
|
G |
H1-0 |
H1.0 linker histone |
affects expression |
ISO |
Fluorouracil affects the expression of H1F0 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432
|
|
G |
H1-3 |
H1.3 linker histone, cluster member |
increases expression |
EXP |
Fluorouracil results in increased expression of H1-3 protein |
CTD |
PMID:15585135 |
|
NCBI chr 6:26,234,212...26,234,987
Ensembl chr 6:26,234,212...26,234,987
|
|
G |
H2AX |
H2A.X variant histone |
affects expression multiple interactions increases phosphorylation |
EXP |
Fluorouracil affects the expression of H2AX mRNA [Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased expression of H2AX protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein]; TP53 gene mutant form affects the reaction [benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein]]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of H2AX mRNA] Fluorouracil results in increased phosphorylation of H2AX protein |
CTD |
PMID:15016801 PMID:16584549 PMID:25940438 PMID:26544897 PMID:34510228 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
H2BC12 |
H2B clustered histone 12 |
decreases expression affects response to substance increases expression |
EXP |
Fluorouracil results in decreased expression of H2BC12 mRNA H2BC12 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of H2BC12 protein |
CTD |
PMID:15352031 PMID:16101138 PMID:16217747 |
|
NCBI chr 6:27,138,293...27,146,858
Ensembl chr 6:27,137,298...27,146,855
|
|
G |
H3-7 |
H3.7 histone (putative) |
decreases expression |
EXP |
Fluorouracil results in decreased expression of H3-7 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 1:143,902,386...143,905,977
Ensembl chr 1:143,894,544...143,905,977
|
|
G |
H4C14 |
H4 clustered histone 14 |
affects expression |
EXP |
Fluorouracil affects the expression of H4C14 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:149,832,657...149,833,052
Ensembl chr 1:149,832,657...149,839,767
|
|
G |
H4C2 |
H4 clustered histone 2 |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of H4C2 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of H4C2 mRNA] |
CTD |
PMID:15016801 PMID:17039268 |
|
NCBI chr 6:26,026,896...26,027,283
Ensembl chr 6:26,025,802...26,027,283
|
|
G |
H4C3 |
H4 clustered histone 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of H4C3 mRNA |
CTD |
PMID:16510598 PMID:17039268 |
|
NCBI chr 6:26,103,933...26,104,337
Ensembl chr 6:26,103,933...26,104,337
|
|
G |
HACD1 |
3-hydroxyacyl-CoA dehydratase 1 |
affects response to substance |
EXP |
HACD1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:17,589,032...17,617,374
Ensembl chr10:17,589,032...17,617,374
|
|
G |
HAND1 |
heart and neural crest derivatives expressed 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HAND1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:154,474,972...154,478,227
Ensembl chr 5:154,474,972...154,478,227
|
|
G |
HAND2 |
heart and neural crest derivatives expressed 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of HAND2 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 4:173,526,091...173,530,229
Ensembl chr 4:173,524,969...173,530,229
|
|
G |
HAPLN2 |
hyaluronan and proteoglycan link protein 2 |
affects expression |
EXP |
Fluorouracil affects the expression of HAPLN2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:156,601,504...156,625,725
Ensembl chr 1:156,619,331...156,625,725
|
|
G |
HBA1 |
hemoglobin subunit alpha 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HBA1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522
|
|
G |
HBB |
hemoglobin subunit beta |
affects splicing |
EXP |
Fluorouracil affects the splicing of HBB mRNA |
CTD |
PMID:17169984 |
|
NCBI chr11:5,225,464...5,227,071
Ensembl chr11:5,225,464...5,229,395
|
|
G |
HBE1 |
hemoglobin subunit epsilon 1 |
affects response to substance decreases expression |
EXP |
HBE1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of HBE1 protein |
CTD |
PMID:15352031 |
|
NCBI chr11:5,268,345...5,269,945
Ensembl chr11:5,268,345...5,505,652
|
|
G |
HBZ |
hemoglobin subunit zeta |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HBZ protein |
CTD |
PMID:21296659 |
|
NCBI chr16:152,644...154,503
Ensembl chr16:142,728...154,503
|
|
G |
HDAC1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]]; [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA]]; Fluorouracil inhibits the reaction [TCF7L2 protein binds to HDAC1 protein] |
CTD |
PMID:25178657 |
|
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
|
|
G |
HDAC2 |
histone deacetylase 2 |
multiple interactions increases response to substance |
ISO EXP |
[HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]]; [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA]]; Fluorouracil inhibits the reaction [TCF7L2 protein binds to HDAC2 protein] HDAC2 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:25178657 PMID:35608750 |
|
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
|
|
G |
HDAC3 |
histone deacetylase 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HDAC3 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 5:141,620,881...141,636,849
Ensembl chr 5:141,620,876...141,636,849
|
|
G |
HDAC4 |
histone deacetylase 4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of HDAC4 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 2:239,048,168...239,401,649 NCBI chr 2:239,193,331...239,195,457
Ensembl chr 2:239,048,168...239,401,654
|
|
G |
HDAC7 |
histone deacetylase 7 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of HDAC7 mRNA |
CTD |
PMID:26272751 |
|
NCBI chr12:47,782,722...47,821,344
Ensembl chr12:47,782,722...47,833,132
|
|
G |
HDAC9 |
histone deacetylase 9 |
increases expression |
EXP |
Fluorouracil results in increased expression of HDAC9 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 7:18,086,825...19,002,416
Ensembl chr 7:18,086,949...19,002,416
|
|
G |
HDGFL3 |
HDGF like 3 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HDGFL3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr15:83,112,738...83,207,823
Ensembl chr15:83,112,738...83,207,875
|
|
G |
HERPUD1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HERPUD1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
|
|
G |
HES1 |
hes family bHLH transcription factor 1 |
increases activity |
EXP |
Fluorouracil results in increased activity of HES1 protein |
CTD |
PMID:19147571 |
|
NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
|
|
G |
HGF |
hepatocyte growth factor |
increases expression |
EXP |
Fluorouracil results in increased expression of HGF mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
|
|
G |
HIC2 |
HIC ZBTB transcriptional repressor 2 |
affects response to substance |
EXP |
HIC2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr22:21,417,371...21,451,463
Ensembl chr22:21,417,371...21,451,463
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
affects localization multiple interactions increases expression decreases expression decreases uptake affects response to substance decreases response to substance |
EXP ISO |
Fluorouracil affects the localization of HIF1A protein [diacerein co-treated with Fluorouracil] inhibits the reaction [Trichloroacetic Acid results in increased expression of HIF1A protein]; Fluorouracil inhibits the reaction [Trichloroacetic Acid results in increased expression of HIF1A protein] Fluorouracil results in increased expression of HIF1A mRNA Fluorouracil results in decreased expression of HIF1A mRNA; Fluorouracil results in decreased expression of HIF1A protein HIF1A protein results in decreased uptake of Fluorouracil HIF1A protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased susceptibility to HIF1A protein; HIF1A results in decreased susceptibility to Fluorouracil Acetylcysteine inhibits the reaction [Fluorouracil affects the localization of HIF1A protein]; Cyclosporine inhibits the reaction [HIF1A protein results in decreased uptake of Fluorouracil] |
CTD |
PMID:16628086 PMID:17066447 PMID:17219956 PMID:27163855 PMID:34794354 PMID:37338137 PMID:39241941 More...
|
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HINT1 |
histidine triad nucleotide binding protein 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of HINT1 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 5:131,159,027...131,165,256
Ensembl chr 5:131,155,383...131,224,468
|
|
G |
HK2 |
hexokinase 2 |
decreases expression affects response to substance multiple interactions |
EXP |
Fluorouracil results in decreased expression of HK2 protein HK2 protein affects the susceptibility to Fluorouracil HK2 protein affects the reaction [Fluorouracil results in increased activity of CASP3 protein] |
CTD |
PMID:16595493 PMID:18772588 |
|
NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359
|
|
G |
HLA-F |
major histocompatibility complex, class I, F |
increases expression |
EXP |
Fluorouracil results in increased expression of HLA-F mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 6:29,723,434...29,738,532
Ensembl chr 6:29,722,775...29,738,528
|
|
G |
HLA-G |
major histocompatibility complex, class I, G |
increases expression |
EXP |
Fluorouracil results in increased expression of HLA-G mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
|
|
G |
HM13 |
histocompatibility minor 13 |
affects expression |
EXP |
Fluorouracil affects the expression of HM13 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr20:31,514,442...31,569,543
Ensembl chr20:31,514,428...31,577,923
|
|
G |
HMCES |
5-hydroxymethylcytosine binding, ES cell specific |
affects response to substance |
EXP |
HMCES protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 3:129,278,832...129,306,186
Ensembl chr 3:129,278,828...129,306,186
|
|
G |
HMG20B |
high mobility group 20B |
decreases expression |
EXP |
Fluorouracil results in decreased expression of HMG20B mRNA |
CTD |
PMID:16709241 |
|
NCBI chr19:3,572,944...3,579,083
Ensembl chr19:3,572,777...3,579,088
|
|
G |
HMGB1 |
high mobility group box 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HMG1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
|
|
G |
HMGN5 |
high mobility group nucleosome binding domain 5 |
increases expression |
EXP |
Fluorouracil results in increased expression of HMGN5 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr X:81,113,699...81,201,913
Ensembl chr X:81,113,699...81,201,913
|
|
G |
HMMR |
hyaluronan mediated motility receptor |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HMMR mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression affects expression |
ISO |
Fluorouracil results in increased expression of HMOX1 Fluorouracil affects the expression of HMOX1 mRNA |
CTD |
PMID:20722640 PMID:22954530 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNF1A |
HNF1 homeobox A |
affects expression |
EXP |
Fluorouracil affects the expression of HNF1A mRNA |
CTD |
PMID:34151400 |
|
NCBI chr12:120,978,543...121,002,512
Ensembl chr12:120,978,543...121,002,512
|
|
G |
HNF4A |
hepatocyte nuclear factor 4 alpha |
affects expression |
EXP |
Fluorouracil affects the expression of HNF4A mRNA |
CTD |
PMID:34151400 |
|
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
|
|
G |
HNRNPA1 |
heterogeneous nuclear ribonucleoprotein A1 |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of HNRNPA1 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPA1 mRNA] |
CTD |
PMID:15016801 PMID:16101138 |
|
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
|
|
G |
HNRNPA2B1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPA2B1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:26,189,927...26,200,746
Ensembl chr 7:26,171,151...26,201,529
|
|
G |
HNRNPC |
heterogeneous nuclear ribonucleoprotein C |
increases expression |
EXP |
Fluorouracil results in increased expression of HNRNPC protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr14:21,209,147...21,269,442
Ensembl chr14:21,209,136...21,269,494
|
|
G |
HNRNPF |
heterogeneous nuclear ribonucleoprotein F |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPF mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:43,385,618...43,409,186
Ensembl chr10:43,385,617...43,409,186
|
|
G |
HNRNPH1 |
heterogeneous nuclear ribonucleoprotein H1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPH1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:179,614,178...179,634,784
Ensembl chr 5:179,614,178...179,634,784
|
|
G |
HNRNPL |
heterogeneous nuclear ribonucleoprotein L |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPL mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:38,836,370...38,852,347
Ensembl chr19:38,836,370...38,852,347
|
|
G |
HOXA1 |
homeobox A1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of HOXA1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 7:27,092,993...27,096,000
Ensembl chr 7:27,092,993...27,096,000
|
|
G |
HOXB3 |
homeobox B3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of HOXB3 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr17:48,548,870...48,590,241
Ensembl chr17:48,548,870...48,604,912
|
|
G |
HOXC11 |
homeobox C11 |
affects expression affects response to substance |
EXP |
Fluorouracil affects the expression of HOXC11 protein HOXC11 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15331170 |
|
NCBI chr12:53,973,126...53,977,643
Ensembl chr12:53,973,126...53,977,643
|
|
G |
HOXD1 |
homeobox D1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of HOXD1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 2:176,188,668...176,190,907
Ensembl chr 2:176,188,668...176,190,907
|
|
G |
HPX |
hemopexin |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of HPX mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr11:6,431,049...6,440,987
Ensembl chr11:6,431,049...6,442,617
|
|
G |
HRAS |
HRas proto-oncogene, GTPase |
increases expression |
EXP |
Fluorouracil results in increased expression of HRAS mRNA |
CTD |
PMID:16557594 |
|
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
|
|
G |
HS6ST2 |
heparan sulfate 6-O-sulfotransferase 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of HS6ST2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr X:132,626,015...132,961,370
Ensembl chr X:132,626,015...132,961,395
|
|
G |
HSD17B2 |
hydroxysteroid 17-beta dehydrogenase 2 |
affects expression |
EXP |
Fluorouracil affects the expression of HSD17B2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534
|
|
G |
HSPA1B |
heat shock protein family A (Hsp70) member 1B |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of HSPA1B protein HSPA1B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
|
|
G |
HSPA2 |
heat shock protein family A (Hsp70) member 2 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of HSPA2 mRNA HSPA2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16101138 PMID:16217747 |
|
NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173
|
|
G |
HSPA4 |
heat shock protein family A (Hsp70) member 4 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of HSPA4 protein HSPA4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of HSPA5 mRNA; Fluorouracil results in decreased expression of HSPA5 protein |
CTD |
PMID:29879413 PMID:32535746 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
affects response to substance |
EXP |
HSPA8 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
HSPB1 |
heat shock protein family B (small) member 1 |
multiple interactions decreases response to substance |
EXP |
HSPB1 protein affects the susceptibility to [Cisplatin co-treated with Fluorouracil co-treated with Leucovorin] HSPB1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18949417 PMID:19088045 |
|
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,305,813
|
|
G |
HSPB2 |
heat shock protein family B (small) member 2 |
increases phosphorylation multiple interactions |
EXP |
Fluorouracil results in increased phosphorylation of HSPB2 protein SB 203580 inhibits the reaction [Fluorouracil results in increased phosphorylation of HSPB2 protein] |
CTD |
PMID:18757417 |
|
NCBI chr11:111,912,734...111,914,093
Ensembl chr11:111,912,734...111,914,093
|
|
G |
HSPB8 |
heat shock protein family B (small) member 8 |
increases expression |
EXP |
Fluorouracil results in increased expression of HSPB8 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr12:119,178,931...119,194,746
Ensembl chr12:119,171,555...119,224,855
|
|
G |
HSPE1 |
heat shock protein family E (Hsp10) member 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of HSPE1 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr 2:197,500,379...197,503,449
Ensembl chr 2:197,500,140...197,503,449
|
|
G |
HTATIP2 |
HIV-1 Tat interactive protein 2 |
multiple interactions increases response to substance |
EXP ISO |
[Fluorouracil co-treated with irinotecan] results in increased expression of HTATIP2 mRNA HTATIP2 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:16391804 PMID:16799960 |
|
NCBI chr11:20,363,714...20,383,782
Ensembl chr11:20,363,685...20,383,782
|
|
G |
HTR7 |
5-hydroxytryptamine receptor 7 |
affects expression |
EXP |
Fluorouracil affects the expression of HTR7 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr10:90,740,823...90,858,039
Ensembl chr10:90,740,823...90,858,039
|
|
G |
HTRA1 |
HtrA serine peptidase 1 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of HTRA1 protein HTRA1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr10:122,461,553...122,514,907
Ensembl chr10:122,458,551...122,514,907
|
|
G |
IAPP |
islet amyloid polypeptide |
decreases expression |
ISO |
Fluorouracil results in decreased expression of IAPP protein |
CTD |
PMID:21296659 |
|
NCBI chr12:21,354,959...21,379,980
Ensembl chr12:21,354,959...21,379,980
|
|
G |
ID1 |
inhibitor of DNA binding 1 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of ID1 mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of ID1 mRNA] |
CTD |
PMID:16557594 |
|
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,573,014...31,606,515
|
|
G |
ID2 |
inhibitor of DNA binding 2 |
decreases expression increases expression multiple interactions affects response to substance |
EXP ISO |
Fluorouracil results in decreased expression of ID2 protein Fluorouracil results in increased expression of ID2 mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of ID2 mRNA] ID2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15016739 PMID:15352031 PMID:16557594 PMID:25178657 |
|
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
|
|
G |
ID2B |
inhibitor of DNA binding 2B (pseudogene) |
affects response to substance multiple interactions |
EXP |
ID2B protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in increased expression of ID2B mRNA] |
CTD |
PMID:15016801 PMID:15352031 |
|
NCBI chr 3:62,123,426...62,124,718
|
|
G |
ID3 |
inhibitor of DNA binding 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of ID3 mRNA |
CTD |
PMID:15205334 PMID:16557594 |
|
NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501
|
|
G |
IDI1 |
isopentenyl-diphosphate delta isomerase 1 |
affects response to substance |
EXP |
IDI1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
|
|
G |
IER5 |
immediate early response 5 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of IER5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:181,088,700...181,092,900
Ensembl chr 1:181,088,700...181,092,900
|
|
G |
IFI16 |
interferon gamma inducible protein 16 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of IFI16 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:158,999,976...159,055,151
Ensembl chr 1:158,999,968...159,055,155
|
|
G |
IFI27L2 |
interferon alpha inducible protein 27 like 2 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in increased expression of IFI27L2 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr14:94,127,781...94,129,604
Ensembl chr14:94,127,779...94,130,253
|
|
G |
IFI35 |
interferon induced protein 35 |
increases expression |
EXP |
Fluorouracil results in increased expression of IFI35 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr17:43,006,784...43,014,456
Ensembl chr17:43,006,740...43,014,456
|
|
G |
IFI6 |
interferon alpha inducible protein 6 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of IFI6 mRNA IFI6 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein] |
CTD |
PMID:15685448 PMID:17039268 |
|
NCBI chr 1:27,666,064...27,672,192
Ensembl chr 1:27,666,064...27,672,212
|
|
G |
IFIT1 |
interferon induced protein with tetratricopeptide repeats 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of IFIT1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
|
|
G |
IFIT2 |
interferon induced protein with tetratricopeptide repeats 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of IFIT2 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr10:89,302,046...89,309,271
Ensembl chr10:89,283,694...89,309,271
|
|
G |
IFITM1 |
interferon induced transmembrane protein 1 |
increases expression decreases expression |
EXP ISO |
Fluorouracil results in increased expression of IFITM1 mRNA Fluorouracil results in decreased expression of IFITM1 protein |
CTD |
PMID:16101138 PMID:16510598 PMID:17039268 PMID:21296659 |
|
NCBI chr11:314,040...315,272
Ensembl chr11:310,041...315,272
|
|
G |
IFITM2 |
interferon induced transmembrane protein 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of IFITM2 protein |
CTD |
PMID:21296659 |
|
NCBI chr11:307,816...309,395
Ensembl chr11:303,655...309,397
|
|
G |
IFITM4P |
interferon induced transmembrane protein 4 pseudogene |
increases expression |
EXP |
Fluorouracil results in increased expression of IFITM4P mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 6:29,750,807...29,751,148
Ensembl chr 6:29,750,729...29,751,148
|
|
G |
IFNA1 |
interferon alpha 1 |
multiple interactions increases abundance increases response to substance |
EXP ISO |
[Fluorouracil co-treated with IFNA1 protein] results in decreased expression of BCL2L1 mRNA; [Fluorouracil co-treated with IFNA1 protein] results in decreased expression of CFLAR protein; ANGPT1 protein promotes the reaction [Fluorouracil results in increased expression of IFNA1 protein]; ANGPT2 protein promotes the reaction [Fluorouracil results in decreased expression of IFNA1 protein]; Fluorouracil promotes the reaction [IFNA1 protein results in increased expression of TP53AIP1 mRNA]; IFNA1 promotes the reaction [Fluorouracil results in decreased expression of BCL2L1 mRNA]; IFNA1 promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of BID protein]; IFNA1 promotes the reaction [Fluorouracil results in increased expression of CASP8 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of CFLAR mRNA]; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP3 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP8 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP9 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased expression of BAX mRNA]; IFNA1 protein promotes the reaction [Fluorouracil results in increased phosphorylation of TP53 protein]; VEGFA protein promotes the reaction [Fluorouracil results in decreased expression of IFNA1 protein] IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of FLT1 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of RGS5 mRNA] IFNA1 protein results in increased abundance of Fluorouracil IFNA1 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:16101138 PMID:16568373 PMID:17016659 PMID:17045692 PMID:17786339 PMID:17971768 PMID:18157009 PMID:21474236 More...
|
|
NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316
|
|
G |
IFNAR1 |
interferon alpha and beta receptor subunit 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of IFNAR1 mRNA; Fluorouracil results in increased expression of IFNAR1 protein |
CTD |
PMID:17088986 |
|
NCBI chr21:33,324,395...33,359,864
Ensembl chr21:33,324,387...33,359,864
|
|
G |
IFNAR2 |
interferon alpha and beta receptor subunit 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of IFNAR2 mRNA; Fluorouracil results in increased expression of IFNAR2 protein |
CTD |
PMID:16101138 PMID:17088986 |
|
NCBI chr21:33,229,938...33,265,664
Ensembl chr21:33,205,282...33,265,675
|
|
G |
IFNB1 |
interferon beta 1 |
multiple interactions increases response to substance |
EXP |
[Fluorouracil co-treated with IFNB1 protein] results in increased activity of CASP3 protein IFNB1 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:15937643 PMID:16101138 PMID:18608205 PMID:18695887 |
|
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
|
|
G |
IFNG |
interferon gamma |
multiple interactions decreases expression increases abundance |
EXP ISO |
[IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to Fluorouracil; Fluorouracil promotes the reaction [IL18 protein modified form results in increased expression of IFNG protein]; IFNG protein inhibits the reaction [GADD45B protein results in decreased susceptibility to Fluorouracil] Fluorouracil results in decreased expression of IFNG protein LCS101 inhibits the reaction [Fluorouracil results in decreased expression of IFNG protein] IFNG protein results in increased abundance of Fluorouracil |
CTD |
PMID:15162350 PMID:15301717 PMID:15754409 PMID:16568373 PMID:17711513 PMID:23637542 More...
|
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IGF1 |
insulin like growth factor 1 |
increases expression multiple interactions |
ISO EXP |
Fluorouracil results in increased expression of IGF1 mRNA [Fluorouracil co-treated with IGF1 protein] results in increased expression of MT2A mRNA; IGF1 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; IGF1 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; IGF1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; IGF1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein] |
CTD |
PMID:16888818 PMID:28507149 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGF1R |
insulin like growth factor 1 receptor |
multiple interactions |
EXP |
Fluorouracil promotes the reaction [Curcumin results in decreased phosphorylation of and results in decreased activity of IGF1R protein]; Fluorouracil results in decreased phosphorylation of and results in decreased activity of IGF1R protein |
CTD |
PMID:17918158 |
|
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
|
|
G |
IGFBP2 |
insulin like growth factor binding protein 2 |
increases expression |
ISO |
Fluorouracil results in increased expression of IGFBP2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436
|
|
G |
IGFBP4 |
insulin like growth factor binding protein 4 |
multiple interactions |
EXP |
IGFBP4 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr17:40,443,450...40,457,725
Ensembl chr17:40,443,450...40,457,725
|
|
G |
IGFBP5 |
insulin like growth factor binding protein 5 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
|
|
G |
IGFBP6 |
insulin like growth factor binding protein 6 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of IGFBP6 protein IGFBP6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr12:53,097,667...53,102,340
Ensembl chr12:53,097,436...53,102,345
|
|
G |
IHH |
Indian hedgehog signaling molecule |
decreases expression |
EXP |
Fluorouracil results in decreased expression of IHH mRNA; Fluorouracil results in decreased expression of IHH protein |
CTD |
PMID:25190613 |
|
NCBI chr 2:219,054,424...219,060,921
Ensembl chr 2:219,054,424...219,060,921
|
|
G |
IKBIP |
IKBKB interacting protein |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of IKBIP mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of IKBIP mRNA] |
CTD |
PMID:17982676 |
|
NCBI chr12:98,613,404...98,644,788
Ensembl chr12:98,613,405...98,645,113
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
decreases expression |
EXP |
Fluorouracil results in decreased expression of IKBKB protein |
CTD |
PMID:30177839 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
G |
IL10 |
interleukin 10 |
multiple interactions decreases expression |
ISO |
[Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil] results in decreased expression of IL10 protein Fluorouracil results in decreased expression of IL10 protein [Thymol co-treated with Fluorouracil] results in increased expression of IL10 protein |
CTD |
PMID:31651976 PMID:34665902 PMID:38078205 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12B |
interleukin 12B |
decreases expression |
ISO |
Fluorouracil results in decreased expression of IL12B protein |
CTD |
PMID:15754409 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL18 |
interleukin 18 |
multiple interactions affects expression |
EXP ISO |
[Fluorouracil co-treated with Irinotecan] results in decreased expression of IL18 mRNA; Fluorouracil promotes the reaction [IL18 protein modified form results in increased expression of IFNG protein]; Fluorouracil results in increased cleavage of and results in increased secretion of IL18 protein Fluorouracil affects the expression of IL18 mRNA |
CTD |
PMID:15162350 PMID:16391804 PMID:20421339 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions |
ISO |
[Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil] results in decreased expression of IL1A protein |
CTD |
PMID:31651976 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
increases expression multiple interactions increases secretion |
ISO EXP |
Fluorouracil results in increased expression of IL1B mRNA; Fluorouracil results in increased expression of IL1B protein [diacerein co-treated with Fluorouracil] inhibits the reaction [Trichloroacetic Acid results in increased expression of IL1B protein] Fluorouracil results in increased secretion of IL1B protein [Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil] results in decreased expression of IL1B protein; Hydroxychloroquine inhibits the reaction [Fluorouracil results in increased secretion of IL1B protein] IL1B promoter polymorphism affects the susceptibility to [Fluorouracil co-treated with Cisplatin] |
CTD |
PMID:16820919 PMID:18523641 PMID:18535404 PMID:19528421 PMID:20844880 PMID:31651976 PMID:32314717 PMID:34794354 More...
|
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
multiple interactions |
ISO |
IL1RN protein affects the reaction [Fluorouracil results in increased expression of BAX protein]; IL1RN protein affects the reaction [Fluorouracil results in increased expression of CASP3 protein modified form]; IL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein]; IL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2L1 protein] |
CTD |
PMID:20844880 |
|
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL27RA |
interleukin 27 receptor subunit alpha |
affects response to substance |
EXP |
IL27RA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:14,031,762...14,053,218
Ensembl chr19:14,031,762...14,053,218
|
|
G |
IL3 |
interleukin 3 |
multiple interactions |
ISO |
[Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil] results in decreased expression of IL3 protein |
CTD |
PMID:31651976 |
|
NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
|
|
G |
IL6 |
interleukin 6 |
multiple interactions increases secretion increases expression |
EXP ISO |
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Fluorouracil results in increased expression of IL6 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Fluorouracil results in increased secretion of IL6 protein]; [Fluorouracil co-treated with IL6 protein] results in increased expression of MT2A mRNA; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Fluorouracil results in increased expression of IL6 mRNA]; IL6 promoter polymorphism affects the susceptibility to [Fluorouracil co-treated with Cisplatin]; IL6 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; IL6 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; IL6 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; IL6 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]; pyrazolanthrone inhibits the reaction [Fluorouracil results in increased expression of IL6 mRNA]; SB 203580 inhibits the reaction [Fluorouracil results in increased expression of IL6 mRNA] Fluorouracil promotes the reaction [Valsartan results in decreased secretion of IL6 protein] Fluorouracil results in increased expression of IL6 protein Fluorouracil inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IL6 protein]; Thymol inhibits the reaction [Fluorouracil results in increased expression of IL6 protein] |
CTD |
PMID:16820919 PMID:18344199 PMID:18523641 PMID:25824412 PMID:28507149 PMID:34665902 PMID:35147423 PMID:35235860 More...
|
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IL7 |
interleukin 7 |
affects expression |
ISO |
Fluorouracil affects the expression of IL7 mRNA |
CTD |
PMID:18344199 |
|
NCBI chr 8:78,675,044...78,805,463
Ensembl chr 8:78,675,743...78,805,523
|
|
G |
IMPA2 |
inositol monophosphatase 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of IMPA2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr18:11,981,507...12,030,877
Ensembl chr18:11,981,025...12,030,877
|
|
G |
IMPDH2 |
inosine monophosphate dehydrogenase 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of IMPDH2 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr 3:49,024,325...49,029,398
Ensembl chr 3:49,024,325...49,029,447
|
|
G |
INKA2 |
inka box actin regulator 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of INKA2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:111,722,064...111,755,797
Ensembl chr 1:111,680,630...111,755,824
|
|
G |
INPP5E |
inositol polyphosphate-5-phosphatase E |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of INPP5E mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 9:136,428,619...136,439,845
Ensembl chr 9:136,428,619...136,439,845
|
|
G |
INS |
insulin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of INS2 protein |
CTD |
PMID:21296659 |
|
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
|
|
G |
INSIG1 |
insulin induced gene 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of INSIG1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
|
|
G |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of IQGAP2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:76,403,285...76,708,132
Ensembl chr 5:76,403,285...76,708,132
|
|
G |
IRAK1 |
interleukin 1 receptor associated kinase 1 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of IRAK1 mRNA IRAK1 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:15109396 |
|
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
|
|
G |
IREB2 |
iron responsive element binding protein 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of IREB2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr15:78,437,431...78,501,453
Ensembl chr15:78,437,431...78,501,453
|
|
G |
IRF9 |
interferon regulatory factor 9 |
increases expression |
EXP |
Fluorouracil results in increased expression of IRF9 mRNA |
CTD |
PMID:16101138 PMID:17039268 |
|
NCBI chr14:24,161,265...24,166,565
Ensembl chr14:24,161,234...24,168,043
|
|
G |
IRGM |
immunity related GTPase M |
affects response to substance |
ISO |
IRGM1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:18371424 |
|
NCBI chr 5:150,846,521...150,902,402
Ensembl chr 5:150,846,521...150,900,736
|
|
G |
ISG15 |
ISG15 ubiquitin like modifier |
increases expression |
EXP |
Fluorouracil results in increased expression of ISG15 mRNA |
CTD |
PMID:16101138 PMID:16557594 |
|
NCBI chr 1:1,013,497...1,014,540
Ensembl chr 1:1,001,138...1,014,540
|
|
G |
ISL1 |
ISL LIM homeobox 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ISL1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 5:51,383,448...51,394,730
Ensembl chr 5:51,383,448...51,394,730
|
|
G |
ITGAV |
integrin subunit alpha V |
affects response to substance |
EXP |
ITGAV protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901
|
|
G |
ITGB2 |
integrin subunit beta 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ITGB2 |
CTD |
PMID:15485462 |
|
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
|
|
G |
ITGB4 |
integrin subunit beta 4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ITGB4 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr17:75,721,459...75,757,818
Ensembl chr17:75,721,328...75,757,818
|
|
G |
ITPR1 |
inositol 1,4,5-trisphosphate receptor type 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ITPR1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
|
|
G |
ITSN1 |
intersectin 1 |
affects response to substance |
EXP |
ITSN1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr21:33,642,501...33,899,861
Ensembl chr21:33,642,400...33,899,861
|
|
G |
JAG1 |
jagged canonical Notch ligand 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of JAG1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
|
|
G |
JMJD4 |
jumonji domain containing 4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of JMJD4 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:227,731,191...227,735,302
Ensembl chr 1:227,730,425...227,735,411
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
affects expression increases expression |
EXP |
Fluorouracil affects the expression of JUN mRNA Fluorouracil results in increased expression of JUN mRNA |
CTD |
PMID:15205334 PMID:16557594 PMID:17355264 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
JUNB |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of JUNB mRNA JUNB results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] |
CTD |
PMID:16557594 PMID:18678097 |
|
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
|
|
G |
KANSL1 |
KAT8 regulatory NSL complex subunit 1 |
multiple interactions |
EXP |
KANSL1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr17:46,029,916...46,225,367
Ensembl chr17:46,029,916...46,225,389
|
|
G |
KCNA5 |
potassium voltage-gated channel subfamily A member 5 |
increases response to substance |
EXP |
KCNA5 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:17428690 |
|
NCBI chr12:5,043,879...5,046,788
Ensembl chr12:5,043,879...5,046,788
|
|
G |
KCNQ2 |
potassium voltage-gated channel subfamily Q member 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of KCNQ2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr20:63,400,208...63,472,655
Ensembl chr20:63,400,208...63,472,677
|
|
G |
KCTD12 |
potassium channel tetramerization domain containing 12 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of KCTD12 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr13:76,880,175...76,886,405
Ensembl chr13:76,880,175...76,886,405
|
|
G |
KDM4B |
lysine demethylase 4B |
multiple interactions affects expression |
EXP ISO |
KDM4B mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] Fluorouracil affects the expression of KDM4B mRNA |
CTD |
PMID:16896004 PMID:20421339 |
|
NCBI chr19:4,969,113...5,153,598
Ensembl chr19:4,969,113...5,153,611
|
|
G |
KDM5A |
lysine demethylase 5A |
decreases expression |
EXP |
Fluorouracil results in decreased expression of KDM5A mRNA |
CTD |
PMID:16557594 |
|
NCBI chr12:280,057...389,320
Ensembl chr12:280,057...389,320
|
|
G |
KDR |
kinase insert domain receptor |
increases expression |
ISO |
Fluorouracil results in increased expression of KDR mRNA |
CTD |
PMID:26272751 |
|
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
affects response to substance |
EXP |
KEAP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:18692501 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
KHK |
ketohexokinase |
affects response to substance increases expression |
EXP |
KHK protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of KHK protein |
CTD |
PMID:15352031 |
|
NCBI chr 2:27,086,772...27,100,762
Ensembl chr 2:27,086,772...27,100,762
|
|
G |
KIAA0040 |
KIAA0040 |
increases expression |
EXP |
Fluorouracil results in increased expression of KIAA0040 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:175,156,986...175,192,987
Ensembl chr 1:175,156,986...175,192,999
|
|
G |
KIF14 |
kinesin family member 14 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of KIF14 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:200,551,497...200,620,751
Ensembl chr 1:200,551,497...200,620,751
|
|
G |
KIF15 |
kinesin family member 15 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of KIF15 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:44,761,794...44,868,687
Ensembl chr 3:44,761,721...44,873,376
|
|
G |
KIF23 |
kinesin family member 23 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of KIF23 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr15:69,414,349...69,448,427
Ensembl chr15:69,414,246...69,448,427
|
|
G |
KIF26B |
kinesin family member 26B |
decreases expression |
EXP |
Fluorouracil results in decreased expression of KIF26B mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:245,154,985...245,709,432
Ensembl chr 1:245,154,985...245,709,432
|
|
G |
KIF2C |
kinesin family member 2C |
affects response to substance |
EXP |
KIF2C protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 1:44,739,837...44,767,767
Ensembl chr 1:44,739,818...44,767,767
|
|
G |
KIF3A |
kinesin family member 3A |
multiple interactions |
EXP |
KIF3A mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 5:132,688,812...132,737,546
Ensembl chr 5:132,692,628...132,737,638
|
|
G |
KIT |
KIT proto-oncogene, receptor tyrosine kinase |
affects response to substance decreases expression |
ISO |
KIT protein mutant form affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of KIT protein |
CTD |
PMID:19100679 PMID:21296659 |
|
NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
|
|
G |
KITLG |
KIT ligand |
increases expression |
EXP |
Fluorouracil results in increased expression of KITLG mRNA |
CTD |
PMID:19098008 |
|
NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
|
|
G |
KLF4 |
KLF transcription factor 4 |
increases expression decreases response to substance |
EXP |
Fluorouracil results in increased expression of KLF4 mRNA KLF4 results in decreased susceptibility to Fluorouracil |
CTD |
PMID:16557594 PMID:17039268 PMID:21833590 |
|
NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482
|
|
G |
KLF5 |
KLF transcription factor 5 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of KLF5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr13:73,054,976...73,077,538
Ensembl chr13:73,054,976...73,077,541
|
|
G |
KLF6 |
KLF transcription factor 6 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of KLF6 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
|
|
G |
KLHL24 |
kelch like family member 24 |
increases expression |
EXP |
Fluorouracil results in increased expression of KLHL24 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519
|
|
G |
KLHL7 |
kelch like family member 7 |
affects response to substance |
EXP |
KLHL7 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:23,105,785...23,177,914
Ensembl chr 7:23,105,758...23,177,914
|
|
G |
KLHL9 |
kelch like family member 9 |
affects response to substance |
EXP |
KLHL9 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:21,329,665...21,335,404
Ensembl chr 9:21,320,024...21,335,404
|
|
G |
KLK15 |
kallikrein related peptidase 15 |
affects expression |
EXP |
Fluorouracil affects the expression of KLK15 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:50,825,289...50,833,574
Ensembl chr19:50,825,289...50,837,213
|
|
G |
KLK6 |
kallikrein related peptidase 6 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of KLK6 protein KLK6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr19:50,958,631...50,969,591
Ensembl chr19:50,958,631...50,969,673
|
|
G |
KMT2E |
lysine methyltransferase 2E (inactive) |
affects response to substance |
ISO |
KMT2E protein affects the susceptibility to Fluorouracil |
CTD |
PMID:18818388 |
|
NCBI chr 7:105,014,205...105,115,019
Ensembl chr 7:104,940,943...105,115,019
|
|
G |
KNG1 |
kininogen 1 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of KNG1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
|
|
G |
KPNA2 |
karyopherin subunit alpha 2 |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of KPNA2 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of KPNA2 mRNA] |
CTD |
PMID:15016801 PMID:17374387 |
|
NCBI chr17:68,035,735...68,046,854
Ensembl chr17:68,035,636...68,047,364
|
|
G |
KPNA3 |
karyopherin subunit alpha 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of KPNA3 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr13:49,699,320...49,792,682
Ensembl chr13:49,699,320...49,792,682
|
|
G |
KRAS |
KRAS proto-oncogene, GTPase |
decreases expression increases expression |
EXP |
Fluorouracil results in decreased expression of KRAS protein Fluorouracil results in increased expression of KRAS mRNA mutant form |
CTD |
PMID:15585135 PMID:16803524 PMID:38423379 |
|
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
|
|
G |
KRT1 |
keratin 1 |
affects expression |
ISO |
Fluorouracil affects the expression of KRT1 protein |
CTD |
PMID:21296659 |
|
NCBI chr12:52,674,736...52,680,407
Ensembl chr12:52,674,736...52,680,407
|
|
G |
KRT16 |
keratin 16 |
increases expression |
EXP |
Fluorouracil results in increased expression of KRT16 mRNA |
CTD |
PMID:19528421 |
|
NCBI chr17:41,609,778...41,612,767
Ensembl chr17:41,609,778...41,615,899
|
|
G |
KRT17 |
keratin 17 |
affects expression |
EXP |
Fluorouracil affects the expression of KRT17 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr17:41,619,442...41,624,575
Ensembl chr17:41,619,442...41,624,842
|
|
G |
KRT18 |
keratin 18 |
multiple interactions affects expression |
EXP |
[Fluorouracil co-treated with irinotecan co-treated with vorinostat] results in increased cleavage of KRT18 protein Fluorouracil affects the expression of KRT18 mRNA |
CTD |
PMID:15754201 PMID:34151400 |
|
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
|
|
G |
KRT5 |
keratin 5 |
affects response to substance decreases expression |
EXP |
KRT5 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of KRT5 protein |
CTD |
PMID:15352031 |
|
NCBI chr12:52,514,575...52,520,394
Ensembl chr12:52,514,575...52,520,530
|
|
G |
KRT6A |
keratin 6A |
affects expression |
EXP |
Fluorouracil affects the expression of KRT6A mRNA |
CTD |
PMID:16584549 |
|
NCBI chr12:52,487,176...52,493,257
Ensembl chr12:52,487,176...52,493,257
|
|
G |
KRT86 |
keratin 86 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of KRT86 protein KRT86 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr12:52,274,645...52,309,163
Ensembl chr12:52,249,300...52,309,163
|
|
G |
L1CAM |
L1 cell adhesion molecule |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of L1CAM protein L1CAM protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr X:153,861,514...153,886,173
Ensembl chr X:153,861,514...153,886,173
|
|
G |
L1TD1 |
LINE1 type transposase domain containing 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of L1TD1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:62,194,849...62,212,328
Ensembl chr 1:62,194,790...62,235,060
|
|
G |
LAMA1 |
laminin subunit alpha 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LAMA1 protein |
CTD |
PMID:21296659 |
|
NCBI chr18:6,941,742...7,117,797
Ensembl chr18:6,941,742...7,117,797
|
|
G |
LAMB1 |
laminin subunit beta 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LAMB1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 7:107,923,799...108,003,161
Ensembl chr 7:107,923,799...108,003,213
|
|
G |
LAMC1 |
laminin subunit gamma 1 |
affects response to substance decreases expression |
EXP ISO |
LAMC1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of LAMC1 protein |
CTD |
PMID:16217747 PMID:21296659 |
|
NCBI chr 1:183,023,420...183,145,592
Ensembl chr 1:183,023,420...183,145,592
|
|
G |
LARP4B |
La ribonucleoprotein 4B |
affects response to substance |
EXP |
LARP4B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:806,914...988,341
Ensembl chr10:806,933...931,821
|
|
G |
LASP1 |
LIM and SH3 protein 1 |
affects response to substance |
EXP |
LASP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:38,870,058...38,921,770
Ensembl chr17:38,869,859...38,921,770
|
|
G |
LCMT2 |
leucine carboxyl methyltransferase 2 |
multiple interactions increases response to substance |
ISO |
LCMT2 results in increased susceptibility to [pyrrolidine dithiocarbamic acid co-treated with Fluorouracil] LCMT2 results in increased susceptibility to Fluorouracil |
CTD |
PMID:9359698 |
|
NCBI chr15:43,323,649...43,330,573
Ensembl chr15:43,323,649...43,330,582
|
|
G |
LDHA |
lactate dehydrogenase A |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of LDHA mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
|
|
G |
LDHB |
lactate dehydrogenase B |
affects response to substance |
EXP |
LDHB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr12:21,635,342...21,657,842
Ensembl chr12:21,635,342...21,757,857
|
|
G |
LEFTY1 |
left-right determination factor 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LEFTY1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:225,886,282...225,889,146
Ensembl chr 1:225,886,282...225,911,382
|
|
G |
LEFTY2 |
left-right determination factor 2 |
decreases expression |
ISO EXP |
Fluorouracil results in decreased expression of LEFTY2 protein Fluorouracil results in decreased expression of LEFTY2 mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr 1:225,936,603...225,941,220
Ensembl chr 1:225,936,598...225,941,383
|
|
G |
LGALS3 |
galectin 3 |
affects response to substance multiple interactions decreases response to substance |
EXP ISO |
LGALS3 protein affects the susceptibility to Fluorouracil 5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum] LGALS3 protein mutant form results in decreased susceptibility to Fluorouracil |
CTD RGD |
PMID:16217747 PMID:21750908 PMID:28032729 |
RGD:150530464 |
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
|
|
G |
LGALS3BP |
galectin 3 binding protein |
affects response to substance |
EXP |
LGALS3BP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:78,971,255...78,979,923
Ensembl chr17:78,971,238...78,979,947
|
|
G |
LGALS7 |
galectin 7 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of LGALS7 protein LGALS7 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr19:38,770,968...38,773,517
Ensembl chr19:38,789,200...38,791,754 Ensembl chr19:38,789,200...38,791,754
|
|
G |
LGALS8 |
galectin 8 |
multiple interactions |
EXP |
LGALS8 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 1:236,518,214...236,552,981
Ensembl chr 1:236,518,000...236,552,981
|
|
G |
LGR4 |
leucine rich repeat containing G protein-coupled receptor 4 |
affects expression |
ISO |
Fluorouracil affects the expression of LGR4 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr11:27,365,961...27,472,790
Ensembl chr11:27,365,961...27,472,790
|
|
G |
LGR5 |
leucine rich repeat containing G protein-coupled receptor 5 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of LGR5 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr12:71,439,129...71,586,310
Ensembl chr12:71,439,798...71,586,310
|
|
G |
LHX1 |
LIM homeobox 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of LHX1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr17:36,936,785...36,944,612
Ensembl chr17:36,936,785...36,944,612
|
|
G |
LIFR |
LIF receptor subunit alpha |
decreases expression |
ISO |
Fluorouracil results in decreased expression of LIFR protein |
CTD |
PMID:21296659 |
|
NCBI chr 5:38,474,668...38,608,403
Ensembl chr 5:38,474,668...38,608,354
|
|
G |
LIG1 |
DNA ligase 1 |
affects response to substance |
EXP |
LIG1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr19:48,115,445...48,170,344
Ensembl chr19:48,115,445...48,170,603
|
|
G |
LIMK1 |
LIM domain kinase 1 |
affects expression |
EXP |
Fluorouracil affects the expression of LIMK1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:74,083,804...74,122,525
Ensembl chr 7:74,082,933...74,122,525
|
|
G |
LIMK2 |
LIM domain kinase 2 |
affects response to substance |
EXP |
LIMK2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr22:31,212,298...31,280,080
Ensembl chr22:31,212,239...31,280,080
|
|
G |
LIN28A |
lin-28 homolog A |
increases expression |
ISO |
Fluorouracil results in increased expression of LIN28A protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:26,410,817...26,429,728
Ensembl chr 1:26,410,817...26,429,728
|
|
G |
LIPH |
lipase H |
decreases expression |
EXP |
Fluorouracil results in decreased expression of LIPH mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 3:185,506,262...185,552,588
Ensembl chr 3:185,506,262...185,552,588
|
|
G |
LMF1 |
lipase maturation factor 1 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in increased expression of LMF1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr16:853,634...981,613
Ensembl chr16:853,634...981,318
|
|
G |
LMNA |
lamin A/C |
increases cleavage |
EXP |
Fluorouracil results in increased cleavage of LMNA protein |
CTD |
PMID:18497562 |
|
NCBI chr 1:156,082,573...156,140,081
Ensembl chr 1:156,082,572...156,140,081
|
|
G |
LMNB1 |
lamin B1 |
affects response to substance decreases expression |
EXP |
LMNB1 affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of LMNB1 mRNA |
CTD |
PMID:15067352 PMID:34151400 |
|
NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020
|
|
G |
LMNB2 |
lamin B2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of LMNB2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr19:2,428,166...2,456,959
Ensembl chr19:2,427,638...2,456,959
|
|
G |
LPAR6 |
lysophosphatidic acid receptor 6 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of LPAR6 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr13:48,389,571...48,444,669
Ensembl chr13:48,389,567...48,444,704
|
|
G |
LPO |
lactoperoxidase |
decreases expression |
EXP |
Fluorouracil results in decreased expression of LPO mRNA |
CTD |
PMID:34748853 |
|
NCBI chr17:58,238,584...58,268,518
Ensembl chr17:58,218,548...58,268,518
|
|
G |
LPXN |
leupaxin |
affects response to substance |
EXP |
LPXN protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr11:58,526,871...58,578,891
Ensembl chr11:58,526,871...58,578,220
|
|
G |
LRATD1 |
LRAT domain containing 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of LRATD1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 2:14,632,717...14,651,916
Ensembl chr 2:14,632,700...14,650,814
|
|
G |
LRBA |
LPS responsive beige-like anchor protein |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of LRBA mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:150,264,435...151,015,727
Ensembl chr 4:150,264,435...151,015,727
|
|
G |
LRP8 |
LDL receptor related protein 8 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of LRP8 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 1:53,242,364...53,328,070
Ensembl chr 1:53,242,364...53,328,469
|
|
G |
LSS |
lanosterol synthase |
affects response to substance |
EXP |
LSS protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
|
|
G |
LXN |
latexin |
affects response to substance |
EXP |
LXN protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:158,666,414...158,672,648
Ensembl chr 3:158,645,822...158,672,648
|
|
G |
LY6G6C |
lymphocyte antigen 6 family member G6C |
affects response to substance |
EXP |
LY6G6C protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:31,718,648...31,721,746
Ensembl chr 6:31,718,648...31,721,746
|
|
G |
LY6G6D |
lymphocyte antigen 6 family member G6D |
affects response to substance |
EXP |
LY6G6D protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:31,715,348...31,717,919
Ensembl chr 6:31,715,348...31,717,919
|
|
G |
LYPLA1 |
lysophospholipase 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of LYPLA1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:54,042,987...54,101,947
Ensembl chr 8:54,046,367...54,102,017
|
|
G |
M6PR |
mannose-6-phosphate receptor, cation dependent |
increases expression |
EXP |
Fluorouracil results in increased expression of M6PR protein |
CTD |
PMID:15585135 |
|
NCBI chr12:8,940,361...8,949,645
Ensembl chr12:8,940,361...8,949,761
|
|
G |
MACF1 |
microtubule actin crosslinking factor 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MACF1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:39,084,167...39,487,138
Ensembl chr 1:39,081,316...39,487,177
|
|
G |
MAD2L1 |
mitotic arrest deficient 2 like 1 |
affects expression decreases expression |
EXP ISO |
Fluorouracil affects the expression of MAD2L1 mRNA Fluorouracil results in decreased expression of MAD2L1 mRNA |
CTD |
PMID:16557594 PMID:17039268 PMID:19272435 |
|
NCBI chr 4:120,055,623...120,066,848
Ensembl chr 4:120,055,623...120,066,858
|
|
G |
MAD2L2 |
mitotic arrest deficient 2 like 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of MAD2L2 protein |
CTD |
PMID:16803524 |
|
NCBI chr 1:11,674,480...11,691,830
Ensembl chr 1:11,657,230...11,691,811
|
|
G |
MADD |
MAP kinase activating death domain |
affects expression |
EXP |
Fluorouracil affects the expression of MADD mRNA |
CTD |
PMID:34151400 |
|
NCBI chr11:47,269,188...47,330,031
Ensembl chr11:47,269,161...47,330,031
|
|
G |
MAF |
MAF bZIP transcription factor |
increases expression |
EXP |
Fluorouracil results in increased expression of MAF mRNA |
CTD |
PMID:16557594 |
|
NCBI chr16:79,202,622...79,600,737
Ensembl chr16:79,585,843...79,600,737
|
|
G |
MAFF |
MAF bZIP transcription factor F |
affects response to substance |
EXP |
MAFF protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
|
|
G |
MAGEA12 |
MAGE family member A12 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of MAGEA12 protein MAGEA12 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr X:152,733,757...152,737,669
Ensembl chr X:152,733,757...152,737,669
|
|
G |
MAGEA2 |
MAGE family member A2 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of MAGEA2 protein MAGEA2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr X:152,749,863...152,753,884
Ensembl chr X:152,714,586...152,718,607 Ensembl chr X:152,714,586...152,718,607
|
|
G |
MAGEA4 |
MAGE family member A4 |
affects response to substance |
EXP |
MAGEA4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:151,912,474...151,925,170
Ensembl chr X:151,912,495...151,925,171
|
|
G |
MAGEA6 |
MAGE family member A6 |
affects response to substance decreases expression |
EXP |
MAGEA6 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of MAGEA6 protein |
CTD |
PMID:15352031 |
|
NCBI chr X:152,766,136...152,769,689
Ensembl chr X:152,766,136...152,769,716
|
|
G |
MAGEB2 |
MAGE family member B2 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of MAGEB2 protein MAGEB2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr X:30,215,563...30,220,089
Ensembl chr X:30,215,563...30,220,089
|
|
G |
MAGED1 |
MAGE family member D1 |
affects response to substance |
EXP |
MAGED1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 PMID:16217747 |
|
NCBI chr X:51,803,076...51,902,354
Ensembl chr X:51,803,007...51,902,354
|
|
G |
MAGED4B |
MAGE family member D4B |
affects response to substance |
EXP |
MAGED4B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:52,061,827...52,069,272
Ensembl chr X:52,061,827...52,069,219
|
|
G |
MALAT1 |
metastasis associated lung adenocarcinoma transcript 1 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of MALAT1 mRNA MALAT1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:16510598 PMID:18927307 |
|
NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,606...65,508,073
|
|
G |
MALT1 |
MALT1 paracaspase |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of MALT1 mRNA MALT1 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:15109396 |
|
NCBI chr18:58,671,465...58,754,477
Ensembl chr18:58,671,465...58,754,477
|
|
G |
MAMDC2 |
MAM domain containing 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of MAMDC2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 9:70,043,581...70,226,972
Ensembl chr 9:70,043,848...70,226,972
|
|
G |
MAML2 |
mastermind like transcriptional coactivator 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of MAML2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr11:95,976,598...96,343,195
Ensembl chr11:95,976,598...96,343,195
|
|
G |
MAN1A1 |
mannosidase alpha class 1A member 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of MAN1A1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:119,177,205...119,350,605
Ensembl chr 6:119,177,205...119,349,761
|
|
G |
MANEA |
mannosidase endo-alpha |
affects expression |
ISO |
Fluorouracil affects the expression of MANEA mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 6:95,577,535...95,609,452
Ensembl chr 6:95,577,485...95,609,470
|
|
G |
MAP1LC3B |
microtubule associated protein 1 light chain 3 beta |
affects response to substance |
EXP |
MAP1LC3B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
|
|
G |
MAP2 |
microtubule associated protein 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of MAP2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147
|
|
G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
multiple interactions |
EXP |
[U 0126 results in decreased activity of MAP2K1 protein] results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; MAP2K1 protein results in decreased susceptibility to [Cisplatin co-treated with Fluorouracil] |
CTD |
PMID:21444628 |
|
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
|
|
G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
multiple interactions |
EXP |
[U 0126 results in decreased activity of MAP2K2 protein] results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; MAP2K2 protein results in decreased susceptibility to [Cisplatin co-treated with Fluorouracil] |
CTD |
PMID:21444628 |
|
NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122
|
|
G |
MAP2K7 |
mitogen-activated protein kinase kinase 7 |
decreases expression |
EXP |
5-fluorouracil decreases expression of MAP2K7 protein in tongue squamous carcinoma cells |
RGD |
PMID:34411913 |
RGD:155630595 |
NCBI chr19:7,903,877...7,914,478
Ensembl chr19:7,903,843...7,914,478
|
|
G |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1 |
affects expression |
EXP |
Fluorouracil affects the expression of MAP3K1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 5:56,815,549...56,896,152
Ensembl chr 5:56,815,549...56,896,152
|
|
G |
MAP3K20 |
mitogen-activated protein kinase kinase kinase 20 |
affects expression |
EXP |
Fluorouracil affects the expression of MAP3K20 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:173,075,517...173,268,015
Ensembl chr 2:173,075,435...173,268,015
|
|
G |
MAP4K5 |
mitogen-activated protein kinase kinase kinase kinase 5 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MAP4K5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr14:50,418,521...50,561,126
Ensembl chr14:50,418,501...50,561,126
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation increases phosphorylation |
EXP |
Fluorouracil inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK1 protein]; Fluorouracil results in decreased expression of and results in decreased phosphorylation of MAPK1 protein; Nicotine inhibits the reaction [Fluorouracil results in increased phosphorylation of MAPK1 protein] Fluorouracil results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:21444628 PMID:24095863 PMID:37625625 PMID:39334374 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK13 |
mitogen-activated protein kinase 13 |
increases expression |
EXP |
Fluorouracil results in increased expression of MAPK13 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 6:36,130,513...36,144,521
Ensembl chr 6:36,127,809...36,144,524
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation increases phosphorylation |
EXP |
Fluorouracil inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK3 protein]; Fluorouracil results in decreased expression of and results in decreased phosphorylation of MAPK3 protein; Nicotine inhibits the reaction [Fluorouracil results in increased phosphorylation of MAPK3 protein] Fluorouracil results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:21444628 PMID:24095863 PMID:37625625 PMID:39334374 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK7 |
mitogen-activated protein kinase 7 |
multiple interactions decreases response to substance |
EXP |
[BIX 02188 results in decreased activity of MAPK7] which results in increased susceptibility to Fluorouracil MAPK7 results in decreased susceptibility to Fluorouracil |
CTD |
PMID:22008504 |
|
NCBI chr17:19,377,750...19,383,544
Ensembl chr17:19,377,721...19,383,544
|
|
G |
MAPKAP1 |
MAPK associated protein 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of MAPKAP1 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 9:125,437,394...125,707,208
Ensembl chr 9:125,437,393...125,707,234
|
|
G |
MAPT |
microtubule associated protein tau |
multiple interactions |
EXP |
MAPT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr17:45,894,554...46,028,334
Ensembl chr17:45,894,527...46,028,334
|
|
G |
MARCKS |
myristoylated alanine rich protein kinase C substrate |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of MARCKS mRNA MARCKS protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:17039268 |
|
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
|
|
G |
MARS1 |
methionyl-tRNA synthetase 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MARS1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:57,488,068...57,516,652
Ensembl chr12:57,475,445...57,517,569
|
|
G |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
increases expression |
EXP |
Fluorouracil results in increased expression of MAST4 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 5:66,596,393...67,169,593
Ensembl chr 5:66,596,380...67,169,593
|
|
G |
MBD4 |
methyl-CpG binding domain 4, DNA glycosylase |
increases metabolic processing |
ISO |
MBD4 protein results in increased metabolism of Fluorouracil |
CTD |
PMID:16885370 |
|
NCBI chr 3:129,430,947...129,439,948
Ensembl chr 3:129,430,947...129,440,179
|
|
G |
MBNL1 |
muscleblind like splicing regulator 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of MBNL1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 3:152,243,632...152,465,780
Ensembl chr 3:152,243,828...152,465,780
|
|
G |
MBP |
myelin basic protein |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of MBP mRNA; Fluorouracil results in decreased expression of MBP protein [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]]; TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA] |
CTD |
PMID:25178657 |
|
NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
|
|
G |
MCCC2 |
methylcrotonyl-CoA carboxylase subunit 2 |
multiple interactions |
EXP |
MCCC2 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr 5:71,587,340...71,658,706
Ensembl chr 5:71,579,531...71,658,706
|
|
G |
MCF2 |
MCF.2 cell line derived transforming sequence |
increases expression |
EXP |
Fluorouracil results in increased expression of MCF2 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr X:139,581,770...139,708,167
Ensembl chr X:139,581,770...139,708,216
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
affects expression decreases expression multiple interactions decreases response to substance |
EXP ISO |
Fluorouracil affects the expression of MCL1 protein Fluorouracil results in decreased expression of MCL1 mRNA Apigenin promotes the reaction [Fluorouracil results in decreased expression of MCL1 mRNA]; Fluorouracil promotes the reaction [Apigenin results in decreased expression of MCL1 mRNA] MCL1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15262975 PMID:21036698 PMID:28025107 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
MCM10 |
minichromosome maintenance 10 replication initiation factor |
affects expression |
EXP |
Fluorouracil affects the expression of MCM10 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr10:13,161,558...13,211,110
Ensembl chr10:13,161,558...13,211,110
|
|
G |
MCM2 |
minichromosome maintenance complex component 2 |
affects response to substance |
EXP |
MCM2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 3:127,598,411...127,622,436
Ensembl chr 3:127,598,223...127,622,436
|
|
G |
MCM3 |
minichromosome maintenance complex component 3 |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of MCM3 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM3 mRNA] |
CTD |
PMID:15016801 PMID:16709241 |
|
NCBI chr 6:52,264,015...52,284,742
Ensembl chr 6:52,264,014...52,284,881
|
|
G |
MCM4 |
minichromosome maintenance complex component 4 |
affects expression |
EXP |
Fluorouracil affects the expression of MCM4 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 8:47,960,941...47,978,160
Ensembl chr 8:47,960,185...47,978,160
|
|
G |
MCM6 |
minichromosome maintenance complex component 6 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM6 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:135,839,626...135,876,443
Ensembl chr 2:135,839,626...135,876,443
|
|
G |
MCM7 |
minichromosome maintenance complex component 7 |
affects response to substance multiple interactions |
EXP |
MCM7 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM7 mRNA] |
CTD |
PMID:15016801 PMID:15548681 |
|
NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,233...100,101,940
|
|
G |
MCMBP |
minichromosome maintenance complex binding protein |
increases expression |
EXP |
Fluorouracil results in increased expression of MCMBP mRNA |
CTD |
PMID:17039268 |
|
NCBI chr10:119,829,440...119,873,581
Ensembl chr10:119,829,404...119,892,556
|
|
G |
MDFI |
MyoD family inhibitor |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of MDFI protein MDFI protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 6:41,637,018...41,654,244
Ensembl chr 6:41,636,882...41,654,244
|
|
G |
MDFIC |
MyoD family inhibitor domain containing |
affects expression |
EXP |
Fluorouracil affects the expression of MDFIC mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:114,922,094...115,019,917
Ensembl chr 7:114,922,094...115,019,917
|
|
G |
MDM2 |
MDM2 proto-oncogene |
multiple interactions increases phosphorylation increases expression |
EXP ISO |
Cadmium Chloride affects the reaction [Fluorouracil results in increased phosphorylation of MDM2 protein]; Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 protein] Fluorouracil results in increased expression of MDM2 mRNA; Fluorouracil results in increased expression of MDM2 protein; Fluorouracil results in increased expression of MDM2 protein modified form |
CTD |
PMID:14665630 PMID:15546879 PMID:16557594 PMID:16949053 PMID:17982676 PMID:18096571 PMID:19098008 PMID:22525470 PMID:25744307 PMID:28785074 PMID:30177839 More...
|
|
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
|
|
G |
MDM4 |
MDM4 regulator of p53 |
multiple interactions |
EXP |
MDM4 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] |
CTD |
PMID:18678097 |
|
NCBI chr 1:204,516,406...204,558,120
Ensembl chr 1:204,516,379...204,558,120
|
|
G |
MED13L |
mediator complex subunit 13L |
multiple interactions |
EXP |
MED13L mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr12:115,958,576...116,277,693
Ensembl chr12:115,957,905...116,277,693
|
|
G |
MEF2B |
myocyte enhancer factor 2B |
affects expression |
EXP |
Fluorouracil affects the expression of MEF2B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:19,145,567...19,170,263
Ensembl chr19:19,145,567...19,192,131
|
|
G |
MELK |
maternal embryonic leucine zipper kinase |
affects response to substance multiple interactions |
EXP |
MELK protein affects the susceptibility to Fluorouracil MELK mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:15548681 PMID:16896004 |
|
NCBI chr 9:36,572,895...36,677,682
Ensembl chr 9:36,572,862...36,677,683
|
|
G |
MEOX1 |
mesenchyme homeobox 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of MEOX1 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr17:43,640,389...43,661,922
Ensembl chr17:43,640,389...43,661,922
|
|
G |
MESP1 |
mesoderm posterior bHLH transcription factor 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MESP1 mRNA |
CTD |
PMID:26272751 |
|
NCBI chr15:89,732,446...89,751,249
Ensembl chr15:89,749,875...89,751,249
|
|
G |
MESP2 |
mesoderm posterior bHLH transcription factor 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of MESP2 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr15:89,776,332...89,778,754
Ensembl chr15:89,760,591...89,778,754
|
|
G |
METAP2 |
methionyl aminopeptidase 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of METAP2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:95,474,152...95,515,839
Ensembl chr12:95,473,520...95,515,839
|
|
G |
METRN |
meteorin, glial cell differentiation regulator |
multiple interactions |
EXP |
METRN mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr16:715,118...719,655
Ensembl chr16:715,118...719,655
|
|
G |
MFN1 |
mitofusin 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of MFN1 protein |
CTD |
PMID:30518710 |
|
NCBI chr 3:179,347,709...179,394,936
Ensembl chr 3:179,347,709...179,394,936
|
|
G |
MFN2 |
mitofusin 2 |
affects expression increases expression |
EXP |
Fluorouracil affects the expression of MFN2 mRNA Fluorouracil results in increased expression of MFN2 protein |
CTD |
PMID:16584549 PMID:30518710 |
|
NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211
|
|
G |
MGAT2 |
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
affects response to substance |
EXP |
MGAT2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:49,620,799...49,623,481
Ensembl chr14:49,620,799...49,623,481
|
|
G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
decreases expression multiple interactions decreases response to substance |
EXP |
Fluorouracil results in decreased expression of MGMT mRNA; Fluorouracil results in decreased expression of MGMT protein O(6)-benzylguanine inhibits the reaction [MGMT protein results in decreased susceptibility to Fluorouracil] |
CTD |
PMID:17487405 PMID:24737281 |
|
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
|
|
G |
MICA |
MHC class I polypeptide-related sequence A |
affects response to substance |
EXP |
MICA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:31,400,711...31,415,315
Ensembl chr 6:31,399,784...31,415,315
|
|
G |
MICB |
MHC class I polypeptide-related sequence B |
affects response to substance |
EXP |
MICB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:31,494,918...31,511,124
Ensembl chr 6:31,494,881...31,511,124
|
|
G |
MIR532 |
microRNA 532 |
multiple interactions |
EXP |
[Melatonin results in increased expression of MIR532] which results in increased susceptibility to Fluorouracil |
CTD |
PMID:37755321 |
|
NCBI chr X:50,003,148...50,003,238
Ensembl chr X:50,003,148...50,003,238
|
|
G |
MIR577 |
microRNA 577 |
increases response to substance |
EXP |
MIR577 mRNA results in increased susceptibility to Fluorouracil |
CTD |
PMID:28150434 |
|
NCBI chr 4:114,656,759...114,656,854
Ensembl chr 4:114,656,759...114,656,854
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
affects response to substance affects expression decreases expression |
EXP ISO |
MKI67 mRNA affects the susceptibility to Fluorouracil; MKI67 protein affects the susceptibility to Fluorouracil Fluorouracil affects the expression of MKI67 protein Fluorouracil results in decreased expression of MKI67 protein Fluorouracil results in decreased expression of MKI67; Fluorouracil results in decreased expression of MKI67 mRNA |
CTD |
PMID:11300326 PMID:15205334 PMID:15548681 PMID:16709241 PMID:18286688 PMID:21594360 PMID:36203040 More...
|
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MKX |
mohawk homeobox |
decreases expression |
EXP |
Fluorouracil results in decreased expression of MKX mRNA |
CTD |
PMID:16510598 |
|
NCBI chr10:27,672,874...27,745,819
Ensembl chr10:27,672,874...27,746,060
|
|
G |
MLF1 |
myeloid leukemia factor 1 |
affects expression |
ISO |
Fluorouracil affects the expression of MLF1 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 3:158,571,194...158,606,456
Ensembl chr 3:158,571,163...158,607,252
|
|
G |
MLH1 |
mutL homolog 1 |
affects response to substance increases response to substance |
EXP |
MLH1 mRNA affects the susceptibility to Fluorouracil; MLH1 protein affects the susceptibility to Fluorouracil MLH1 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:17914563 PMID:18497967 PMID:18949393 |
|
NCBI chr 3:36,993,466...37,050,846
Ensembl chr 3:36,993,226...37,050,896
|
|
G |
MLLT11 |
MLLT11 transcription factor 7 cofactor |
affects response to substance |
EXP |
MLLT11 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544
|
|
G |
MMP1 |
matrix metallopeptidase 1 |
multiple interactions increases expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MMP1 mRNA] Fluorouracil results in increased expression of MMP1 mRNA |
CTD |
PMID:15016801 PMID:19528421 |
|
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions decreases activity |
EXP ISO |
MMP2 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] Fluorouracil results in decreased activity of MMP2 protein Fluorouracil promotes the reaction [Valsartan results in decreased activity of MMP2 protein]; Valsartan promotes the reaction [Fluorouracil results in decreased activity of MMP2 protein] |
CTD |
PMID:18678097 PMID:35235860 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP3 |
matrix metallopeptidase 3 |
multiple interactions |
EXP |
MMP3 promoter polymorphism affects the susceptibility to [Fluorouracil co-treated with Cisplatin] |
CTD |
PMID:15102660 |
|
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
affects expression multiple interactions increases expression |
EXP ISO |
Fluorouracil affects the expression of MMP9 mRNA Fluorouracil promotes the reaction [Valsartan results in decreased activity of MMP9 protein] Fluorouracil results in increased expression of MMP9 protein |
CTD |
PMID:15205334 PMID:26310874 PMID:35235860 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MMS19 |
MMS19 homolog, cytosolic iron-sulfur assembly component |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of MMS19 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:97,458,324...97,498,794
Ensembl chr10:97,458,324...97,498,794
|
|
G |
MNX1 |
motor neuron and pancreas homeobox 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MNX1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 7:157,004,854...157,010,663
Ensembl chr 7:156,994,051...157,010,663
|
|
G |
MORF4L2 |
mortality factor 4 like 2 |
decreases response to substance |
EXP |
MORF4L2 mRNA results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18593893 |
|
NCBI chr X:103,675,498...103,688,047
Ensembl chr X:103,675,496...103,688,158
|
|
G |
MPC2 |
mitochondrial pyruvate carrier 2 |
affects response to substance |
EXP |
MPC2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:167,916,675...167,937,072
Ensembl chr 1:167,916,675...167,937,072
|
|
G |
MPIG6B |
megakaryocyte and platelet inhibitory receptor G6b |
affects response to substance |
EXP |
MPIG6B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:31,720,296...31,726,714
Ensembl chr 6:31,718,594...31,726,714
|
|
G |
MPO |
myeloperoxidase |
multiple interactions increases expression increases activity |
ISO |
Ascorbic Acid inhibits the reaction [Fluorouracil results in increased activity of MPO protein]; Silybin inhibits the reaction [Fluorouracil results in increased expression of MPO protein] |
CTD |
PMID:26921358 PMID:37335224 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MPP7 |
MAGUK p55 scaffold protein 7 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of MPP7 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr10:28,050,993...28,335,203
Ensembl chr10:28,050,993...28,334,486
|
|
G |
MPRIP |
myosin phosphatase Rho interacting protein |
affects response to substance |
EXP |
MPRIP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:17,042,457...17,192,643
Ensembl chr17:17,042,457...17,217,679
|
|
G |
MR1 |
major histocompatibility complex, class I-related |
increases expression |
EXP |
Fluorouracil results in increased expression of MR1 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 1:181,033,387...181,061,938
Ensembl chr 1:181,033,374...181,061,938
|
|
G |
MRAS |
muscle RAS oncogene homolog |
affects expression |
EXP |
Fluorouracil affects the expression of MRAS mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:138,347,648...138,405,535
Ensembl chr 3:138,347,648...138,405,534
|
|
G |
MSH2 |
mutS homolog 2 |
affects response to substance decreases expression |
EXP |
MSH2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of MSH2 mRNA |
CTD |
PMID:16557594 PMID:16709241 PMID:18949393 |
|
NCBI chr 2:47,403,067...47,709,830
Ensembl chr 2:47,403,067...47,663,146
|
|
G |
MSX2 |
msh homeobox 2 |
affects response to substance decreases expression |
EXP |
MSX2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of MSX2 protein |
CTD |
PMID:15352031 |
|
NCBI chr 5:174,724,582...174,730,896
Ensembl chr 5:174,724,582...174,730,896
|
|
G |
MT-ATP6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in increased expression of ATP6 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr MT:8,527...9,207
Ensembl chr MT:8,527...9,207
|
|
G |
MT1E |
metallothionein 1E |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of MT1E protein MT1E protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr16:56,625,781...56,627,112
Ensembl chr16:56,625,475...56,627,112
|
|
G |
MT1M |
metallothionein 1M |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of MT1M protein MT1M protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr16:56,632,659...56,633,981
Ensembl chr16:56,632,659...56,633,981
|
|
G |
MT1X |
metallothionein 1X |
decreases expression |
EXP |
Fluorouracil results in decreased expression of MT1X mRNA |
CTD |
PMID:17039268 |
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
MT2A |
metallothionein 2A |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of MT2A protein [Fluorouracil co-treated with EGF protein] results in increased expression of MT2A mRNA; [Fluorouracil co-treated with IGF1 protein] results in increased expression of MT2A mRNA; [Fluorouracil co-treated with IL6 protein] results in increased expression of MT2A mRNA; [Fluorouracil co-treated with TGFB1 protein] results in increased expression of MT2A mRNA; EGF protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; IGF1 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; IL6 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]]; TGFB1 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein] |
CTD |
PMID:28507149 |
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
MTAP |
methylthioadenosine phosphorylase |
decreases expression |
EXP |
Fluorouracil results in decreased expression of MTAP mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 9:21,802,636...21,941,115
Ensembl chr 9:21,802,636...21,937,651
|
|
G |
MTHFR |
methylenetetrahydrofolate reductase |
multiple interactions increases response to substance increases metabolic processing affects response to substance |
EXP |
MTHFR gene polymorphism results in increased susceptibility to [Fluorouracil co-treated with Leucovorin] MTHFR gene polymorphism results in increased susceptibility to Fluorouracil MTHFR protein results in increased metabolism of Fluorouracil MTHFR gene polymorphism affects the susceptibility to Fluorouracil; MTHFR protein affects the susceptibility to Fluorouracil; MTHFR protein affects the susceptibility to Fluorouracil analog |
CTD |
PMID:15608557 PMID:15735113 PMID:16399440 PMID:16785472 PMID:17047490 PMID:18034621 PMID:18633250 PMID:19203896 More...
|
|
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions decreases expression |
EXP |
rebamipide inhibits the reaction [Fluorouracil results in decreased expression of MTOR protein modified form] Fluorouracil results in decreased expression of MTOR mRNA; Fluorouracil results in decreased expression of MTOR protein modified form |
CTD |
PMID:29054700 PMID:34748853 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
MTTP |
microsomal triglyceride transfer protein |
decreases expression |
EXP |
Fluorouracil results in decreased expression of MTTP mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 4:99,564,130...99,623,997
Ensembl chr 4:99,564,081...99,623,997
|
|
G |
MTUS1 |
microtubule associated scaffold protein 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of MTUS1 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 8:17,643,802...17,801,521
Ensembl chr 8:17,643,795...17,801,094
|
|
G |
MVP |
major vault protein |
multiple interactions increases expression |
EXP |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of MVP mRNA; Fluorouracil promotes the reaction [YBX1 protein binds to MVP promoter] Fluorouracil results in increased expression of MVP mRNA; Fluorouracil results in increased expression of MVP protein |
CTD |
PMID:15750632 PMID:32800223 |
|
NCBI chr16:29,820,394...29,848,039
Ensembl chr16:29,820,394...29,848,039
|
|
G |
MXI1 |
MAX interactor 1, dimerization protein |
affects response to substance |
EXP |
MXI1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:110,207,605...110,287,365
Ensembl chr10:110,207,605...110,287,365
|
|
G |
MYB |
MYB proto-oncogene, transcription factor |
decreases expression affects response to substance |
EXP ISO |
Fluorouracil results in decreased expression of MYB mRNA MYB protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15235111 PMID:15548681 PMID:16557594 |
|
NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173
|
|
G |
MYBL2 |
MYB proto-oncogene like 2 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of MYBL2 mRNA MYBL2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 PMID:16557594 |
|
NCBI chr20:43,667,114...43,716,482
Ensembl chr20:43,667,019...43,716,495
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
decreases expression affects expression increases expression multiple interactions decreases response to substance affects response to substance |
EXP ISO |
Fluorouracil results in decreased expression of MYC mRNA; Fluorouracil results in decreased expression of MYC protein Fluorouracil affects the expression of MYC mRNA Fluorouracil results in increased expression of MYC protein [Cadmium Chloride co-treated with Fluorouracil] affects the expression of MYC protein; [Fluorouracil co-treated with Cadmium Chloride] affects the expression of MYC mRNA; TP53 protein promotes the reaction [Fluorouracil results in decreased expression of MYC mRNA] MYC protein results in decreased susceptibility to Fluorouracil MYC protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15585135 PMID:16557594 PMID:16709241 PMID:16803524 PMID:17628013 PMID:18802399 PMID:23941782 PMID:26272751 PMID:34151400 More...
|
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
MYCL |
MYCL proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MYCL mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 1:39,895,428...39,901,917
Ensembl chr 1:39,895,428...39,902,256
|
|
G |
MYCN |
MYCN proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MYCN mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 2:15,940,550...15,947,004
Ensembl chr 2:15,940,550...15,947,007
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of MYD88 protein Bosentan inhibits the reaction [Fluorouracil results in increased expression of MYD88 protein] |
CTD |
PMID:34800596 |
|
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
|
|
G |
MYF5 |
myogenic factor 5 |
affects expression |
ISO |
Fluorouracil affects the expression of MYF5 protein |
CTD |
PMID:21296659 |
|
NCBI chr12:80,716,912...80,719,671
Ensembl chr12:80,716,912...80,719,671
|
|
G |
MYL4 |
myosin light chain 4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of MYL4 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr17:47,189,433...47,227,650
Ensembl chr17:47,200,446...47,223,679
|
|
G |
MYL9 |
myosin light chain 9 |
affects response to substance |
EXP |
MYL9 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447
|
|
G |
MYLIP |
myosin regulatory light chain interacting protein |
affects expression |
EXP |
Fluorouracil affects the expression of MYLIP mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 6:16,129,086...16,163,887
Ensembl chr 6:16,129,086...16,151,367
|
|
G |
MYO1E |
myosin IE |
increases expression |
EXP |
Fluorouracil results in increased expression of MYO1E protein |
CTD |
PMID:15331170 |
|
NCBI chr15:59,132,434...59,372,871
Ensembl chr15:59,132,434...59,372,871
|
|
G |
MYO6 |
myosin VI |
affects response to substance |
EXP |
MYO6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:75,749,239...75,919,537
Ensembl chr 6:75,749,201...75,919,537
|
|
G |
MYOD1 |
myogenic differentiation 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of MYOD1 protein |
CTD |
PMID:21296659 |
|
NCBI chr11:17,719,571...17,722,136
Ensembl chr11:17,719,571...17,722,136
|
|
G |
MYOF |
myoferlin |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of MYOF protein MYOF protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr10:93,306,429...93,482,334
Ensembl chr10:93,306,429...93,482,334
|
|
G |
NAF1 |
nuclear assembly factor 1 ribonucleoprotein |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NAF1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 4:163,103,929...163,166,890
Ensembl chr 4:163,110,073...163,166,890
|
|
G |
NAIP |
NLR family apoptosis inhibitory protein |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NAIP mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 5:70,968,166...71,025,339
Ensembl chr 5:70,968,166...71,025,339
|
|
G |
NANOG |
Nanog homeobox |
affects expression decreases expression |
ISO EXP |
Fluorouracil affects the expression of NANOG protein Fluorouracil results in decreased expression of NANOG mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr12:7,789,402...7,799,146
Ensembl chr12:7,787,794...7,799,146
|
|
G |
NASP |
nuclear autoantigenic sperm protein |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NASP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:45,584,041...45,618,893
Ensembl chr 1:45,583,846...45,618,904
|
|
G |
NBL1 |
NBL1, DAN family BMP antagonist |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NBL1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 1:19,643,229...19,658,452
Ensembl chr 1:19,596,979...19,658,456
|
|
G |
NBN |
nibrin |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NBN mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:89,933,331...89,984,667
Ensembl chr 8:89,924,515...90,003,228
|
|
G |
NBPF10 |
NBPF member 10 |
increases expression |
EXP |
Fluorouracil results in increased expression of NBPF10 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:146,064,699...146,144,804
Ensembl chr 1:146,064,711...146,229,000
|
|
G |
NCAPG |
non-SMC condensin I complex subunit G |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NCAPG mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:17,810,979...17,844,865
Ensembl chr 4:17,810,979...17,844,865
|
|
G |
NCL |
nucleolin |
affects splicing |
EXP |
Fluorouracil affects the splicing of NCL mRNA |
CTD |
PMID:17169984 |
|
NCBI chr 2:231,453,531...231,464,484
Ensembl chr 2:231,453,531...231,483,641
|
|
G |
NCOR1 |
nuclear receptor corepressor 1 |
multiple interactions |
EXP |
NCOR1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr17:16,029,157...16,215,534
Ensembl chr17:16,029,065...16,218,185
|
|
G |
NDUFA10 |
NADH:ubiquinone oxidoreductase subunit A10 |
affects response to substance increases expression |
EXP |
NDUFA10 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of NDUFA10 protein |
CTD |
PMID:15548681 PMID:15585135 PMID:16803524 |
|
NCBI chr 2:239,892,442...240,025,342
Ensembl chr 2:239,892,450...240,025,743
|
|
G |
NDUFA4 |
NDUFA4 mitochondrial complex associated |
affects expression |
EXP |
Fluorouracil affects the expression of NDUFA4 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:10,931,943...10,940,153
Ensembl chr 7:10,931,943...10,940,153
|
|
G |
NDUFA6 |
NADH:ubiquinone oxidoreductase subunit A6 |
affects expression |
EXP |
Fluorouracil affects the expression of NDUFA6 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr22:42,085,526...42,090,772
Ensembl chr22:42,085,526...42,090,884
|
|
G |
NDUFAB1 |
NADH:ubiquinone oxidoreductase subunit AB1 |
affects expression |
EXP |
Fluorouracil affects the expression of NDUFAB1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr16:23,581,014...23,596,316
Ensembl chr16:23,581,014...23,596,316
|
|
G |
NDUFAF1 |
NADH:ubiquinone oxidoreductase complex assembly factor 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of NDUFAF1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr15:41,387,353...41,403,026
Ensembl chr15:41,387,218...41,409,403
|
|
G |
NDUFAF3 |
NADH:ubiquinone oxidoreductase complex assembly factor 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NDUFAF3 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 3:49,020,452...49,023,495
Ensembl chr 3:49,020,459...49,023,495
|
|
G |
NDUFAF4 |
NADH:ubiquinone oxidoreductase complex assembly factor 4 |
affects expression |
EXP |
Fluorouracil affects the expression of NDUFAF4 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 6:96,889,315...96,897,891
Ensembl chr 6:96,889,315...96,897,891
|
|
G |
NDUFB10 |
NADH:ubiquinone oxidoreductase subunit B10 |
affects expression |
EXP |
Fluorouracil affects the expression of NDUFB10 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr16:1,959,538...1,961,975
Ensembl chr16:1,959,538...1,961,975
|
|
G |
NDUFB2 |
NADH:ubiquinone oxidoreductase subunit B2 |
increases expression |
EXP |
Fluorouracil results in increased expression of NDUFB2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 7:140,696,708...140,706,643
Ensembl chr 7:140,690,777...140,722,790
|
|
G |
NDUFB9 |
NADH:ubiquinone oxidoreductase subunit B9 |
affects expression |
EXP |
Fluorouracil affects the expression of NDUFB9 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 8:124,539,123...124,549,979
Ensembl chr 8:124,539,101...124,580,648
|
|
G |
NDUFC1 |
NADH:ubiquinone oxidoreductase subunit C1 |
affects expression |
EXP |
Fluorouracil affects the expression of NDUFC1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 4:139,289,917...139,302,551
Ensembl chr 4:139,266,880...139,302,551
|
|
G |
NDUFV1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
affects expression |
EXP |
Fluorouracil affects the expression of NDUFV1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr11:67,606,936...67,612,554
Ensembl chr11:67,605,653...67,612,554
|
|
G |
NDUFV3 |
NADH:ubiquinone oxidoreductase subunit V3 |
increases expression |
EXP |
Fluorouracil results in increased expression of NDUFV3 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr21:42,893,309...42,913,299
Ensembl chr21:42,879,644...42,913,304
|
|
G |
NEDD4 |
NEDD4 E3 ubiquitin protein ligase |
affects response to substance |
EXP |
NEDD4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr15:55,826,917...55,993,612
Ensembl chr15:55,826,922...55,993,660
|
|
G |
NEK1 |
NIMA related kinase 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NEK1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 4:169,392,809...169,612,583
Ensembl chr 4:169,369,704...169,612,632
|
|
G |
NEK2 |
NIMA related kinase 2 |
multiple interactions decreases expression |
EXP ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NEK2 mRNA] |
CTD |
PMID:15016801 PMID:19272435 |
|
NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
|
|
G |
NEK4 |
NIMA related kinase 4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NEK4 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 3:52,708,444...52,770,940
Ensembl chr 3:52,708,444...52,770,946
|
|
G |
NEK6 |
NIMA related kinase 6 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NEK6 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 9:124,257,606...124,353,307
Ensembl chr 9:124,257,606...124,353,307
|
|
G |
NEK9 |
NIMA related kinase 9 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NEK9 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr14:75,079,353...75,127,202
Ensembl chr14:75,079,353...75,127,344
|
|
G |
NES |
nestin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NES mRNA; Fluorouracil results in decreased expression of NES protein |
CTD |
PMID:21296659 PMID:26272751 |
|
NCBI chr 1:156,668,763...156,677,407
Ensembl chr 1:156,668,763...156,677,407
|
|
G |
NETO2 |
neuropilin and tolloid like 2 |
affects response to substance |
EXP |
NETO2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr16:47,077,703...47,143,945
Ensembl chr16:47,077,703...47,143,945
|
|
G |
NEUROD1 |
neuronal differentiation 1 |
affects expression decreases expression |
EXP ISO |
Fluorouracil affects the expression of NEUROD1 mRNA Fluorouracil results in decreased expression of NEUROD1 protein |
CTD |
PMID:16584549 PMID:21296659 |
|
NCBI chr 2:181,668,295...181,680,517
Ensembl chr 2:181,668,295...181,680,827
|
|
G |
NEUROG2 |
neurogenin 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NEUROG2 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 4:112,513,516...112,516,180
Ensembl chr 4:112,513,516...112,516,180
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
affects response to substance multiple interactions affects localization decreases expression affects expression decreases response to substance |
EXP ISO |
NFE2L2 protein affects the susceptibility to Fluorouracil Ascorbic Acid promotes the reaction [Fluorouracil affects the localization of NFE2L2 protein] Fluorouracil results in decreased expression of NFE2L2 protein Fluorouracil affects the expression of NFE2L2 mRNA NFE2L2 results in decreased susceptibility to Fluorouracil NFE2L2 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18692501 PMID:20722640 PMID:21489257 PMID:26921358 PMID:34151400 PMID:35101590 More...
|
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFE2L3 |
NFE2 like bZIP transcription factor 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of NFE2L3 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 7:26,152,198...26,187,137
Ensembl chr 7:26,152,198...26,187,137
|
|
G |
NFIB |
nuclear factor I B |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NFIB mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 9:14,081,843...14,532,077
Ensembl chr 9:14,081,843...14,398,983
|
|
G |
NFIC |
nuclear factor I C |
increases expression |
EXP |
Fluorouracil results in increased expression of NFIC mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:3,359,630...3,469,217
Ensembl chr19:3,314,403...3,469,217
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions affects localization increases phosphorylation decreases response to substance |
EXP ISO |
[N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] affects the localization of NFKB1 protein; [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] results in decreased expression of [NFKB1 protein binds to RELA protein]; resveratrol inhibits the reaction [Fluorouracil results in increased phosphorylation of NFKB1 protein] Ascorbic Acid inhibits the reaction [Fluorouracil affects the localization of NFKB1 protein] NFKB1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15548681 PMID:16637064 PMID:26310874 PMID:26921358 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
affects activity increases phosphorylation decreases expression multiple interactions increases expression decreases degradation |
EXP ISO |
Fluorouracil affects the activity of NFKBIA protein Fluorouracil results in increased phosphorylation of NFKBIA protein Fluorouracil results in decreased expression of NFKBIA protein Curcumin inhibits the reaction [Fluorouracil results in decreased expression of NFKBIA protein] [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] results in decreased expression of NFKBIA protein; Fluorouracil results in increased phosphorylation of and results in increased activity of NFKBIA protein; resveratrol inhibits the reaction [Fluorouracil results in increased phosphorylation of NFKBIA protein] Fluorouracil results in increased expression of NFKBIA protein Fluorouracil results in decreased degradation of NFKBIA protein |
CTD |
PMID:10891390 PMID:12941601 PMID:16337965 PMID:16637064 PMID:16929163 PMID:26310874 PMID:27194111 More...
|
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NFYA |
nuclear transcription factor Y subunit alpha |
multiple interactions |
EXP |
Fluorouracil inhibits the reaction [NFYA protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]] |
CTD |
PMID:27129209 |
|
NCBI chr 6:41,072,974...41,102,403
Ensembl chr 6:41,072,974...41,102,403
|
|
G |
NFYB |
nuclear transcription factor Y subunit beta |
affects expression multiple interactions |
ISO EXP |
Fluorouracil affects the expression of NFYB mRNA Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]] |
CTD |
PMID:20421339 PMID:27129209 |
|
NCBI chr12:104,117,086...104,138,210
Ensembl chr12:104,117,086...104,138,241
|
|
G |
NGFR |
nerve growth factor receptor |
increases response to substance |
ISO |
TNFRSF10B protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:15374982 |
|
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
|
|
G |
NINJ1 |
ninjurin 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of NINJ1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 9:93,121,496...93,134,251
Ensembl chr 9:93,121,496...93,134,251
|
|
G |
NIPSNAP2 |
nipsnap homolog 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NIPSNAP2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:55,964,585...56,000,179
Ensembl chr 7:55,951,793...56,000,181
|
|
G |
NKAIN1 |
sodium/potassium transporting ATPase interacting 1 |
multiple interactions |
EXP |
NKAIN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 1:31,179,745...31,239,887
Ensembl chr 1:31,179,745...31,239,887
|
|
G |
NKIRAS1 |
NFKB inhibitor interacting Ras like 1 |
affects expression |
EXP |
Fluorouracil affects the expression of NKIRAS1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:23,889,951...23,946,562
Ensembl chr 3:23,889,951...23,946,591
|
|
G |
NME1 |
NME/NM23 nucleoside diphosphate kinase 1 |
affects response to substance |
EXP |
NME1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr17:51,153,559...51,162,168
Ensembl chr17:51,153,559...51,162,428
|
|
G |
NME4 |
NME/NM23 nucleoside diphosphate kinase 4 |
affects response to substance |
EXP |
NME4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr16:396,729...400,754
Ensembl chr16:396,725...410,367
|
|
G |
NODAL |
nodal growth differentiation factor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NODAL protein |
CTD |
PMID:21296659 |
|
NCBI chr10:70,431,936...70,447,951
Ensembl chr10:70,431,936...70,447,951
|
|
G |
NOG |
noggin |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NOG protein |
CTD |
PMID:21296659 |
|
NCBI chr17:56,593,699...56,595,611
Ensembl chr17:56,593,699...56,595,611
|
|
G |
NOM1 |
nucleolar protein with MIF4G domain 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NOM1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 7:156,949,712...156,973,176
Ensembl chr 7:156,949,712...156,973,176
|
|
G |
NOS2 |
nitric oxide synthase 2 |
increases expression multiple interactions |
EXP ISO |
Fluorouracil results in increased expression of NOS2 protein Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of NOS2 mRNA] Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Fluorouracil results in increased expression of and results in increased activity of NOS2 protein |
CTD |
PMID:12150722 PMID:16724238 PMID:18069768 PMID:31129132 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions decreases expression |
ISO |
Bosentan inhibits the reaction [Fluorouracil results in decreased expression of NOS3 protein]; Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of NOS3 mRNA] |
CTD |
PMID:31129132 PMID:34800596 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NOTCH1 |
notch receptor 1 |
multiple interactions |
EXP |
[Fluorouracil co-treated with Chloroquine] results in increased expression of NOTCH1 protein |
CTD |
PMID:29917191 |
|
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
|
|
G |
NPM1 |
nucleophosmin 1 |
decreases response to substance |
EXP |
NPM1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:24736981 |
|
NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
|
|
G |
NPM3 |
nucleophosmin/nucleoplasmin 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of NPM3 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr10:101,781,325...101,783,446
Ensembl chr10:101,781,325...101,783,446
|
|
G |
NPPA |
natriuretic peptide A |
increases expression |
ISO |
Fluorouracil results in increased expression of NPPA protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NQO1 protein |
CTD |
PMID:35101590 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR1D2 |
nuclear receptor subfamily 1 group D member 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NR1D2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:23,945,286...23,980,617
Ensembl chr 3:23,945,286...23,980,637
|
|
G |
NR4A1 |
nuclear receptor subfamily 4 group A member 1 |
affects expression |
EXP |
Fluorouracil affects the expression of NR4A1 mRNA |
CTD |
PMID:15205334 PMID:16557594 |
|
NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507
|
|
G |
NR5A2 |
nuclear receptor subfamily 5 group A member 2 |
affects expression |
ISO |
Fluorouracil affects the expression of NR5A2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420
|
|
G |
NR6A1 |
nuclear receptor subfamily 6 group A member 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of NR6A1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 9:124,517,275...124,771,311
Ensembl chr 9:124,517,275...124,771,311
|
|
G |
NRG1 |
neuregulin 1 |
affects response to substance |
EXP |
NRG1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
|
|
G |
NRIP1 |
nuclear receptor interacting protein 1 |
multiple interactions decreases expression |
EXP |
[Fluorouracil co-treated with irinotecan] results in increased expression of NRIP1 mRNA Fluorouracil results in decreased expression of NRIP1 mRNA |
CTD |
PMID:16391804 PMID:16510598 |
|
NCBI chr21:14,961,235...15,065,936
Ensembl chr21:14,961,235...15,065,936
|
|
G |
NRP1 |
neuropilin 1 |
decreases response to substance |
EXP |
NRP1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15956974 |
|
NCBI chr10:33,177,493...33,334,667
Ensembl chr10:33,177,492...33,336,262
|
|
G |
NT5C1A |
5'-nucleotidase, cytosolic IA |
decreases response to substance multiple interactions |
ISO |
NT5C1A protein results in decreased susceptibility to Fluorouracil NT5C1A protein results in decreased susceptibility to [Fluorouracil co-treated with Cladribine] |
CTD |
PMID:16362297 |
|
NCBI chr 1:39,651,229...39,672,107
Ensembl chr 1:39,651,229...39,672,107
|
|
G |
NT5E |
5'-nucleotidase ecto |
increases expression |
EXP |
Fluorouracil results in increased expression of NT5E mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 6:85,450,083...85,495,784
Ensembl chr 6:85,449,584...85,495,791
|
|
G |
NT5M |
5',3'-nucleotidase, mitochondrial |
increases expression |
EXP |
Fluorouracil results in increased expression of NT5M mRNA |
CTD |
PMID:19219653 |
|
NCBI chr17:17,303,373...17,347,663
Ensembl chr17:17,303,335...17,347,663
|
|
G |
NTN4 |
netrin 4 |
increases expression |
EXP |
Fluorouracil results in increased expression of NTN4 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr12:95,657,807...95,791,155
Ensembl chr12:95,657,807...95,791,189
|
|
G |
NTRK2 |
neurotrophic receptor tyrosine kinase 2 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of NTRK2 protein NTRK2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
|
|
G |
NTS |
neurotensin |
affects response to substance |
EXP |
NTS protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr12:85,874,295...85,882,992
Ensembl chr12:85,874,295...85,882,992
|
|
G |
NTSR1 |
neurotensin receptor 1 |
affects response to substance decreases expression |
EXP |
NTSR1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of NTSR1 protein |
CTD |
PMID:15352031 |
|
NCBI chr20:62,708,836...62,762,771
Ensembl chr20:62,708,836...62,762,771
|
|
G |
NUCKS1 |
nuclear casein kinase and cyclin dependent kinase substrate 1 |
multiple interactions decreases expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of NUCKS1 mRNA] Fluorouracil results in decreased expression of NUCKS1 protein |
CTD |
PMID:15016801 PMID:15585135 PMID:16803524 |
|
NCBI chr 1:205,712,822...205,750,182
Ensembl chr 1:205,712,822...205,750,182
|
|
G |
NUPR1 |
nuclear protein 1, transcriptional regulator |
affects expression |
EXP |
Fluorouracil affects the expression of NUPR1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr16:28,532,708...28,538,974
Ensembl chr16:28,532,708...28,539,008
|
|
G |
OAS2 |
2'-5'-oligoadenylate synthetase 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of OAS2 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr12:112,978,519...113,011,723
Ensembl chr12:112,978,395...113,011,723
|
|
G |
ODC1 |
ornithine decarboxylase 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ODC1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327
|
|
G |
OGFRL1 |
opioid growth factor receptor like 1 |
affects response to substance |
EXP |
OGFRL1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:71,288,811...71,309,059
Ensembl chr 6:71,288,811...71,309,059
|
|
G |
OLFM1 |
olfactomedin 1 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of OLFM1 protein OLFM1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 9:135,075,505...135,121,184
Ensembl chr 9:135,075,422...135,121,180
|
|
G |
OLFM4 |
olfactomedin 4 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of OLFM4 protein |
CTD |
PMID:36203040 |
|
NCBI chr13:53,028,813...53,052,057
Ensembl chr13:53,028,813...53,052,057
|
|
G |
OLIG2 |
oligodendrocyte transcription factor 2 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of OLIG2 mRNA; Fluorouracil results in decreased expression of OLIG2 protein [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA]]; TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA] |
CTD |
PMID:21296659 PMID:25178657 |
|
NCBI chr21:33,025,935...33,029,185
Ensembl chr21:33,025,935...33,029,196
|
|
G |
OLIG3 |
oligodendrocyte transcription factor 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of OLIG3 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 6:137,492,199...137,494,394
Ensembl chr 6:137,492,199...137,494,394
|
|
G |
OPTN |
optineurin |
affects response to substance increases expression |
EXP |
OPTN protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of OPTN mRNA |
CTD |
PMID:16101138 PMID:16217747 PMID:17039268 |
|
NCBI chr10:13,100,082...13,138,308
Ensembl chr10:13,099,449...13,138,308
|
|
G |
ORC3 |
origin recognition complex subunit 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ORC3 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 6:87,590,135...87,677,823
Ensembl chr 6:87,590,067...87,677,823
|
|
G |
ORC6 |
origin recognition complex subunit 6 |
increases expression |
EXP |
Fluorouracil results in increased expression of ORC6 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr16:46,689,659...46,698,394
Ensembl chr16:46,689,643...46,698,394
|
|
G |
OTX2 |
orthodenticle homeobox 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of OTX2 mRNA |
CTD |
PMID:30518710 |
|
NCBI chr14:56,799,905...56,810,479
Ensembl chr14:56,799,905...56,816,693
|
|
G |
OXCT1 |
3-oxoacid CoA-transferase 1 |
multiple interactions affects response to substance |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of OXCT1 mRNA] OXCT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr 5:41,730,065...41,870,425
Ensembl chr 5:41,730,065...41,870,425
|
|
G |
P4HB |
prolyl 4-hydroxylase subunit beta |
decreases expression |
EXP |
Fluorouracil results in decreased expression of P4HB mRNA |
CTD |
PMID:32535746 |
|
NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
|
|
G |
PAFAH1B1 |
platelet activating factor acetylhydrolase 1b regulatory subunit 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PAFAH1B1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr17:2,593,183...2,685,615
Ensembl chr17:2,593,183...2,685,615
|
|
G |
PAICS |
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase |
increases expression |
EXP |
Fluorouracil results in increased expression of PAICS mRNA |
CTD |
PMID:19219653 |
|
NCBI chr 4:56,410,507...56,464,578
Ensembl chr 4:56,435,741...56,464,578
|
|
G |
PAIP1 |
poly(A) binding protein interacting protein 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PAIP1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:43,526,267...43,557,411
Ensembl chr 5:43,526,267...43,557,758
|
|
G |
PANK1 |
pantothenate kinase 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of PANK1 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr10:89,579,495...89,645,242
Ensembl chr10:89,579,497...89,645,242
|
|
G |
PAQR8 |
progestin and adipoQ receptor family member 8 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PAQR8 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 6:52,362,151...52,407,777
Ensembl chr 6:52,361,421...52,407,777
|
|
G |
PARD3 |
par-3 family cell polarity regulator |
affects response to substance |
EXP |
PARD3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:34,109,561...34,815,296
Ensembl chr10:34,109,560...34,815,325
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases expression affects expression increases cleavage multiple interactions |
EXP ISO |
Fluorouracil results in increased expression of PARP1; Fluorouracil results in increased expression of PARP1 mRNA Fluorouracil affects the expression of PARP1 mRNA Fluorouracil results in increased cleavage of PARP1 protein 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein]; [Fluorouracil co-treated with Genistein] results in increased cleavage of PARP1 protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein; [SM-1 compound co-treated with Fluorouracil] results in increased expression of PARP1 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein]; Celecoxib inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; EGF protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; Fluorouracil promotes the reaction [gambogic acid results in decreased expression of PARP1 mRNA]; Fluorouracil promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein]; Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein; IGF1 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; IL6 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]]; Nicotine inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; S100A11 mutant form promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; SM-1 compound promotes the reaction [Fluorouracil results in increased expression of PARP1 mRNA]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; TNFRSF10B mutant form inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein] 3-methyladenine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein]; Fluorouracil results in increased cleavage of and results in increased activity of PARP1 protein |
CTD |
PMID:11300326 PMID:15896711 PMID:15996812 PMID:16525653 PMID:17461495 PMID:17982676 PMID:19084572 PMID:19116755 PMID:19816940 PMID:21036698 PMID:24095863 PMID:25940438 PMID:26544897 PMID:28507149 PMID:28599477 PMID:32270916 PMID:34151400 More...
|
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PARP14 |
poly(ADP-ribose) polymerase family member 14 |
increases expression |
EXP |
Fluorouracil results in increased expression of PARP14 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 3:122,680,839...122,730,840
Ensembl chr 3:122,680,839...122,730,840
|
|
G |
PAX3 |
paired box 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PAX3 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 2:222,199,887...222,298,998
Ensembl chr 2:222,199,887...222,298,998
|
|
G |
PAX6 |
paired box 6 |
increases expression decreases expression |
ISO EXP |
Fluorouracil results in increased expression of PAX6 protein Fluorouracil results in decreased expression of PAX6 mRNA |
CTD |
PMID:21296659 PMID:30518710 |
|
NCBI chr11:31,789,026...31,817,961
Ensembl chr11:31,784,779...31,817,961
|
|
G |
PBX3 |
PBX homeobox 3 |
affects response to substance |
EXP |
PBX3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:125,747,373...125,967,377
Ensembl chr 9:125,747,345...125,967,377
|
|
G |
PCDHA5 |
protocadherin alpha 5 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PCDHA5 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 5:140,821,613...141,012,347
Ensembl chr 5:140,821,604...141,012,347
|
|
G |
PCLAF |
PCNA clamp associated factor |
multiple interactions decreases expression |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of PCLAF mRNA Fluorouracil results in decreased expression of PCLAF mRNA |
CTD |
PMID:16391804 PMID:17039268 |
|
NCBI chr15:64,364,304...64,387,687
Ensembl chr15:64,364,304...64,387,687
|
|
G |
PCNA |
proliferating cell nuclear antigen |
decreases expression multiple interactions increases expression |
EXP ISO |
Fluorouracil results in decreased expression of PCNA protein [diacerein co-treated with Fluorouracil] inhibits the reaction [Trichloroacetic Acid results in increased expression of PCNA protein]; Fluorouracil inhibits the reaction [Trichloroacetic Acid results in increased expression of PCNA protein] Probucol inhibits the reaction [Fluorouracil results in decreased expression of PCNA protein] Fluorouracil results in increased expression of PCNA mRNA |
CTD |
PMID:16557594 PMID:16709241 PMID:18205257 PMID:19272435 PMID:29678497 PMID:34794354 PMID:39334374 More...
|
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PCOLCE2 |
procollagen C-endopeptidase enhancer 2 |
affects response to substance |
EXP |
PCOLCE2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:142,817,874...142,889,083
Ensembl chr 3:142,815,922...142,889,206
|
|
G |
PDAP1 |
PDGFA associated protein 1 |
decreases expression increases expression |
EXP |
Fluorouracil results in decreased expression of PDAP1 mRNA Fluorouracil results in increased expression of PDAP1 protein |
CTD |
PMID:15585135 PMID:16709241 PMID:16803524 |
|
NCBI chr 7:99,394,673...99,408,597
Ensembl chr 7:99,392,048...99,408,597
|
|
G |
PDCD1LG2 |
programmed cell death 1 ligand 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PDCD1LG2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 9:5,510,531...5,571,282
Ensembl chr 9:5,510,531...5,571,282
|
|
G |
PDCD4 |
programmed cell death 4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PDCD4 mRNA |
CTD |
PMID:15109396 |
|
NCBI chr10:110,871,928...110,900,006
Ensembl chr10:110,871,795...110,900,006
|
|
G |
PDCD6IP |
programmed cell death 6 interacting protein |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PDCD6IP mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 3:33,798,630...33,869,703
Ensembl chr 3:33,798,571...33,869,707
|
|
G |
PDF |
peptide deformylase, mitochondrial |
increases expression decreases response to substance |
EXP |
Fluorouracil results in increased expression of PDF mRNA; Fluorouracil results in increased expression of PDF protein PDF protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:16510598 |
|
NCBI chr16:69,326,913...69,330,588
Ensembl chr16:69,326,913...69,330,588
|
|
G |
PDIA4 |
protein disulfide isomerase family A member 4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PDIA4 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 7:149,003,051...149,028,505
Ensembl chr 7:149,003,062...149,028,662
|
|
G |
PDLIM5 |
PDZ and LIM domain 5 |
affects response to substance |
EXP |
PDLIM5 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:94,451,942...94,668,223
Ensembl chr 4:94,451,857...94,668,227
|
|
G |
PDX1 |
pancreatic and duodenal homeobox 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of IPF1 protein |
CTD |
PMID:21296659 |
|
NCBI chr13:27,920,000...27,926,313
Ensembl chr13:27,920,000...27,926,313
|
|
G |
PDXK |
pyridoxal kinase |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PDXK mRNA |
CTD |
PMID:16510598 |
|
NCBI chr21:43,719,129...43,762,299
Ensembl chr21:43,719,094...43,762,307
|
|
G |
PDXP |
pyridoxal phosphatase |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PDXP mRNA |
CTD |
PMID:16709241 |
|
NCBI chr22:37,658,723...37,666,932
Ensembl chr22:37,658,723...37,666,932
|
|
G |
PECAM1 |
platelet and endothelial cell adhesion molecule 1 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of PECAM1 mRNA; Fluorouracil results in decreased expression of PECAM1 protein Probucol inhibits the reaction [Fluorouracil results in decreased expression of PECAM1 mRNA]; Probucol inhibits the reaction [Fluorouracil results in decreased expression of PECAM1 protein] |
CTD |
PMID:19272435 PMID:21296659 |
|
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
|
|
G |
PEG10 |
paternally expressed 10 |
affects response to substance |
EXP |
PEG10 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
|
|
G |
PER1 |
period circadian regulator 1 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PER1 mRNA |
CTD |
PMID:18329632 |
|
NCBI chr17:8,140,472...8,152,404
Ensembl chr17:8,140,467...8,156,506
|
|
G |
PER2 |
period circadian regulator 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PER2 mRNA |
CTD |
PMID:18329632 |
|
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
|
|
G |
PFN2 |
profilin 2 |
increases expression multiple interactions affects response to substance |
EXP |
Fluorouracil results in increased expression of PFN2 protein TP53 protein affects the reaction [Fluorouracil results in decreased expression of PFN2 mRNA] PFN2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15016801 PMID:15352031 |
|
NCBI chr 3:149,964,904...149,970,895
Ensembl chr 3:149,964,904...150,050,788
|
|
G |
PGLYRP1 |
peptidoglycan recognition protein 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PGLYRP1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:46,019,153...46,023,053
Ensembl chr19:46,019,153...46,023,053
|
|
G |
PGR |
progesterone receptor |
affects expression |
EXP |
Fluorouracil affects the expression of PGR mRNA |
CTD |
PMID:34151400 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
PHIP |
pleckstrin homology domain interacting protein |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PHIP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:78,934,419...79,078,254
Ensembl chr 6:78,934,419...79,078,287
|
|
G |
PHLDA3 |
pleckstrin homology like domain family A member 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of PHLDA3 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:201,464,278...201,469,188
Ensembl chr 1:201,464,278...201,469,237
|
|
G |
PHYH |
phytanoyl-CoA 2-hydroxylase |
affects response to substance |
EXP |
PHYH protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:13,277,799...13,300,064
Ensembl chr10:13,277,796...13,302,412
|
|
G |
PI4KB |
phosphatidylinositol 4-kinase beta |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PI4KB mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:151,291,797...151,327,715
Ensembl chr 1:151,291,797...151,327,715
|
|
G |
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PIK3CA mRNA mutant form |
CTD |
PMID:38423379 |
|
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
|
|
G |
PIR |
pirin |
affects response to substance decreases expression |
EXP |
PIR protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of PIR protein |
CTD |
PMID:15352031 |
|
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
|
|
G |
PISD |
phosphatidylserine decarboxylase |
affects response to substance |
EXP |
PISD protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr22:31,618,491...31,662,564
Ensembl chr22:31,618,491...31,662,221
|
|
G |
PLA2G4A |
phospholipase A2 group IVA |
affects response to substance |
EXP |
PLA2G4A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981
|
|
G |
PLAT |
plasminogen activator, tissue type |
increases expression |
EXP |
Fluorouracil results in increased expression of PLAT mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
|
|
G |
PLAU |
plasminogen activator, urokinase |
affects expression increases expression |
EXP |
Fluorouracil affects the expression of PLAU mRNA Fluorouracil results in increased expression of PLAU mRNA |
CTD |
PMID:16584549 PMID:24737281 |
|
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
|
|
G |
PLCG1 |
phospholipase C gamma 1 |
decreases response to substance |
EXP |
PLCG1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:17531112 |
|
NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
|
|
G |
PLEKHB1 |
pleckstrin homology domain containing B1 |
increases expression |
EXP |
Fluorouracil results in increased expression of PLEKHB1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr11:73,646,581...73,662,819
Ensembl chr11:73,646,178...73,662,819
|
|
G |
PLEKHO1 |
pleckstrin homology domain containing O1 |
affects response to substance |
EXP |
PLEKHO1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:150,149,646...150,160,065
Ensembl chr 1:150,149,183...150,164,720
|
|
G |
PLIN2 |
perilipin 2 |
affects response to substance |
EXP |
PLIN2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 9:19,108,388...19,127,492
Ensembl chr 9:19,108,375...19,149,290
|
|
G |
PLIN3 |
perilipin 3 |
affects response to substance |
EXP |
PLIN3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:4,838,341...4,867,667
Ensembl chr19:4,838,341...4,867,694
|
|
G |
PLK1 |
polo like kinase 1 |
increases expression decreases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of PLK1 protein Fluorouracil results in decreased expression of PLK mRNA; Fluorouracil results in decreased expression of PLK1 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of PLK1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of PLK1 protein] |
CTD |
PMID:15016801 PMID:15205334 PMID:16709241 |
|
NCBI chr16:23,678,889...23,690,367
Ensembl chr16:23,677,656...23,690,367
|
|
G |
PLK2 |
polo like kinase 2 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of PLK2 mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of PLK2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of PLK2 mRNA] |
CTD |
PMID:15016801 PMID:17982676 |
|
NCBI chr 5:58,453,982...58,460,086
Ensembl chr 5:58,453,982...58,460,139
|
|
G |
PLK3 |
polo like kinase 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of PLK3 protein |
CTD |
PMID:14665630 |
|
NCBI chr 1:44,800,377...44,805,990
Ensembl chr 1:44,800,377...44,805,995
|
|
G |
PLOD2 |
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 |
increases expression decreases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of PLOD2 protein Fluorouracil results in decreased expression of PLOD2 mRNA PLOD2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16557594 |
|
NCBI chr 3:146,069,440...146,161,184
Ensembl chr 3:146,035,139...146,163,725
|
|
G |
PLP2 |
proteolipid protein 2 |
affects response to substance |
EXP |
PLP2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:49,171,898...49,175,235
Ensembl chr X:49,171,898...49,175,235
|
|
G |
PLRG1 |
pleiotropic regulator 1 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in increased expression of PLRG1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 4:154,535,005...154,550,400
Ensembl chr 4:154,535,005...154,550,400
|
|
G |
PLSCR1 |
phospholipid scramblase 1 |
affects response to substance |
EXP |
PLSCR1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 3:146,515,180...146,544,607
Ensembl chr 3:146,515,180...146,544,856
|
|
G |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
affects response to substance multiple interactions |
EXP |
PMAIP1 protein affects the susceptibility to Fluorouracil TP53 protein affects the reaction [Fluorouracil results in increased expression of PMAIP1 mRNA] |
CTD |
PMID:15016801 PMID:16217747 |
|
NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,996...59,904,305
|
|
G |
PMF1 |
polyamine modulated factor 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PMF1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:156,213,007...156,240,042
Ensembl chr 1:156,212,993...156,240,042
|
|
G |
PMS2P4 |
PMS1 homolog 2, mismatch repair system component pseudogene 4 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PMS2P4 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:67,276,131...67,302,442
Ensembl chr 7:67,295,608...67,299,424
|
|
G |
PNMA2 |
PNMA family member 2 |
affects response to substance |
EXP |
PNMA2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 8:26,504,701...26,513,872
Ensembl chr 8:26,504,701...26,514,092
|
|
G |
PNP |
purine nucleoside phosphorylase |
affects response to substance |
EXP |
PNP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr14:20,469,406...20,477,089
Ensembl chr14:20,461,992...20,477,094
|
|
G |
PNPLA6 |
patatin like phospholipase domain containing 6 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PNPLA6 mRNA |
CTD |
PMID:26272751 |
|
NCBI chr19:7,534,164...7,561,767
Ensembl chr19:7,534,004...7,561,764
|
|
G |
PNRC1 |
proline rich nuclear receptor coactivator 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of PNRC1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:89,080,751...89,085,160
Ensembl chr 6:89,080,751...89,085,160
|
|
G |
PODXL |
podocalyxin like |
decreases expression |
ISO |
Fluorouracil results in decreased expression of PODXL protein |
CTD |
PMID:21296659 |
|
NCBI chr 7:131,500,271...131,556,628
Ensembl chr 7:131,500,262...131,558,217
|
|
G |
POLA1 |
DNA polymerase alpha 1, catalytic subunit |
decreases expression |
EXP |
Fluorouracil results in decreased expression of POLA1 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr X:24,693,918...24,996,986
Ensembl chr X:24,693,873...24,996,986
|
|
G |
POLA2 |
DNA polymerase alpha 2, accessory subunit |
affects response to substance |
EXP |
POLA2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr11:65,261,962...65,305,985
Ensembl chr11:65,261,913...65,305,959
|
|
G |
POLE2 |
DNA polymerase epsilon 2, accessory subunit |
affects response to substance |
EXP |
POLE2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:49,643,555...49,688,214
Ensembl chr14:49,643,555...49,688,422
|
|
G |
POLG |
DNA polymerase gamma, catalytic subunit |
affects response to substance |
EXP |
POLG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,305,198...89,334,861
|
|
G |
POSTN |
periostin |
decreases response to substance |
EXP |
POSTN protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15731169 |
|
NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
|
|
G |
POU5F1 |
POU class 5 homeobox 1 |
decreases expression |
ISO EXP |
Fluorouracil results in decreased expression of POU5F1 protein Fluorouracil results in decreased expression of POU5F1 mRNA |
CTD |
PMID:21296659 PMID:24737281 |
|
NCBI chr 6:31,164,337...31,170,682
Ensembl chr 6:31,164,337...31,180,731
|
|
G |
PPA2 |
inorganic pyrophosphatase 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PPA2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:105,369,077...105,474,070
Ensembl chr 4:105,369,077...105,474,067
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of PPARG protein PPARG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPFIBP1 |
PPFIA binding protein 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of PPFIBP1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr12:27,524,206...27,695,564
Ensembl chr12:27,523,431...27,695,564
|
|
G |
PPIE |
peptidylprolyl isomerase E |
increases expression |
EXP |
Fluorouracil results in increased expression of PPIE protein |
CTD |
PMID:16803524 |
|
NCBI chr 1:39,738,882...39,763,914
Ensembl chr 1:39,692,182...39,763,914
|
|
G |
PPM1D |
protein phosphatase, Mg2+/Mn2+ dependent 1D |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of PPM1D mRNA; Fluorouracil results in increased expression of PPM1D protein TP53 protein affects the reaction [Fluorouracil results in increased expression of PPM1D mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of PPM1D mRNA] |
CTD |
PMID:14665630 PMID:15016801 PMID:17982676 |
|
NCBI chr17:60,600,193...60,666,280
Ensembl chr17:60,600,193...60,666,280
|
|
G |
PPP1CA |
protein phosphatase 1 catalytic subunit alpha |
affects response to substance |
EXP |
PPP1CA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr11:67,398,183...67,401,858
Ensembl chr11:67,398,181...67,421,183
|
|
G |
PPP1CC |
protein phosphatase 1 catalytic subunit gamma |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PPP1CC mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:110,708,376...110,742,891
Ensembl chr12:110,719,680...110,742,939
|
|
G |
PPP1R15A |
protein phosphatase 1 regulatory subunit 15A |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of PPP1R15A mRNA PPP1R15A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15331170 PMID:16709241 |
|
NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059
|
|
G |
PPP1R17 |
protein phosphatase 1 regulatory subunit 17 |
increases expression |
EXP |
Fluorouracil results in increased expression of PPP1R17 protein |
CTD |
PMID:16803524 |
|
NCBI chr 7:31,687,215...31,708,455
Ensembl chr 7:31,687,215...31,708,455
|
|
G |
PPP1R1B |
protein phosphatase 1 regulatory inhibitor subunit 1B |
increases response to substance |
EXP |
PPP1R1B protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:17470401 |
|
NCBI chr17:39,626,707...39,636,624
Ensembl chr17:39,626,740...39,636,626
|
|
G |
PPP1R2 |
protein phosphatase 1 regulatory inhibitor subunit 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PPP1R2 mRNA |
CTD |
PMID:16557594 PMID:17039268 |
|
NCBI chr 3:195,514,428...195,543,325
Ensembl chr 3:195,514,428...195,543,386
|
|
G |
PPP2CB |
protein phosphatase 2 catalytic subunit beta |
increases expression |
EXP |
Fluorouracil results in increased expression of PPP2CB mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 8:30,785,616...30,812,818
Ensembl chr 8:30,774,457...30,814,314
|
|
G |
PPP3CA |
protein phosphatase 3 catalytic subunit alpha |
multiple interactions increases expression |
EXP |
[Fluorouracil co-treated with Irinotecan] results in increased expression of PPP3CA mRNA; PPP3CA protein affects the susceptibility to [Fluorouracil co-treated with Irinotecan analog] Fluorouracil results in increased expression of PPP3CA protein |
CTD |
PMID:15585135 PMID:16391804 PMID:16803524 PMID:18927307 |
|
NCBI chr 4:101,023,418...101,347,526
Ensembl chr 4:101,023,409...101,348,278
|
|
G |
PRC1 |
protein regulator of cytokinesis 1 |
decreases expression |
EXP ISO |
Fluorouracil results in decreased expression of PRC1 mRNA |
CTD |
PMID:17374387 PMID:19272435 |
|
NCBI chr15:90,966,040...90,994,535
Ensembl chr15:90,966,040...90,995,629
|
|
G |
PRDM14 |
PR/SET domain 14 |
affects expression |
EXP |
Fluorouracil affects the expression of PRDM14 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 8:70,051,651...70,071,252
Ensembl chr 8:70,051,651...70,071,693
|
|
G |
PREPL |
prolyl endopeptidase like |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PREPL mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:44,317,607...44,361,862
Ensembl chr 2:44,316,281...44,361,862
|
|
G |
PRIM1 |
DNA primase subunit 1 |
affects response to substance |
EXP |
PRIM1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr12:56,731,580...56,752,323
Ensembl chr12:56,730,438...56,752,374
|
|
G |
PRKAG2 |
protein kinase AMP-activated non-catalytic subunit gamma 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKAG2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 7:151,556,127...151,877,115
Ensembl chr 7:151,556,124...151,877,214
|
|
G |
PRKCI |
protein kinase C iota |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKCI mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:170,222,424...170,305,977
Ensembl chr 3:170,222,424...170,305,977
|
|
G |
PRKCZ |
protein kinase C zeta |
affects expression |
EXP |
Fluorouracil affects the expression of PRKCZ mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:2,048,504...2,185,395
Ensembl chr 1:2,050,411...2,185,395
|
|
G |
PRKDC |
protein kinase, DNA-activated, catalytic subunit |
multiple interactions |
EXP |
PRKDC mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKDC mRNA] |
CTD |
PMID:15016801 PMID:18546291 |
|
NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
|
|
G |
PRNP |
prion protein (Kanno blood group) |
decreases response to substance |
EXP |
PRNP protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15386405 |
|
NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
|
|
G |
PROC |
protein C, inactivator of coagulation factors Va and VIIIa |
decreases activity |
EXP |
Fluorouracil results in decreased activity of PROC protein |
CTD |
PMID:2297659 |
|
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
|
|
G |
PROCR |
protein C receptor |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of PROCR mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr20:35,171,096...35,216,259
Ensembl chr20:35,172,072...35,216,240
|
|
G |
PRODH2 |
proline dehydrogenase 2 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of PRODH2 protein PRODH2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr19:35,799,988...35,812,845
Ensembl chr19:35,799,988...35,813,299
|
|
G |
PROM1 |
prominin 1 |
affects response to substance increases expression |
EXP |
PROM1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of PROM1 protein |
CTD |
PMID:15352031 |
|
NCBI chr 4:15,968,228...16,084,023
Ensembl chr 4:15,963,076...16,084,378
|
|
G |
PRPF18 |
pre-mRNA processing factor 18 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PRPF18 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr10:13,586,965...13,655,929
Ensembl chr10:13,586,939...13,668,445
|
|
G |
PRPS1 |
phosphoribosyl pyrophosphate synthetase 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of PRPS1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr X:107,628,510...107,651,026
Ensembl chr X:107,628,428...107,651,993
|
|
G |
PRPS2 |
phosphoribosyl pyrophosphate synthetase 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PRPS2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr X:12,791,412...12,824,222
Ensembl chr X:12,791,355...12,824,222
|
|
G |
PRR13 |
proline rich 13 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in increased expression of PRR13 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr12:53,441,734...53,446,638
Ensembl chr12:53,441,678...53,446,645
|
|
G |
PRRG1 |
proline rich and Gla domain 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PRRG1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr X:37,349,364...37,457,291
Ensembl chr X:37,349,309...37,492,702
|
|
G |
PRRX1 |
paired related homeobox 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PRRX1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 1:170,662,768...170,739,421
Ensembl chr 1:170,662,728...170,739,421
|
|
G |
PRSS2 |
serine protease 2 |
affects expression |
EXP |
Fluorouracil affects the expression of PRSS2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 7:142,770,970...142,774,560
Ensembl chr 7:142,760,398...142,774,564
|
|
G |
PSG9 |
pregnancy specific beta-1-glycoprotein 9 |
multiple interactions |
EXP |
PSG9 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr19:43,253,282...43,269,530
Ensembl chr19:43,211,791...43,269,530
|
|
G |
PSMB10 |
proteasome 20S subunit beta 10 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PSMB10 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr16:67,934,506...67,936,850
Ensembl chr16:67,934,506...67,936,864
|
|
G |
PSMC3IP |
PSMC3 interacting protein |
affects expression |
ISO |
Fluorouracil affects the expression of PSMC3IP mRNA |
CTD |
PMID:20421339 |
|
NCBI chr17:42,572,310...42,577,831
Ensembl chr17:42,572,310...42,577,831
|
|
G |
PSRC1 |
proline and serine rich coiled-coil 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PSRC1 mRNA |
CTD |
PMID:17374387 |
|
NCBI chr 1:109,279,556...109,283,145
Ensembl chr 1:109,279,556...109,283,186
|
|
G |
PTCH1 |
patched 1 |
affects localization decreases expression multiple interactions |
EXP |
Fluorouracil affects the localization of PTCH1 protein Fluorouracil results in decreased expression of PTCH1 mRNA; Fluorouracil results in decreased expression of PTCH1 protein [Fluorouracil co-treated with irinotecan] results in increased expression of PTCH1 mRNA; GLI1 protein inhibits the reaction [Fluorouracil affects the localization of PTCH1 protein] |
CTD |
PMID:16391804 PMID:18776995 PMID:25190613 |
|
NCBI chr 9:95,442,980...95,516,971
Ensembl chr 9:95,442,980...95,517,057
|
|
G |
PTEN |
phosphatase and tensin homolog |
decreases expression increases expression |
EXP |
Fluorouracil results in decreased expression of PTEN mRNA Fluorouracil results in increased expression of PTEN mRNA |
CTD |
PMID:17039268 PMID:24737281 |
|
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
G |
PTGR1 |
prostaglandin reductase 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of PTGR1 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression decreases expression increases response to substance |
EXP ISO |
[Cisplatin co-treated with Fluorouracil] affects the expression of PTGS2 protein; [Fluorouracil co-treated with Curcumin] results in decreased expression of PTGS2 protein; [Fluorouracil results in increased expression of PTGS2 protein] which results in increased abundance of and results in increased secretion of Dinoprostone; [Genistein inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]] which results in decreased abundance of Dinoprostone; acadesine inhibits the reaction [[Fluorouracil results in increased expression of PTGS2 protein] which results in increased abundance of and results in increased secretion of Dinoprostone]; acadesine inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]; Curcumin promotes the reaction [Fluorouracil results in decreased phosphorylation of and results in decreased activity of PTGS2 protein]; Fluorouracil results in decreased phosphorylation of and results in decreased activity of PTGS2 protein; Genistein inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]; PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein] Ascorbic Acid inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]; Thymol inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein] Fluorouracil promotes the reaction [resveratrol results in decreased expression of PTGS2 protein]; resveratrol promotes the reaction [Fluorouracil results in decreased expression of PTGS2 protein] PTGS2 protein results in increased susceptibility to Fluorouracil Fluorouracil results in increased expression of PTGS2 mRNA; Fluorouracil results in increased expression of PTGS2 protein Fluorouracil results in decreased expression of PTGS2 mRNA; Fluorouracil results in decreased expression of PTGS2 protein |
CTD |
PMID:12414664 PMID:15205334 PMID:15846114 PMID:15896711 PMID:16322294 PMID:16340194 PMID:16793607 PMID:17918158 PMID:25936796 PMID:26921358 PMID:29678497 PMID:34665902 PMID:35101590 More...
|
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTK2 |
protein tyrosine kinase 2 |
decreases response to substance decreases phosphorylation affects expression |
EXP |
PTK2 protein results in decreased susceptibility to Fluorouracil Fluorouracil results in decreased phosphorylation of PTK2 protein Fluorouracil affects the expression of PTK2 mRNA |
CTD |
PMID:16179862 PMID:34151400 PMID:37625625 |
|
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
|
|
G |
PTPRK |
protein tyrosine phosphatase receptor type K |
affects response to substance |
EXP |
PTPRK protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:127,968,785...128,520,599
Ensembl chr 6:127,968,785...128,520,616
|
|
G |
PTTG1 |
PTTG1 regulator of sister chromatid separation, securin |
increases expression decreases expression multiple interactions |
EXP ISO |
Fluorouracil results in increased expression of PTTG1 protein Fluorouracil results in decreased expression of PTTG1 mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of PTTG1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of PTTG1 protein] |
CTD |
PMID:15016801 PMID:15205334 PMID:16557594 PMID:17039268 PMID:19272435 |
|
NCBI chr 5:160,421,855...160,428,744
Ensembl chr 5:160,421,855...160,428,739
|
|
G |
PTTG3P |
pituitary tumor-transforming 3, pseudogene |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PTTG3P mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:66,767,329...66,768,034
Ensembl chr 8:66,767,400...66,768,005
|
|
G |
PUM1 |
pumilio RNA binding family member 1 |
affects expression |
EXP |
Fluorouracil affects the expression of PUM1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:30,931,506...31,065,717
Ensembl chr 1:30,931,506...31,065,991
|
|
G |
PURA |
purine rich element binding protein A |
affects expression |
EXP |
Fluorouracil affects the expression of PURA mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 5:140,114,109...140,125,619
Ensembl chr 5:140,107,777...140,125,619
|
|
G |
PURG |
purine rich element binding protein G |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of PURG mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:30,995,802...31,033,356
Ensembl chr 8:30,995,802...31,033,715
|
|
G |
PVT1 |
Pvt1 oncogene |
decreases expression |
EXP |
Fluorouracil results in decreased expression of PVT1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 8:127,794,524...128,101,256
Ensembl chr 8:127,794,513...128,188,202
|
|
G |
PWP2 |
PWP2 small subunit processome component |
increases expression |
ISO |
Fluorouracil results in increased expression of PWP2 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr21:44,107,399...44,131,181
Ensembl chr21:44,107,373...44,131,181
|
|
G |
PXMP2 |
peroxisomal membrane protein 2 |
affects expression |
ISO |
Fluorouracil affects the expression of PXMP2 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr12:132,687,587...132,704,985
Ensembl chr12:132,687,587...132,704,985
|
|
G |
QSOX1 |
quiescin sulfhydryl oxidase 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of QSOX1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:180,154,869...180,204,030
Ensembl chr 1:180,154,869...180,204,030
|
|
G |
R3HDM2 |
R3H domain containing 2 |
affects expression |
EXP |
Fluorouracil affects the expression of R3HDM2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr12:57,253,764...57,431,141
Ensembl chr12:57,253,762...57,431,043
|
|
G |
RAB11A |
RAB11A, member RAS oncogene family |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RAB11A mRNA |
CTD |
PMID:17039268 |
|
NCBI chr15:65,869,491...65,891,989
Ensembl chr15:65,726,054...65,891,989
|
|
G |
RAB20 |
RAB20, member RAS oncogene family |
affects response to substance |
EXP |
RAB20 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr13:110,523,066...110,561,722
Ensembl chr13:110,523,066...110,561,722
|
|
G |
RAB21 |
RAB21, member RAS oncogene family |
affects expression |
EXP |
Fluorouracil affects the expression of RAB21 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr12:71,754,863...71,800,286
Ensembl chr12:71,754,863...71,800,286
|
|
G |
RAB25 |
RAB25, member RAS oncogene family |
affects expression |
ISO |
Fluorouracil affects the expression of RAB25 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 1:156,061,160...156,070,504
Ensembl chr 1:156,061,160...156,070,504
|
|
G |
RAB8A |
RAB8A, member RAS oncogene family |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RAB8A mRNA |
CTD |
PMID:16709241 |
|
NCBI chr19:16,111,889...16,134,234
Ensembl chr19:16,111,889...16,134,234
|
|
G |
RAD23B |
RAD23 homolog B, nucleotide excision repair protein |
affects response to substance increases expression |
EXP |
RAD23B affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of RAD23B mRNA |
CTD |
PMID:15067352 PMID:15109396 |
|
NCBI chr 9:107,283,279...107,332,194
Ensembl chr 9:107,283,137...107,332,192
|
|
G |
RAD51C |
RAD51 paralog C |
affects expression |
ISO |
Fluorouracil affects the expression of RAD51C mRNA |
CTD |
PMID:20421339 |
|
NCBI chr17:58,692,573...58,735,611
Ensembl chr17:58,692,573...58,735,611
|
|
G |
RAD54B |
RAD54 homolog B |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RAD54B mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 8:94,371,960...94,475,115
Ensembl chr 8:94,371,960...94,475,115
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
increases expression decreases expression |
EXP ISO |
Fluorouracil results in increased expression of RAF1 mRNA Fluorouracil results in decreased expression of RAF1 protein |
CTD |
PMID:15152939 PMID:21296659 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201
|
|
G |
RAMP1 |
receptor activity modifying protein 1 |
decreases expression affects response to substance multiple interactions |
EXP |
Fluorouracil results in decreased expression of RAMP1 protein RAMP1 protein affects the susceptibility to Fluorouracil RAMP1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:15352031 PMID:16896004 |
|
NCBI chr 2:237,858,880...237,912,106
Ensembl chr 2:237,858,893...237,912,106
|
|
G |
RANBP1 |
RAN binding protein 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of RANBP1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr22:20,116,104...20,127,355
Ensembl chr22:20,115,938...20,127,355
|
|
G |
RARRES2 |
retinoic acid receptor responder 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RARRES2 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 7:150,338,329...150,341,629
Ensembl chr 7:150,338,317...150,341,662
|
|
G |
RAX2 |
retina and anterior neural fold homeobox 2 |
affects expression |
EXP |
Fluorouracil affects the expression of RAX2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:3,769,089...3,772,228
Ensembl chr19:3,769,089...3,772,228
|
|
G |
RB1 |
RB transcriptional corepressor 1 |
affects expression affects response to substance multiple interactions increases phosphorylation |
EXP ISO |
Fluorouracil affects the expression of RB1 mRNA RB1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of and results in increased phosphorylation of RB1 protein; RB1 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] RB1 protein affects the susceptibility to Fluorouracil; RB1 protein modified form affects the susceptibility to Fluorouracil Fluorouracil results in increased phosphorylation of RB1 protein |
CTD |
PMID:9930367 PMID:15064736 PMID:15205334 PMID:17207318 PMID:17640669 PMID:18383818 PMID:18678097 More...
|
|
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
|
|
G |
RBBP4 |
RB binding protein 4, chromatin remodeling factor |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of RBBP4 mRNA RBBP4 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] |
CTD |
PMID:16557594 PMID:18678097 |
|
NCBI chr 1:32,651,208...32,686,211
Ensembl chr 1:32,651,142...32,686,211
|
|
G |
RBM14 |
RNA binding motif protein 14 |
increases expression |
EXP |
Fluorouracil results in increased expression of RBM14 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr11:66,616,630...66,629,934
Ensembl chr11:66,616,626...66,629,934
|
|
G |
RBM5 |
RNA binding motif protein 5 |
affects response to substance |
EXP |
RBM5 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 3:50,088,919...50,119,021
Ensembl chr 3:50,088,919...50,119,021
|
|
G |
RBP1 |
retinol binding protein 1 |
affects response to substance decreases expression |
EXP |
RBP1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of RBP1 protein |
CTD |
PMID:15352031 |
|
NCBI chr 3:139,517,438...139,539,742
Ensembl chr 3:139,517,434...139,539,829
|
|
G |
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of RBPJ mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131
|
|
G |
RCBTB2 |
RCC1 and BTB domain containing protein 2 |
affects expression |
EXP |
Fluorouracil affects the expression of RCBTB2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr13:48,488,963...48,535,895
Ensembl chr13:48,488,963...48,533,256
|
|
G |
RCC1 |
regulator of chromosome condensation 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RCC1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 1:28,506,043...28,538,989
Ensembl chr 1:28,505,943...28,539,300
|
|
G |
RDX |
radixin |
affects expression |
EXP |
Fluorouracil affects the expression of RDX mRNA |
CTD |
PMID:16584549 |
|
NCBI chr11:110,174,922...110,296,614
Ensembl chr11:109,864,295...110,296,712
|
|
G |
RECQL4 |
RecQ like helicase 4 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of RECQL4 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:144,511,288...144,517,833
Ensembl chr 8:144,511,288...144,517,845
|
|
G |
REG4 |
regenerating family member 4 |
decreases response to substance |
EXP |
REG4 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:17237819 |
|
NCBI chr 1:119,794,017...119,811,460
Ensembl chr 1:119,794,017...119,811,580
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases expression increases phosphorylation decreases response to substance affects expression affects response to substance decreases expression |
EXP ISO |
[N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] affects the localization of RELA protein; [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] results in decreased expression of [NFKB1 protein binds to RELA protein]; Fluorouracil affects the localization of and affects the activity of RELA protein; resveratrol inhibits the reaction [Fluorouracil results in increased phosphorylation of RELA protein] Bosentan inhibits the reaction [Fluorouracil results in increased expression of RELA protein]; Thymol inhibits the reaction [Fluorouracil results in increased expression of RELA protein] RELA protein results in decreased susceptibility to Fluorouracil Fluorouracil inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] Fluorouracil affects the expression of RELA protein RELA protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of RELA protein |
CTD |
PMID:12941601 PMID:15548681 PMID:16637064 PMID:16680372 PMID:16724238 PMID:18535404 PMID:19003803 PMID:22905237 PMID:26310874 PMID:34665902 PMID:34800596 More...
|
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
REPS1 |
RALBP1 associated Eps domain containing 1 |
multiple interactions |
EXP |
REPS1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr 6:138,903,493...138,988,253
Ensembl chr 6:138,903,493...138,988,261
|
|
G |
REST |
RE1 silencing transcription factor |
affects expression decreases expression |
EXP ISO |
Fluorouracil affects the expression of REST mRNA Fluorouracil results in decreased expression of REST protein |
CTD |
PMID:16584549 PMID:21296659 |
|
NCBI chr 4:56,907,900...56,935,844
Ensembl chr 4:56,907,876...56,966,808
|
|
G |
REV1 |
REV1 DNA directed polymerase |
affects expression |
EXP |
Fluorouracil affects the expression of REV1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:99,400,477...99,490,202
Ensembl chr 2:99,400,475...99,490,035
|
|
G |
RFC2 |
replication factor C subunit 2 |
affects response to substance |
EXP |
RFC2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 7:74,231,502...74,254,399
Ensembl chr 7:74,231,499...74,254,458
|
|
G |
RFC3 |
replication factor C subunit 3 |
affects response to substance |
EXP |
RFC3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr13:33,818,149...33,977,377
Ensembl chr13:33,818,069...33,966,558
|
|
G |
RFC4 |
replication factor C subunit 4 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of RFC4 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:186,789,900...186,806,482
Ensembl chr 3:186,789,880...186,807,058
|
|
G |
RGS1 |
regulator of G protein signaling 1 |
affects expression |
EXP |
Fluorouracil affects the expression of RGS1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 1:192,575,773...192,580,024
Ensembl chr 1:192,575,763...192,580,024
|
|
G |
RGS13 |
regulator of G protein signaling 13 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RGS13 protein |
CTD |
PMID:16803524 |
|
NCBI chr 1:192,636,147...192,660,311
Ensembl chr 1:192,636,138...192,660,311
|
|
G |
RGS16 |
regulator of G protein signaling 16 |
affects expression |
EXP |
Fluorouracil affects the expression of RGS16 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 1:182,598,623...182,604,389
Ensembl chr 1:182,598,623...182,604,389
|
|
G |
RGS2 |
regulator of G protein signaling 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RGS2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:192,809,039...192,812,275
Ensembl chr 1:192,809,039...192,812,275
|
|
G |
RGS4 |
regulator of G protein signaling 4 |
affects response to substance |
EXP |
RGS4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:163,068,871...163,076,802
Ensembl chr 1:163,068,775...163,076,802
|
|
G |
RGS5 |
regulator of G protein signaling 5 |
decreases expression multiple interactions |
ISO |
Fluorouracil results in decreased expression of RGS5 mRNA IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of RGS5 mRNA] |
CTD |
PMID:18157009 |
|
NCBI chr 1:163,142,299...163,321,735
Ensembl chr 1:163,111,121...163,321,791
|
|
G |
RHBDL2 |
rhomboid like 2 |
affects response to substance |
EXP |
RHBDL2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:38,885,807...38,941,830
Ensembl chr 1:38,885,807...38,941,830
|
|
G |
RHOA |
ras homolog family member A |
decreases response to substance |
EXP |
RHOA protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15448013 |
|
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
|
|
G |
RIPK1 |
receptor interacting serine/threonine kinase 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of RIPK1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 6:3,063,967...3,115,187
Ensembl chr 6:3,063,824...3,115,187
|
|
G |
RIT1 |
Ras like without CAAX 1 |
affects response to substance |
EXP |
RIT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:155,897,808...155,911,349
Ensembl chr 1:155,897,808...155,911,404
|
|
G |
RNASE4 |
ribonuclease A family member 4 |
affects response to substance |
EXP |
RNASE4 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:20,684,560...20,701,216
Ensembl chr14:20,684,560...20,701,216
|
|
G |
RND2 |
Rho family GTPase 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of RND2 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr17:43,025,231...43,032,041
Ensembl chr17:43,025,231...43,032,041
|
|
G |
RNF34 |
ring finger protein 34 |
multiple interactions decreases response to substance |
EXP |
[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 protein; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 mRNA; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 protein; [Fluorouracil co-treated with RNF34 protein] results in increased expression of BIRC5 protein; [Fluorouracil co-treated with RNF34 protein] results in increased expression of FAS protein; BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA]; BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2L1 mRNA]; RNF34 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein]; RNF34 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein] RNF34 protein results in decreased susceptibility to Fluorouracil; RNF34 protein results in decreased susceptibility to Fluorouracil analog |
CTD |
PMID:16080519 PMID:16270526 PMID:16407826 PMID:16596200 |
|
NCBI chr12:121,400,118...121,424,348
Ensembl chr12:121,400,083...121,430,623
|
|
G |
RNF4 |
ring finger protein 4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RNF4 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 4:2,469,106...2,515,857
Ensembl chr 4:2,462,220...2,515,857
|
|
G |
RPL10A |
ribosomal protein L10a |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of RPL10A mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:35,468,401...35,470,780
Ensembl chr 6:35,468,401...35,470,785
|
|
G |
RPL21P4 |
ribosomal protein L21 pseudogene 4 |
increases expression |
EXP |
Fluorouracil results in increased expression of RPL21P4 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr17:43,079,261...43,079,816
Ensembl chr17:43,079,302...43,079,780
|
|
G |
RPL23 |
ribosomal protein L23 |
increases expression |
EXP |
Fluorouracil results in increased expression of RPL23 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr17:38,847,860...38,853,721
Ensembl chr17:38,847,860...38,868,644
|
|
G |
RPL23AP1 |
ribosomal protein L23a pseudogene 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of RPL23AP1 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 6:29,726,597...29,727,154
Ensembl chr 6:29,726,669...29,727,139
|
|
G |
RPL24 |
ribosomal protein L24 |
affects response to substance |
EXP |
RPL24 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 3:101,681,091...101,686,718
Ensembl chr 3:101,681,091...101,686,733
|
|
G |
RPL3 |
ribosomal protein L3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RPL3 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr22:39,312,882...39,319,623
Ensembl chr22:39,312,882...39,320,389
|
|
G |
RPL37 |
ribosomal protein L37 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RPL37 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 5:40,825,262...40,835,222
Ensembl chr 5:40,825,262...40,835,222
|
|
G |
RPL6 |
ribosomal protein L6 |
decreases response to substance |
EXP |
RPL6 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15846068 |
|
NCBI chr12:112,405,181...112,418,835
Ensembl chr12:112,405,189...112,418,838
|
|
G |
RPRD1B |
regulation of nuclear pre-mRNA domain containing 1B |
affects response to substance increases expression |
EXP |
RPRD1B protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of RPRD1B mRNA |
CTD |
PMID:15331170 |
|
NCBI chr20:38,033,746...38,092,364
Ensembl chr20:38,033,725...38,127,780
|
|
G |
RPS26 |
ribosomal protein S26 |
affects expression |
EXP |
Fluorouracil affects the expression of RPS26 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr12:56,041,918...56,044,697
Ensembl chr12:56,041,351...56,044,697
|
|
G |
RPS27L |
ribosomal protein S27 like |
decreases expression increases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of RPS27L protein Fluorouracil results in increased expression of RPS27L mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of RPS27L mRNA] |
CTD |
PMID:15016801 PMID:16557594 PMID:18056458 |
|
NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021
|
|
G |
RPS28 |
ribosomal protein S28 |
increases expression |
EXP |
Fluorouracil results in increased expression of RPS28 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr19:8,321,496...8,323,340
Ensembl chr19:8,321,158...8,323,340
|
|
G |
RRAS |
RAS related |
affects response to substance |
EXP |
RRAS protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:49,635,292...49,640,143
Ensembl chr19:49,635,292...49,640,143
|
|
G |
RRBP1 |
ribosome binding protein 1 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of RRBP1 protein RRBP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr20:17,613,679...17,682,242
Ensembl chr20:17,613,678...17,682,295
|
|
G |
RRM1 |
ribonucleotide reductase catalytic subunit M1 |
increases expression |
EXP |
Fluorouracil results in increased expression of RRM1 protein |
CTD |
PMID:15331170 |
|
NCBI chr11:4,094,685...4,138,932
Ensembl chr11:4,094,707...4,138,932
|
|
G |
RRM2 |
ribonucleotide reductase regulatory subunit M2 |
affects expression affects response to substance multiple interactions increases expression decreases expression |
EXP |
Fluorouracil affects the expression of RRM2 mRNA RRM2 protein affects the susceptibility to Fluorouracil RRM2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] Fluorouracil results in increased expression of RRM2 mRNA Fluorouracil results in decreased expression of RRM2 mRNA |
CTD |
PMID:15205334 PMID:15548681 PMID:16557594 PMID:16584549 PMID:16709241 PMID:16896004 PMID:17039268 More...
|
|
NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725
|
|
G |
RRM2B |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
decreases response to substance increases expression multiple interactions |
EXP |
RRM2B protein results in decreased susceptibility to Fluorouracil Fluorouracil results in increased expression of RRM2B mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of RRM2B mRNA] |
CTD |
PMID:15016801 PMID:15890238 PMID:16557594 PMID:21704725 |
|
NCBI chr 8:102,204,501...102,238,961
Ensembl chr 8:102,204,502...102,238,961
|
|
G |
RRP15 |
ribosomal RNA processing 15 homolog |
decreases expression |
EXP |
Fluorouracil results in decreased expression of RRP15 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:218,285,293...218,337,983
Ensembl chr 1:218,285,293...218,337,983
|
|
G |
RSRC2 |
arginine and serine rich coiled-coil 2 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of RSRC2 mRNA RSRC2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15331170 |
|
NCBI chr12:122,503,454...122,526,936
Ensembl chr12:122,503,454...122,527,000
|
|
G |
RTKN |
rhotekin |
multiple interactions decreases response to substance |
EXP |
Curcumin inhibits the reaction [RTKN protein results in decreased susceptibility to Fluorouracil] |
CTD |
PMID:15480428 |
|
NCBI chr 2:74,425,835...74,441,937
Ensembl chr 2:74,425,835...74,442,422
|
|
G |
RTL8C |
retrotransposon Gag like 8C |
affects response to substance |
EXP |
RTL8C protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:135,032,355...135,033,546
Ensembl chr X:135,032,355...135,033,546
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
affects expression |
ISO |
Fluorouracil affects the expression of RUNX2 mRNA |
CTD |
PMID:24704097 |
|
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
S100A10 |
S100 calcium binding protein A10 |
increases expression |
EXP |
Fluorouracil results in increased expression of S100A10 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:151,982,915...151,993,859
Ensembl chr 1:151,982,915...151,993,859
|
|
G |
S100A11 |
S100 calcium binding protein A11 |
increases expression increases response to substance multiple interactions |
ISO EXP |
Fluorouracil results in increased expression of S100A11 mRNA S100A11 mutant form results in increased susceptibility to Fluorouracil [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased activity of CASP3 protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein; [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased expression of H2AX protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein]; S100A11 mutant form promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein] |
CTD |
PMID:19272435 PMID:25940438 |
|
NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907
|
|
G |
S100A2 |
S100 calcium binding protein A2 |
affects expression increases expression multiple interactions affects response to substance decreases expression |
EXP |
Fluorouracil affects the expression of S100A2 mRNA Fluorouracil results in increased expression of S100A2 mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of S100A2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of S100A2 mRNA] S100A2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of S100A2 protein |
CTD |
PMID:15016801 PMID:15352031 PMID:16584549 PMID:17982676 |
|
NCBI chr 1:153,561,108...153,565,844
Ensembl chr 1:153,561,108...153,567,890
|
|
G |
S100A3 |
S100 calcium binding protein A3 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of S100A3 protein S100A3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr 1:153,547,329...153,549,258
Ensembl chr 1:153,547,329...153,549,258
|
|
G |
S100A4 |
S100 calcium binding protein A4 |
affects response to substance decreases expression |
EXP |
S100A4 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of S100A4 protein |
CTD |
PMID:15352031 |
|
NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
|
|
G |
S100P |
S100 calcium binding protein P |
decreases expression increases response to substance affects response to substance |
EXP |
Fluorouracil results in decreased expression of S100P protein S100P protein results in increased susceptibility to Fluorouracil S100P protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:18636193 |
|
NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170
|
|
G |
SAA1 |
serum amyloid A1 |
increases expression |
EXP |
Fluorouracil results in increased expression of SAA1 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr11:18,266,264...18,269,967
Ensembl chr11:18,266,260...18,269,977
|
|
G |
SAMHD1 |
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 |
affects expression |
EXP |
Fluorouracil affects the expression of SAMHD1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr20:36,889,773...36,951,708
Ensembl chr20:36,890,229...36,951,893
|
|
G |
SAP30 |
Sin3A associated protein 30 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SAP30 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:173,370,954...173,377,532
Ensembl chr 4:173,369,969...173,377,532
|
|
G |
SAT1 |
spermidine/spermine N1-acetyltransferase 1 |
multiple interactions increases expression decreases response to substance |
EXP |
[Fluorouracil co-treated with N(1),N(11)-diethylnorspermine] results in increased expression of SAT1 mRNA; [Fluorouracil co-treated with N(1),N(11)-diethylnorspermine] results in increased expression of SAT1 protein; [N(1), N(12)-diethylspermine co-treated with Fluorouracil] results in increased activity of SAT1 protein; [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] results in increased expression of SAT1 mRNA; TP53 protein affects the reaction [Fluorouracil results in increased expression of SAT1 mRNA] SAT1 mRNA results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15152939 PMID:16510598 PMID:16557594 PMID:16637064 PMID:17237273 PMID:21814787 More...
|
|
NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210
|
|
G |
SCAMP3 |
secretory carrier membrane protein 3 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of SCAMP3 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 1:155,255,981...155,262,360
Ensembl chr 1:155,255,979...155,262,433
|
|
G |
SCCPDH |
saccharopine dehydrogenase (putative) |
increases expression |
EXP |
Fluorouracil results in increased expression of SCCPDH mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 1:246,724,409...246,768,137
Ensembl chr 1:246,724,409...246,768,137
|
|
G |
SCD |
stearoyl-CoA desaturase |
increases expression affects response to substance multiple interactions decreases expression |
EXP |
Fluorouracil results in increased expression of SCD mRNA SCD protein affects the susceptibility to Fluorouracil TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of SCD mRNA] |
CTD |
PMID:16217747 PMID:17039268 PMID:17982676 |
|
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
|
|
G |
SCG2 |
secretogranin II |
decreases expression increases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of SCG2 protein Fluorouracil results in increased expression of SCG2 mRNA SCG2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:24737281 |
|
NCBI chr 2:223,596,940...223,602,361
Ensembl chr 2:223,596,940...223,602,361
|
|
G |
SCN2B |
sodium voltage-gated channel beta subunit 2 |
affects expression |
EXP |
Fluorouracil affects the expression of SCN2B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr11:118,162,806...118,176,639
Ensembl chr11:118,162,806...118,176,639
|
|
G |
SCNN1A |
sodium channel epithelial 1 subunit alpha |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of SCNN1A protein SCNN1A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr12:6,346,847...6,377,359
Ensembl chr12:6,346,843...6,377,730
|
|
G |
SCNN1B |
sodium channel epithelial 1 subunit beta |
affects expression |
EXP |
Fluorouracil affects the expression of SCNN1B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr16:23,278,231...23,381,294
Ensembl chr16:23,278,231...23,381,294
|
|
G |
SCUBE2 |
signal peptide, CUB domain and EGF like domain containing 2 |
multiple interactions |
EXP |
SCUBE2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr11:9,019,476...9,091,599
Ensembl chr11:9,019,476...9,138,114
|
|
G |
SDCCAG8 |
SHH signaling and ciliogenesis regulator SDCCAG8 |
increases expression |
EXP |
Fluorouracil results in increased expression of SDCCAG8 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:243,256,041...243,500,091
Ensembl chr 1:243,256,034...243,500,091
|
|
G |
SDHA |
succinate dehydrogenase complex flavoprotein subunit A |
affects response to substance |
EXP |
SDHA protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 5:218,320...268,746
Ensembl chr 5:218,303...257,082
|
|
G |
SDHD |
succinate dehydrogenase complex subunit D |
affects expression |
EXP |
Fluorouracil affects the expression of SDHD mRNA |
CTD |
PMID:34151400 |
|
NCBI chr11:112,086,873...112,095,794
Ensembl chr11:112,086,824...112,120,016
|
|
G |
SEC14L1 |
SEC14 like lipid binding 1 |
affects response to substance |
EXP |
SEC14L1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:77,088,685...77,217,101
Ensembl chr17:77,088,749...77,217,101
|
|
G |
SEC23A |
SEC23 homolog A, COPII coat complex component |
affects response to substance |
EXP |
SEC23A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:39,031,919...39,103,235
Ensembl chr14:39,031,919...39,109,646
|
|
G |
SEC31A |
SEC31 homolog A, COPII coat complex component |
affects response to substance |
EXP |
SEC31A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:82,818,509...82,900,569
Ensembl chr 4:82,818,509...82,901,166
|
|
G |
SEC31B |
SEC31 homolog B, COPII coat complex component |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SEC31B mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr10:100,486,647...100,519,861
Ensembl chr10:100,486,646...100,519,864
|
|
G |
SELENOP |
selenoprotein P |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SELENOP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
|
|
G |
SEMA3A |
semaphorin 3A |
increases expression |
EXP |
Fluorouracil results in increased expression of SEMA3A mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 7:83,955,777...84,492,725
Ensembl chr 7:83,955,777...84,492,724
|
|
G |
SEPHS1 |
selenophosphate synthetase 1 |
affects response to substance |
EXP |
SEPHS1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:13,317,428...13,348,293
Ensembl chr10:13,317,428...13,348,298
|
|
G |
SEPHS2 |
selenophosphate synthetase 2 |
affects response to substance |
EXP |
SEPHS2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr16:30,443,631...30,445,874
Ensembl chr16:30,443,631...30,445,874
|
|
G |
SEPTIN9 |
septin 9 |
affects expression |
ISO |
Fluorouracil affects the expression of SEPTIN9 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr17:77,281,499...77,500,596
Ensembl chr17:77,280,569...77,500,596
|
|
G |
SERF2 |
small EDRK-rich factor 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SERF2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr15:43,777,086...43,796,089
Ensembl chr15:43,777,087...43,804,427
|
|
G |
SERPINA5 |
serpin family A member 5 |
increases expression |
EXP |
Fluorouracil results in increased expression of SERPINA5 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr14:94,581,426...94,593,118
Ensembl chr14:94,561,442...94,593,118
|
|
G |
SERPINA7 |
serpin family A member 7 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SERPINA7 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr X:106,032,435...106,038,727
Ensembl chr X:106,032,435...106,038,727
|
|
G |
SERPINB2 |
serpin family B member 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of SERPINB2 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr18:63,887,705...63,903,888
Ensembl chr18:63,871,692...63,903,888
|
|
G |
SERPINB4 |
serpin family B member 4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SERPINB4 protein |
CTD |
PMID:16803524 |
|
NCBI chr18:63,637,259...63,644,256
Ensembl chr18:63,637,259...63,644,256
|
|
G |
SERPINB5 |
serpin family B member 5 |
multiple interactions increases response to substance increases expression |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of SERPINB5 mRNA; TP53 protein affects the reaction [Fluorouracil results in increased expression of SERPINB5 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SERPINB5 mRNA] SERPINB5 protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:15016801 PMID:16331619 PMID:16391804 PMID:17982676 |
|
NCBI chr18:63,476,958...63,505,085
Ensembl chr18:63,476,958...63,505,085
|
|
G |
SERPIND1 |
serpin family D member 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SERPIND1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr22:20,774,113...20,787,720
Ensembl chr22:20,774,113...20,787,720
|
|
G |
SERPINE2 |
serpin family E member 2 |
multiple interactions |
EXP |
SERPINE2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr 2:223,975,045...224,039,286
Ensembl chr 2:223,975,045...224,039,318
|
|
G |
SERPINI1 |
serpin family I member 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of SERPINI1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 3:167,735,721...167,825,569
Ensembl chr 3:167,735,243...167,825,569
|
|
G |
SERTAD1 |
SERTA domain containing 1 |
multiple interactions increases expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of SERTAD1 mRNA] |
CTD |
PMID:15016801 PMID:16557594 PMID:16584549 |
|
NCBI chr19:40,421,589...40,425,992
Ensembl chr19:40,421,589...40,425,992
|
|
G |
SESN1 |
sestrin 1 |
multiple interactions increases expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of SESN1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SESN1 mRNA] Fluorouracil results in increased expression of SESN1 mRNA; Fluorouracil results in increased expression of SESN1 protein |
CTD |
PMID:14665630 PMID:15016801 PMID:17982676 PMID:22525470 |
|
NCBI chr 6:108,984,309...109,094,846
Ensembl chr 6:108,984,309...109,094,846
|
|
G |
SESN2 |
sestrin 2 |
multiple interactions increases expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of SESN2 mRNA] |
CTD |
PMID:15016801 PMID:22525470 |
|
NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
|
|
G |
SET |
SET nuclear proto-oncogene |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SET mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 9:128,683,424...128,696,396
Ensembl chr 9:128,683,424...128,696,400
|
|
G |
SETD5 |
SET domain containing 5 |
affects expression |
EXP |
Fluorouracil affects the expression of SETD5 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:9,397,615...9,478,154
Ensembl chr 3:9,397,615...9,479,240
|
|
G |
SEZ6L |
seizure related 6 homolog like |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SEZ6L mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr22:26,169,462...26,383,596
Ensembl chr22:26,169,462...26,383,597
|
|
G |
SF3B3 |
splicing factor 3b subunit 3 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SF3B3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr16:70,523,816...70,577,668
Ensembl chr16:70,523,791...70,577,670
|
|
G |
SFN |
stratifin |
multiple interactions increases expression affects expression |
EXP |
SFN protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SFN mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SFN mRNA] Fluorouracil affects the expression of SFN mRNA |
CTD |
PMID:15016801 PMID:15999354 PMID:16557594 PMID:16584549 PMID:17982676 |
|
NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456
|
|
G |
SFRP2 |
secreted frizzled related protein 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SFRP2 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 4:153,780,591...153,789,083
Ensembl chr 4:153,780,591...153,789,083
|
|
G |
SGCE |
sarcoglycan epsilon |
affects response to substance |
EXP |
SGCE protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:94,584,980...94,656,133
Ensembl chr 7:94,524,204...94,656,572
|
|
G |
SHH |
sonic hedgehog signaling molecule |
decreases expression increases expression |
EXP ISO |
Fluorouracil results in decreased expression of SHH mRNA Fluorouracil results in increased expression of SHH mRNA |
CTD |
PMID:18776995 PMID:26272751 |
|
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
|
|
G |
SHISA9 |
shisa family member 9 |
increases expression |
EXP |
Fluorouracil results in increased expression of SHISA9 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr16:12,901,598...13,563,017
Ensembl chr16:12,901,598...13,240,416
|
|
G |
SHMT2 |
serine hydroxymethyltransferase 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SHMT2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:57,229,711...57,234,935
Ensembl chr12:57,229,573...57,234,935
|
|
G |
SIGLEC1 |
sialic acid binding Ig like lectin 1 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in increased expression of SIGLEC1 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr20:3,686,970...3,712,600
Ensembl chr20:3,686,970...3,712,600
|
|
G |
SIGLEC9 |
sialic acid binding Ig like lectin 9 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SIGLEC9 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:51,119,778...51,136,263
Ensembl chr19:51,124,906...51,136,651
|
|
G |
SIRT4 |
sirtuin 4 |
increases expression |
EXP |
Fluorouracil results in increased expression of SIRT4 mRNA; Fluorouracil results in increased expression of SIRT4 protein |
CTD |
PMID:39241941 |
|
NCBI chr12:120,291,780...120,313,249
Ensembl chr12:120,302,316...120,313,249
|
|
G |
SKIC8 |
SKI8 subunit of superkiller complex |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SKIC8 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr15:78,283,235...78,299,609
Ensembl chr15:78,277,835...78,299,703
|
|
G |
SLC13A5 |
solute carrier family 13 member 5 |
decreases response to substance |
EXP |
SLC13A5 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:32634519 |
|
NCBI chr17:6,684,719...6,713,369
Ensembl chr17:6,684,719...6,713,377
|
|
G |
SLC15A1 |
solute carrier family 15 member 1 |
decreases activity decreases expression |
EXP |
Fluorouracil results in decreased activity of SLC15A1 protein Fluorouracil results in decreased expression of SLC15A1 mRNA |
CTD |
PMID:16253763 |
|
NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672
|
|
G |
SLC16A1 |
solute carrier family 16 member 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SLC16A1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,593
|
|
G |
SLC16A6 |
solute carrier family 16 member 6 |
decreases expression affects response to substance increases expression |
EXP |
Fluorouracil results in decreased expression of SLC16A6 protein SLC16A6 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of SLC16A6 mRNA |
CTD |
PMID:15352031 PMID:16510598 |
|
NCBI chr17:68,267,026...68,291,479
Ensembl chr17:68,267,026...68,291,267
|
|
G |
SLC22A7 |
solute carrier family 22 member 7 |
increases transport |
EXP |
SLC22A7 protein results in increased transport of Fluorouracil |
CTD |
PMID:15901346 |
|
NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
|
|
G |
SLC22A8 |
solute carrier family 22 member 8 |
increases transport |
ISO |
SLC22A8 protein results in increased transport of Fluorouracil |
CTD |
PMID:15100168 |
|
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
|
|
G |
SLC25A23 |
solute carrier family 25 member 23 |
affects expression |
EXP |
Fluorouracil affects the expression of SLC25A23 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:6,436,081...6,459,792
Ensembl chr19:6,436,079...6,465,203
|
|
G |
SLC25A27 |
solute carrier family 25 member 27 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SLC25A27 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 6:46,652,975...46,678,190
Ensembl chr 6:46,652,915...46,678,190
|
|
G |
SLC29A1 |
solute carrier family 29 member 1 (Augustine blood group) |
multiple interactions decreases response to substance affects response to substance increases expression |
EXP |
4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in decreased susceptibility to Fluorouracil]; Fluorouracil promotes the reaction [SLC29A1 protein results in increased uptake of Gemcitabine] SLC29A1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of SLC29A1; Fluorouracil results in increased expression of SLC29A1 mRNA |
CTD |
PMID:16217747 PMID:16868479 PMID:17695509 PMID:18383843 |
|
NCBI chr 6:44,219,615...44,234,142
Ensembl chr 6:44,219,553...44,234,142
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
decreases expression decreases activity increases expression |
EXP |
Fluorouracil results in decreased expression of SLC2A1 mRNA Fluorouracil results in decreased activity of SLC2A1 protein Fluorouracil results in increased expression of SLC2A1 mRNA |
CTD |
PMID:16253763 PMID:16595493 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|
G |
SLC2A14 |
solute carrier family 2 member 14 |
affects response to substance |
EXP |
SLC2A14 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr12:7,812,514...7,891,196
Ensembl chr12:7,812,512...7,891,148
|
|
G |
SLC2A2 |
solute carrier family 2 member 2 |
multiple interactions increases expression |
ISO |
Fluorouracil promotes the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]; Phloretin inhibits the reaction [Fluorouracil promotes the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]] Fluorouracil results in increased expression of SLC2A2 mRNA; Fluorouracil results in increased expression of SLC2A2 protein |
CTD |
PMID:15986457 |
|
NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743
|
|
G |
SLC2A3 |
solute carrier family 2 member 3 |
affects response to substance |
EXP |
SLC2A3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
|
|
G |
SLC35F5 |
solute carrier family 35 member F5 |
affects response to substance |
EXP |
SLC35F5 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16477629 |
|
NCBI chr 2:113,702,682...113,756,642
Ensembl chr 2:113,705,011...113,756,693
|
|
G |
SLC3A2 |
solute carrier family 3 member 2 |
increases expression affects response to substance |
EXP |
Fluorouracil results in increased expression of SLC3A2 mRNA SLC3A2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15331170 |
|
NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
|
|
G |
SLC47A1 |
solute carrier family 47 member 1 |
affects response to substance |
EXP |
SLC47A1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034
|
|
G |
SLC48A1 |
solute carrier family 48 member 1 |
affects expression |
EXP |
Fluorouracil affects the expression of SLC48A1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr12:47,753,934...47,782,751
Ensembl chr12:47,753,916...47,782,751
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of SLC5A1 protein |
CTD |
PMID:15986457 |
|
NCBI chr22:32,043,261...32,113,029
Ensembl chr22:32,043,261...32,113,029
|
|
G |
SLC9A3 |
solute carrier family 9 member A3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SLC9A3 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 5:470,456...524,449
Ensembl chr 5:470,456...524,449
|
|
G |
SLCO2A1 |
solute carrier organic anion transporter family member 2A1 |
affects expression |
EXP |
Fluorouracil affects the expression of SLCO2A1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:133,932,701...134,029,925
Ensembl chr 3:133,932,701...134,052,184
|
|
G |
SMAD4 |
SMAD family member 4 |
multiple interactions |
EXP |
SMAD4 results in decreased susceptibility to [Fluorouracil co-treated with alpha-Tocopherol] |
CTD |
PMID:20562578 |
|
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
|
|
G |
SMARCA1 |
SNF2 related chromatin remodeling ATPase 1 |
affects response to substance increases expression |
EXP |
SMARCA1 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of SMARCA1 protein |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr X:129,446,506...129,523,490
Ensembl chr X:129,446,501...129,523,500
|
|
G |
SMCHD1 |
structural maintenance of chromosomes flexible hinge domain containing 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of SMCHD1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr18:2,655,726...2,805,017
Ensembl chr18:2,655,726...2,805,017
|
|
G |
SMIM10L2A |
small integral membrane protein 10 like 2A |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SMIM10L2A mRNA |
CTD |
PMID:34151400 |
|
NCBI chr X:135,421,944...135,428,075
Ensembl chr X:135,421,944...135,428,075
|
|
G |
SMIM14 |
small integral membrane protein 14 |
increases expression |
EXP |
Fluorouracil results in increased expression of SMIM14 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 4:39,546,336...39,638,865
Ensembl chr 4:39,546,336...39,638,902
|
|
G |
SMN2 |
survival of motor neuron 2, centromeric |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SMN2 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr 5:70,049,523...70,090,528
Ensembl chr 5:70,049,638...70,078,522 Ensembl chr 5:70,049,638...70,078,522
|
|
G |
SMO |
smoothened, frizzled class receptor |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SMO mRNA; Fluorouracil results in decreased expression of SMO protein |
CTD |
PMID:18776995 PMID:25190613 |
|
NCBI chr 7:129,188,633...129,213,545
Ensembl chr 7:129,188,633...129,213,545
|
|
G |
SMOX |
spermine oxidase |
multiple interactions |
EXP |
[oxaliplatin co-treated with Fluorouracil] results in increased expression of and results in increased activity of SMOX protein; [oxaliplatin co-treated with Fluorouracil] results in increased expression of SMOX mRNA |
CTD |
PMID:17987291 |
|
NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747
|
|
G |
SMS |
spermine synthase |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of SMS mRNA TP53 protein affects the reaction [Fluorouracil results in decreased expression of SMS mRNA] |
CTD |
PMID:15016801 PMID:15152939 |
|
NCBI chr X:21,940,709...21,994,837
Ensembl chr X:21,940,709...21,994,837
|
|
G |
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of SMURF1 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 7:99,027,440...99,144,108
Ensembl chr 7:99,027,440...99,144,108
|
|
G |
SNAI2 |
snail family transcriptional repressor 2 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of SNAI2 protein resveratrol inhibits the reaction [Fluorouracil results in increased expression of SNAI2 protein] |
CTD |
PMID:26310874 |
|
NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
|
|
G |
SNAP29 |
synaptosome associated protein 29 |
increases expression |
EXP |
Fluorouracil results in increased expression of SNAP29 protein |
CTD |
PMID:16803524 |
|
NCBI chr22:20,859,007...20,891,214
Ensembl chr22:20,859,007...20,891,214
|
|
G |
SNAPC1 |
small nuclear RNA activating complex polypeptide 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SNAPC1 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr14:61,762,420...61,796,428
Ensembl chr14:61,762,420...61,796,428
|
|
G |
SNHG15 |
small nucleolar RNA host gene 15 |
affects expression affects response to substance |
EXP |
Fluorouracil affects the expression of SNHG15 protein SNHG15 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15331170 |
|
NCBI chr 7:44,983,023...44,986,696
Ensembl chr 7:44,983,019...44,986,961
|
|
G |
SNORD22 |
small nucleolar RNA, C/D box 22 |
increases expression |
EXP |
Fluorouracil results in increased expression of SNORD22 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr11:62,852,910...62,853,035
Ensembl chr11:62,852,910...62,853,035
|
|
G |
SNRNP48 |
small nuclear ribonucleoprotein U11/U12 subunit 48 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SNRNP48 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:7,590,198...7,611,967
Ensembl chr 6:7,590,198...7,611,967
|
|
G |
SNRPA1 |
small nuclear ribonucleoprotein polypeptide A' |
multiple interactions |
EXP |
SNRPA1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr15:101,281,510...101,295,248
Ensembl chr15:101,281,510...101,295,282
|
|
G |
SNTB1 |
syntrophin beta 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of SNTB1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 8:120,535,756...120,812,046
Ensembl chr 8:120,535,745...120,813,273
|
|
G |
SNX6 |
sorting nexin 6 |
affects response to substance |
EXP |
SNX6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr14:34,561,093...34,630,148
Ensembl chr14:34,561,093...34,630,160
|
|
G |
SOAT1 |
sterol O-acyltransferase 1 |
affects response to substance |
EXP |
SOAT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:179,293,797...179,358,680
Ensembl chr 1:179,293,714...179,358,680
|
|
G |
SOCS1 |
suppressor of cytokine signaling 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of SOCS1 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
|
|
G |
SOD1 |
superoxide dismutase 1 |
increases expression decreases activity multiple interactions |
ISO |
Fluorouracil results in increased expression of SOD1 protein Fluorouracil results in decreased activity of SOD1 protein casticin promotes the reaction [Fluorouracil results in increased expression of SOD1 protein]; Fluorouracil promotes the reaction [casticin results in increased expression of SOD1 protein] |
CTD |
PMID:29117755 PMID:32270916 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
[irinotecan co-treated with Fluorouracil] results in increased activity of SOD2 protein |
CTD |
PMID:15886469 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SOX17 |
SRY-box transcription factor 17 |
decreases expression decreases localization |
ISO EXP |
Fluorouracil results in decreased expression of SOX17 protein Fluorouracil results in decreased expression of SOX17 mRNA Fluorouracil results in decreased localization of SOX17 protein |
CTD |
PMID:21296659 PMID:24154490 PMID:24737281 |
|
NCBI chr 8:54,457,935...54,460,892
Ensembl chr 8:54,457,935...54,460,892
|
|
G |
SOX18 |
SRY-box transcription factor 18 |
affects response to substance |
EXP |
SOX18 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:64,047,582...64,049,639
Ensembl chr20:64,047,582...64,049,639
|
|
G |
SOX2 |
SRY-box transcription factor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SOX2 protein |
CTD |
PMID:21296659 |
|
NCBI chr 3:181,711,925...181,714,436
Ensembl chr 3:181,711,925...181,714,436
|
|
G |
SOX4 |
SRY-box transcription factor 4 |
increases expression |
EXP |
Fluorouracil results in increased expression of SOX4 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619
|
|
G |
SP1 |
Sp1 transcription factor |
multiple interactions |
EXP |
Fluorouracil promotes the reaction [[TP53 protein binds to SP1 protein] which binds to CDKN1A promoter]; SP1 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:15489892 PMID:18927307 |
|
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
|
|
G |
SP3 |
Sp3 transcription factor |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SP3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:173,900,775...173,965,702
Ensembl chr 2:173,880,850...173,965,373
|
|
G |
SPAG5 |
sperm associated antigen 5 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SPAG5 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr17:28,577,574...28,599,025
Ensembl chr17:28,577,565...28,599,025
|
|
G |
SPANXA1 |
sperm protein associated with the nucleus, X-linked, family member A1 |
affects response to substance |
EXP |
SPANXA1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:141,583,674...141,584,738
Ensembl chr X:141,583,674...141,584,738
|
|
G |
SPANXC |
SPANX family member C |
affects response to substance |
EXP |
SPANXC protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:141,241,463...141,242,517
Ensembl chr X:141,241,463...141,242,517
|
|
G |
SPARC |
secreted protein acidic and cysteine rich |
multiple interactions affects expression increases response to substance |
EXP ISO |
[decitabine affects the methylation of SPARC promoter] which affects the susceptibility to Fluorouracil Fluorouracil affects the expression of SPARC mRNA SPARC protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:15902309 PMID:18458674 PMID:24704097 |
|
NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975
|
|
G |
SPATA25 |
spermatogenesis associated 25 |
increases expression |
EXP |
Fluorouracil results in increased expression of SPATA25 protein |
CTD |
PMID:15331170 |
|
NCBI chr20:45,886,491...45,891,016
Ensembl chr20:45,886,491...45,887,622
|
|
G |
SPINK4 |
serine peptidase inhibitor Kazal type 4 |
affects expression |
EXP |
Fluorouracil affects the expression of SPINK4 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 9:33,240,167...33,248,567
Ensembl chr 9:33,218,365...33,248,567
|
|
G |
SPN |
sialophorin |
multiple interactions |
EXP |
Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN mRNA]; Fluorouracil inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN protein] |
CTD |
PMID:31404653 |
|
NCBI chr16:29,662,963...29,670,876
Ensembl chr16:29,662,979...29,670,876
|
|
G |
SPOCK1 |
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of SPOCK1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 5:136,975,298...137,499,326
Ensembl chr 5:136,975,298...137,598,379
|
|
G |
SPON1 |
spondin 1 |
affects expression |
EXP |
Fluorouracil affects the expression of SPON1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr11:13,962,723...14,268,133
Ensembl chr11:13,962,723...14,268,133
|
|
G |
SPRR1A |
small proline rich protein 1A |
increases expression |
EXP |
Fluorouracil results in increased expression of SPRR1A mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:152,984,081...152,985,814
Ensembl chr 1:152,984,081...152,985,814
|
|
G |
SPRR1B |
small proline rich protein 1B |
affects expression |
EXP |
Fluorouracil affects the expression of SPRR1B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:153,031,203...153,032,900
Ensembl chr 1:153,031,203...153,032,900
|
|
G |
SPRR3 |
small proline rich protein 3 |
affects expression |
EXP |
Fluorouracil affects the expression of SPRR3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 1:153,001,749...153,003,856
Ensembl chr 1:153,001,747...153,003,856
|
|
G |
SPRY1 |
sprouty RTK signaling antagonist 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of SPRY1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 4:123,396,795...123,403,760
Ensembl chr 4:123,396,795...123,403,760
|
|
G |
SPTAN1 |
spectrin alpha, non-erythrocytic 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of SPTAN1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 9:128,552,587...128,633,662
Ensembl chr 9:128,552,558...128,633,662
|
|
G |
SQLE |
squalene epoxidase |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SQLE mRNA |
CTD |
PMID:15205334 |
|
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
|
|
G |
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases phosphorylation decreases expression affects response to substance |
EXP |
Fluorouracil results in increased phosphorylation of SRC protein Fluorouracil results in decreased expression of SRC protein SRC protein affects the susceptibility to Fluorouracil |
CTD |
PMID:18794807 PMID:39334374 |
|
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
affects expression |
EXP |
Fluorouracil affects the expression of SREBF1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
|
|
G |
SREBF2 |
sterol regulatory element binding transcription factor 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SREBF2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
|
|
G |
SRI |
sorcin |
decreases response to substance |
EXP |
SRI protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18423116 |
|
NCBI chr 7:88,205,115...88,226,976
Ensembl chr 7:88,205,115...88,226,993
|
|
G |
SRP19 |
signal recognition particle 19 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of SRP19 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 5:112,861,287...112,898,371
Ensembl chr 5:112,861,188...112,898,371
|
|
G |
SRP72 |
signal recognition particle 72 |
increases expression |
EXP |
Fluorouracil results in increased expression of SRP72 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 4:56,467,617...56,503,681
Ensembl chr 4:56,467,617...56,503,681
|
|
G |
SRP9 |
signal recognition particle 9 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SRP9 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:225,777,826...225,790,464
Ensembl chr 1:225,777,813...225,790,468
|
|
G |
SRRM1 |
serine and arginine repetitive matrix 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SRRM1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 1:24,643,302...24,673,281
Ensembl chr 1:24,631,716...24,673,281
|
|
G |
SRSF11 |
serine and arginine rich splicing factor 11 |
increases expression |
EXP |
Fluorouracil results in increased expression of SRSF11 protein |
CTD |
PMID:15331170 |
|
NCBI chr 1:70,205,696...70,253,052
Ensembl chr 1:70,205,682...70,253,052
|
|
G |
SRSF6 |
serine and arginine rich splicing factor 6 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of SRSF6 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr20:43,457,896...43,464,243
Ensembl chr20:43,457,893...43,466,046
|
|
G |
SST |
somatostatin |
increases expression |
ISO |
Fluorouracil results in increased expression of SST protein |
CTD |
PMID:21296659 |
|
NCBI chr 3:187,668,912...187,670,394
Ensembl chr 3:187,668,912...187,670,394
|
|
G |
STARD7 |
StAR related lipid transfer domain containing 7 |
affects expression |
EXP |
Fluorouracil affects the expression of STARD7 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 2:96,184,859...96,208,827
Ensembl chr 2:96,184,859...96,208,827
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of STAT1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
increases expression affects response to substance decreases phosphorylation |
EXP |
Fluorouracil results in increased expression of STAT3 mRNA STAT3 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:15682485 PMID:15730734 PMID:16557594 PMID:18161298 PMID:18205257 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
STAU1 |
staufen double-stranded RNA binding protein 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of STAU1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr20:49,113,339...49,219,295
Ensembl chr20:49,113,339...49,188,367
|
|
G |
STBD1 |
starch binding domain 1 |
affects response to substance |
EXP |
STBD1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:76,306,733...76,311,130
Ensembl chr 4:76,306,733...76,311,130
|
|
G |
STK38 |
serine/threonine kinase 38 |
affects response to substance |
EXP |
STK38 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 6:36,493,892...36,547,479
Ensembl chr 6:36,493,892...36,547,479
|
|
G |
STK4 |
serine/threonine kinase 4 |
multiple interactions |
EXP |
STK4 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr20:44,966,512...45,080,021
Ensembl chr20:44,966,494...45,084,214
|
|
G |
STOM |
stomatin |
decreases expression |
EXP |
Fluorouracil results in decreased expression of STOM mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 9:121,338,987...121,370,250
Ensembl chr 9:121,338,987...121,370,304
|
|
G |
STX5 |
syntaxin 5 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in increased expression of STX5 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr11:62,806,860...62,832,051
Ensembl chr11:62,806,860...62,832,051
|
|
G |
STXBP4 |
syntaxin binding protein 4 |
affects expression |
ISO |
Fluorouracil affects the expression of STXBP4 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr17:54,968,765...55,213,273
Ensembl chr17:54,968,727...55,173,632
|
|
G |
SUFU |
SUFU negative regulator of hedgehog signaling |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SUFU mRNA |
CTD |
PMID:18776995 |
|
NCBI chr10:102,502,819...102,633,535
Ensembl chr10:102,503,972...102,633,535
|
|
G |
SUPV3L1 |
Suv3 like RNA helicase |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SUPV3L1 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr10:69,180,234...69,209,093
Ensembl chr10:69,180,234...69,209,099
|
|
G |
SWAP70 |
switching B cell complex subunit SWAP70 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SWAP70 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr11:9,664,077...9,752,993
Ensembl chr11:9,664,077...9,752,993
|
|
G |
SYCP3 |
synaptonemal complex protein 3 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of SYCP3 protein |
CTD |
PMID:21296659 |
|
NCBI chr12:101,728,648...101,739,462
Ensembl chr12:101,728,648...101,739,472
|
|
G |
SYMPK |
symplekin scaffold protein |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SYMPK mRNA |
CTD |
PMID:16709241 |
|
NCBI chr19:45,815,410...45,863,147
Ensembl chr19:45,815,410...45,863,225
|
|
G |
SYNCRIP |
synaptotagmin binding cytoplasmic RNA interacting protein |
decreases expression |
EXP |
Fluorouracil results in decreased expression of SYNCRIP mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 6:85,607,784...85,643,870
Ensembl chr 6:85,607,779...85,644,063
|
|
G |
SYP |
synaptophysin |
increases expression |
ISO |
Fluorouracil results in increased expression of SYP protein |
CTD |
PMID:21296659 |
|
NCBI chr X:49,187,815...49,200,193
Ensembl chr X:49,187,815...49,200,218
|
|
G |
SYTL2 |
synaptotagmin like 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of SYTL2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr11:85,694,229...85,854,870
Ensembl chr11:85,694,224...85,811,159
|
|
G |
TAF3 |
TATA-box binding protein associated factor 3 |
affects expression |
EXP |
Fluorouracil affects the expression of TAF3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr10:7,818,505...8,016,631
Ensembl chr10:7,818,497...8,016,631
|
|
G |
TAF5L |
TATA-box binding protein associated factor 5 like |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of TAF5L mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 1:229,593,134...229,626,122
Ensembl chr 1:229,593,134...229,626,122
|
|
G |
TAGLN |
transgelin |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of TAGLN protein TAGLN protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 PMID:16217747 |
|
NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
|
|
G |
TANK |
TRAF family member associated NFKB activator |
increases expression |
EXP |
Fluorouracil results in increased expression of TANK protein |
CTD |
PMID:16803524 |
|
NCBI chr 2:161,136,963...161,236,230
Ensembl chr 2:161,136,908...161,236,230
|
|
G |
TAOK3 |
TAO kinase 3 |
affects response to substance |
EXP |
TAOK3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr12:118,149,801...118,372,907
Ensembl chr12:118,149,801...118,372,907
|
|
G |
TAP1 |
transporter 1, ATP binding cassette subfamily B member |
multiple interactions increases expression |
EXP |
TP53 protein promotes the reaction [Fluorouracil results in increased expression of TAP1 mRNA] |
CTD |
PMID:17982676 PMID:20737486 |
|
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
|
|
G |
TAP2 |
transporter 2, ATP binding cassette subfamily B member |
increases expression |
EXP |
Fluorouracil results in increased expression of TAP2 mRNA |
CTD |
PMID:20737486 |
|
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
|
|
G |
TAT |
tyrosine aminotransferase |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TAT protein |
CTD |
PMID:21296659 |
|
NCBI chr16:71,565,660...71,577,092
Ensembl chr16:71,565,660...71,577,092
|
|
G |
TAX1BP3 |
Tax1 binding protein 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of TAX1BP3 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr17:3,662,895...3,668,578
Ensembl chr17:3,662,895...3,668,679
|
|
G |
TBCD |
tubulin folding cofactor D |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TBCD mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr17:82,752,065...82,945,914
Ensembl chr17:82,752,042...82,945,914
|
|
G |
TBCE |
tubulin folding cofactor E |
affects response to substance |
EXP |
TBCE protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 1:235,367,427...235,452,443
Ensembl chr 1:235,367,360...235,452,443
|
|
G |
TBRG4 |
transforming growth factor beta regulator 4 |
increases expression |
ISO |
Fluorouracil results in increased expression of TBRG4 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr 7:45,100,100...45,111,697
Ensembl chr 7:45,100,100...45,112,047
|
|
G |
TBXT |
T-box transcription factor T |
decreases expression |
ISO |
Fluorouracil results in decreased expression of T protein |
CTD |
PMID:21296659 |
|
NCBI chr 6:166,157,656...166,168,655
Ensembl chr 6:166,157,656...166,168,700
|
|
G |
TCF15 |
transcription factor 15 |
increases expression |
EXP |
Fluorouracil results in increased expression of TCF15 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr20:604,257...610,309
Ensembl chr20:604,257...610,309
|
|
G |
TCF19 |
transcription factor 19 |
affects response to substance increases expression |
EXP |
TCF19 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of TCF19 mRNA |
CTD |
PMID:15331170 |
|
NCBI chr 6:31,158,589...31,164,215
Ensembl chr 6:31,158,331...31,167,159
|
|
G |
TCF3 |
transcription factor 3 |
affects expression |
EXP |
Fluorouracil affects the expression of TCF3 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr19:1,609,292...1,652,615
Ensembl chr19:1,609,291...1,652,615
|
|
G |
TCF7L2 |
transcription factor 7 like 2 |
multiple interactions decreases expression |
EXP ISO |
TCF7L2 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]]; [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA]]; Fluorouracil inhibits the reaction [TCF7L2 protein binds to HDAC1 protein]; Fluorouracil inhibits the reaction [TCF7L2 protein binds to HDAC2 protein]; TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]; TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA] Fluorouracil results in decreased expression of TCF7L2 mRNA; Fluorouracil results in decreased expression of TCF7L2 protein |
CTD |
PMID:18678097 PMID:25178657 |
|
NCBI chr10:112,950,247...113,167,678
Ensembl chr10:112,950,247...113,167,678
|
|
G |
TEK |
TEK receptor tyrosine kinase |
increases expression |
ISO |
Fluorouracil results in increased expression of TEK mRNA |
CTD |
PMID:15817675 |
|
NCBI chr 9:27,109,225...27,230,174
Ensembl chr 9:27,109,141...27,230,174
|
|
G |
TERF2 |
telomeric repeat binding factor 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of TERF2 protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr16:69,355,567...69,386,007
Ensembl chr16:69,355,567...69,408,571
|
|
G |
TERT |
telomerase reverse transcriptase |
multiple interactions decreases expression affects response to substance decreases response to substance decreases activity |
EXP ISO |
[Fluorouracil co-treated with Gemcitabine] results in decreased activity of TERT protein; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TERT mRNA] Fluorouracil results in decreased expression of TERT protein TERT protein affects the susceptibility to Fluorouracil TERT mRNA results in decreased susceptibility to Fluorouracil Fluorouracil results in decreased expression of TERT mRNA; Fluorouracil results in decreased expression of TERT mRNA alternative form; Fluorouracil results in decreased expression of TERT protein modified form Fluorouracil results in decreased activity of TERT protein |
CTD |
PMID:15003732 PMID:15016801 PMID:15608686 PMID:16455633 PMID:16929163 PMID:17923759 PMID:17996122 PMID:18396642 PMID:21296659 More...
|
|
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
|
|
G |
TFCP2L1 |
transcription factor CP2 like 1 |
increases expression |
ISO |
Fluorouracil results in increased expression of TFCP2L1 protein |
CTD |
PMID:21296659 |
|
NCBI chr 2:121,216,587...121,285,202
Ensembl chr 2:121,216,587...121,285,202
|
|
G |
TFDP1 |
transcription factor Dp-1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TFDP1 mRNA |
CTD |
PMID:16510598 PMID:34151400 |
|
NCBI chr13:113,584,688...113,641,473
Ensembl chr13:113,584,721...113,641,473
|
|
G |
TFF1 |
trefoil factor 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TFF1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
|
|
G |
TFPI |
tissue factor pathway inhibitor |
affects response to substance |
EXP |
TFPI protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 2:187,464,230...187,554,435
Ensembl chr 2:187,464,230...187,565,760
|
|
G |
TFRC |
transferrin receptor |
multiple interactions increases expression |
EXP ISO |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TFRC mRNA] Fluorouracil results in increased expression of TFRC protein ferrostatin-1 inhibits the reaction [Fluorouracil results in increased expression of TFRC protein] |
CTD |
PMID:15016801 PMID:35101590 |
|
NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153
|
|
G |
TGFA |
transforming growth factor alpha |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of TGFA mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
increases expression multiple interactions affects response to substance |
EXP ISO |
Fluorouracil results in increased expression of TGFB1 mRNA [Fluorouracil co-treated with TGFB1 protein] results in increased expression of MT2A mRNA; TGFB1 protein inhibits the reaction [Fluorouracil results in decreased expression of MT2A protein]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein] Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 protein] Fluorouracil results in increased expression of TGFB1 mRNA; Fluorouracil results in increased expression of TGFB1 protein TGFB1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:16557594 PMID:16888818 PMID:18344199 PMID:28507149 PMID:34665902 More...
|
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TGFB2 |
transforming growth factor beta 2 |
affects response to substance decreases response to substance |
EXP ISO |
TGFB2 protein affects the susceptibility to Fluorouracil TGFB2 gene polymorphism results in decreased susceptibility to Fluorouracil |
CTD |
PMID:16217747 PMID:18941179 |
|
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
|
|
G |
TGFBI |
transforming growth factor beta induced |
affects response to substance |
EXP |
TGFBI protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 5:136,028,988...136,063,818
Ensembl chr 5:136,028,988...136,063,818
|
|
G |
TGFBR3 |
transforming growth factor beta receptor 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of TGFBR3 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:91,680,343...91,906,002
Ensembl chr 1:91,680,343...91,906,335
|
|
G |
TH |
tyrosine hydroxylase |
affects expression |
ISO |
Fluorouracil affects the expression of TH protein |
CTD |
PMID:21296659 |
|
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
|
|
G |
THBS1 |
thrombospondin 1 |
multiple interactions affects response to substance affects expression increases expression |
EXP |
EGR1 protein affects the reaction [Fluorouracil results in increased expression of THBS1 mRNA]; EGR1 protein affects the reaction [Fluorouracil results in increased expression of THBS1 protein]; Fluorouracil promotes the reaction [EGR1 protein binds to THBS1 promoter]; SB 203580 inhibits the reaction [Fluorouracil results in increased expression of THBS1 mRNA] THBS1 protein affects the susceptibility to Fluorouracil Fluorouracil affects the expression of THBS1 mRNA Fluorouracil results in increased expression of THBS1 mRNA; Fluorouracil results in increased expression of THBS1 protein |
CTD |
PMID:15205334 PMID:16217747 PMID:18757417 |
|
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
|
|
G |
THNSL2 |
threonine synthase like 2 |
multiple interactions |
EXP |
THNSL2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr 2:88,170,346...88,186,627
Ensembl chr 2:88,170,295...88,186,636
|
|
G |
THOC1 |
THO complex subunit 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of THOC1 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr18:214,520...268,047
Ensembl chr18:214,520...268,050
|
|
G |
THSD7A |
thrombospondin type 1 domain containing 7A |
increases expression |
EXP |
Fluorouracil results in increased expression of THSD7A mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 7:11,370,365...11,832,198
Ensembl chr 7:11,370,365...11,832,198
|
|
G |
TIAL1 |
TIA1 cytotoxic granule associated RNA binding protein like 1 |
affects response to substance |
EXP |
TIAL1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr10:119,573,465...119,596,964
Ensembl chr10:119,571,802...119,597,029
|
|
G |
TIGAR |
TP53 induced glycolysis regulatory phosphatase |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of TIGAR mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:4,321,213...4,360,028
Ensembl chr12:4,307,763...4,360,028
|
|
G |
TIMELESS |
timeless circadian regulator |
affects response to substance |
EXP |
TIMELESS protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr12:56,416,363...56,449,426
Ensembl chr12:56,416,363...56,449,426
|
|
G |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of TIMP3 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr22:32,801,705...32,863,041
Ensembl chr22:32,801,705...32,863,041
|
|
G |
TINF2 |
TERF1 interacting nuclear factor 2 |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TINF2 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr14:24,239,640...24,242,674
Ensembl chr14:24,238,286...24,242,663
|
|
G |
TJP3 |
tight junction protein 3 |
affects expression |
EXP |
Fluorouracil affects the expression of TJP3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr19:3,708,384...3,750,813
Ensembl chr19:3,708,362...3,750,813
|
|
G |
TK1 |
thymidine kinase 1 |
affects expression affects response to substance multiple interactions |
EXP |
Fluorouracil affects the expression of TK1 mRNA TK1 protein affects the susceptibility to Fluorouracil Fluorouracil promotes the reaction [geraniol results in decreased expression of TK1 mRNA] |
CTD |
PMID:15374632 PMID:15548681 PMID:16557594 |
|
NCBI chr17:78,174,079...78,187,204
Ensembl chr17:78,174,091...78,187,233
|
|
G |
TK2 |
thymidine kinase 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of TK2 mRNA |
CTD |
PMID:19219653 |
|
NCBI chr16:66,508,003...66,550,291
Ensembl chr16:66,508,003...66,552,544
|
|
G |
TLR3 |
toll like receptor 3 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of TLR3 mRNA TP53 protein affects the reaction [Fluorouracil results in increased expression of TLR3 mRNA] |
CTD |
PMID:18779317 PMID:20367642 |
|
NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073
|
|
G |
TLR4 |
toll like receptor 4 |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of TLR4 protein Bosentan inhibits the reaction [Fluorouracil results in increased expression of TLR4 protein] |
CTD |
PMID:34800596 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TLR9 |
toll like receptor 9 |
increases secretion multiple interactions |
ISO |
Fluorouracil results in increased secretion of TLR9 protein Hydroxychloroquine inhibits the reaction [Fluorouracil results in increased secretion of TLR9 protein] |
CTD |
PMID:32314717 |
|
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
|
|
G |
TMEM150C |
transmembrane protein 150C |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TMEM150C mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 4:82,483,176...82,562,253
Ensembl chr 4:82,483,170...82,562,357
|
|
G |
TMEM184B |
transmembrane protein 184B |
affects response to substance |
EXP |
TMEM184B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr22:38,216,395...38,273,010
Ensembl chr22:38,219,291...38,273,010
|
|
G |
TMEM187 |
transmembrane protein 187 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TMEM187 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr X:153,972,754...153,983,194
Ensembl chr X:153,972,754...153,983,194
|
|
G |
TMEM33 |
transmembrane protein 33 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TMEM33 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 4:41,935,137...41,960,803
Ensembl chr 4:41,935,129...41,960,803
|
|
G |
TMEM40 |
transmembrane protein 40 |
affects expression |
EXP |
Fluorouracil affects the expression of TMEM40 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 3:12,733,528...12,769,457
Ensembl chr 3:12,733,528...12,769,457
|
|
G |
TMEM74 |
transmembrane protein 74 |
increases expression |
EXP |
Fluorouracil results in increased expression of TMEM74 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 8:108,606,850...108,787,594
Ensembl chr 8:108,606,850...108,787,594
|
|
G |
TMEM9B |
TMEM9 domain family member B |
affects expression |
ISO |
Fluorouracil affects the expression of TMEM9B mRNA |
CTD |
PMID:20421339 |
|
NCBI chr11:8,947,202...8,964,947
Ensembl chr11:8,947,202...8,965,011
|
|
G |
TMSB10 |
thymosin beta 10 |
increases expression |
EXP |
Fluorouracil results in increased expression of TMSB10 mRNA |
CTD |
PMID:15152939 |
|
NCBI chr 2:84,905,656...84,906,671
Ensembl chr 2:84,905,656...84,906,671
|
|
G |
TMSB15A |
thymosin beta 15A |
affects response to substance |
EXP |
TMSB15A affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 |
|
NCBI chr X:102,513,682...102,516,739
Ensembl chr X:102,513,682...102,516,739
|
|
G |
TMSB4X |
thymosin beta 4 X-linked |
increases expression |
EXP |
Fluorouracil results in increased expression of TMSB4X mRNA |
CTD |
PMID:15152939 |
|
NCBI chr X:12,975,110...12,977,223
Ensembl chr X:12,975,110...12,977,227
|
|
G |
TMSB4XP6 |
TMSB4X pseudogene 6 |
affects response to substance |
EXP |
TMSB4XP6 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr20:50,840,219...50,840,824
Ensembl chr20:50,840,615...50,840,749
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases expression |
EXP ISO |
TNF promoter polymorphism affects the susceptibility to [Fluorouracil co-treated with Cisplatin] [Cyclophosphamide co-treated with Methotrexate co-treated with Fluorouracil] results in decreased expression of TNF protein Fluorouracil inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TNF protein]; Silybin inhibits the reaction [Fluorouracil results in increased expression of TNF protein]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF protein] Fluorouracil results in increased expression of TNF mRNA; Fluorouracil results in increased expression of TNF protein |
CTD |
PMID:16820919 PMID:18344199 PMID:18523641 PMID:18535404 PMID:25824412 PMID:31651976 PMID:34665902 PMID:37335224 PMID:38078205 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFAIP3 |
TNF alpha induced protein 3 |
increases expression |
EXP |
Fluorouracil results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
|
|
G |
TNFRSF10A |
TNF receptor superfamily member 10a |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of TNFRSF10A mRNA; Fluorouracil results in increased expression of TNFRSF10A protein [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of TNFRSF10A mRNA |
CTD |
PMID:15585621 PMID:26544897 PMID:32800223 PMID:34151400 |
|
NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
|
|
G |
TNFRSF10B |
TNF receptor superfamily member 10b |
multiple interactions increases expression |
EXP |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of TNFRSF10B mRNA; TNFRSF10B mutant form inhibits the reaction [Fluorouracil results in increased cleavage of CASP3 protein]; TNFRSF10B mutant form inhibits the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFRSF10B mRNA] Fluorouracil results in increased expression of TNFRSF10B mRNA; Fluorouracil results in increased expression of TNFRSF10B protein |
CTD |
PMID:15585621 PMID:17982676 PMID:26544897 PMID:32800223 PMID:34151400 |
|
NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
|
|
G |
TNFRSF10C |
TNF receptor superfamily member 10c |
increases expression |
EXP |
Fluorouracil results in increased expression of TNFRSF10C protein |
CTD |
PMID:15585621 |
|
NCBI chr 8:23,102,921...23,117,445
Ensembl chr 8:23,102,921...23,117,445
|
|
G |
TNFRSF10D |
TNF receptor superfamily member 10d |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of TNFRSF10D protein TP53 protein affects the reaction [Fluorouracil results in increased expression of TNFRSF10D mRNA] |
CTD |
PMID:15016801 PMID:15585621 |
|
NCBI chr 8:23,135,588...23,164,027
Ensembl chr 8:23,135,588...23,164,027
|
|
G |
TNFRSF11B |
TNF receptor superfamily member 11b |
increases expression |
EXP |
Fluorouracil results in increased expression of TNFRSF11B mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
|
|
G |
TNFRSF18 |
TNF receptor superfamily member 18 |
increases expression |
EXP |
Fluorouracil results in increased expression of TNFRSF18 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:1,203,508...1,206,592
Ensembl chr 1:1,203,508...1,206,592
|
|
G |
TNFRSF19 |
TNF receptor superfamily member 19 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TNFRSF19 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr13:23,570,412...23,676,093
Ensembl chr13:23,570,370...23,676,104
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
affects expression |
EXP |
Fluorouracil affects the expression of TNFRSF1A mRNA |
CTD |
PMID:34151400 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
affects response to substance |
EXP |
TNFRSF1B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16477629 |
|
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
multiple interactions affects expression increases expression increases activity increases response to substance increases abundance |
EXP ISO |
[Fluorouracil co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [Fluorouracil results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein; CFLAR protein alternative form inhibits the reaction [Fluorouracil results in increased activity of TNFSF10 protein]; CFLAR protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein]; Fluorouracil promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein]; Fluorouracil promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 protein]; XIAP protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein] Fluorouracil affects the expression of TNFSF10 mRNA TNFSF10 results in increased abundance of Fluorouracil Fluorouracil results in increased expression of TNFSF10 mRNA; Fluorouracil results in increased expression of TNFSF10 protein |
CTD |
PMID:11750847 PMID:15120327 PMID:16373718 PMID:19106633 PMID:20876774 PMID:34151400 More...
|
|
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
|
|
G |
TNFSF13 |
TNF superfamily member 13 |
increases expression |
EXP |
Fluorouracil results in increased expression of TNFSF13 mRNA |
CTD |
PMID:18423122 PMID:20003335 |
|
NCBI chr17:7,558,282...7,561,601
Ensembl chr17:7,558,292...7,561,608
|
|
G |
TNNI1 |
troponin I1, slow skeletal type |
increases expression multiple interactions |
ISO |
Fluorouracil results in increased expression of TNNI1 protein Bosentan inhibits the reaction [Fluorouracil results in increased expression of TNNI1 protein] |
CTD |
PMID:34800596 |
|
NCBI chr 1:201,403,784...201,421,730
Ensembl chr 1:201,403,784...201,429,866
|
|
G |
TNNI3 |
troponin I3, cardiac type |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of TNNI3 protein TNNI3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr19:55,151,767...55,157,732
Ensembl chr19:55,151,767...55,157,773
|
|
G |
TNNT1 |
troponin T1, slow skeletal type |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of TNNT1 protein TNNT1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15352031 |
|
NCBI chr19:55,132,698...55,149,206
Ensembl chr19:55,132,698...55,149,206
|
|
G |
TNS3 |
tensin 3 |
affects response to substance |
EXP |
TNS3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 7:47,275,154...47,582,586
Ensembl chr 7:47,275,154...47,582,558
|
|
G |
TOB1 |
transducer of ERBB2, 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of TOB1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr17:50,862,223...50,867,978
Ensembl chr17:50,862,223...50,867,978
|
|
G |
TOP1 |
DNA topoisomerase I |
affects response to substance decreases expression |
EXP |
TOP1 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of TOP1 mRNA |
CTD |
PMID:16709241 PMID:18509181 |
|
NCBI chr20:41,028,822...41,124,487
Ensembl chr20:41,028,822...41,124,487
|
|
G |
TOP2A |
DNA topoisomerase II alpha |
decreases expression multiple interactions |
EXP ISO |
Fluorouracil results in decreased expression of TOP2A mRNA TOP2A protein affects the susceptibility to [Cyclophosphamide co-treated with Epirubicin co-treated with Fluorouracil]; TOP2A protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TOP2A mRNA] |
CTD |
PMID:15016801 PMID:15205334 PMID:16557594 PMID:16682728 PMID:18465341 PMID:19272435 More...
|
|
NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
|
|
G |
TOPBP1 |
DNA topoisomerase II binding protein 1 |
affects response to substance |
EXP |
TOPBP1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 3:133,600,238...133,661,941
Ensembl chr 3:133,598,175...133,662,380
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions affects activity increases acetylation affects phosphorylation increases phosphorylation decreases response to substance decreases expression increases expression increases response to substance increases activity affects response to substance decreases degradation |
EXP ISO |
[[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in decreased expression of TP53 mRNA; [CHEK1 protein co-treated with TP53 protein] affects the susceptibility to Fluorouracil; [Fluorouracil co-treated with Genistein] results in increased expression of TP53 mRNA; [Fluorouracil co-treated with olaparib] results in increased expression of TP53 protein; [Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein; [nutlin 3 results in increased stability of TP53 protein] which results in increased susceptibility to Fluorouracil; [TP53 affects the expression of TYMS] which affects the susceptibility to Fluorouracil; anacardic acid inhibits the reaction [[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein]; Cadmium Chloride affects the reaction [Fluorouracil affects the phosphorylation of TP53 protein]; Cadmium Chloride affects the reaction [Fluorouracil results in increased expression of TP53 mRNA]; Cadmium Chloride affects the reaction [Fluorouracil results in increased phosphorylation of TP53 protein]; Cycloheximide inhibits the reaction [Fluorouracil results in increased expression of TP53 protein]; Fluorouracil affects the reaction [Cadmium Chloride affects the phosphorylation of TP53 protein]; Fluorouracil affects the reaction [Cadmium Chloride results in increased expression of TP53 mRNA]; Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of TP53 protein]; Fluorouracil promotes the reaction [[TP53 protein binds to SP1 protein] which binds to CDKN1A promoter]; Fluorouracil promotes the reaction [allose results in increased expression of TP53 protein]; Fluorouracil promotes the reaction [andrographolide results in increased expression of TP53]; Fluorouracil promotes the reaction [TP53 protein binds to CES2 intron]; Fluorouracil promotes the reaction [TP53 protein mutant form binds to UBE2C promoter]; Fluorouracil results in increased expression of and results in increased phosphorylation of TP53 protein; Fluorouracil results in increased phosphorylation of and results in increased activity of TP53 protein; Genistein promotes the reaction [Fluorouracil results in increased expression of TP53 protein]; IFNA1 protein promotes the reaction [Fluorouracil results in increased phosphorylation of TP53 protein]; N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased expression of TP53 protein]; Pravastatin inhibits the reaction [Fluorouracil results in decreased degradation of TP53 protein]; TP53 affects the reaction [Resveratrol affects the reaction [Fluorouracil results in increased activity of CASP6 protein]]; TP53 gene mutant form affects the reaction [benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AX protein]]; TP53 protein affects the reaction [CHEK1 protein affects the susceptibility to Fluorouracil]; TP53 protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of AARS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACKR3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACTL8 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACY1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAM10 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAM3A mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ADAMTS9 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of AGR2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ALG3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ANLN mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ANP32E mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of AP3S1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ARMCX1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ASAH1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ATP5F1D mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ATXN10 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of BCAT1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of BNIP3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of BOP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CA14 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CAD mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CANX mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CBS mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCNB1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCNB2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCND2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CD52 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CD8A mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CDC20 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CDKN3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CHEK1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CHRNA4 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CLTC mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of COL6A3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CPD mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CRYGS mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CRYL1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CSE1L mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CUTC mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of CYC1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCK mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCLK1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCXR mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DIMT1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DLC1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DLK1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of DTYMK mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EGFR protein]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EHF mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EIF4E mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EIPR1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of EP400 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ETF1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ETS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of FAH mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of FAM107B mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of FKBP5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GAMT mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GCSH mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GDF1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GPX2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GSPT1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of GYG2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of H2AX mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of H4C2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HAND1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HBA1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HDGFL3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HERPUD1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HMG1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HMMR mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPA1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPA2B1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPF mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPH1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPL mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of HPX mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of IFI16 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of INPP5E mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of IQGAP2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ITPR1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of KCNQ2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of KIF15 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of KIF23 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of KLF5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of KPNA2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of L1TD1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of LDHA mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of LRBA mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of LYPLA1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MACF1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MAP4K5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MARS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM6 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM7 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of METAP2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MMP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of MMS19 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NASP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NBN mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NCAPG mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NEK2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NIPSNAP2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NR1D2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of NUCKS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ODC1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of OXCT1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PAFAH1B1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PAIP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PDCD1LG2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PFN2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PGLYRP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PHIP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PI4KB mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PLK1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PMF1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PMS2P4 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PPA2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PPP1CC mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PREPL mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKAG2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKCI mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKDC mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PTTG1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PTTG3P mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of PURG mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of QSOX1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of RANBP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of RECQL4 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of RFC4 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of RPL10A mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SAH mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SAP30 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SEC31B mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SELENOP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SERPINA7 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SERPIND1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SEZ6L mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SF3B3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SHMT2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SIGLEC9 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SKIC8 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SMS mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SP3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SPAG5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SRP9 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of SRSF6 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TBCD mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TERT mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TFF1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TFRC mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TOP2A mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TRAP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TROAP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TSPO mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TUBA4B mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TXNIP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TXNRD3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UBE2S mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UGT8 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UQCRB mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of USH2A mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of VANGL2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of WARS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of WEE1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of WTAP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of YARS1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ZIM2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ZMYND8 mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of ZNF266 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of ANXA2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of ATF3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BBC3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BBC3 protein]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BDKRB2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of BTG2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CES2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CNK mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of DUSP14 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of DUSP5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of EPHA2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FAS mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FAS protein]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FDXR mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of FMOD mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of GADD45A mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of GDF15 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of GJC1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of ID2B mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of IER5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of INKA2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of NINJ1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of PLK2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of PMAIP1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of PPM1D mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of PROCR mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of RPS27L mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of RRM2B mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of S100A2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SAT1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SERPINB5 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SERTAD1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SESN1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SESN2 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SFN mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TGFA mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TIGAR mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TLR3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TNFRSF10D mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TOB1 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TP53I3 mRNA]; TP53 protein affects the reaction [Fluorouracil results in increased expression of TP53INP1 mRNA]; TP53 protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of ANLN mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of BRCA1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNA2 protein]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNB1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCNB1 protein]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CCND1 protein]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CRYZ mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of SCD mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C protein]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of VEGFA mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of CHEK1 protein]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of EEF1A1 mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of PLK1 protein]; TP53 protein inhibits the reaction [Fluorouracil results in increased expression of PTTG1 protein]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNA2 protein]]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in decreased expression of CCNB1 protein]]; TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein]]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]]; TP53 protein promotes the reaction [Fluorouracil results in decreased expression of ECT2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in decreased expression of MYC mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of BTG2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CCNG1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of DDB2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of DRAM1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FAS protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FDXR mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of FDXR protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of GADD45A mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of GPX1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of ID1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of ID2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of IKBIP mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of PLK2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of PPM1D mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of S100A2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SERPINB5 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SESN1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SFN mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TAP1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFRSF10B mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 protein]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TP53I3 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TP53INP1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TRIAP1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of ZMAT3 mRNA]; TP53 protein promotes the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased expression of FAS protein]]; TP53 protein results in increased susceptibility to [Cisplatin co-treated with Fluorouracil]; TP53 protein results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; TP53 results in increased susceptibility to [Poly I-C co-treated with Fluorouracil] Fluorouracil affects the activity of TP53 protein Fluorouracil promotes the reaction [Luteolin results in increased expression of TRP53 protein]; Luteolin promotes the reaction [Fluorouracil results in increased expression of TRP53 protein] TP53 promoter mutant form results in decreased susceptibility to Fluorouracil Fluorouracil results in decreased expression of TP53 mRNA TRP53 results in increased susceptibility to Fluorouracil Fluorouracil results in increased activity of TRP53 protein Fluorouracil results in increased expression of TP53 protein; Fluorouracil results in increased expression of TRP53 protein ferrostatin-1 inhibits the reaction [Fluorouracil results in increased expression of TRP53 protein]; Fluorouracil promotes the reaction [Acetaminophen results in increased phosphorylation of TP53 protein]; Tetrachlorodibenzodioxin inhibits the reaction [Fluorouracil results in increased expression of TP53 protein] TP53 protein results in increased susceptibility to Fluorouracil; TP53 results in increased susceptibility to Fluorouracil TP53 gene polymorphism affects the susceptibility to Fluorouracil; TP53 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of TP53; Fluorouracil results in increased expression of TP53 mRNA; Fluorouracil results in increased expression of TP53 protein; Fluorouracil results in increased expression of TP53 protein modified form Fluorouracil results in increased activity of TP53 protein |
CTD |
PMID:9050858 PMID:9192825 PMID:11750847 PMID:12082016 PMID:12792779 PMID:14646558 PMID:14665630 PMID:14704126 PMID:15016801 PMID:15041737 PMID:15152939 PMID:15161716 PMID:15254702 PMID:15459018 PMID:15489892 PMID:15534911 PMID:15546879 PMID:15608686 PMID:15625077 PMID:15865071 PMID:15896711 PMID:15999354 PMID:16077963 PMID:16168113 PMID:16330492 PMID:16557594 PMID:16584549 PMID:16686938 PMID:16709241 PMID:16949053 PMID:16963839 PMID:17056233 PMID:17339891 PMID:17634554 PMID:17637740 PMID:17699798 PMID:17971768 PMID:17982676 PMID:18497562 PMID:18498133 PMID:18600534 PMID:18698031 PMID:18779317 PMID:18930000 PMID:19010883 PMID:19015155 PMID:19097688 PMID:19098008 PMID:19106633 PMID:20367642 PMID:21205074 PMID:22445862 PMID:22525470 PMID:22966307 PMID:23056627 PMID:23941782 PMID:25744307 PMID:26544897 PMID:27129209 PMID:29879413 PMID:30177839 PMID:31288002 PMID:32800223 PMID:34151400 PMID:35101590 PMID:35435491 More...
|
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TP53AIP1 |
tumor protein p53 regulated apoptosis inducing protein 1 |
multiple interactions |
EXP |
Fluorouracil promotes the reaction [IFNA1 protein results in increased expression of TP53AIP1 mRNA] |
CTD |
PMID:17971768 |
|
NCBI chr11:128,934,731...128,942,871
Ensembl chr11:128,934,731...128,943,399
|
|
G |
TP53I3 |
tumor protein p53 inducible protein 3 |
increases expression multiple interactions affects response to substance |
EXP |
Fluorouracil results in increased expression of TP53I3 mRNA; Fluorouracil results in increased expression of TP53I3 protein TP53 protein affects the reaction [Fluorouracil results in increased expression of TP53I3 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TP53I3 mRNA] TP53I3 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:14665630 PMID:15016801 PMID:15205334 PMID:16217747 PMID:16557594 PMID:16709241 PMID:17982676 More...
|
|
NCBI chr 2:24,077,433...24,084,834
Ensembl chr 2:24,077,433...24,085,861
|
|
G |
TP53INP1 |
tumor protein p53 inducible nuclear protein 1 |
multiple interactions increases expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in increased expression of TP53INP1 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of TP53INP1 mRNA] |
CTD |
PMID:15016801 PMID:16510598 PMID:16557594 PMID:17039268 PMID:17982676 |
|
NCBI chr 8:94,925,972...94,949,378
Ensembl chr 8:94,925,972...94,949,378
|
|
G |
TP73 |
tumor protein p73 |
affects response to substance multiple interactions |
EXP |
TP73 protein affects the susceptibility to Fluorouracil TP73 protein promotes the reaction [Fluorouracil results in increased expression of GRAMD4 mRNA] |
CTD |
PMID:18714155 PMID:21127500 |
|
NCBI chr 1:3,652,516...3,736,201
Ensembl chr 1:3,652,516...3,736,201
|
|
G |
TPI1 |
triosephosphate isomerase 1 |
decreases expression affects response to substance |
EXP |
Fluorouracil results in decreased expression of TPI1 mRNA TPI1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16510598 PMID:18309519 |
|
NCBI chr12:6,867,420...6,870,948
Ensembl chr12:6,867,119...6,870,948
|
|
G |
TPM1 |
tropomyosin 1 |
affects response to substance |
EXP |
TPM1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,620...63,071,915
|
|
G |
TPMT |
thiopurine S-methyltransferase |
multiple interactions |
EXP |
TPMT protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] |
CTD |
PMID:18927307 |
|
NCBI chr 6:18,128,311...18,155,169
Ensembl chr 6:18,128,311...18,155,077
|
|
G |
TPP1 |
tripeptidyl peptidase 1 |
affects expression |
EXP |
Fluorouracil affects the expression of TPP1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr11:6,612,768...6,619,422
Ensembl chr11:6,612,768...6,619,448
|
|
G |
TPP2 |
tripeptidyl peptidase 2 |
affects localization |
EXP ISO |
Fluorouracil affects the localization of TPP2 protein |
CTD |
PMID:20643100 |
|
NCBI chr13:102,596,986...102,679,958
Ensembl chr13:102,596,958...102,679,958
|
|
G |
TPST2 |
tyrosylprotein sulfotransferase 2 |
affects response to substance |
EXP |
TPST2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr22:26,521,996...26,590,132
Ensembl chr22:26,521,996...26,596,717
|
|
G |
TPT1 |
tumor protein, translationally-controlled 1 |
decreases response to substance |
EXP |
TPT1 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:15262975 |
|
NCBI chr13:45,333,471...45,341,183
Ensembl chr13:45,333,471...45,341,284
|
|
G |
TRADD |
TNFRSF1A associated via death domain |
affects expression |
EXP |
Fluorouracil affects the expression of TRADD mRNA |
CTD |
PMID:34151400 |
|
NCBI chr16:67,154,185...67,159,909
Ensembl chr16:67,154,185...67,159,909
|
|
G |
TRAF2 |
TNF receptor associated factor 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TRAF2 |
CTD |
PMID:10891390 |
|
NCBI chr 9:136,881,958...136,926,607
Ensembl chr 9:136,881,912...136,926,607
|
|
G |
TRAP1 |
TNF receptor associated protein 1 |
multiple interactions affects expression |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TRAP1 mRNA] Fluorouracil affects the expression of TRAP1 mRNA |
CTD |
PMID:15016801 PMID:34151400 |
|
NCBI chr16:3,658,037...3,717,524
Ensembl chr16:3,651,639...3,717,553
|
|
G |
TRIAP1 |
TP53 regulated inhibitor of apoptosis 1 |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of TRIAP1 mRNA TP53 protein promotes the reaction [Fluorouracil results in increased expression of TRIAP1 mRNA] |
CTD |
PMID:17982676 |
|
NCBI chr12:120,443,964...120,446,384
Ensembl chr12:120,443,964...120,446,384
|
|
G |
TRIB2 |
tribbles pseudokinase 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of TRIB2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 2:12,716,936...12,742,734
Ensembl chr 2:12,716,910...12,742,734
|
|
G |
TRIB3 |
tribbles pseudokinase 3 |
affects expression |
EXP |
Fluorouracil affects the expression of TRIB3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
|
|
G |
TRIM2 |
tripartite motif containing 2 |
affects response to substance |
EXP |
TRIM2 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:153,152,163...153,339,317
Ensembl chr 4:153,152,163...153,339,319
|
|
G |
TRIOBP |
TRIO and F-actin binding protein |
affects response to substance |
EXP |
TRIOBP protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr22:37,697,048...37,776,556
Ensembl chr22:37,697,048...37,776,556
|
|
G |
TROAP |
trophinin associated protein |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TROAP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr12:49,323,255...49,331,731
Ensembl chr12:49,323,236...49,331,731
|
|
G |
TSC2 |
TSC complex subunit 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of TSC2 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr16:2,047,985...2,089,491
Ensembl chr16:2,047,967...2,089,491
|
|
G |
TSHB |
thyroid stimulating hormone subunit beta |
affects expression |
EXP |
Fluorouracil affects the expression of TSHB protein |
CTD |
PMID:17649788 |
|
NCBI chr 1:115,029,826...115,034,309
Ensembl chr 1:115,029,826...115,034,302
|
|
G |
TSHZ1 |
teashirt zinc finger homeobox 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of TSHZ1 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr18:75,210,797...75,289,944
Ensembl chr18:75,210,755...75,289,950
|
|
G |
TSPAN8 |
tetraspanin 8 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in decreased expression of TSPAN8 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr12:71,125,096...71,157,999
Ensembl chr12:71,125,085...71,441,898
|
|
G |
TSPO |
translocator protein |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TSPO mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr22:43,151,559...43,163,242
Ensembl chr22:43,151,547...43,163,242
|
|
G |
TSR1 |
TSR1 ribosome maturation factor |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TSR1 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr17:2,322,396...2,336,457
Ensembl chr17:2,322,396...2,336,657
|
|
G |
TST |
thiosulfate sulfurtransferase |
affects response to substance |
EXP |
TST protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr22:37,010,859...37,020,183
Ensembl chr22:37,010,859...37,020,183
|
|
G |
TTYH2 |
tweety family member 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TTYH2 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr17:74,213,571...74,262,020
Ensembl chr17:74,213,571...74,262,020
|
|
G |
TUBA4B |
tubulin alpha 4b |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TUBA4B mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 2:219,253,243...219,272,197
Ensembl chr 2:219,253,243...219,272,197
|
|
G |
TUBA8 |
tubulin alpha 8 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TUBA8 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr22:18,110,809...18,131,732
Ensembl chr22:18,110,100...18,146,683
|
|
G |
TUBB |
tubulin beta class I |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TUBB mRNA |
CTD |
PMID:17039268 |
|
NCBI chr 6:30,720,352...30,725,422
Ensembl chr 6:30,717,435...30,725,538
|
|
G |
TUBB2A |
tubulin beta 2A class IIa |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TUBB2A mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544
|
|
G |
TUBB3 |
tubulin beta 3 class III |
decreases expression |
ISO |
Fluorouracil results in decreased expression of TUBB3 mRNA |
CTD |
PMID:19272435 |
|
NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
|
|
G |
TUBB4B |
tubulin beta 4B class IVb |
affects response to substance |
EXP |
TUBB4B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr 9:137,241,287...137,243,707
Ensembl chr 9:137,241,287...137,243,707
|
|
G |
TUBD1 |
tubulin delta 1 |
affects response to substance |
EXP |
TUBD1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr17:59,859,479...59,892,943
Ensembl chr17:59,859,426...59,892,945
|
|
G |
TXNIP |
thioredoxin interacting protein |
multiple interactions affects response to substance increases expression |
EXP |
[allose co-treated with Fluorouracil] results in increased expression of TXNIP protein; Fluorouracil promotes the reaction [allose results in increased expression of TXNIP mRNA]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of TXNIP mRNA] TXNIP protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of TXNIP mRNA |
CTD |
PMID:15016801 PMID:15548681 PMID:18930000 |
|
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
decreases expression decreases activity |
EXP ISO |
Fluorouracil results in decreased expression of TXNRD1 mRNA Fluorouracil results in decreased activity of TXNRD1 protein |
CTD |
PMID:19219653 PMID:31288002 |
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|
G |
TXNRD3 |
thioredoxin reductase 3 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of TXNRD3 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 3:126,607,050...126,655,124
Ensembl chr 3:126,571,779...126,655,124
|
|
G |
TYMP |
thymidine phosphorylase |
multiple interactions affects response to substance decreases response to substance decreases expression |
EXP ISO |
[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein; [IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to Fluorouracil; acetylleucyl-leucyl-norleucinal inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; TYMP mRNA affects the susceptibility to [Irinotecan co-treated with Fluorouracil co-treated with Leucovorin] TYMP protein affects the susceptibility to Fluorouracil TYMP mRNA results in decreased susceptibility to Fluorouracil Fluorouracil results in decreased expression of TYMP mRNA |
CTD |
PMID:15041737 PMID:15301717 PMID:15538739 PMID:15655543 PMID:16160472 PMID:16525674 PMID:16568373 PMID:17454858 PMID:21444628 More...
|
|
NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032
|
|
G |
TYMS |
thymidylate synthetase |
multiple interactions decreases expression decreases activity increases expression increases response to substance affects response to substance decreases response to substance increases activity affects expression |
EXP ISO |
[Arsenic Trioxide co-treated with Fluorouracil co-treated with Leucovorin] results in decreased expression of TYMS mRNA; [Cisplatin co-treated with Fluorouracil] results in decreased expression of TYMS mRNA; [Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMS protein; [SU 9516 results in decreased expression of TYMS] which results in increased susceptibility to Fluorouracil; [TP53 affects the expression of TYMS] which affects the susceptibility to Fluorouracil; [trichostatin A results in decreased expression of TYMS protein] which results in increased susceptibility to Fluorouracil; [wogonin co-treated with Fluorouracil] results in increased expression of TYMS mRNA; acetylleucyl-leucyl-norleucinal inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMS protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMS protein]; Dichlororibofuranosylbenzimidazole inhibits the reaction [Fluorouracil results in increased expression of TYMS protein]; Docetaxel inhibits the reaction [Fluorouracil results in increased activity of TYMS protein]; Docetaxel inhibits the reaction [Fluorouracil results in increased expression of TYMS mRNA]; Fluorouracil inhibits the reaction [[Doxorubicin co-treated with Paclitaxel] results in decreased expression of TYMS protein]; Fluorouracil promotes the reaction [Docetaxel results in decreased expression of TYMS protein]; Fluorouracil promotes the reaction [geraniol results in decreased expression of TYMS mRNA]; gambogic acid inhibits the reaction [Fluorouracil results in increased expression of TYMS mRNA]; TYMS 3' UTR polymorphism affects the susceptibility to [Fluorouracil co-treated with Oxaliplatin]; TYMS gene polymorphism affects the susceptibility to [Fluorouracil co-treated with Oxaliplatin]; TYMS gene polymorphism results in decreased susceptibility to [Fluorouracil co-treated with Cisplatin]; TYMS gene polymorphism results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with Cisplatin co-treated with Paclitaxel]; TYMS mRNA affects the susceptibility to [Irinotecan co-treated with Fluorouracil co-treated with Leucovorin]; TYMS promoter polymorphism results in increased susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Oxaliplatin co-treated with Docetaxel]; TYMS protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin] Fluorouracil results in decreased expression of TYMS protein [Fluorouracil results in decreased activity of TYMS protein] which results in decreased abundance of Thymidine Monophosphate; [Fluorouracil results in decreased activity of TYMS protein] which results in increased abundance of 2'-deoxyuridylic acid; Leucovorin promotes the reaction [Fluorouracil results in decreased expression of TYMS]; Thymidine inhibits the reaction [Fluorouracil results in decreased expression of TYMS] Fluorouracil results in increased expression of TYMS mRNA; Fluorouracil results in increased expression of TYMS protein TYMS gene polymorphism results in increased susceptibility to Fluorouracil; TYMS mRNA results in increased susceptibility to Fluorouracil; TYMS protein results in increased susceptibility to Fluorouracil; TYMS results in increased susceptibility to Fluorouracil TYMS affects the susceptibility to Fluorouracil; TYMS gene polymorphism affects the susceptibility to Fluorouracil; TYMS mRNA affects the susceptibility to Fluorouracil; TYMS promoter polymorphism affects the susceptibility to Fluorouracil; TYMS protein affects the susceptibility to Fluorouracil; TYMS protein affects the susceptibility to Fluorouracil analog TYMS 3' UTR mutant form results in decreased susceptibility to Fluorouracil; TYMS 5' UTR polymorphism results in decreased susceptibility to Fluorouracil; TYMS gene polymorphism results in decreased susceptibility to Fluorouracil; TYMS mRNA results in decreased susceptibility to Fluorouracil; TYMS protein results in decreased susceptibility to Fluorouracil; TYMS results in decreased susceptibility to Fluorouracil Fluorouracil affects the expression of TYMS mRNA; Fluorouracil affects the expression of TYMS protein |
CTD |
PMID:2537495 PMID:7763285 PMID:8060136 PMID:9050858 PMID:9299594 PMID:10482907 PMID:12739060 PMID:14970324 PMID:15067352 PMID:15109396 PMID:15213713 PMID:15239142 PMID:15246190 PMID:15374632 PMID:15446554 PMID:15538739 PMID:15548681 PMID:15608557 PMID:15655543 PMID:15735113 PMID:15737843 PMID:15770397 PMID:15788669 PMID:15865071 PMID:15890242 PMID:15918040 PMID:15993511 PMID:16160472 PMID:16168113 PMID:16267625 PMID:16282729 PMID:16424979 PMID:16557585 PMID:16568373 PMID:16584549 PMID:16596248 PMID:16622263 PMID:17016601 PMID:17018589 PMID:17047489 PMID:17172411 PMID:17203168 PMID:17330233 PMID:17339891 PMID:17377791 PMID:17454858 PMID:17520254 PMID:17609664 PMID:18197934 PMID:18383874 PMID:18425338 PMID:18448328 PMID:18490900 PMID:18505590 PMID:18507058 PMID:18593893 PMID:18600534 PMID:18607850 PMID:18633250 PMID:18661526 PMID:18676755 PMID:18722050 PMID:18794807 PMID:18986760 PMID:19020767 PMID:19074750 PMID:19082493 PMID:19084572 PMID:19105824 PMID:19219653 PMID:20501625 PMID:20570612 PMID:20714149 PMID:21444628 PMID:21814787 PMID:23056627 PMID:29258758 PMID:35608750 More...
|
|
NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578
|
|
G |
TYRP1 |
tyrosinase related protein 1 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of TYRP1 mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 9:12,693,385...12,710,285
Ensembl chr 9:12,685,439...12,710,285
|
|
G |
U2SURP |
U2 snRNP associated SURP domain containing |
decreases expression |
EXP |
Fluorouracil results in decreased expression of U2SURP mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 3:143,001,570...143,060,725
Ensembl chr 3:142,964,497...143,060,725
|
|
G |
UBE2C |
ubiquitin conjugating enzyme E2 C |
decreases expression multiple interactions |
EXP |
Fluorouracil results in decreased expression of UBE2C mRNA; Fluorouracil results in decreased expression of UBE2C protein [Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein; anacardic acid inhibits the reaction [[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein]; CDKN1A protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; CDKN1A protein affects the reaction [Fluorouracil results in decreased expression of UBE2C protein]; Fluorouracil inhibits the reaction [NFYA protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [EP300 protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [TP53 protein mutant form binds to UBE2C promoter]; TP53 protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C protein]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]] |
CTD |
PMID:16557594 PMID:17039268 PMID:17374387 PMID:27129209 |
|
NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
|
|
G |
UBE2S |
ubiquitin conjugating enzyme E2 S |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of UBE2S mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:55,399,745...55,407,788
Ensembl chr19:55,399,745...55,407,788
|
|
G |
UBE2T |
ubiquitin conjugating enzyme E2 T |
affects expression |
EXP |
Fluorouracil affects the expression of UBE2T mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:202,331,657...202,341,936
Ensembl chr 1:202,331,544...202,341,984
|
|
G |
UCHL1 |
ubiquitin C-terminal hydrolase L1 |
affects response to substance |
EXP |
UCHL1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
|
|
G |
UCK2 |
uridine-cytidine kinase 2 |
affects response to substance decreases expression |
EXP |
UCK2 protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of UCK2 mRNA |
CTD |
PMID:15548681 PMID:19219653 |
|
NCBI chr 1:165,827,614...165,911,618
Ensembl chr 1:165,827,614...165,911,618
|
|
G |
UCP2 |
uncoupling protein 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of UCP2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,061...73,982,843
|
|
G |
UGDH |
UDP-glucose 6-dehydrogenase |
affects response to substance |
EXP |
UGDH protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr 4:39,498,755...39,527,439
Ensembl chr 4:39,498,755...39,528,311
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
EXP |
UGT1A1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with irinotecan] |
CTD |
PMID:18797458 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT8 |
UDP glycosyltransferase 8 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of UGT8 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 4:114,598,402...114,678,225
Ensembl chr 4:114,598,770...114,678,588
|
|
G |
UMPS |
uridine monophosphate synthetase |
multiple interactions decreases response to substance affects response to substance increases response to substance |
EXP |
[docetaxel co-treated with Fluorouracil] results in increased expression of UMPS mRNA; Fluorouracil inhibits the reaction [wogonin results in decreased expression of UMPS mRNA]; Fluorouracil promotes the reaction [docetaxel results in increased expression of UMPS protein]; Fluorouracil promotes the reaction [gambogic acid results in increased expression of UMPS mRNA] UMPS protein results in decreased susceptibility to Fluorouracil UMPS affects the susceptibility to Fluorouracil; UMPS mRNA affects the susceptibility to Fluorouracil; UMPS protein affects the susceptibility to Fluorouracil Fluorouracil results in increased susceptibility to UMPS protein |
CTD |
PMID:15548681 PMID:16477629 PMID:16557585 PMID:16757204 PMID:17237621 PMID:17303323 PMID:17854773 PMID:19020740 PMID:19020767 PMID:19082440 PMID:19084572 PMID:20570612 More...
|
|
NCBI chr 3:124,730,452...124,749,273
Ensembl chr 3:124,730,433...124,749,273
|
|
G |
UNC13B |
unc-13 homolog B |
affects expression |
ISO |
Fluorouracil affects the expression of UNC13B mRNA |
CTD |
PMID:20421339 |
|
NCBI chr 9:35,162,009...35,405,335
Ensembl chr 9:35,161,992...35,405,338
|
|
G |
UNC5B |
unc-5 netrin receptor B |
affects expression |
EXP |
Fluorouracil affects the expression of UNC5B mRNA |
CTD |
PMID:16584549 |
|
NCBI chr10:71,212,570...71,302,864
Ensembl chr10:71,212,570...71,302,864
|
|
G |
UNG |
uracil DNA glycosylase |
affects expression affects response to substance |
EXP |
Fluorouracil affects the expression of UNG protein UNG protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16951200 PMID:18714155 |
|
NCBI chr12:109,097,597...109,110,992
Ensembl chr12:109,097,597...109,126,725
|
|
G |
UPP1 |
uridine phosphorylase 1 |
increases expression affects response to substance multiple interactions |
EXP ISO |
Fluorouracil results in increased expression of UPP1 mRNA; Fluorouracil results in increased expression of UPP1 protein UPP1 protein affects the susceptibility to Fluorouracil [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil UPP1 affects the susceptibility to Fluorouracil |
CTD |
PMID:15067352 PMID:15109396 PMID:15331170 PMID:15772079 PMID:24737281 |
|
NCBI chr 7:48,088,704...48,108,736
Ensembl chr 7:48,088,628...48,108,736
|
|
G |
UPRT |
uracil phosphoribosyltransferase homolog |
increases metabolic processing |
EXP |
UPRT protein results in increased metabolism of Fluorouracil |
CTD |
PMID:18575323 |
|
NCBI chr X:75,156,369...75,304,897
Ensembl chr X:75,156,388...75,304,885
|
|
G |
UQCR10 |
ubiquinol-cytochrome c reductase, complex III subunit X |
affects expression |
EXP |
Fluorouracil affects the expression of UQCR10 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr22:29,767,369...29,770,413
Ensembl chr22:29,767,369...29,770,413
|
|
G |
UQCR11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
increases expression |
EXP |
Fluorouracil results in increased expression of UQCR11 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr19:1,597,169...1,605,462
Ensembl chr19:1,597,169...1,605,473
|
|
G |
UQCRB |
ubiquinol-cytochrome c reductase binding protein |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of UQCRB mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 8:96,222,947...96,235,545
Ensembl chr 8:96,222,947...96,235,546
|
|
G |
UQCRC2 |
ubiquinol-cytochrome c reductase core protein 2 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of UQCRC2 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr16:21,953,361...21,983,660
Ensembl chr16:21,953,288...21,983,660
|
|
G |
UQCRFS1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
affects expression |
EXP |
Fluorouracil affects the expression of UQCRFS1 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr19:29,205,320...29,213,151
Ensembl chr19:29,205,320...29,213,151
|
|
G |
UQCRH |
ubiquinol-cytochrome c reductase hinge protein |
affects expression |
EXP |
Fluorouracil affects the expression of UQCRH mRNA |
CTD |
PMID:34151400 |
|
NCBI chr 1:46,303,698...46,316,776
Ensembl chr 1:46,303,698...46,316,776
|
|
G |
UROD |
uroporphyrinogen decarboxylase |
decreases response to substance |
EXP |
UROD protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:21270338 |
|
NCBI chr 1:45,012,254...45,015,575
Ensembl chr 1:45,010,950...45,015,575
|
|
G |
USH2A |
usherin |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of USH2A mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:215,622,891...216,423,448
Ensembl chr 1:215,622,891...216,423,448
|
|
G |
USP14 |
ubiquitin specific peptidase 14 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of USP14 protein |
CTD |
PMID:16803524 |
|
NCBI chr18:158,557...214,629
Ensembl chr18:158,383...214,629
|
|
G |
USP9X |
ubiquitin specific peptidase 9 X-linked |
affects response to substance |
EXP |
USP9X protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:41,085,445...41,236,579
Ensembl chr X:41,085,445...41,236,579
|
|
G |
UTP3 |
UTP3 small subunit processome component |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in increased expression of UTP3 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr 4:70,688,532...70,690,551
Ensembl chr 4:70,688,532...70,690,551
|
|
G |
UXT |
ubiquitously expressed prefoldin like chaperone |
increases expression |
EXP |
Fluorouracil results in increased expression of UXT protein |
CTD |
PMID:15585135 PMID:16803524 |
|
NCBI chr X:47,651,796...47,659,180
Ensembl chr X:47,651,796...47,659,180
|
|
G |
VANGL2 |
VANGL planar cell polarity protein 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of VANGL2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:160,400,564...160,428,670
Ensembl chr 1:160,400,564...160,428,678
|
|
G |
VASP |
vasodilator stimulated phosphoprotein |
multiple interactions decreases expression |
ISO |
Fluorouracil promotes the reaction [resveratrol results in decreased expression of VASP protein]; resveratrol promotes the reaction [Fluorouracil results in decreased expression of VASP protein] |
CTD |
PMID:25936796 |
|
NCBI chr19:45,507,479...45,526,983
Ensembl chr19:45,506,579...45,526,989
|
|
G |
VAT1 |
vesicle amine transport 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of VAT1 mRNA |
CTD |
PMID:16101138 |
|
NCBI chr17:43,014,607...43,022,385
Ensembl chr17:43,014,607...43,025,123
|
|
G |
VAV3 |
vav guanine nucleotide exchange factor 3 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of VAV3 mRNA |
CTD |
PMID:16557594 |
|
NCBI chr 1:107,571,161...107,965,180
Ensembl chr 1:107,571,161...107,965,180
|
|
G |
VCL |
vinculin |
affects response to substance |
EXP |
VCL protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr10:73,998,116...74,121,363
Ensembl chr10:73,995,193...74,121,363
|
|
G |
VEGFA |
vascular endothelial growth factor A |
decreases expression multiple interactions increases expression decreases response to substance |
EXP ISO |
Fluorouracil results in decreased expression of VEGFA mRNA; Fluorouracil results in decreased expression of VEGFA protein [diacerein co-treated with Fluorouracil] inhibits the reaction [Trichloroacetic Acid results in increased expression of VEGFA protein] Fluorouracil promotes the reaction [Resveratrol results in decreased expression of VEGFA protein]; Fluorouracil promotes the reaction [Valsartan results in decreased expression of VEGFA mRNA]; Resveratrol promotes the reaction [Fluorouracil results in decreased expression of VEGFA protein]; Valsartan promotes the reaction [Fluorouracil results in decreased expression of VEGFA mRNA] Fluorouracil results in increased expression of VEGFA protein VEGFA mRNA results in decreased susceptibility to Fluorouracil; VEGFA protein results in decreased susceptibility to Fluorouracil TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of VEGFA mRNA]; VEGFA protein promotes the reaction [Fluorouracil results in decreased expression of IFNA1 protein] Fluorouracil results in increased expression of VEGFA mRNA |
CTD |
PMID:15817675 PMID:17039268 PMID:17786339 PMID:17982676 PMID:18494554 PMID:25936796 PMID:26272751 PMID:29678497 PMID:34794354 PMID:35235860 More...
|
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VGF |
VGF nerve growth factor inducible |
increases expression |
EXP |
Fluorouracil results in increased expression of VGF mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 7:101,162,509...101,169,952
Ensembl chr 7:101,162,509...101,165,569
|
|
G |
VIM |
vimentin |
increases expression multiple interactions |
EXP |
Fluorouracil results in increased expression of VIM protein resveratrol inhibits the reaction [Fluorouracil results in increased expression of VIM protein] |
CTD |
PMID:26310874 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
G |
VPREB3 |
V-set pre-B cell surrogate light chain 3 |
affects expression |
EXP |
Fluorouracil affects the expression of VPREB3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr22:23,752,743...23,754,425
Ensembl chr22:23,752,743...23,754,425
|
|
G |
VPS35 |
VPS35 retromer complex component |
affects expression |
EXP |
Fluorouracil affects the expression of VPS35 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr16:46,656,132...46,689,178
Ensembl chr16:46,656,132...46,689,518
|
|
G |
VPS37A |
VPS37A subunit of ESCRT-I |
increases response to substance |
EXP |
VPS37A protein results in increased susceptibility to Fluorouracil |
CTD |
PMID:31152734 |
|
NCBI chr 8:17,246,958...17,333,455
Ensembl chr 8:17,246,931...17,302,427
|
|
G |
VPS52 |
VPS52 subunit of GARP complex |
decreases expression |
EXP |
Fluorouracil results in decreased expression of VPS52 mRNA |
CTD |
PMID:16709241 |
|
NCBI chr 6:33,250,272...33,271,965
Ensembl chr 6:33,250,272...33,272,047
|
|
G |
WARS1 |
tryptophanyl-tRNA synthetase 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of WARS1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr14:100,333,790...100,376,327
Ensembl chr14:100,333,790...100,376,805
|
|
G |
WBP4 |
WW domain binding protein 4 |
affects expression |
EXP |
Fluorouracil affects the expression of WBP4 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr13:41,061,509...41,084,006
Ensembl chr13:41,061,509...41,084,006
|
|
G |
WDR4 |
WD repeat domain 4 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of WDR4 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr21:42,843,094...42,892,998
Ensembl chr21:42,843,094...42,879,568
|
|
G |
WEE1 |
WEE1 G2 checkpoint kinase |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of WEE1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr11:9,573,670...9,589,985
Ensembl chr11:9,573,670...9,593,457
|
|
G |
WNT3 |
Wnt family member 3 |
increases expression |
ISO |
Fluorouracil results in increased expression of WNT3 mRNA |
CTD |
PMID:26272751 |
|
NCBI chr17:46,762,506...46,818,692
Ensembl chr17:46,762,506...46,833,154
|
|
G |
WNT5A |
Wnt family member 5A |
increases expression multiple interactions |
EXP ISO |
Fluorouracil results in increased expression of WNT5A mRNA 5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon] |
CTD RGD |
PMID:31711903 PMID:28032729 |
RGD:150530464 |
NCBI chr 3:55,465,715...55,505,263
Ensembl chr 3:55,465,715...55,490,539
|
|
G |
WNT8A |
Wnt family member 8A |
decreases expression |
EXP |
Fluorouracil results in decreased expression of WNT8A mRNA |
CTD |
PMID:24737281 |
|
NCBI chr 5:138,077,367...138,092,365
Ensembl chr 5:138,083,990...138,092,365
|
|
G |
WT1 |
WT1 transcription factor |
decreases expression |
ISO |
Fluorouracil results in decreased expression of WT1 protein |
CTD |
PMID:21296659 |
|
NCBI chr11:32,387,775...32,435,539
Ensembl chr11:32,387,775...32,435,564
|
|
G |
WTAP |
WT1 associated protein |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of WTAP mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 6:159,726,693...159,756,319
Ensembl chr 6:159,725,585...159,756,319
|
|
G |
XAF1 |
XIAP associated factor 1 |
increases response to substance multiple interactions increases expression |
ISO EXP |
XAF1 protein results in increased susceptibility to Fluorouracil EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]; IGF1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; IGF1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]; IL6 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; IL6 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]; MT2A protein affects the reaction [EGF protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein]]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 mRNA]; TGFB1 protein inhibits the reaction [Fluorouracil results in increased expression of XAF1 protein] Fluorouracil results in increased expression of XAF1 mRNA; Fluorouracil results in increased expression of XAF1 protein |
CTD |
PMID:15843754 PMID:17570219 PMID:18544999 PMID:28507149 |
|
NCBI chr17:6,755,447...6,775,647
Ensembl chr17:6,755,447...6,775,647
|
|
G |
XAGE1B |
X antigen family member 1B |
affects response to substance |
EXP |
XAGE1B protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr X:52,512,077...52,517,068
Ensembl chr X:52,512,077...52,520,803
|
|
G |
XBP1 |
X-box binding protein 1 |
increases expression |
EXP |
Fluorouracil results in increased expression of XBP1 mRNA |
CTD |
PMID:15205334 |
|
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
|
|
G |
XIAP |
X-linked inhibitor of apoptosis |
increases expression decreases expression multiple interactions affects response to substance |
EXP |
Fluorouracil results in increased expression of XIAP mRNA; Fluorouracil results in increased expression of XIAP protein Fluorouracil results in decreased expression of XIAP mRNA [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of XIAP mRNA; [SM-1 compound co-treated with Fluorouracil] results in decreased expression of XIAP mRNA; Fluorouracil promotes the reaction [Arsenic Trioxide results in decreased expression of XIAP protein]; SM-1 compound promotes the reaction [Fluorouracil results in decreased expression of XIAP mRNA]; XIAP protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein] XIAP affects the susceptibility to Fluorouracil |
CTD |
PMID:16628085 PMID:20876774 PMID:22963400 PMID:28599477 PMID:32800223 |
|
NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,712...123,913,972
|
|
G |
XIST |
X inactive specific transcript |
affects expression |
ISO |
Fluorouracil affects the expression of XIST protein |
CTD |
PMID:21296659 |
|
NCBI chr X:73,820,656...73,852,714
Ensembl chr X:73,820,649...73,852,723
|
|
G |
XRCC1 |
X-ray repair cross complementing 1 |
multiple interactions |
EXP |
XRCC1 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin]; XRCC1 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin] |
CTD |
PMID:22452940 |
|
NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473
|
|
G |
XRCC3 |
X-ray repair cross complementing 3 |
multiple interactions |
EXP |
XRCC3 gene polymorphism affects the susceptibility to [Cisplatin co-treated with Fluorouracil] |
CTD |
PMID:21347786 |
|
NCBI chr14:103,697,617...103,715,451
Ensembl chr14:103,697,609...103,715,504
|
|
G |
XRCC5 |
X-ray repair cross complementing 5 |
multiple interactions |
EXP |
XRCC5 mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] |
CTD |
PMID:18546291 |
|
NCBI chr 2:216,109,348...216,206,293
Ensembl chr 2:216,107,464...216,206,303
|
|
G |
XRCC6 |
X-ray repair cross complementing 6 |
multiple interactions |
EXP |
XRCC6 mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin]; XRCC6 protein results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] |
CTD |
PMID:18546291 |
|
NCBI chr22:41,621,295...41,664,041
Ensembl chr22:41,621,163...41,664,048
|
|
G |
YARS1 |
tyrosyl-tRNA synthetase 1 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of YARS1 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr 1:32,775,239...32,817,358
Ensembl chr 1:32,775,237...32,818,031
|
|
G |
YARS2 |
tyrosyl-tRNA synthetase 2 |
increases expression |
EXP |
Fluorouracil results in increased expression of YARS2 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr12:32,746,544...32,755,897
Ensembl chr12:32,727,490...32,755,897
|
|
G |
YBX1 |
Y-box binding protein 1 |
multiple interactions |
EXP |
Fluorouracil promotes the reaction [YBX1 protein binds to MVP promoter] |
CTD |
PMID:15750632 |
|
NCBI chr 1:42,682,418...42,703,805
Ensembl chr 1:42,682,418...42,703,805
|
|
G |
YES1 |
YES proto-oncogene 1, Src family tyrosine kinase |
affects response to substance |
EXP |
YES1 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:15548681 |
|
NCBI chr18:721,588...812,753
Ensembl chr18:721,588...812,546
|
|
G |
YIF1A |
Yip1 interacting factor homolog A, membrane trafficking protein |
affects response to substance |
EXP |
YIF1A protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr11:66,284,580...66,289,143
Ensembl chr11:66,284,572...66,289,184
|
|
G |
YWHAB |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta |
increases expression |
ISO |
Fluorouracil results in increased expression of YWHAB mRNA |
CTD |
PMID:19272435 |
|
NCBI chr20:44,885,705...44,908,532
Ensembl chr20:44,885,702...44,908,532
|
|
G |
YWHAE |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon |
decreases expression |
EXP |
Fluorouracil results in decreased expression of YWHAE mRNA |
CTD |
PMID:16709241 |
|
NCBI chr17:1,344,275...1,400,222
Ensembl chr17:1,344,275...1,400,222
|
|
G |
YWHAH |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta |
decreases response to substance |
EXP |
YWHAH protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:30572915 |
|
NCBI chr22:31,944,535...31,957,603
Ensembl chr22:31,944,522...31,957,603
|
|
G |
ZBTB18 |
zinc finger and BTB domain containing 18 |
increases expression |
EXP |
Fluorouracil results in increased expression of ZBTB18 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 1:244,048,491...244,057,476
Ensembl chr 1:244,048,547...244,057,476
|
|
G |
ZBTB20 |
zinc finger and BTB domain containing 20 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ZBTB20 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 3:114,314,500...115,147,288
Ensembl chr 3:114,314,500...115,147,292
|
|
G |
ZBTB7A |
zinc finger and BTB domain containing 7A |
affects response to substance decreases expression |
EXP |
ZBTB7A protein affects the susceptibility to Fluorouracil Fluorouracil results in decreased expression of ZBTB7A protein |
CTD |
PMID:15352031 |
|
NCBI chr19:4,043,303...4,066,899
Ensembl chr19:4,043,303...4,066,899
|
|
G |
ZC3H3 |
zinc finger CCCH-type containing 3 |
affects expression |
EXP |
Fluorouracil affects the expression of ZC3H3 mRNA |
CTD |
PMID:16584549 |
|
NCBI chr 8:143,437,659...143,541,447
Ensembl chr 8:143,437,659...143,541,447
|
|
G |
ZCCHC18 |
zinc finger CCHC-type containing 18 |
affects expression |
ISO |
Fluorouracil affects the expression of ZCCHC18 mRNA |
CTD |
PMID:20421339 |
|
NCBI chr X:104,112,523...104,115,842
Ensembl chr X:104,112,131...104,115,842
|
|
G |
ZDHHC9 |
zinc finger DHHC-type palmitoyltransferase 9 |
increases expression |
EXP |
Fluorouracil results in increased expression of ZDHHC9 mRNA |
CTD |
PMID:17039268 |
|
NCBI chr X:129,803,288...129,843,886
Ensembl chr X:129,803,288...129,843,909
|
|
G |
ZFP42 |
ZFP42 zinc finger protein |
decreases expression |
ISO |
Fluorouracil results in decreased expression of ZFP42 protein |
CTD |
PMID:21296659 |
|
NCBI chr 4:187,995,771...188,005,246
Ensembl chr 4:187,995,771...188,005,046
|
|
G |
ZIM2 |
zinc finger imprinted 2 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ZIM2 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:56,774,547...56,840,726
Ensembl chr19:56,774,547...56,840,731
|
|
G |
ZKSCAN3 |
zinc finger with KRAB and SCAN domains 3 |
decreases response to substance |
EXP |
ZKSCAN3 protein results in decreased susceptibility to Fluorouracil |
CTD |
PMID:18519692 |
|
NCBI chr 6:28,349,878...28,369,172
Ensembl chr 6:28,349,947...28,369,172
|
|
G |
ZMAT3 |
zinc finger matrin-type 3 |
multiple interactions increases expression |
EXP |
TP53 protein promotes the reaction [Fluorouracil results in increased expression of ZMAT3 mRNA] |
CTD |
PMID:17982676 |
|
NCBI chr 3:179,017,223...179,072,513
Ensembl chr 3:178,960,121...179,072,215
|
|
G |
ZMYND8 |
zinc finger MYND-type containing 8 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ZMYND8 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr20:47,209,214...47,356,699
Ensembl chr20:47,209,214...47,356,889
|
|
G |
ZNF263 |
zinc finger protein 263 |
affects expression |
EXP |
Fluorouracil affects the expression of ZNF263 mRNA |
CTD |
PMID:34151400 |
|
NCBI chr16:3,283,491...3,301,401
Ensembl chr16:3,283,283...3,301,401
|
|
G |
ZNF266 |
zinc finger protein 266 |
multiple interactions |
EXP |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of ZNF266 mRNA] |
CTD |
PMID:15016801 |
|
NCBI chr19:9,412,429...9,435,573
Ensembl chr19:9,412,429...9,435,573
|
|
G |
ZNF282 |
zinc finger protein 282 |
increases expression |
EXP |
Fluorouracil results in increased expression of ZNF282 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 7:149,195,546...149,226,243
Ensembl chr 7:149,195,546...149,226,243
|
|
G |
ZNF32 |
zinc finger protein 32 |
multiple interactions |
EXP |
ZNF32 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr10:43,643,862...43,648,881
Ensembl chr10:43,643,860...43,648,881
|
|
G |
ZNF367 |
zinc finger protein 367 |
decreases expression |
EXP |
Fluorouracil results in decreased expression of ZNF367 mRNA |
CTD |
PMID:16510598 |
|
NCBI chr 9:96,385,941...96,418,370
Ensembl chr 9:96,385,941...96,418,370
|
|
G |
ZNF408 |
zinc finger protein 408 |
multiple interactions |
EXP |
[Fluorouracil co-treated with irinotecan] results in increased expression of ZNF408 mRNA |
CTD |
PMID:16391804 |
|
NCBI chr11:46,701,031...46,705,912
Ensembl chr11:46,701,030...46,705,912
|
|
G |
ZNF473 |
zinc finger protein 473 |
affects response to substance increases expression |
EXP |
ZNF473 protein affects the susceptibility to Fluorouracil Fluorouracil results in increased expression of ZNF473 mRNA |
CTD |
PMID:15331170 |
|
NCBI chr19:50,026,005...50,048,776
Ensembl chr19:50,025,714...50,053,414
|
|
G |
ZNF518A |
zinc finger protein 518A |
affects expression |
ISO |
Fluorouracil affects the expression of ZFP518A mRNA |
CTD |
PMID:20421339 |
|
NCBI chr10:96,129,715...96,205,291
Ensembl chr10:96,129,715...96,205,288
|
|
G |
ZNF532 |
zinc finger protein 532 |
affects response to substance |
EXP |
ZNF532 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr18:58,862,924...58,986,480
Ensembl chr18:58,862,600...58,986,480
|
|
G |
ZNF552 |
zinc finger protein 552 |
multiple interactions |
EXP |
ZNF552 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] |
CTD |
PMID:16896004 |
|
NCBI chr19:57,807,082...57,814,913
Ensembl chr19:57,803,841...57,814,913
|
|
G |
ZNF582 |
zinc finger protein 582 |
multiple interactions |
EXP |
ZNF582 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr19:56,382,751...56,393,534
Ensembl chr19:56,375,846...56,393,538
|
|
G |
ZRSR2 |
zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 |
multiple interactions |
EXP |
ZRSR2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] |
CTD |
PMID:17327601 |
|
NCBI chr X:15,790,484...15,823,260
Ensembl chr X:15,790,156...15,830,694
|
|
G |
ZSCAN18 |
zinc finger and SCAN domain containing 18 |
affects response to substance |
EXP |
ZSCAN18 protein affects the susceptibility to Fluorouracil |
CTD |
PMID:16217747 |
|
NCBI chr19:58,083,842...58,118,426
Ensembl chr19:58,083,838...58,118,427
|
|